EMA3ElliottAntmanElliott Marshall Antman, M.D.42.33510370000000-71.1061649000000019141Antman, ElliottMarshall617/732-7143Professor of Medicinecatalyst:eCommonsLogineCommons Loginprns:coAuthorOfcoauthor ofFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:physicalNeighborOfphysical neighborprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:similarTosimilar toprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierAddressvivo:address1address line 1vivo:address2address line 2vivo:address3address line 3vivo:addressCitycityvivo:addressPostalCodepostal codevivo:addressStatestate or provincevivo:authorInAuthorshipselected publicationsvivo:authorRankauthor rank in publicationAuthorshipDepartmentDivisionvivo:hasMemberRolemember ofvivo:hasResearchArearesearch areasvivo:hrJobTitleHR job titleInformation Resourcevivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcevivo:mailingAddressmailing addressMember Rolevivo:memberRoleOfmember role ofvivo:middleNamemiddle name or initialvivo:personInPositionpositionsvivo:phoneNumberphonePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titleRolevivo:roleContributesTocontributes tordf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst nameGroupfoaf:lastNamelast nameOrganizationPerson11466123Llevadot J, Giugliano RP, Antman EMJAMABolus fibrinolytic therapy in acute myocardial infarction. JAMA. 2001 Jul 25; 286(4):442-9.JAMA2001-07-25T00:00:002001Bolus fibrinolytic therapy in acute myocardial infarction.11511120Giugliano RP, Llevadot J, Wilcox RG, Gurfinkel EP, McCabe CH, Charlesworth A, Thompson SL, Antman EM, Braunwald EEuropean heart journalGeographic variation in patient and hospital characteristics, management, and clinical outcomes in ST-elevation myocardial infarction treated with fibrinolysis. Results from InTIME-II. Eur Heart J. 2001 Sep; 22(18):1702-15.Eur Heart J2001-09-01T00:00:002001Geographic variation in patient and hospital characteristics, management, and clinical outcomes in ST-elevation myocardial infarction treated with fibrinolysis. Results from InTIME-II.11738322Hunt SA, Baker DW, Chin MH, Cinquegrani MP, Feldman AM, Francis GS, Ganiats TG, Goldstein S, Gregoratos G, Jessup ML, Noble RJ, Packer M, Silver MA, Stevenson LW, Gibbons RJ, Antman EM, Alpert JS, Faxon DP, Fuster V, Jacobs AK, Hiratzka LF, Russell RO, Smith SCJournal of the American College of CardiologyACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1995 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol. 2001 Dec; 38(7):2101-13.J Am Coll Cardiol2001-12-01T00:00:002001ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1995 Guidelines for the Evaluation and Management of Heart Failure).Frelinger AL, Michelson AD, Wiviott SD, Trenk D, Neumann FJ, Miller DL, Jakuboswki JA, Costigan TM, McCabe CH, Antman EM, Braunwald ECirculationIntrinsic platelet variability in response to ADP before exposure to thienopyridines contributes to the variability in residual platelet reactivity to ADP after treatment with clopidogrel or prasugrel: results from PRINCIPLE-TIMI 44. Circulation. 2008; 118(Suppl2):S814.2008-01-01T00:00:002008Intrinsic platelet variability in response to ADP before exposure to thienopyridines contributes to the variability in residual platelet reactivity to ADP after treatment with clopidogrel or prasugrel: results from PRINCIPLE-TIMI 4410966533De Lemos JA, Antman EM, Giugliano RP, Morrow DA, McCabe CH, Charlesworth A, Schröder R, Braunwald EAmerican heart journalVery early risk stratification after thrombolytic therapy with a bedside myoglobin assay and the 12-lead electrocardiogram. Am Heart J. 2000 Sep; 140(3):373-8.Am Heart J2000-09-01T00:00:002000Very early risk stratification after thrombolytic therapy with a bedside myoglobin assay and the 12-lead electrocardiogram.11137825Ziegelstein RC, Hilbe JM, French WJ, Antman EM, Chandra-Strobos NThe American journal of cardiologyMagnesium use in the treatment of acute myocardial infarction in the United States (observations from the Second National Registry of Myocardial Infarction). Am J Cardiol. 2001 Jan 01; 87(1):7-10.Am J Cardiol2001-01-01T00:00:002001Magnesium use in the treatment of acute myocardial infarction in the United States (observations from the Second National Registry of Myocardial Infarction).11823097Eagle KA, Berger PB, Calkins H, Chaitman BR, Ewy GA, Fleischmann KE, Fleisher LA, Froehlich JB, Gusberg RJ, Leppo JA, Ryan T, Schlant RC, Winters WL, Gibbons RJ, Antman EM, Alpert JS, Faxon DP, Fuster V, Gregoratos G, Jacobs AK, Hiratzka LF, Russell RO, Smith SCJournal of the American College of CardiologyACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). J Am Coll Cardiol. 2002 Feb 06; 39(3):542-53.J Am Coll Cardiol2002-02-06T00:00:002002ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery).Authorship 101962512383588Braunwald E, Antman EM, Beasley JW, Califf RM, Cheitlin MD, Hochman JS, Jones RH, Kereiakes D, Kupersmith J, Levin TN, Pepine CJ, Schaeffer JW, Smith EE, Steward DE, Theroux P, Gibbons RJ, Alpert JS, Faxon DP, Fuster V, Gregoratos G, Hiratzka LF, Jacobs AK, Smith SCJournal of the American College of CardiologyACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol. 2002 Oct 02; 40(7):1366-74.J Am Coll Cardiol2002-10-02T00:00:002002ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients With Unstable Angina).Syllabus material on Clinical Pharmacology, Acute Coronary SyndromesSyllabus material on Clinical Pharmacology, Acute Coronary Syndromes. 1980.1980-01-01T00:00:001980Syllabus material on Clinical Pharmacology, Acute Coronary SyndromesAuthorship 1052704929395361Cavallari I, Ruff CT, Nordio F, Deenadayalu N, Shi M, Lanz H, Rutman H, Mercuri MF, Antman EM, Braunwald E, Giugliano RPInternational journal of cardiologyClinical events after interruption of anticoagulation in patients with atrial fibrillation: An analysis from the ENGAGE AF-TIMI 48 trial. Int J Cardiol. 2018 04 15; 257:102-107.Int J Cardiol2018-02-02T00:00:002018Clinical events after interruption of anticoagulation in patients with atrial fibrillation: An analysis from the ENGAGE AF-TIMI 48 trial.15492331Popp RJ, Smith SC, Adams RJ, Antman EM, Kavey RE, DeMaria AN, Ohman EM, Pitt B, Willerson JT, Bellande BJ, Fonarow GC, Nishimura RA, Shah PM, Hirshfeld JW, Messer JV, Peterson ED, Prystowsky EN, Anderson JL, Cheitlin MD, Goldstein LB, Grant AO, Beller GA, Hines EF, Livingston DW, McEntree CWCirculationACCF/AHA consensus conference report on professionalism and ethics. Circulation. 2004 Oct 19; 110(16):2506-49.Circulation2004-10-19T00:00:002004ACCF/AHA consensus conference report on professionalism and ethics.15753225Leopold JA, Antman EMCirculationDual antiplatelet therapy for coronary stenting: a clear path for a research agenda. Circulation. 2005 Mar 08; 111(9):1097-9.Circulation2005-03-08T00:00:002005Dual antiplatelet therapy for coronary stenting: a clear path for a research agenda.19237657Cheng S, Morrow DA, Sloan S, Antman EM, Sabatine MSCirculationPredictors of initial nontherapeutic anticoagulation with unfractionated heparin in ST-segment elevation myocardial infarction. Circulation. 2009 Mar 10; 119(9):1195-202.Circulation2009-02-23T00:00:002009Predictors of initial nontherapeutic anticoagulation with unfractionated heparin in ST-segment elevation myocardial infarction.16355367Smith SC, Feldman TE, Hirshfeld JW, Jacobs AK, Kern MJ, King SB, Morrison DA, O'Neill WW, Schaff HV, Whitlow PL, Williams DO, Antman EM, Smith SC, Adams CD, Anderson JL, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Jacobs AK, Nishimura R, Ornato JP, Page RL, Riegel BCatheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & InterventionsACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to update the 2001 Guidelines for Percutaneous Coronary Intervention). Catheter Cardiovasc Interv. 2006 Jan; 67(1):87-112.Catheter Cardiovasc Interv2006-01-01T00:00:002006ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to update the 2001 Guidelines for Percutaneous Coronary Intervention).Antman EM, Smith TWCurrent Therapy in Cardiovascular Disease. Hurst JW, ed"Digitalis Toxicity". Current Therapy in Cardiovascular Disease. Hurst JW, ed. 1990; 89-94.1990-01-01T00:00:001990"Digitalis Toxicity"Guzman LA, Henquin R, Gurfinkel E, Bozovich G, Radley A, Antman EMEuropean Heart JournalRole of enoxaparin in patients undergoing percutaneous revascularization in the setting of unstable angina. A TIMI 11B substudy. European Heart Journal. 1999; 20(Suppl):260.1999-01-01T00:00:001999Role of enoxaparin in patients undergoing percutaneous revascularization in the setting of unstable angina. A TIMI 11B substudyFriedman PL, Antman EMDigitalis Glycosides. Smith TW, ed. "Electrocardiographic Manifestations of Digitalis Toxicity". Digitalis Glycosides. Smith TW, ed. 1986; 241-76.1986-01-01T00:00:001986"Electrocardiographic Manifestations of Digitalis Toxicity"O'Donoghue M, Wiviott SD, Sabatine MS, Braunwald E, Antman EM, Murphy SA, Bates ER, Rozenman Y, Michelson AD, Hautvast RW, Ver Lee P, Close SL, Shen L, Mega JLLancet, in pressThe pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with and without a proton pump inhibitor. Lancet, in press. 2009.2009-01-01T00:00:002009The pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with and without a proton pump inhibitorPlatia EV, Fitzpatrick P, Wallis D, Antman EM, Michelson EL, Hua TAJournal of the American College of CardiologyEsmolol vs verapamil for the treatment of recent-onset atrial fibrillation/flutter: A multicenter study. Journal of the American College of Cardiology. 1988; 11:170A.1988-01-01T00:00:001988Esmolol vs verapamil for the treatment of recent-onset atrial fibrillation/flutter: A multicenter studyAntman EM, Smith TWDigitalis Glycosides. Smith TW, ed."Drug Interactions with Digitalis Glycosides". Digitalis Glycosides. Smith TW, ed. 1986; 65-82.1986-01-01T00:00:001986"Drug Interactions with Digitalis Glycosides"Rao SV, Mahaffey KW, Antman E, Kleiman NS, Ferguson JJ, Califf RM, Becker RC, Goodman SG, Aylward PEJournal of the American College of CardiologyPredictors of major bleeding and transfusion in SYNERGY: effects of pretreatment variables and treatment assignment. Journal of the American College of Cardiology. 2005; 45(Suppl):247A.2005-01-01T00:00:002005Predictors of major bleeding and transfusion in SYNERGY: effects of pretreatment variables and treatment assignmentRabbani LE, Antman EMConn's Current Therapy. Rakel RE, ed."Acute Myocardial Infarction". Conn's Current Therapy. Rakel RE, ed. 1993; 296-313.1993-01-01T00:00:001993"Acute Myocardial Infarction"3577998Arnold JM, Antman EM, Przyklenk K, Braunwald E, Sandor T, Vivaldi MT, Schoen FJ, Kloner RAAmerican heart journalDifferential effects of reperfusion on incidence of ventricular arrhythmias and recovery of ventricular function at 4 days following coronary occlusion. Am Heart J. 1987 May; 113(5):1055-65.Am Heart J1987-05-01T00:00:001987Differential effects of reperfusion on incidence of ventricular arrhythmias and recovery of ventricular function at 4 days following coronary occlusion.7586332Antman EMCirculationMagnesium in acute MI. Timing is critical. Circulation. 1995 Nov 01; 92(9):2367-72.Circulation1995-11-01T00:00:001995Magnesium in acute MI. Timing is critical.9929748Tanasijevic MJ, Cannon CP, Antman EMClinical cardiologyThe role of cardiac troponin-I (cTnI) in risk stratification of patients with unstable coronary artery disease. Clin Cardiol. 1999 Jan; 22(1):13-6.Clin Cardiol1999-01-01T00:00:001999The role of cardiac troponin-I (cTnI) in risk stratification of patients with unstable coronary artery disease.10500307Ridker PM, Antman EMJournal of thrombosis and thrombolysisPathogenesis and pathology of coronary heart disease syndromes. J Thromb Thrombolysis. 1999 Oct; 8(3):167-89.J Thromb Thrombolysis1999-10-01T00:00:001999Pathogenesis and pathology of coronary heart disease syndromes.10987629Braunwald E, Antman EM, Beasley JW, Califf RM, Cheitlin MD, Hochman JS, Jones RH, Kereiakes D, Kupersmith J, Levin TN, Pepine CJ, Schaeffer JW, Smith EE, Steward DE, Theroux P, Alpert JS, Eagle KA, Faxon DP, Fuster V, Gardner TJ, Gregoratos G, Russell RO, Smith SCJournal of the American College of CardiologyACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol. 2000 Sep; 36(3):970-1062.J Am Coll Cardiol2000-09-01T00:00:002000ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina).Becker RC, Spencer FA, Bruno R, Ball SP, Antman EMCirculationExcess body weight does not adversely influence either bioavailability or anticoagulant activity of enoxaparin administered subcutaneously in acute coronary syndromes. Circulation. 2001; 102:II-427.2001-01-01T00:00:002001Excess body weight does not adversely influence either bioavailability or anticoagulant activity of enoxaparin administered subcutaneously in acute coronary syndromesFriedman PL, Antman EMHeart Disease: Clinical Update. Brauwald E, ed."Management of Ventricular Arrhythmias Following Myocardial Infarction". Heart Disease: Clinical Update. Brauwald E, ed. 1992; 41-53.1992-01-01T00:00:001992"Management of Ventricular Arrhythmias Following Myocardial Infarction"Antman, EMLibby P (ed.). Essential Atlas of Cardiovascular DiseaseAcute coronary syndromes. Libby P (ed.). Essential Atlas of Cardiovascular Disease. 2009; 21-38.2009-01-01T00:00:002009Acute coronary syndromesGelfand EV, Morrow DA, Sabatine MS, Rifai N, Murphy SA, McCabe CH, Antman EMJournal of the American College of CardiologyRisk stratification in ST-elevation myocardial infarction with multiple biomarkers. Journal of the American College of Cardiology. 2004; 43(Suppl. A):259A.2004-01-01T00:00:002004Risk stratification in ST-elevation myocardial infarction with multiple biomarkersAuthorship 103233257347Liang BT, Antman EM, Taus R, Collins JJ, Schoen FJThe American journal of cardiologyAtherosclerotic aneurysms of aortocoronary vein grafts. Am J Cardiol. 1988 Jan 01; 61(1):185-8.Am J Cardiol1988-01-01T00:00:001988Atherosclerotic aneurysms of aortocoronary vein grafts.8638998Barsky AJ, Delamater BA, Clancy SA, Antman EM, Ahern DKArchives of internal medicineSomatized psychiatric disorder presenting as palpitations. Arch Intern Med. 1996 May 27; 156(10):1102-8.Arch Intern Med1996-05-27T00:00:001996Somatized psychiatric disorder presenting as palpitations.17101859Marple AF, Antman EM, Hand MMCirculationCardiology patient pages. Modern treatment for heart attacks: opening blocked arteries quickly. Circulation. 2006 Nov 14; 114(20):e578-80.Circulation2006-11-14T00:00:002006Cardiology patient pages. Modern treatment for heart attacks: opening blocked arteries quickly.17179034Dzau VJ, Antman EM, Black HR, Hayes DL, Manson JE, Plutzky J, Popma JJ, Stevenson WCirculationThe cardiovascular disease continuum validated: clinical evidence of improved patient outcomes: part I: Pathophysiology and clinical trial evidence (risk factors through stable coronary artery disease). Circulation. 2006 Dec 19; 114(25):2850-70.Circulation2006-12-19T00:00:002006The cardiovascular disease continuum validated: clinical evidence of improved patient outcomes: part I: Pathophysiology and clinical trial evidence (risk factors through stable coronary artery disease).11717592Antman EM, Braunwald EAmerican heart journalA second look at bivalirudin. Am Heart J. 2001 Dec; 142(6):929-31.Am Heart J2001-12-01T00:00:002001A second look at bivalirudin.11973163Eagle KA, Berger PB, Calkins H, Chaitman BR, Ewy GA, Fleischmann KE, Fleisher LA, Froehlich JB, Gusberg RJ, Leppo JA, Ryan T, Schlant RC, Winters WL, Gibbons RJ, Antman EM, Alpert JS, Faxon DP, Fuster V, Gregoratos G, Jacobs AK, Hiratzka LF, Russell RO, Smith SCAnesthesia and analgesiaACC/AHA Guideline Update for Perioperative Cardiovascular Evaluation for Noncardiac Surgery--Executive Summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Anesth Analg. 2002 May; 94(5):1052-64.Anesth Analg2002-05-01T00:00:002002ACC/AHA Guideline Update for Perioperative Cardiovascular Evaluation for Noncardiac Surgery--Executive Summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery).1682069Andrews TC, Reimold SC, Berlin JA, Antman EMCirculationPrevention of supraventricular arrhythmias after coronary artery bypass surgery. A meta-analysis of randomized control trials. Circulation. 1991 Nov; 84(5 Suppl):III236-44.Circulation1991-11-01T00:00:001991Prevention of supraventricular arrhythmias after coronary artery bypass surgery. A meta-analysis of randomized control trials.18695943Gibson CM, Pride YB, Aylward PE, Col JJ, Goodman SG, Gulba D, Bergovec M, Kunadian V, Zorkun C, Buros JL, Murphy SA, Antman EMJournal of thrombosis and thrombolysisAssociation of non-steroidal anti-inflammatory drugs with outcomes in patients with ST-segment elevation myocardial infarction treated with fibrinolytic therapy: an ExTRACT-TIMI 25 analysis. J Thromb Thrombolysis. 2009 Jan; 27(1):11-7.J Thromb Thrombolysis2008-08-10T00:00:002008Association of non-steroidal anti-inflammatory drugs with outcomes in patients with ST-segment elevation myocardial infarction treated with fibrinolytic therapy: an ExTRACT-TIMI 25 analysis.19038677Warnes CA, Williams RG, Bashore TM, Child JS, Connolly HM, Dearani JA, Del Nido P, Fasules JW, Graham TP, Hijazi ZM, Hunt SA, King ME, Landzberg MJ, Miner PD, Radford MJ, Walsh EP, Webb GDJournal of the American College of CardiologyACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease). Developed in Collaboration With the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2008 Dec 02; 52(23):e143-e263.J Am Coll Cardiol2008-12-02T00:00:002008ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease). Developed in Collaboration With the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.19634922Giraldez RR, Wiviott SD, Nicolau JC, Mohanavelu S, Morrow DA, Antman EM, Giugliano RPDrugsStreptokinase and enoxaparin as an alternative to fibrin-specific lytic-based regimens: an ExTRACT-TIMI 25 analysis. Drugs. 2009 Jul 30; 69(11):1433-43.Drugs2009-07-30T00:00:002009Streptokinase and enoxaparin as an alternative to fibrin-specific lytic-based regimens: an ExTRACT-TIMI 25 analysis.19699846Pride YB, Wiviott SD, Buros JL, Zorkun C, Tariq MU, Antman EM, Braunwald E, Gibson CMAmerican heart journalEffect of prasugrel versus clopidogrel on outcomes among patients with acute coronary syndrome undergoing percutaneous coronary intervention without stent implantation: a TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet inhibitioN with prasugrel (TRITON)-Thrombolysis in Myocardial Infarction (TIMI) 38 substudy. Am Heart J. 2009 Sep; 158(3):e21-6.Am Heart J2009-09-01T00:00:002009Effect of prasugrel versus clopidogrel on outcomes among patients with acute coronary syndrome undergoing percutaneous coronary intervention without stent implantation: a TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet inhibitioN with prasugrel (TRITON)-Thrombolysis in Myocardial Infarction (TIMI) 38 substudy.Authorship 1028952Authorship 1058952129673466Antman EMJournal of the American College of CardiologyThe Aspirin-NSAID Interaction: More Data, But a Lack of Clarity Remains. J Am Coll Cardiol. 2018 04 24; 71(16):1752-1754.J Am Coll Cardiol2018-04-24T00:00:002018The Aspirin-NSAID Interaction: More Data, But a Lack of Clarity Remains.21093072Ruff CT, Giugliano RP, Antman EM, Murphy SA, Lotan C, Heuer H, Merkely B, Baracioli L, Schersten F, Seabro-Gomes R, Braunwald E, Wiviott SDInternational journal of cardiologySafety and efficacy of prasugrel compared with clopidogrel in different regions of the world. Int J Cardiol. 2012 Mar 22; 155(3):424-9.Int J Cardiol2010-11-19T00:00:002010Safety and efficacy of prasugrel compared with clopidogrel in different regions of the world.21131924Abraham NS, Hlatky MA, Antman EM, Bhatt DL, Bjorkman DJ, Clark CB, Furberg CD, Johnson DA, Kahi CJ, Laine L, Mahaffey KW, Quigley EM, Scheiman J, Sperling LS, Tomaselli GFThe American journal of gastroenterologyACCF/ACG/AHA 2010 expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use. Am J Gastroenterol. 2010 Dec; 105(12):2533-49.Am J Gastroenterol2010-12-01T00:00:002010ACCF/ACG/AHA 2010 expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use.15588742Domanski M, Antman EM, McKinlay S, Varshavsky S, Platonov P, Assmann SF, Norman JControlled clinical trialsGeographic variability in patient characteristics, treatment and outcome in an International Trial of Magnesium in acute myocardial infarction. Control Clin Trials. 2004 Dec; 25(6):553-62.Control Clin Trials2004-12-01T00:00:002004Geographic variability in patient characteristics, treatment and outcome in an International Trial of Magnesium in acute myocardial infarction.15653037Kirtane AJ, Martinezclark P, Rahman AM, Ray KK, Karmpaliotis D, Murphy SA, Giugliano RP, Cannon CP, Antman EM, Roe MT, Harrington RA, Ohman EM, Braunwald E, Gibson CMJournal of the American College of CardiologyAssociation of smoking with improved myocardial perfusion and the angiographic characterization of myocardial tissue perfusion after fibrinolytic therapy for ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2005 Jan 18; 45(2):321-3.J Am Coll Cardiol2005-01-18T00:00:002005Association of smoking with improved myocardial perfusion and the angiographic characterization of myocardial tissue perfusion after fibrinolytic therapy for ST-segment elevation myocardial infarction.16061757Antman EM, DeMets D, Loscalzo JCirculationCyclooxygenase inhibition and cardiovascular risk. Circulation. 2005 Aug 02; 112(5):759-70.Circulation2005-08-02T00:00:002005Cyclooxygenase inhibition and cardiovascular risk.16368287Sabatine MS, Morrow DA, McCabe CH, Antman EM, Gibson CM, Cannon CPAmerican heart journalCombination of quantitative ST deviation and troponin elevation provides independent prognostic and therapeutic information in unstable angina and non-ST-elevation myocardial infarction. Am Heart J. 2006 Jan; 151(1):25-31.Am Heart J2006-01-01T00:00:002006Combination of quantitative ST deviation and troponin elevation provides independent prognostic and therapeutic information in unstable angina and non-ST-elevation myocardial infarction.18585514Leung S, Gallup D, Mahaffey KW, Cohen M, Antman EM, Goodman SG, Harrington RA, Langer A, Aylward P, Ferguson JJ, Califf RMAmerican heart journalSmoking status and antithrombin therapy in patients with non-ST-segment elevation acute coronary syndrome. Am Heart J. 2008 Jul; 156(1):177-84.Am Heart J2008-04-03T00:00:002008Smoking status and antithrombin therapy in patients with non-ST-segment elevation acute coronary syndrome.19726078O'Donoghue ML, Braunwald E, Antman EM, Murphy SA, Bates ER, Rozenman Y, Michelson AD, Hautvast RW, Ver Lee PN, Close SL, Shen L, Mega JL, Sabatine MS, Wiviott SDLancet (London, England)Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials. Lancet. 2009 Sep 19; 374(9694):989-997.Lancet2009-08-31T00:00:002009Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials.Authorship 102841423238451Jacobs AK, Kushner FG, Ettinger SM, Guyton RA, Anderson JL, Ohman EM, Albert NM, Antman EM, Arnett DK, Bertolet M, Bhatt DL, Brindis RG, Creager MA, DeMets DL, Dickersin K, Fonarow GC, Gibbons RJ, Halperin JL, Hochman JS, Koster MA, Normand SL, Ortiz E, Peterson ED, Roach WH, Sacco RL, Smith SC, Stevenson WG, Tomaselli GF, Yancy CW, Zoghbi WA, Harold JG, He Y, Mangu PB, Qaseem A, Sayre MR, Somerfield MRJournal of the American College of CardiologyACCF/AHA clinical practice guideline methodology summit report: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013 Jan 15; 61(2):213-65.J Am Coll Cardiol2012-12-10T00:00:002012ACCF/AHA clinical practice guideline methodology summit report: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.American Heart JournalThe SYNERGY trial: study design and rationale. American Heart Journal. 2002; 143:952-60.2002-01-01T00:00:002002The SYNERGY trial: study design and rationaleAuthorship 1062731329723874Douketis JD, Murphy SA, Antman EM, Grip LT, Mercuri MF, Ruff CT, Weitz JI, Braunwald E, Giugliano RPThrombosis and haemostasisPeri-operative Adverse Outcomes in Patients with Atrial Fibrillation Taking Warfarin or Edoxaban: Analysis of the ENGAGE AF-TIMI 48 Trial. Thromb Haemost. 2018 06; 118(6):1001-1008.Thromb Haemost2018-05-03T00:00:002018Peri-operative Adverse Outcomes in Patients with Atrial Fibrillation Taking Warfarin or Edoxaban: Analysis of the ENGAGE AF-TIMI 48 Trial.Antman EM, Braunwald EHarrison's Principles of Internal Medicine. Fauci AS, Braunwald E, Isselbacher KJ, Wislon JD, Martin JB, Kasper DL, Hauser SL, Longo DO, eds."Acute Myocardial Infarction". Harrison's Principles of Internal Medicine. Fauci AS, Braunwald E, Isselbacher KJ, Wislon JD, Martin JB, Kasper DL, Hauser SL, Longo DO, eds. 1997; 1352-65.1997-01-01T00:00:001997"Acute Myocardial Infarction"Frelinger AL, Michelson AD, Braunwald E, Downey WE, Angiolillo DJ, Xenopoulos NP, Jakubowski JA, Li Y, Murphy SA, McCabe CH, Antman EM, Wiviott SDCirculationPharmacodynamic assessment of platelet inhibition by prasugrel versus clopidogrel in the TRITON-TIMI 38 trial. Circulation. 2008; 118(Suppl2):S814.2008-01-01T00:00:002008Pharmacodynamic assessment of platelet inhibition by prasugrel versus clopidogrel in the TRITON-TIMI 38 trialAntman EM, Braunwald EIn: Fauci AS, Kasper DL, Longo DL, Braunwald E, Hauser SL, Jameson JL, Loscalzo J (eds). Harrison's Principles of Internal MedicineST-Segment Elevation Myocardial Infarction. In: Fauci AS, Kasper DL, Longo DL, Braunwald E, Hauser SL, Jameson JL, Loscalzo J (eds). Harrison's Principles of Internal Medicine. 2008; 1532-1544.2008-01-01T00:00:002008ST-Segment Elevation Myocardial InfarctionAntman EMCirculationBook review: Inside the FDA: The Business and Politics Behind the Drugs We Take and the Food We Eat. Circulation. 2005; 112:e98.2005-01-01T00:00:002005Book review: Inside the FDA: The Business and Politics Behind the Drugs We Take and the Food We EatSchoen MW, Antman EM, Strichartz GR, Lilly LSPathophysiology of Heart DiseaseCardiovascular drugs. Pathophysiology of Heart Disease. 2008; in press:397-449.2008-01-01T00:00:002008Cardiovascular drugsHenry TD, Haugland JM, Berger C, Gleason R, Antman EM, Sharkey SW, for the TIMI 9 Registry InvestigatorsCirculationIs "door to needle" time, unadjusted for severity of illness, a suitable measure of mortality risk in patients with acute myocardial infarction?. Circulation. 1995; 92:I-775.1995-01-01T00:00:001995Is "door to needle" time, unadjusted for severity of illness, a suitable measure of mortality risk in patients with acute myocardial infarction?Antman EMIn press, Revista Espanola de CardiologiaPresent and future of antithrombotic therapy in acute coronary syndromes. In press, Revista Espanola de Cardiologia. 2003.2003-01-01T00:00:002003Present and future of antithrombotic therapy in acute coronary syndromesFleisher LA, Beckman JA, Brown KA, Calkins H, Chaikoff EL, Fleischmann KE, Freeman WK, Froehlich JB, Kasper EK, Kersten JR, Riegel B, Robb JF, Smith SC Jr., Jacobs AK, Adams CD, Anderson JL, Antman EM, Buller CE, Creager MA, Ettinger SM, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Lytle BW, Nishimura R, Ornato JP, Page RL, Riegel B, Tarkington LG, Yancy CWJournal of the American College of CardiologyACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Journal of the American College of Cardiology. 2007; 50:e159-241.2007-01-01T00:00:002007ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery)Murphy SA, Giugliano RP, Wong G, Cannon CP, Antman EM, Gibson MJournal of the American College of CardiologyComparison of the frequency and outcomes of investigator assessed recurrent MI versus clinical event committee (CEC) adjudicated recurrent MI in acute MI trials: a TIMI 14 and TIMI 9 substudy. Journal of the American College of Cardiology. 2002; 39(Suppl. A):279A.2002-01-01T00:00:002002Comparison of the frequency and outcomes of investigator assessed recurrent MI versus clinical event committee (CEC) adjudicated recurrent MI in acute MI trials: a TIMI 14 and TIMI 9 substudy3947167Lamas GA, Antman EM, Gold JP, Braunwald NS, Collins JJThe Annals of thoracic surgeryPacemaker backup-mode reversion and injury during cardiac surgery. Ann Thorac Surg. 1986 Feb; 41(2):155-7.Ann Thorac Surg1986-02-01T00:00:001986Pacemaker backup-mode reversion and injury during cardiac surgery.833525Reiffel JA, Antman EM, Casella AJ, Drusin RJournal of electrocardiologyCase studies: Simultaneous intermittent intraatrial and intraventricular conduction defects mimicking trifascicular conduction delay. J Electrocardiol. 1977 Jan; 10(1):59-62.J Electrocardiol1977-01-01T00:00:001977Case studies: Simultaneous intermittent intraatrial and intraventricular conduction defects mimicking trifascicular conduction delay.17538043Mensah GA, Hand MM, Antman EM, Ryan TJ, Schriever R, Smith SCCirculationDevelopment of systems of care for ST-elevation myocardial infarction patients: the patient and public perspective. Circulation. 2007 Jul 10; 116(2):e33-8.Circulation2007-05-30T00:00:002007Development of systems of care for ST-elevation myocardial infarction patients: the patient and public perspective.Authorship 1065195929748353Aisenberg J, Chatterjee-Murphy P, Friedman Flack K, Weitz JI, Ruff CT, Nordio F, Mercuri MF, Choi Y, Antman EM, Braunwald E, Giugliano RPCirculation. Cardiovascular quality and outcomesGastrointestinal Bleeding With Edoxaban Versus Warfarin: Results From the ENGAGE AF-TIMI 48 Trial (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis In Myocardial Infarction). Circ Cardiovasc Qual Outcomes. 2018 05; 11(5):e003998.Circ Cardiovasc Qual Outcomes2018-05-01T00:00:002018Gastrointestinal Bleeding With Edoxaban Versus Warfarin: Results From the ENGAGE AF-TIMI 48 Trial (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis In Myocardial Infarction).17695733Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Le Heuzey JY, Kay GN, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann S, Priori SG, Blanc JJ, Budaj A, Camm AJ, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Zamorano JL, Smith SC, Jacobs AK, Adams CD, Anderson JL, Antman EM, Hunt SA, Nishimura R, Ornato JP, Page RL, Riegel BRevista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology[ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation--excutive summary]. Rev Port Cardiol. 2007 Apr; 26(4):383-446.Rev Port Cardiol2007-04-01T00:00:002007[ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation--excutive summary].18285564Choudhry NK, Patrick AR, Antman EM, Avorn J, Shrank WHCirculationCost-effectiveness of providing full drug coverage to increase medication adherence in post-myocardial infarction Medicare beneficiaries. Circulation. 2008 Mar 11; 117(10):1261-8.Circulation2008-02-19T00:00:002008Cost-effectiveness of providing full drug coverage to increase medication adherence in post-myocardial infarction Medicare beneficiaries.20118176Gibbons RJ, Antman EM, Smith SCBMJ (Clinical research ed.)Has guideline development gone astray? No. BMJ. 2010 Jan 29; 340:c343.BMJ2010-01-29T00:00:002010Has guideline development gone astray? No.2656541Antman EM, Dupont WD, Bonalsky J, Califf RM, Corwin S, Fink L, Hansen DE, Kawanishi DT, Kronenberg MW, McKay CRInternational journal of cardiologyEarly treatment with intravenous metoprolol for suspected acute myocardial infarction: a phase IV United States trial. Phase IV Metoprolol in Myocardial Infarction Study Group. Int J Cardiol. 1989 May; 23(2):185-97.Int J Cardiol1989-05-01T00:00:001989Early treatment with intravenous metoprolol for suspected acute myocardial infarction: a phase IV United States trial. Phase IV Metoprolol in Myocardial Infarction Study Group.20599020Wiviott SD, Antman EM, Braunwald EThe American journal of cardiologyMortality in the TRITON trial: update from the FDA prasugrel action package. Am J Cardiol. 2010 Jul 15; 106(2):293-4.Am J Cardiol2010-07-15T00:00:002010Mortality in the TRITON trial: update from the FDA prasugrel action package.2863013Kirshenbaum JM, Kloner RA, Antman EM, Braunwald ECirculationUse of an ultra short-acting beta-blocker in patients with acute myocardial ischemia. Circulation. 1985 Oct; 72(4):873-80.Circulation1985-10-01T00:00:001985Use of an ultra short-acting beta-blocker in patients with acute myocardial ischemia.2864848Kloner RA, Kirshenbaum J, Lange R, Antman EM, Braunwald EThe American journal of cardiologyExperimental and clinical observations on the efficacy of esmolol in myocardial ischemia. Am J Cardiol. 1985 Oct 23; 56(11):40F-48F.Am J Cardiol1985-10-23T00:00:001985Experimental and clinical observations on the efficacy of esmolol in myocardial ischemia.22199016Bonaca MP, Wiviott SD, Braunwald E, Murphy SA, Ruff CT, Antman EM, Morrow DACirculationAmerican College of Cardiology/American Heart Association/European Society of Cardiology/World Heart Federation universal definition of myocardial infarction classification system and the risk of cardiovascular death: observations from the TRITON-TIMI 38 trial (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis in Myocardial Infarction 38). Circulation. 2012 Jan 31; 125(4):577-83.Circulation2011-12-23T00:00:002011American College of Cardiology/American Heart Association/European Society of Cardiology/World Heart Federation universal definition of myocardial infarction classification system and the risk of cardiovascular death: observations from the TRITON-TIMI 38 trial (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis in Myocardial Infarction 38).22581565Antman E, Weiss S, Loscalzo JWiley interdisciplinary reviews. Systems biology and medicineSystems pharmacology, pharmacogenetics, and clinical trial design in network medicine. Wiley Interdiscip Rev Syst Biol Med. 2012 Jul-Aug; 4(4):367-83.Wiley Interdiscip Rev Syst Biol Med2012-05-11T00:00:002012Systems pharmacology, pharmacogenetics, and clinical trial design in network medicine.12087146Antman EMThe New England journal of medicineDecision making with cardiac troponin tests. N Engl J Med. 2002 Jun 27; 346(26):2079-82.N Engl J Med2002-06-27T00:00:002002Decision making with cardiac troponin tests.12851605Spinler SA, Inverso SM, Cohen M, Goodman SG, Stringer KA, Antman EMAmerican heart journalSafety and efficacy of unfractionated heparin versus enoxaparin in patients who are obese and patients with severe renal impairment: analysis from the ESSENCE and TIMI 11B studies. Am Heart J. 2003 Jul; 146(1):33-41.Am Heart J2003-07-01T00:00:002003Safety and efficacy of unfractionated heparin versus enoxaparin in patients who are obese and patients with severe renal impairment: analysis from the ESSENCE and TIMI 11B studies.14573735Finn AV, Antman EMThe New England journal of medicineImages in clinical medicine. Isolated right ventricular infarction. N Engl J Med. 2003 Oct 23; 349(17):1636.N Engl J Med2003-10-23T00:00:002003Images in clinical medicine. Isolated right ventricular infarction.15231372Morrow DA, Antman EM, Murphy SA, Assmann SF, Giugliano RP, Cannon CP, Michael Gibson C, McCabe CH, Barron HV, Van De Werf F, Braunwald EEuropean heart journalThe Risk Score Profile: a novel approach to characterising the risk of populations enrolled in clinical studies. Eur Heart J. 2004 Jul; 25(13):1139-45.Eur Heart J2004-07-01T00:00:002004The Risk Score Profile: a novel approach to characterising the risk of populations enrolled in clinical studies.Graboys TB, Antman EMManual and Synopsis of Cardiology. Kloner RA, ed.Diagnosis and Management of Cardiac Arrhythmias. Manual and Synopsis of Cardiology. Kloner RA, ed. 1984; 319-37.1984-01-01T00:00:001984Diagnosis and Management of Cardiac Arrhythmias15337239Eagle KA, Guyton RA, Davidoff R, Edwards FH, Ewy GA, Gardner TJ, Hart JC, Herrmann HC, Hillis LD, Hutter AM, Lytle BW, Marlow RA, Nugent WC, Orszulak TA, Antman EM, Smith SC, Alpert JS, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Gregoratos G, Halperin JL, Hiratzka LF, Hunt SA, Jacobs AK, Ornato JPJournal of the American College of CardiologyACC/AHA 2004 guideline update for coronary artery bypass graft surgery: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). J Am Coll Cardiol. 2004 Sep 01; 44(5):e213-310.J Am Coll Cardiol2004-09-01T00:00:002004ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery).16442899Januzzi JL, Newby LK, Murphy SA, Pieper K, Antman EM, Morrow DA, Sabatine MS, Ohman EM, Cannon CP, Braunwald EAmerican heart journalPredicting a late positive serum troponin in initially troponin-negative patients with non-ST-elevation acute coronary syndrome: clinical predictors and validated risk score results from the TIMI IIIB and GUSTO IIA studies. Am Heart J. 2006 Feb; 151(2):360-6.Am Heart J2006-02-01T00:00:002006Predicting a late positive serum troponin in initially troponin-negative patients with non-ST-elevation acute coronary syndrome: clinical predictors and validated risk score results from the TIMI IIIB and GUSTO IIA studies.16537665Antman EM, Morrow DA, McCabe CH, Murphy SA, Ruda M, Sadowski Z, Budaj A, López-Sendón JL, Guneri S, Jiang F, White HD, Fox KA, Braunwald EThe New England journal of medicineEnoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction. N Engl J Med. 2006 Apr 06; 354(14):1477-88.N Engl J Med2006-03-14T00:00:002006Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction.Antman EM"Advances in pharmacologic reperfusion for myocardial infarction--Thrombolysis, IIb/IIIa Receptor Antagonists, and antithrombins." (CD-ROM)"Advances in pharmacologic reperfusion for myocardial infarction--Thrombolysis, IIb/IIIa Receptor Antagonists, and antithrombins." (CD-ROM). 2001.2001-01-01T00:00:002001"Advances in pharmacologic reperfusion for myocardial infarction--Thrombolysis, IIb/IIIa Receptor Antagonists, and antithrombins." (CD-ROM)Antman EM, Marsh JD, Green LH, Grossman WAmerican Journal of CardiologyBlood oxygen measurements in the assessment of intracardiac left-to-right shunts -- a critical appraisal of methodology. American Journal of Cardiology. 1980; 46:265-271.1980-01-01T00:00:001980Blood oxygen measurements in the assessment of intracardiac left-to-right shunts -- a critical appraisal of methodologyYeh RW, Wiviott WD, Giugliano RP, Morrow DA, Bradner JE, Jang IK, Gibson CM, Antman EMJournal of the American College of CardiologyThrombocytopenia is associated with adverse outcomes following treatment with either enoxaparin or unfractionated heparin in patients presenting with acute coronary syndromes: a TIMI 11B substudy. Journal of the American College of Cardiology. 2006; 47(Suppl1):207A.2006-01-01T00:00:002006Thrombocytopenia is associated with adverse outcomes following treatment with either enoxaparin or unfractionated heparin in patients presenting with acute coronary syndromes: a TIMI 11B substudyReimold SC, Lamas GA, Cantillon CO, Antman EMJournal of the American College of CardiologyDual-chamber pacing reduces the risk of recurrent atrial fibrillation. Journal of the American College of Cardiology. 1993; 21:202A.1993-01-01T00:00:001993Dual-chamber pacing reduces the risk of recurrent atrial fibrillationWright S, Gersh BJ, Assmann SF, Domanski M, Cooper HA, Hochman J, McKinlay S, Antman EMJournal of the American College of CardiologyPredictors of life-threatening ventricular arrhythmias in high-risk patients with ST elevation acute myocardial infarction. Journal of the American College of Cardiology. 2004; 43(Suppl. A):261A.2004-01-01T00:00:002004Predictors of life-threatening ventricular arrhythmias in high-risk patients with ST elevation acute myocardial infarctionGoodman SG, Mahaffey KW, Chiswell K, Cohen M, Kontos MC, Antman EM, Ferguson JJ, Califf RM, Becker RJournal of the American College of CardiologyActivated partial thromboplastin time measurement is not associated with clinical outcomes in patients with high-risk non-ST-segment elevation acute coronary syndromes treated with unfractionated heparin. Journal of the American College of Cardiology. 2007; 49(Suppl1):186A.2007-01-01T00:00:002007Activated partial thromboplastin time measurement is not associated with clinical outcomes in patients with high-risk non-ST-segment elevation acute coronary syndromes treated with unfractionated heparinAntman EMAmerican Journal of CardiologyRandomized trials of magnesium in acute myocardial infarction: Big numbers do not tell the whole story. (Editorial). American Journal of Cardiology. 1995; 75:391-93.1995-01-01T00:00:001995Randomized trials of magnesium in acute myocardial infarction: Big numbers do not tell the whole story. (Editorial)Antman, EM, Kirshenbaum, J, Stone P"Acute Myocardial Infarction" (Videocassette)"Acute Myocardial Infarction" (Videocassette). 1992.1992-01-01T00:00:001992"Acute Myocardial Infarction" (Videocassette)Antman EM"Coronary Artery Spasm" (Videocassette)."Coronary Artery Spasm" (Videocassette). 1982.1982-01-01T00:00:001982"Coronary Artery Spasm" (Videocassette)11716882Morrow DA, Antman EM, Giugliano RP, Cairns R, Charlesworth A, Murphy SA, de Lemos JA, McCabe CH, Braunwald ELancet (London, England)A simple risk index for rapid initial triage of patients with ST-elevation myocardial infarction: an InTIME II substudy. Lancet. 2001 Nov 10; 358(9293):1571-5.Lancet2001-11-10T00:00:002001A simple risk index for rapid initial triage of patients with ST-elevation myocardial infarction: an InTIME II substudy.12069446Antman EM, Cooper HA, Gibson CM, de Lemos JA, McCabe CH, Giugliano RP, Coussement P, Murphy S, Scherer J, Anderson K, Van de Werf F, Braunwald EEuropean heart journalDeterminants of improvement in epicardial flow and myocardial perfusion for ST elevation myocardial infarction; insights from TIMI 14 and InTIME-II. Eur Heart J. 2002 Jun; 23(12):928-33.Eur Heart J2002-06-01T00:00:002002Determinants of improvement in epicardial flow and myocardial perfusion for ST elevation myocardial infarction; insights from TIMI 14 and InTIME-II.12208405Fox KA, Antman EM, Cohen M, Bigonzi FThe American journal of cardiologyComparison of enoxaparin versus unfractionated heparin in patients with unstable angina pectoris/non-ST-segment elevation acute myocardial infarction having subsequent percutaneous coronary intervention. Am J Cardiol. 2002 Sep 01; 90(5):477-82.Am J Cardiol2002-09-01T00:00:002002Comparison of enoxaparin versus unfractionated heparin in patients with unstable angina pectoris/non-ST-segment elevation acute myocardial infarction having subsequent percutaneous coronary intervention.12968985Bruno R, Baille P, Retout S, Vivier N, Veyrat-Follet C, Sanderink GJ, Becker R, Antman EMBritish journal of clinical pharmacologyPopulation pharmacokinetics and pharmacodynamics of enoxaparin in unstable angina and non-ST-segment elevation myocardial infarction. Br J Clin Pharmacol. 2003 Oct; 56(4):407-14.Br J Clin Pharmacol2003-10-01T00:00:002003Population pharmacokinetics and pharmacodynamics of enoxaparin in unstable angina and non-ST-segment elevation myocardial infarction.12975245Klocke FJ, Baird MG, Lorell BH, Bateman TM, Messer JV, Berman DS, O'Gara PT, Carabello BA, Russell RO, Cerqueira MD, St John Sutton MG, DeMaria AN, Udelson JE, Kennedy JW, Verani MS, Williams KA, Antman EM, Smith SC, Alpert JS, Gregoratos G, Anderson JL, Hiratzka LF, Faxon DP, Hunt SA, Fuster V, Jacobs AK, Gibbons RJ, Russell ROCirculationACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging). Circulation. 2003 Sep 16; 108(11):1404-18.Circulation2003-09-16T00:00:002003ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging).23525425Amin ST, Morrow DA, Braunwald E, Sloan S, Contant C, Murphy S, Antman EMJournal of the American Heart AssociationDynamic TIMI risk score for STEMI. J Am Heart Assoc. 2013 Jan 29; 2(1):e003269.J Am Heart Assoc2013-01-29T00:00:002013Dynamic TIMI risk score for STEMI.Mega JL, Murphy S, Morrow DA, McCabe CH, Antman EM, Braunwald E, Gibson CMJournal of the American College of CardiologyA risk score to predict sudden cardiac death in patients with ST-elevation myocardial infarction. Journal of the American College of Cardiology. 2007; 49(Suppl1):212A.2007-01-01T00:00:002007A risk score to predict sudden cardiac death in patients with ST-elevation myocardial infarctionSabatine MS, McCabe CH, Morrow DA, Giugliano RP, de Lemos JA, Antman EMCirculationPredicting risk of post-discharge events in unstable angina. Circulation. 2001; 102:II-589.2001-01-01T00:00:002001Predicting risk of post-discharge events in unstable anginaStone SJ, Mahaffey KW, Clare R, Pieper KS, Antman EM, Col J, Ferguson JJ, Califf RM, Hochman JS, Grines CLJournal of the American College of CardiologyWomen and men have differences in outcomes and potentially response to antithrombin therapy: preliminary results from subgroup analyses in SYNERGY. Journal of the American College of Cardiology. 2007; 49(Suppl1):191A.2007-01-01T00:00:002007Women and men have differences in outcomes and potentially response to antithrombin therapy: preliminary results from subgroup analyses in SYNERGYAuthorship 1112833Finn AV, Antman EMNew England Journal of MedicineIsolated right ventricular infarction. Images in Clinical Medicine. New England Journal of Medicine. 2003; 349:17.2003-01-01T00:00:002003Isolated right ventricular infarction. Images in Clinical MedicineVan de Werf FJ, Antman EM, Simoons MLEuropean Heart JournalManaging ST-elevation myocardial infarction. European Heart Journal. 2002; 4 (Suppl E):E15-E23.2002-01-01T00:00:002002Managing ST-elevation myocardial infarctionKashani A, Murphy SA, Antman EM, Giugliano RPJACCHeart failure following ST elevation myocardial infarction: are we aggressive enough?. JACC. 2003; 41 (Suppl. A):195A.2003-01-01T00:00:002003Heart failure following ST elevation myocardial infarction: are we aggressive enough?Braunwald E, Antman EMEuropean Heart Journal SupplementEpicardial flow and myocardial reperfusion following abciximab and low-dose thrombolytic therapy for acute myocardial infarction. European Heart Journal Supplement. 2001; Suppl. A:A8-A13.2001-01-01T00:00:002001Epicardial flow and myocardial reperfusion following abciximab and low-dose thrombolytic therapy for acute myocardial infarctionAlbert M, Antman EMCardiac Surgery in the Adult. Cohn LH, Edmunds Jr LH, eds."Preoperative Evaluation for Cardiac Surgery". Cardiac Surgery in the Adult. Cohn LH, Edmunds Jr LH, eds. 2003; 235-48.2003-01-01T00:00:002003"Preoperative Evaluation for Cardiac Surgery"Fung AY, Gawad Y, Thompson CR, Jackowski G, Leitman R, Antman EM, Tanasijevic MJ, Canner J, Thompson B, Braunwald EJournal of the American College of CardiologyThe prognostic value of cardiac myosin light chains in acute ischemic syndromes--results from TIMI 9B. Journal of the American College of Cardiology. 1998; 31:380A.1998-01-01T00:00:001998The prognostic value of cardiac myosin light chains in acute ischemic syndromes--results from TIMI 9BAntman EM, Horowitz J, Stone PHCalcium Channel Blocking Agents in the Treatment of Cardiovascular Disorders. Stone PH, Antman EM, eds."Clinical Pharmacology of the Calcium Channel Blocking Agents". Calcium Channel Blocking Agents in the Treatment of Cardiovascular Disorders. Stone PH, Antman EM, eds. 1983; 177-202.1983-01-01T00:00:001983"Clinical Pharmacology of the Calcium Channel Blocking Agents"Antman EM"Atrial Arrhythmias" (Audiocassette). In: Cohn PF, Smith TW, Braunwald E, eds., Intensive Review of Cardiovascular Disease, Department of Medicine, Cardiovascular Division"Atrial Arrhythmias" (Audiocassette). In: Cohn PF, Smith TW, Braunwald E, eds., Intensive Review of Cardiovascular Disease, Department of Medicine, Cardiovascular Division. 1981.1981-01-01T00:00:001981"Atrial Arrhythmias" (Audiocassette). In: Cohn PF, Smith TW, Braunwald E, eds., Intensive Review of Cardiovascular Disease, Department of Medicine, Cardiovascular DivisionCannon CP, Antman EM, Walls R, Braunwald EJournal of Thrombosis and ThrombolysisTime as an Adjunctive Agent to Thrombolytic Therapy (editorial). Journal of Thrombosis and Thrombolysis. 1994; 1:27-34.1994-01-01T00:00:001994Time as an Adjunctive Agent to Thrombolytic Therapy (editorial)Antman EM, Friedman PLDigitalis Glycosides. Smith TW, ed."Use of Digitalis Glycosides in the Management of Cardiac Arrhythmias". Digitalis Glycosides. Smith TW, ed. 1986; 127-52.1986-01-01T00:00:001986"Use of Digitalis Glycosides in the Management of Cardiac Arrhythmias"Lau J, Antman EMChoices in Cardiology"Lessons from Meta-Analyses of Acute Myocardial Infarction Trials". Choices in Cardiology. 1994; 8:386-89.1994-01-01T00:00:001994"Lessons from Meta-Analyses of Acute Myocardial Infarction Trials"Giugliano RP, Antman EM, McCabe CH, Anderson KM, Adgey AAJ, Kleiman NS, Ghali M, Van de Werf F, Braunwald ECirculationAbciximab + tPA improves coronary flow in a wide range of subgroups: results from TIMI 14. Circulation. 1998; 98:I-560.1998-01-01T00:00:001998Abciximab + tPA improves coronary flow in a wide range of subgroups: results from TIMI 14Authorship 1077533229967197Yin OQP, Antman EM, Braunwald E, Mercuri MF, Miller R, Morrow D, Ruff CT, Truitt K, Weitz JI, Giugliano RPCirculationLinking Endogenous Factor Xa Activity, a Biologically Relevant Pharmacodynamic Marker, to Edoxaban Plasma Concentrations and Clinical Outcomes in the ENGAGE AF-TIMI 48 Trial. Circulation. 2018 10 30; 138(18):1963-1973.Circulation2018-10-30T00:00:002018Linking Endogenous Factor Xa Activity, a Biologically Relevant Pharmacodynamic Marker, to Edoxaban Plasma Concentrations and Clinical Outcomes in the ENGAGE AF-TIMI 48 Trial.20934556Ruff CT, Giugliano RP, Antman EM, Crugnale SE, Bocanegra T, Mercuri M, Hanyok J, Patel I, Shi M, Salazar D, McCabe CH, Braunwald EAmerican heart journalEvaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: design and rationale for the Effective aNticoaGulation with factor xA next GEneration in Atrial Fibrillation-Thrombolysis In Myocardial Infarction study 48 (ENGAGE AF-TIMI 48). Am Heart J. 2010 Oct; 160(4):635-41.Am Heart J2010-10-01T00:00:002010Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: design and rationale for the Effective aNticoaGulation with factor xA next GEneration in Atrial Fibrillation-Thrombolysis In Myocardial Infarction study 48 (ENGAGE AF-TIMI 48).21545940Wright RS, Anderson JL, Adams CD, Bridges CR, Casey DE, Ettinger SM, Fesmire FM, Ganiats TG, Jneid H, Lincoff AM, Peterson ED, Philippides GJ, Theroux P, Wenger NK, Zidar JP, Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE, Chavey WE, Fesmire FM, Hochman JS, Levin TN, Lincoff AM, Peterson ED, Theroux P, Wenger NK, Zidar JPJournal of the American College of Cardiology2011 ACCF/AHA focused update incorporated into the ACC/AHA 2007 Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in collaboration with the American Academy of Family Physicians, Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons. J Am Coll Cardiol. 2011 May 10; 57(19):e215-367.J Am Coll Cardiol2011-05-10T00:00:0020112011 ACCF/AHA focused update incorporated into the ACC/AHA 2007 Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in collaboration with the American Academy of Family Physicians, Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons.Morrow DA, Antman EMLow molecular weight heparin in non-ST elevation acute coronary syndromesLow molecular weight heparin in non-ST elevation acute coronary syndromes. 2000.2000-01-01T00:00:002000Low molecular weight heparin in non-ST elevation acute coronary syndromes14557344Blomström-Lundqvist C, Scheinman MM, Aliot EM, Alpert JS, Calkins H, Camm AJ, Campbell WB, Haines DE, Kuck KH, Lerman BB, Miller DD, Shaeffer CW, Stevenson WG, Tomaselli GF, Antman EM, Smith SC, Alpert JS, Faxon DP, Fuster V, Gibbons RJ, Gregoratos G, Hiratzka LF, Hunt SA, Jacobs AK, Russell RO, Priori SG, Blanc JJ, Budaj A, Burgos EF, Cowie M, Deckers JW, Garcia MA, Klein WW, Lekakis J, Lindahl B, Mazzotta G, Morais JC, Oto A, Smiseth O, Trappe HJCirculationACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Supraventricular Arrhythmias). Circulation. 2003 Oct 14; 108(15):1871-909.Circulation2003-10-14T00:00:002003ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Supraventricular Arrhythmias).14739628Gibson CM, Kirtane AJ, Murphy SA, Karha J, Cannon CP, Giugliano RP, Roe MT, Harrington RA, Ohman EM, Antman EMJournal of thrombosis and thrombolysisDistance from the coronary ostium to the culprit lesion in acute ST-elevation myocardial infarction and its implications regarding the potential prevention of proximal plaque rupture. J Thromb Thrombolysis. 2003 Jun; 15(3):189-96.J Thromb Thrombolysis2003-06-01T00:00:002003Distance from the coronary ostium to the culprit lesion in acute ST-elevation myocardial infarction and its implications regarding the potential prevention of proximal plaque rupture.15007008De Luca G, Suryapranata H, Ottervanger JP, Antman EMCirculationTime delay to treatment and mortality in primary angioplasty for acute myocardial infarction: every minute of delay counts. Circulation. 2004 Mar 16; 109(10):1223-5.Circulation2004-03-08T00:00:002004Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction: every minute of delay counts.15238596Petersen JL, Mahaffey KW, Hasselblad V, Antman EM, Cohen M, Goodman SG, Langer A, Blazing MA, Le-Moigne-Amrani A, de Lemos JA, Nessel CC, Harrington RA, Ferguson JJ, Braunwald E, Califf RMJAMAEfficacy and bleeding complications among patients randomized to enoxaparin or unfractionated heparin for antithrombin therapy in non-ST-Segment elevation acute coronary syndromes: a systematic overview. JAMA. 2004 Jul 07; 292(1):89-96.JAMA2004-07-07T00:00:002004Efficacy and bleeding complications among patients randomized to enoxaparin or unfractionated heparin for antithrombin therapy in non-ST-Segment elevation acute coronary syndromes: a systematic overview.15566912Turakhia MP, Murphy SA, Pinto TL, Antman EM, Giugliano RP, Cannon CP, Braunwald E, Gibson CMThe American journal of cardiologyAssociation of platelet count with residual thrombus in the myocardial infarct-related coronary artery among patients treated with fibrinolytic therapy for ST-segment elevation acute myocardial infarction. Am J Cardiol. 2004 Dec 01; 94(11):1406-10.Am J Cardiol2004-12-01T00:00:002004Association of platelet count with residual thrombus in the myocardial infarct-related coronary artery among patients treated with fibrinolytic therapy for ST-segment elevation acute myocardial infarction.16908781Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Le Heuzey JY, Kay GN, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann S, Smith SC, Jacobs AK, Adams CD, Anderson JL, Antman EM, Halperin JL, Hunt SA, Nishimura R, Ornato JP, Page RL, Riegel B, Priori SG, Blanc JJ, Budaj A, Camm AJ, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JLCirculationACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation. 2006 Aug 15; 114(7):e257-354.Circulation2006-08-15T00:00:002006ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society.17075010Pinto DS, Kirtane AJ, Nallamothu BK, Murphy SA, Cohen DJ, Laham RJ, Cutlip DE, Bates ER, Frederick PD, Miller DP, Carrozza JP, Antman EM, Cannon CP, Gibson CMCirculationHospital delays in reperfusion for ST-elevation myocardial infarction: implications when selecting a reperfusion strategy. Circulation. 2006 Nov 07; 114(19):2019-25.Circulation2006-10-30T00:00:002006Hospital delays in reperfusion for ST-elevation myocardial infarction: implications when selecting a reperfusion strategy.17325246Antman EM, Bennett JS, Daugherty A, Furberg C, Roberts H, Taubert KACirculationUse of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association. Circulation. 2007 Mar 27; 115(12):1634-42.Circulation2007-02-26T00:00:002007Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association.The Planning and Steering Committees of the AFFIRM Study for the NHLBI AFFIRM Investigators. (E. Antman, MD, member, Steering Committee)American Journal of CardiologyAtrial fibrillation follow-up investigation of rhythm management - the AFFIRM Study design. American Journal of Cardiology. 1997; 79:1198-1202.1997-01-01T00:00:001997Atrial fibrillation follow-up investigation of rhythm management - the AFFIRM Study designDirect Thrombin Inhibitor Trialists' Collaborative Group. Direct Thrombin Inhibitor Trialist: TIMI 9B: Elliott M. Antman, M.D.LancetDirect thrombin inhibitors in acute coronary syndromes: principal results of a meta-analysis based on individual patients' data. Lancet. 2002; 359:294-302.2002-01-01T00:00:002002Direct thrombin inhibitors in acute coronary syndromes: principal results of a meta-analysis based on individual patients' data17950159Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikof EL, Chaikof E, Fleischmann KE, Freeman WK, Froehlich JB, Kasper EK, Kersten JR, Riegel B, Robb JF, Smith SC, Jacobs AK, Adams CD, Anderson JL, Antman EM, Buller CE, Creager MA, Ettinger SM, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Lytle BW, Nishimura R, Ornato JP, Page RL, Riegel B, Tarkington LG, Yancy CWJournal of the American College of CardiologyACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery) Developed in Collaboration With the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. J Am Coll Cardiol. 2007 Oct 23; 50(17):1707-32.J Am Coll Cardiol2007-10-23T00:00:002007ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery) Developed in Collaboration With the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery.17982182Wiviott SD, Braunwald E, McCabe CH, Montalescot G, Ruzyllo W, Gottlieb S, Neumann FJ, Ardissino D, De Servi S, Murphy SA, Riesmeyer J, Weerakkody G, Gibson CM, Antman EMThe New England journal of medicinePrasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2007 Nov 15; 357(20):2001-15.N Engl J Med2007-11-04T00:00:002007Prasugrel versus clopidogrel in patients with acute coronary syndromes.18187215Ahmed S, Cannon CP, Giugliano RP, Murphy SA, Morrow DA, Antman EM, Braunwald E, Gibson CMInternational journal of cardiologyThe independent and combined risk of diabetes and non-endstage renal impairment in non-ST-segment elevation acute coronary syndromes. Int J Cardiol. 2008 Dec 17; 131(1):105-12.Int J Cardiol2008-01-09T00:00:002008The independent and combined risk of diabetes and non-endstage renal impairment in non-ST-segment elevation acute coronary syndromes.19924773Kushner FG, Hand M, Smith SC, King SB, Anderson JL, Antman EM, Bailey SR, Bates ER, Blankenship JC, Casey DE, Green LA, Jacobs AK, Hochman JS, Krumholz HM, Morrison DA, Ornato JP, Pearle DL, Peterson ED, Sloan MA, Whitlow PL, Williams DOCatheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Catheter Cardiovasc Interv. 2009 Dec 01; 74(7):E25-68.Catheter Cardiovasc Interv2009-12-01T00:00:0020092009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.20031648Antman EM, Morrow DACirculation. Cardiovascular interventionsBiomarker release after percutaneous coronary intervention: a message from the heart. Circ Cardiovasc Interv. 2008 Aug; 1(1):3-6.Circ Cardiovasc Interv2008-08-01T00:00:002008Biomarker release after percutaneous coronary intervention: a message from the heart.20723851Pride YB, Tung P, Mohanavelu S, Zorkun C, Wiviott SD, Antman EM, Giugliano R, Braunwald E, Gibson CMJACC. Cardiovascular interventionsAngiographic and clinical outcomes among patients with acute coronary syndromes presenting with isolated anterior ST-segment depression: a TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis In Myocardial Infarction 38) substudy. JACC Cardiovasc Interv. 2010 Aug; 3(8):806-11.JACC Cardiovasc Interv2010-08-01T00:00:002010Angiographic and clinical outcomes among patients with acute coronary syndromes presenting with isolated anterior ST-segment depression: a TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis In Myocardial Infarction 38) substudy.21126648Abraham NS, Hlatky MA, Antman EM, Bhatt DL, Bjorkman DJ, Clark CB, Furberg CD, Johnson DA, Kahi CJ, Laine L, Mahaffey KW, Quigley EM, Scheiman J, Sperling LS, Tomaselli GFJournal of the American College of CardiologyACCF/ACG/AHA 2010 expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use. A Report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. J Am Coll Cardiol. 2010 Dec 07; 56(24):2051-66.J Am Coll Cardiol2010-12-07T00:00:002010ACCF/ACG/AHA 2010 expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use. A Report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents.21713327Frelinger AL, Michelson AD, Wiviott SD, Trenk D, Neumann FJ, Miller DL, Jakubowski JA, Costigan TM, McCabe CH, Antman EM, Braunwald EThrombosis and haemostasisIntrinsic platelet reactivity before P2Y12 blockade contributes to residual platelet reactivity despite high-level P2Y12 blockade by prasugrel or high-dose clopidogrel. Results from PRINCIPLE-TIMI 44. Thromb Haemost. 2011 Aug; 106(2):219-26.Thromb Haemost2011-06-28T00:00:002011Intrinsic platelet reactivity before P2Y12 blockade contributes to residual platelet reactivity despite high-level P2Y12 blockade by prasugrel or high-dose clopidogrel. Results from PRINCIPLE-TIMI 44.Rabbani LE, Antman EMCardiovascular Reviews and ReportsExercise Testing. Cardiovascular Reviews and Reports. 1989; 10:46-53.1989-01-01T00:00:001989Exercise Testing17010793Cohen M, Mahaffey KW, Pieper K, Pollack CV, Antman EM, Hoekstra J, Goodman SG, Langer A, Col JJ, White HD, Califf RM, Ferguson JJJournal of the American College of CardiologyA subgroup analysis of the impact of prerandomization antithrombin therapy on outcomes in the SYNERGY trial: enoxaparin versus unfractionated heparin in non-ST-segment elevation acute coronary syndromes. J Am Coll Cardiol. 2006 Oct 03; 48(7):1346-54.J Am Coll Cardiol2006-09-12T00:00:002006A subgroup analysis of the impact of prerandomization antithrombin therapy on outcomes in the SYNERGY trial: enoxaparin versus unfractionated heparin in non-ST-segment elevation acute coronary syndromes.17515461Mega JL, Morrow DA, Ostör E, Dorobantu M, Qin J, Antman EM, Braunwald ECirculationOutcomes and optimal antithrombotic therapy in women undergoing fibrinolysis for ST-elevation myocardial infarction. Circulation. 2007 Jun 05; 115(22):2822-8.Circulation2007-05-21T00:00:002007Outcomes and optimal antithrombotic therapy in women undergoing fibrinolysis for ST-elevation myocardial infarction.17951284Thygesen K, Alpert JS, White HD, Jaffe AS, Apple FS, Galvani M, Katus HA, Newby LK, Ravkilde J, Chaitman B, Clemmensen PM, Dellborg M, Hod H, Porela P, Underwood R, Bax JJ, Beller GA, Bonow R, Van der Wall EE, Bassand JP, Wijns W, Ferguson TB, Steg PG, Uretsky BF, Williams DO, Armstrong PW, Antman EM, Fox KA, Hamm CW, Ohman EM, Simoons ML, Poole-Wilson PA, Gurfinkel EP, Lopez-Sendon JL, Pais P, Mendis S, Zhu JR, Wallentin LC, Fernández-Avilés F, Fox KM, Parkhomenko AN, Priori SG, Tendera M, Voipio-Pulkki LM, Vahanian A, Camm AJ, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Morais J, Brener S, Harrington R, Morrow D, Lim M, Martinez-Rios MA, Steinhubl S, Levine GN, Gibler WB, Goff D, Tubaro M, Dudek D, Al-Attar NCirculationUniversal definition of myocardial infarction. Circulation. 2007 Nov 27; 116(22):2634-53.Circulation2007-10-19T00:00:002007Universal definition of myocardial infarction.18191746Antman EM, Hand M, Armstrong PW, Bates ER, Green LA, Halasyamani LK, Hochman JS, Krumholz HM, Lamas GA, Mullany CJ, Pearle DL, Sloan MA, Smith SC, Anbe DT, Kushner FG, Ornato JP, Pearle DL, Sloan MA, Jacobs AK, Adams CD, Anderson JL, Buller CE, Creager MA, Ettinger SM, Halperin JL, Hunt SA, Lytle BW, Nishimura R, Page RL, Riegel B, Tarkington LG, Yancy CWJournal of the American College of Cardiology2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2008 Jan 15; 51(2):210-47.J Am Coll Cardiol2008-01-15T00:00:0020082007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.Authorship 1085224930039978Zelniker TA, Ruff CT, Wiviott SD, Blanc JJ, Cappato R, Nordio F, Mercuri MF, Lanz H, Antman EM, Braunwald E, Giugliano RPEuropean heart journal. Acute cardiovascular careEdoxaban in atrial fibrillation patients with established coronary artery disease: Insights from ENGAGE AF-TIMI 48. Eur Heart J Acute Cardiovasc Care. 2019 Mar; 8(2):176-185.Eur Heart J Acute Cardiovasc Care2018-07-24T00:00:002018Edoxaban in atrial fibrillation patients with established coronary artery disease: Insights from ENGAGE AF-TIMI 48.Antman EM, Friedman PLPrimary CardiologyPropafenone hydrochloride: A unique new antiarrhythmic agent. Primary Cardiology. 1988; 14:24-34.1988-01-01T00:00:001988Propafenone hydrochloride: A unique new antiarrhythmic agentWiviott SD, Antman EMMushlin SB, Greene HL (eds). Decision Making in Medicine: An Algorithmic ApproachAssessment and initial management of ST-segment elevation myocardial infarction. Mushlin SB, Greene HL (eds). Decision Making in Medicine: An Algorithmic Approach. 2009; in press.2009-01-01T00:00:002009Assessment and initial management of ST-segment elevation myocardial infarctionAdams D, Antman EMHeart Disease: A Textbook of Cardiovascular Medicine. Braunwald E, Zipes DW, Libby P, eds."Medical Management of the Patient Undergoing Cardiac Surgery". Heart Disease: A Textbook of Cardiovascular Medicine. Braunwald E, Zipes DW, Libby P, eds. 2001; 2059-83.2001-01-01T00:00:002001"Medical Management of the Patient Undergoing Cardiac Surgery"Antman EM, Smith TWCardiac Arrhythmias, Mandel W, ed."Digitalis Toxicity. An Overview of Mechanisms, Manifestations, and Management". Cardiac Arrhythmias, Mandel W, ed. 1995; 1051-73.1995-01-01T00:00:001995"Digitalis Toxicity. An Overview of Mechanisms, Manifestations, and Management"Antman EM, Section Editor"Ischemic Heart Disease." Cardiovascular Therapeutics. In Smith TE (ed.), Antman EM, Bittl JA, Colucci WS, Gotto AM, Loscalzo J, Williams GH, Zipes DP (Section eds.)"Ischemic Heart Disease." Cardiovascular Therapeutics. In Smith TE (ed.), Antman EM, Bittl JA, Colucci WS, Gotto AM, Loscalzo J, Williams GH, Zipes DP (Section eds.). 1996.1996-01-01T00:00:001996"Ischemic Heart Disease." Cardiovascular Therapeutics. In Smith TE (ed.), Antman EM, Bittl JA, Colucci WS, Gotto AM, Loscalzo J, Williams GH, Zipes DP (Section eds.)Antman EMCirculationClinical trials in cardiovascular medicine (Clinical Cardiology: Physician Update). Circulation. 2001; 103:e101-e104.2001-01-01T00:00:002001Clinical trials in cardiovascular medicine (Clinical Cardiology: Physician Update)448840Antman E, Graboys TB, Lown BJAMAContinuous monitoring for ventricular arrhythmias during exercise tests. JAMA. 1979 Jun 29; 241(26):2802-5.JAMA1979-06-29T00:00:001979Continuous monitoring for ventricular arrhythmias during exercise tests.Antman EM, Braunwald E.Pharmacoinvasive Therapy in Acute Myocardial Infarction. Dauerman, H Sobel BE (eds)“Pharmacological Developments Likely to Enhance Benefits of Pharmacoinvasive Therapy”. Pharmacoinvasive Therapy in Acute Myocardial Infarction. Dauerman, H Sobel BE (eds). 2005; 149-180.2005-01-01T00:00:002005“Pharmacological Developments Likely to Enhance Benefits of Pharmacoinvasive Therapy”6685592Lee TH, DiSesa VJ, Cohn LH, Lilly LS, Antman EMClinical cardiologyCorrection of intraoperative diastolic myocardial dysfunction with nifedipine. Clin Cardiol. 1983 Nov; 6(11):549-52.Clin Cardiol1983-11-01T00:00:001983Correction of intraoperative diastolic myocardial dysfunction with nifedipine.6778665Hill NS, Antman EM, Green LH, Alpert JSChestIntravenous nitroglycerin. A review of pharmacology, indications, therapeutic effects and complications. Chest. 1981 Jan; 79(1):69-76.Chest1981-01-01T00:00:001981Intravenous nitroglycerin. A review of pharmacology, indications, therapeutic effects and complications.Abben RP, Antman EMCardiovascular MedicineManaging bradyarrhythmias. Cardiovascular Medicine. 1985; 10:49-51.1985-01-01T00:00:001985Managing bradyarrhythmiasAntman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, Hochman JS, Krumholtz HM, Kushner FG, Lamas GA, Mullany CJ, Ornato JP, Pearle DL, Sloan MA, Smith SC JrCanadian Journal of CardiologyACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: executive summary: a report of the ACC/AHA Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines on the Management of Patients with Acute Myocardial Infarction). Canadian Journal of Cardiology. 2004; 20:977-1025.2004-01-01T00:00:002004ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: executive summary: a report of the ACC/AHA Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines on the Management of Patients with Acute Myocardial Infarction)Antman EM, Jacob G, Volpe B, Finkel S, Savona MNYS J MedCamphor overdosage: Therapeutic considerations. NYS J Med. 1978; 78:898-907.1978-01-01T00:00:001978Camphor overdosage: Therapeutic considerationsAntman EM, Grossman WNifedipineClinical Applications of Calcium Channel Blockade: An Overview of the Use of Nifedipine (Japanese). Nifedipine. 1983; 9-27.1983-01-01T00:00:001983Clinical Applications of Calcium Channel Blockade: An Overview of the Use of Nifedipine (Japanese)Antman EM, Smith TWDigitalis Glycosides. Smith TW, ed."Pharmacokinetics of Digitalis Glycosides". Digitalis Glycosides. Smith TW, ed. 1986; 45-60.1986-01-01T00:00:001986"Pharmacokinetics of Digitalis Glycosides"19017521Bhatt DL, Scheiman J, Abraham NS, Antman EM, Chan FK, Furberg CD, Johnson DA, Mahaffey KW, Quigley EM, Harrington RA, Bates ER, Bridges CR, Eisenberg MJ, Ferrari VA, Hlatky MA, Kaul S, Lindner JR, Moliterno DJ, Mukherjee D, Schofield RS, Rosenson RS, Stein JH, Weitz HH, Wesley DJJournal of the American College of CardiologyACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol. 2008 Oct 28; 52(18):1502-17.J Am Coll Cardiol2008-10-28T00:00:002008ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents.18082517Yeh RW, Wiviott SD, Giugliano RP, Morrow DA, Shui A, Qin J, Scirica B, Bradner JE, Jang IK, Gibson CM, Antman EMThe American journal of cardiologyEffect of thrombocytopenia on outcomes following treatment with either enoxaparin or unfractionated heparin in patients presenting with acute coronary syndromes. Am J Cardiol. 2007 Dec 15; 100(12):1734-8.Am J Cardiol2007-10-29T00:00:002007Effect of thrombocytopenia on outcomes following treatment with either enoxaparin or unfractionated heparin in patients presenting with acute coronary syndromes.6326196Smith TW, Antman EM, Friedman PL, Blatt CM, Marsh JDProgress in cardiovascular diseasesDigitalis glycosides: mechanisms and manifestations of toxicity. Part II. Prog Cardiovasc Dis. 1984 May-Jun; 26(6):495-540.Prog Cardiovasc Dis1984-05-01T00:00:001984Digitalis glycosides: mechanisms and manifestations of toxicity. Part II.Authorship 1088346830115235Heydari B, Abdullah S, Shah R, Francis SA, Feng JH, McConnell J, Harris W, Antman EM, Jerosch-Herold M, Kwong RYJournal of the American College of CardiologyOmega-3 Fatty Acids Effect on Post-Myocardial Infarction ST2 Levels for Heart Failure and Myocardial Fibrosis. J Am Coll Cardiol. 2018 08 21; 72(8):953-955.J Am Coll Cardiol2018-08-21T00:00:002018Omega-3 Fatty Acids Effect on Post-Myocardial Infarction ST2 Levels for Heart Failure and Myocardial Fibrosis.19106084Mega JL, Close SL, Wiviott SD, Shen L, Hockett RD, Brandt JT, Walker JR, Antman EM, Macias W, Braunwald E, Sabatine MSThe New England journal of medicineCytochrome p-450 polymorphisms and response to clopidogrel. N Engl J Med. 2009 Jan 22; 360(4):354-62.N Engl J Med2008-12-22T00:00:002008Cytochrome p-450 polymorphisms and response to clopidogrel.19679245O'Donoghue M, Antman EM, Braunwald E, Murphy SA, Steg PG, Finkelstein A, Penny WF, Fridrich V, McCabe CH, Sabatine MS, Wiviott SDJournal of the American College of CardiologyThe efficacy and safety of prasugrel with and without a glycoprotein IIb/IIIa inhibitor in patients with acute coronary syndromes undergoing percutaneous intervention: a TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis In Myocardial Infarction 38) analysis. J Am Coll Cardiol. 2009 Aug 18; 54(8):678-85.J Am Coll Cardiol2009-08-18T00:00:002009The efficacy and safety of prasugrel with and without a glycoprotein IIb/IIIa inhibitor in patients with acute coronary syndromes undergoing percutaneous intervention: a TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis In Myocardial Infarction 38) analysis.Rabbani LE, Antman EMCardiovascular Reviews and ReportsAmbulatory Monitoring. Cardiovascular Reviews and Reports. 1989; 10:59-64.1989-01-01T00:00:001989Ambulatory MonitoringBonaca MP, Morrow DA, Wiviott SD, Sabatine MS, Murphy SA, Scirica BM, Rifai N, Antman EM, Braunwald ECirculationClinical correlates and impact of aspirin on the inflammatory response to percutaneous coronary intervention: results from TIMI 26. Circulation. 2005; 112:II-322.2005-01-01T00:00:002005Clinical correlates and impact of aspirin on the inflammatory response to percutaneous coronary intervention: results from TIMI 26Antman EMCardiovascular Reviews & ReportsNifedipine therapy for Prinzmetal's angina. Cardiovascular Reviews & Reports. 1982; 3:54-57.1982-01-01T00:00:001982Nifedipine therapy for Prinzmetal's anginaGiraldez RR, Sabatine MS, Morrow DA, Shui A, McCabe CH, Antman EM, Braunwald EJournal of the American College of CardiologyBaseline hemoglobin and white blood cell composite CBC index improves risk stratification in STEMI patients. Journal of the American College of Cardiology. 2007; 49(Suppl1):224A.2007-01-01T00:00:002007Baseline hemoglobin and white blood cell composite CBC index improves risk stratification in STEMI patientsWiviott SD, Ruff CT, Antman EM, Murphy SA, Ver Lee PN, White HD, Braunwald ECirculationRegional safety and efficacy of prasugrel compared to clopidogrel: a TRITON-TIMI 38 analysis. Circulation. 2008; 118(Suppl2):S917.2008-01-01T00:00:002008Regional safety and efficacy of prasugrel compared to clopidogrel: a TRITON-TIMI 38 analysisMorrow DA, Antman EMTherapeutic Agents in Thrombosis and Thrombolysis. Sasahara A, Loscalzo J, eds."Low-Molecular-Weight Heparins in the Acute Coronary Syndromes". Therapeutic Agents in Thrombosis and Thrombolysis. Sasahara A, Loscalzo J, eds. 2002; 75-90.2002-01-01T00:00:002002"Low-Molecular-Weight Heparins in the Acute Coronary Syndromes"Gibson CM, Murphy SA, McCabe CH, Morrow DA, Antman EM, Braunwald ECirculationAssociation of treatment with non-steroidal anti-inflammatory agents (NSAIDS) on study entry with 30 day adverse outcomes among ST elevation MI (STEMI) patients treated with a fibrinolytic agent. An ExTRACT-TIMI 25 analysis. Circulation. 2006; 114:II_697-II_698.2006-01-01T00:00:002006Association of treatment with non-steroidal anti-inflammatory agents (NSAIDS) on study entry with 30 day adverse outcomes among ST elevation MI (STEMI) patients treated with a fibrinolytic agent. An ExTRACT-TIMI 25 analysisWarnica W, Antman EM, Wilcox R, McCabe C, Neuhaus K, Braunwald EJournal of the American College of CardiologyRecurrent ischemia and clinical outcome after thrombolysis for myocardial infarction: observations from InTIME II. Journal of the American College of Cardiology. 2000; 35(Suppl.A):386A.2000-01-01T00:00:002000Recurrent ischemia and clinical outcome after thrombolysis for myocardial infarction: observations from InTIME IIAntman EMDiagnostic Methods in Clinical Cardiology. Cohn PF, Wynne J, eds."Ambulatory Electrocardiographic Monitoring". Diagnostic Methods in Clinical Cardiology. Cohn PF, Wynne J, eds. 1982; 29-50.1982-01-01T00:00:001982"Ambulatory Electrocardiographic Monitoring"Ahmed S, Cannon CP, Giugliano RP, Shui A, Murphy SA, Morrow DA, Antman EM, Braunwald E, Gibson CMJournal of the American College of CardiologyThe independent and combined risks of diabetes and non-endstage renal impairment in non ST-segment elevation acute coronary syndromes. Journal of the American College of Cardiology. 2006; 47(Suppl1):207A.2006-01-01T00:00:002006The independent and combined risks of diabetes and non-endstage renal impairment in non ST-segment elevation acute coronary syndromes3487980Rabinowe SL, Larsen PR, Antman EM, George KL, Friedman PL, Jackson RA, Eisenbarth GSThe American journal of medicineAmiodarone therapy and autoimmune thyroid disease. Increase in a new monoclonal antibody-defined T cell subset. Am J Med. 1986 Jul; 81(1):53-7.Am J Med1986-07-01T00:00:001986Amiodarone therapy and autoimmune thyroid disease. Increase in a new monoclonal antibody-defined T cell subset.475168Antman EM, Cargill V, Grossman WAnnals of internal medicineLow-pressure cardiac tamponade. Ann Intern Med. 1979 Sep; 91(3):403-6.Ann Intern Med1979-09-01T00:00:001979Low-pressure cardiac tamponade.2859831Antman EM, Smith TWAnnual review of medicineDigitalis toxicity. Annu Rev Med. 1985; 36:357-67.Annu Rev Med1985-01-01T00:00:001985Digitalis toxicity.22323092Thomas MP, Mahaffey KW, Chiswell K, Cohen M, Kontos MC, Antman EM, Ferguson JJ, Califf RM, Goodman SG, Becker RCJournal of thrombosis and thrombolysisActivated partial thromboplastin time measurement is not associated with clinical outcomes in patients with high-risk non-ST-segment elevation acute coronary syndromes treated with unfractionated heparin. J Thromb Thrombolysis. 2012 Jul; 34(1):114-9.J Thromb Thrombolysis2012-07-01T00:00:002012Activated partial thromboplastin time measurement is not associated with clinical outcomes in patients with high-risk non-ST-segment elevation acute coronary syndromes treated with unfractionated heparin.22398655Salazar DE, Mendell J, Kastrissios H, Green M, Carrothers TJ, Song S, Patel I, Bocanegra TS, Antman EM, Giugliano RP, Kunitada S, Dornseif B, Shi M, Tachibana M, Zhou S, Rohatagi SThrombosis and haemostasisModelling and simulation of edoxaban exposure and response relationships in patients with atrial fibrillation. Thromb Haemost. 2012 May; 107(5):925-36.Thromb Haemost2012-03-08T00:00:002012Modelling and simulation of edoxaban exposure and response relationships in patients with atrial fibrillation.19012977Mahaffey KW, Tonev ST, Spinler SA, Levine GN, Gallo R, Ducas J, Goodman SG, Antman EM, Becker RC, Langer A, White HD, Aylward PE, Col JJ, Ferguson JJ, Califf RMInternational journal of cardiologyObesity in patients with non-ST-segment elevation acute coronary syndromes: results from the SYNERGY trial. Int J Cardiol. 2010 Mar 04; 139(2):123-33.Int J Cardiol2008-11-14T00:00:002008Obesity in patients with non-ST-segment elevation acute coronary syndromes: results from the SYNERGY trial.19584335Antman EM, Gibbons RJJAMAClinical practice guidelines and scientific evidence. JAMA. 2009 Jul 08; 302(2):143-4; author reply 145-7.JAMA2009-07-08T00:00:002009Clinical practice guidelines and scientific evidence.20026770Mahoney EM, Wang K, Arnold SV, Proskorovsky I, Wiviott S, Antman E, Braunwald E, Cohen DJCirculationCost-effectiveness of prasugrel versus clopidogrel in patients with acute coronary syndromes and planned percutaneous coronary intervention: results from the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with Prasugrel-Thrombolysis in Myocardial Infarction TRITON-TIMI 38. Circulation. 2010 Jan 05; 121(1):71-9.Circulation2009-12-21T00:00:002009Cost-effectiveness of prasugrel versus clopidogrel in patients with acute coronary syndromes and planned percutaneous coronary intervention: results from the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with Prasugrel-Thrombolysis in Myocardial Infarction TRITON-TIMI 38.Authorship 109243411Authorship 10929911Authorship 10943211330239697Antman EMEuropean heart journalImproving care at the population and individual level: lessons from SWEDEHEART. Eur Heart J. 2018 11 07; 39(42):3777-3779.Eur Heart J2018-11-07T00:00:002018Improving care at the population and individual level: lessons from SWEDEHEART.30239711Berg DD, Wiviott SD, Braunwald E, Guo J, Im K, Kashani A, Gibson CM, Cannon CP, Morrow DA, Bhatt DL, Mega JL, O'Donoghue ML, Antman EM, Newby LK, Sabatine MS, Giugliano RPEuropean heart journalModes and timing of death in 66?252 patients with non-ST-segment elevation acute coronary syndromes enrolled in 14 TIMI trials. Eur Heart J. 2018 11 07; 39(42):3810-3820.Eur Heart J2018-11-07T00:00:002018Modes and timing of death in 66?252 patients with non-ST-segment elevation acute coronary syndromes enrolled in 14 TIMI trials.30236308Corbalán R, Nicolau JC, López-Sendon J, Garcia-Castillo A, Botero R, Sotomora G, Horna M, Ruff CT, Hamershock RA, Grip LT, Antman EM, Braunwald E, Giugliano RPJournal of the American College of CardiologyEdoxaban Versus Warfarin in Latin American Patients With Atrial Fibrillation: The ENGAGE AF-TIMI 48 Trial. J Am Coll Cardiol. 2018 09 25; 72(13):1466-1475.J Am Coll Cardiol2018-09-25T00:00:002018Edoxaban Versus Warfarin in Latin American Patients With Atrial Fibrillation: The ENGAGE AF-TIMI 48 Trial.Authorship 13266716Antman EM, Smith TWCardiac Impulse"Management of digitalis toxicity". Cardiac Impulse. 1987; 8:1-11.1987-01-01T00:00:001987"Management of digitalis toxicity"Antman EM, Rutherford JDCoronary Care Medicine: A Practical ApproachCoronary Care Medicine: A Practical Approach. 1986.1986-01-01T00:00:001986Coronary Care Medicine: A Practical ApproachAntman EM, Braunwald EBraunwald's Heart Disease: A Textbook of Cardiovascular Medicine. Zipes DW, Libby P, Bonow RO, Braunwald E (eds.)"ST-Elevation Myocardial Infarction: Pathology, Pathophysiology, and Clinical Features". Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. Zipes DW, Libby P, Bonow RO, Braunwald E (eds.). 2005.2005-01-01T00:00:002005"ST-Elevation Myocardial Infarction: Pathology, Pathophysiology, and Clinical Features"Choudhry NK, Avorn J, Antman EM, Schneeweiss S, Shrank WHHealth AffairsShould patients receive secondary prevention medications for free after a myocardial infarction? An economic analysis. Health Affairs. 2007; 26:186-194.2007-01-01T00:00:002007Should patients receive secondary prevention medications for free after a myocardial infarction? An economic analysisAntman EMEuropean Heart JournalThe re-emergence of anticoagulation in coronary disease. European Heart Journal. 2004; 25 (Suppl.6SB):B2-B8.2004-01-01T00:00:002004The re-emergence of anticoagulation in coronary diseaseSchamroth L, Antman EMCalcium Channel Blocking Agents in the Treatment of Cardiovascular Disorders. Stone PH, Antman EM, eds."Calcium Channel Blocking Agents in the Treatment of Cardiac Arrhythmias". Calcium Channel Blocking Agents in the Treatment of Cardiovascular Disorders. Stone PH, Antman EM, eds. 1983; 347-75.1983-01-01T00:00:001983"Calcium Channel Blocking Agents in the Treatment of Cardiac Arrhythmias"Moliterno DJ, Antman EM, Ohman EM, Miller J, Marble SJ, Murphy SA, Ivanc TB, Schuhwerk K, Gibson CMCirculationConcordance between core labs in trial results using TIMI flow grades & frame counts. Circulation. 2001; 102:II-590.2001-01-01T00:00:002001Concordance between core labs in trial results using TIMI flow grades & frame countsAntman EM, Bittl JAClinical Trials in Cardiovascular Disease. Hennekens C, ed."Direct Thrombin Inhibitors". Clinical Trials in Cardiovascular Disease. Hennekens C, ed. 1999; 145-65.1999-01-01T00:00:001999"Direct Thrombin Inhibitors"O'Donoghue M, Wiviott SD, Murphy SA, Bates ER, Sabatine MS, Mega JL, Desai NR, McCabe CH, Antman EM, Braunwald EJ Am Coll CardiolAbsence of an interaction between drugs metabolized by Cytochrome P450 enzymes and the benefit of treatment with prasugrel versus clopidogrel in patients with acute coronary syndromes undergoing percutaneous intervention: a TRITON TIMI-38 analysis. J Am Coll Cardiol. 2009; in press.2009-01-01T00:00:002009Absence of an interaction between drugs metabolized by Cytochrome P450 enzymes and the benefit of treatment with prasugrel versus clopidogrel in patients with acute coronary syndromes undergoing percutaneous intervention: a TRITON TIMI-38 analysisCohen M, Mahaffey KW, Berdan LG, Reist CJ, Traylor L, Langer A, Goodman SG, Antman E, Dietrich F, Califf RM, Fergusion JJJournal of the American College of CardiologySuperiority of enoxaparin low-molecular-weight heparin over unfractionated heparin in patients with no prior antithrombin therapy or maintained on consistent antithrombin therapy: results from SYNERGY. Journal of the American College of Cardiology. 2005; 45(Suppl1):202A.2005-01-01T00:00:002005Superiority of enoxaparin low-molecular-weight heparin over unfractionated heparin in patients with no prior antithrombin therapy or maintained on consistent antithrombin therapy: results from SYNERGYAntman EMBates ER (ed.) Reperfusion Therapy for Acute Myocardial Infarction.The future of reperfusion therapy. Bates ER (ed.) Reperfusion Therapy for Acute Myocardial Infarction. 2008.2008-01-01T00:00:002008The future of reperfusion therapyNguyen M, Murphy SA, Mega JL, Brieger D, Antman EM, Gibson CMCirculation Triple therapy (TTx): ASA, thienopyridine and oral anticoagulation (OA) therapy following ST elevation myocardial infarction (STEMI): is it safe?. Circulation. 2007; 116:II_483.2007-01-01T00:00:002007Triple therapy (TTx): ASA, thienopyridine and oral anticoagulation (OA) therapy following ST elevation myocardial infarction (STEMI): is it safe?Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikoff EL, Fleischmann KE, Freeman WK, Froehlich JB, Kasper EK, Kersten JR, Riegel B, Robb JF, Smith SC Jr., Jacobs AK, Adams CD, Anderson JL, Antman EM, Buller CE, Creager MA, Ettinger SM, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Lytle BW, Nishimura R, Ornato JP, Page RL, Riegel B, Tarkington LG, Yancy CWCirculationACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: executive summary. Circulation. 2007; 116:1971-1996.2007-01-01T00:00:002007ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: executive summaryAntman EM, Kuntz KMNew England Journal of MedicineThe length of the hospital stay after myocardial infarction. (Editorial). New England Journal of Medicine. 2000; 342:808-10.2000-01-01T00:00:002000The length of the hospital stay after myocardial infarction. (Editorial)Ganz LI, Antman EMContemporary Cardiology: Management of Cardiac Arrhythmias. Ganz LI, ed."Cardiac Arrhythmias During Myocardial Infarction". Contemporary Cardiology: Management of Cardiac Arrhythmias. Ganz LI, ed. 2001; 419-60.2001-01-01T00:00:002001"Cardiac Arrhythmias During Myocardial Infarction"Antman EMCardiology ReviewAntiplatelet therapy in daily practice. Cardiology Review. 1999; 15:55.1999-01-01T00:00:001999Antiplatelet therapy in daily practice3591690Ludmer PL, Baim DS, Antman EM, Gauthier DF, Rocco MB, Friedman PL, Colucci WSThe American journal of cardiologyEffects of milrinone on complex ventricular arrhythmias in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol. 1987 Jun 01; 59(15):1351-5.Am J Cardiol1987-06-01T00:00:001987Effects of milrinone on complex ventricular arrhythmias in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.7935639Ayanian JZ, Hauptman PJ, Guadagnoli E, Antman EM, Pashos CL, McNeil BJThe New England journal of medicineKnowledge and practices of generalist and specialist physicians regarding drug therapy for acute myocardial infarction. N Engl J Med. 1994 Oct 27; 331(17):1136-42.N Engl J Med1994-10-27T00:00:001994Knowledge and practices of generalist and specialist physicians regarding drug therapy for acute myocardial infarction.8438741Reimold SC, Cantillon CO, Friedman PL, Antman EMThe American journal of cardiologyPropafenone versus sotalol for suppression of recurrent symptomatic atrial fibrillation. Am J Cardiol. 1993 Mar 01; 71(7):558-63.Am J Cardiol1993-03-01T00:00:001993Propafenone versus sotalol for suppression of recurrent symptomatic atrial fibrillation.18056526Wiviott SD, Trenk D, Frelinger AL, O'Donoghue M, Neumann FJ, Michelson AD, Angiolillo DJ, Hod H, Montalescot G, Miller DL, Jakubowski JA, Cairns R, Murphy SA, McCabe CH, Antman EM, Braunwald ECirculationPrasugrel compared with high loading- and maintenance-dose clopidogrel in patients with planned percutaneous coronary intervention: the Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation-Thrombolysis in Myocardial Infarction 44 trial. Circulation. 2007 Dec 18; 116(25):2923-32.Circulation2007-12-03T00:00:002007Prasugrel compared with high loading- and maintenance-dose clopidogrel in patients with planned percutaneous coronary intervention: the Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation-Thrombolysis in Myocardial Infarction 44 trial.Gibson CM, Bigelow B, James D, Tepper MR, Murphy SA, Giugliano RP, Cannon CP, Antman EM, Braunwald E, for the TIMI Study GroupAmerican Journal of CardiologyClassification of lesion complexity following fibrinolytic administration with mortality in ST elevation myocardial infarction. American Journal of Cardiology. 2004; 94:108-111.2004-01-01T00:00:002004Classification of lesion complexity following fibrinolytic administration with mortality in ST elevation myocardial infarctionAuthorship 1079019Antman EM, Marsh JDBasic and Clinical Electrophysiology and Pharmacology of the Heart. Dangman KH, Miura DS, eds."Class IV Antiarrhythmic Drugs". Basic and Clinical Electrophysiology and Pharmacology of the Heart. Dangman KH, Miura DS, eds. 1991; 697-722.1991-01-01T00:00:001991"Class IV Antiarrhythmic Drugs"7004293Stone PH, Antman EM, Muller JE, Braunwald EAnnals of internal medicineCalcium channel blocking agents in the treatment of cardiovascular disorders. Part II: Hemodynamic effects and clinical applications. Ann Intern Med. 1980 Dec; 93(6):886-904.Ann Intern Med1980-12-01T00:00:001980Calcium channel blocking agents in the treatment of cardiovascular disorders. Part II: Hemodynamic effects and clinical applications.Authorship 109875114Authorship 1098092330338834Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, White HD, Mickley H, Crea F, Van de Werf F, Bucciarelli-Ducci C, Katus HA, Pinto FJ, Antman EM, Hamm CW, De Caterina R, Januzzi JL, Apple FS, Alonso Garcia MA, Underwood SR, Canty JM, Lyon AR, Devereaux PJ, Zamorano JL, Lindahl B, Weintraub WS, Newby LK, Virmani R, Vranckx P, Cutlip D, Gibbons RJ, Smith SC, Atar D, Luepker RV, Robertson RM, Bonow RO, Steg PG, O'Gara PT, Fox KAAKardiologia polska[Fourth universal definition of myocardial infarction (2018)]. Kardiol Pol. 2018; 76(10):1383-1415.Kardiol Pol2018-01-01T00:00:002018[Fourth universal definition of myocardial infarction (2018)].30318902Zelniker TA, Ruff CT, Antman EM, Giugliano RPEuropean heart journal. Acute cardiovascular careThe efficacy and safety of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation and coronary artery disease: A meta-analysis of randomized trials. Eur Heart J Acute Cardiovasc Care. 2019 Sep; 8(6):554-561.Eur Heart J Acute Cardiovasc Care2018-10-15T00:00:002018The efficacy and safety of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation and coronary artery disease: A meta-analysis of randomized trials.9527073Borzak S, Cannon CP, Kraft PL, Douthat L, Becker RC, Palmeri ST, Henry T, Hochman JS, Fuchs J, Antman EM, McCabe C, Braunwald EThe American journal of cardiologyEffects of prior aspirin and anti-ischemic therapy on outcome of patients with unstable angina. TIMI 7 Investigators. Thrombin Inhibition in Myocardial Ischemia. Am J Cardiol. 1998 Mar 15; 81(6):678-81.Am J Cardiol1998-03-15T00:00:001998Effects of prior aspirin and anti-ischemic therapy on outcome of patients with unstable angina. TIMI 7 Investigators. Thrombin Inhibition in Myocardial Ischemia.8186561Antman EMJournal of cardiac surgeryCurrent diagnosis and prescription for Marfan syndrome: when to operate. J Card Surg. 1994 Mar; 9(2 Suppl):174-6.J Card Surg1994-03-01T00:00:001994Current diagnosis and prescription for Marfan syndrome: when to operate.8199744Berlin JA, Antman EMThe Online journal of current clinical trialsAdvantages and limitations of metaanalytic regressions of clinical trials data. Online J Curr Clin Trials. 1994 Jun 04; Doc No 134:[8425 words; 84 paragraphs].Online J Curr Clin Trials1994-06-04T00:00:001994Advantages and limitations of metaanalytic regressions of clinical trials data.9711931Antman EM, Handin RCirculationLow-molecular-weight heparins: an intriguing new twist with profound implications. Circulation. 1998 Jul 28; 98(4):287-9.Circulation1998-07-28T00:00:001998Low-molecular-weight heparins: an intriguing new twist with profound implications.576898Antman EM, Bilezikian JPJAMAAsymptomatic hyperparathyroidism. JAMA. 1977 May 16; 237(20):2186-7.JAMA1977-05-16T00:00:001977Asymptomatic hyperparathyroidism.Authorship 1253342Morrow DA, Sabatine MS, Antman EM, Cannon CP, Braunwald E, Theroux PAmerican College of CardiologyUsefulness of tirofiban in patients treated without percutaneous coronary intervention (TIMI high risk patients in PRISM-PLUS). American College of Cardiology. 2004; 94:774-776.2004-01-01T00:00:002004Usefulness of tirofiban in patients treated without percutaneous coronary intervention (TIMI high risk patients in PRISM-PLUS)Morrow DA, Wiviott SD, Sabatine MS, Giugliano RP, McCabe CH, Antman EM, Braunwald EJournal of the American College of CardiologyEvaluation of the TIMI risk index in a multi-continental population of 19,103 patients with STEMI in the ExTRACT-TIMI 25 trial. Journal of the American College of Cardiology. 2006; 47(Suppl1):223A.2006-01-01T00:00:002006Evaluation of the TIMI risk index in a multi-continental population of 19,103 patients with STEMI in the ExTRACT-TIMI 25 trialRoss A, Van de Werf F, Weaver D, Antman EM"Combining Antithrombotics with Thrombolytics" at interactive videoconference (satellite and Internet) on The Pursuit of Optimal Infarct Therapy: Changing Options in the Management of Acute MI"Combining Antithrombotics with Thrombolytics" at interactive videoconference (satellite and Internet) on The Pursuit of Optimal Infarct Therapy: Changing Options in the Management of Acute MI. 1999.1999-04-29T00:00:001999"Combining Antithrombotics with Thrombolytics" at interactive videoconference (satellite and Internet) on The Pursuit of Optimal Infarct Therapy: Changing Options in the Management of Acute MIAntman EMAcute Myocardial Infarction and other Acute Ischemic Syndromes. Califf RM, vol. ed., Atlas of Heart Diseases. Braunwald E, ed. "Overview of Medical Therapy". Acute Myocardial Infarction and other Acute Ischemic Syndromes. Califf RM, vol. ed., Atlas of Heart Diseases. Braunwald E, ed. 1996; 8:10.1-10.25.1996-01-01T00:00:001996"Overview of Medical Therapy"Authorship 11095111030369307Fanola CL, Ruff CT, Murphy SA, Jin J, Duggal A, Babilonia NA, Sritara P, Mercuri MF, Kamphuisen PW, Antman EM, Braunwald E, Giugliano RPJournal of the American Heart AssociationEfficacy and Safety of Edoxaban in Patients With Active Malignancy and Atrial Fibrillation: Analysis of the ENGAGE AF - TIMI 48 Trial. J Am Heart Assoc. 2018 08 21; 7(16):e008987.J Am Heart Assoc2018-08-21T00:00:002018Efficacy and Safety of Edoxaban in Patients With Active Malignancy and Atrial Fibrillation: Analysis of the ENGAGE AF - TIMI 48 Trial.9924150Tanasijevic MJ, Antman EMAmerican heart journalDiagnostic performance of cardiac troponin I in suspected acute myocardial infarction: implications for clinicians. Am Heart J. 1999 Feb; 137(2):203-6.Am Heart J1999-02-01T00:00:001999Diagnostic performance of cardiac troponin I in suspected acute myocardial infarction: implications for clinicians.Gibson CM, Mesley R, Saunders T, Hynes C, Murphy S, Zemble R, Marble SJ, McCabe CH, Antman EM, Braunwald EJournal of the American College of CardiologyQuantitative angiographic measurement of absolute coronary blood flow & its relation to mortality in acute myocardial infarction. Journal of the American College of Cardiology. 2000; 35(Suppl. A):396A.2000-01-01T00:00:002000Quantitative angiographic measurement of absolute coronary blood flow & its relation to mortality in acute myocardial infarctionGibson CM, Wong GC, Antman EM, Marble SJ, Kalapanda R, Kraimer N, Markovic R, Cannon CPJACCHigher platelet counts are associated with greater thrombus burden in patent arteries following thrombolytic administration: a TIMI angiographic substudy. JACC. 2003; 41(Suppl. A):322A.2003-01-01T00:00:002003Higher platelet counts are associated with greater thrombus burden in patent arteries following thrombolytic administration: a TIMI angiographic substudyKloner RA, Kirshenbaum J, Lange R, Antman EM, Braunwald EAmerican Journal of CardiologyReview of the basic and clinical efficacy of esmolol in ischemic heart disease. American Journal of Cardiology. 1985; 56:40F-48F.1985-01-01T00:00:001985Review of the basic and clinical efficacy of esmolol in ischemic heart diseaseAuthorship 1109553Antman EM, Smith TWMod Conc Cardiovasc Dis.Digitalis Toxicity. Mod Conc Cardiovasc Dis. 1986; 55:26-30.1986-01-01T00:00:001986Digitalis ToxicitySabatine MS, Antman EM, Ganz LI, Lilly LSPathophysiology of Heart Disease: a Collaborative Project of Medical Students and Faculty. Lilly LS, ed.Diagnosis of Cardiac Arrhythmias. Pathophysiology of Heart Disease: a Collaborative Project of Medical Students and Faculty. Lilly LS, ed. 1997; 249-66.1997-01-01T00:00:001997Diagnosis of Cardiac ArrhythmiasAntman, EMFuster V (ed). The AHA Guidelines and Scientific Statements HandbookST-Elevation Myocardial Infarction. Fuster V (ed). The AHA Guidelines and Scientific Statements Handbook. 2009; 46-90.2009-01-01T00:00:002009ST-Elevation Myocardial Infarctionde Lemos JA, Antman EM, Murphy SA, McCabe CH, Morrow DA, Marble SJ, Giugliano RP, Braunwald ECirculationEarly adjunctive stenting is associated with less ST resolution than early adjunctive PTCA. Circulation. 2001; 102:II-754.2001-01-01T00:00:002001Early adjunctive stenting is associated with less ST resolution than early adjunctive PTCAFleisher LA, Beckman JA, Brown KA, Calkins H, Chaikoff EL, Fleischmann KE, Freeman WK, Froehlich JB, Kasper EK, Kersten JR, Riegel B, Robb JF, Smith SC Jr., Jacobs AK, Adams CD, Anderson JL, Antman EM, Buller CE, Creager MA, Ettinger SM, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Lytle BW, Nishimura R, Ornato JP, Page RL, Riegel B, Tarkington LG, Yancy CWCirculationACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Circulation. 2007; 116:e418-499.2007-01-01T00:00:002007ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery)Tischler MD, Antman EMCongestive Cardiac Failure: Pathophysiology and Treatment. Barnett, Pouleur and Francis, eds."Cardiac Glycosides in the Treatment of Heart Failure". Congestive Cardiac Failure: Pathophysiology and Treatment. Barnett, Pouleur and Francis, eds. 1993; 119-43.1993-01-01T00:00:001993"Cardiac Glycosides in the Treatment of Heart Failure"Antman EM, Graboys TBManual and Synopsis of Cardiology. Kloner RA, ed.Exercise Testing and Ambulatory Electrocardiographic Monitoring. Manual and Synopsis of Cardiology. Kloner RA, ed. 1984; 111-32.1984-01-01T00:00:001984Exercise Testing and Ambulatory Electrocardiographic MonitoringAntman EM, Cargill V, Grossman WAnnals of Internal MedicineLow pressure cardiac tamponade. Annals of Internal Medicine. 1979; 91:403-406.1979-01-01T00:00:001979Low pressure cardiac tamponade3728515Lee TH, Salomon DR, Rayment CM, Antman EMThe American journal of medicineHypotension and sinus arrest with exercise-induced hyperkalemia and combined verapamil/propranolol therapy. Am J Med. 1986 Jun; 80(6):1203-4.Am J Med1986-06-01T00:00:001986Hypotension and sinus arrest with exercise-induced hyperkalemia and combined verapamil/propranolol therapy.Reimold SC, Antman EMJournal of Thrombosis and ThrombolysisNoninvasive cardiac imaging in chest pain syndromes. Journal of Thrombosis and Thrombolysis. 1998; 6:239-52.1998-01-01T00:00:001998Noninvasive cardiac imaging in chest pain syndromesAntman EM, Ludmer PL, Friedman PLClin Prog in Electrophysiol & PacingClinical Applications of Transtelephonic ECG Transmission. Clin Prog in Electrophysiol & Pacing. 1986; 4:168-74.1986-01-01T00:00:001986Clinical Applications of Transtelephonic ECG TransmissionLee TH, Solomon DR, Rayment C, Antman EMAmerican Journal of MedicineHypotension and sinus arrest with exercise-induced hyperkalemia and combined verapamil-therapy. American Journal of Medicine. 1986; 80:1203-04.1986-01-01T00:00:001986Hypotension and sinus arrest with exercise-induced hyperkalemia and combined verapamil-therapyKelly RA, Antman EM, Smith TWPrincipals of Pharmacology: Basic Concepts and Clinical Applications. Munson P, Mueller RA, Bresse G, eds."Monitoring of Cardiovascular and Pulmonary Drugs". Principals of Pharmacology: Basic Concepts and Clinical Applications. Munson P, Mueller RA, Bresse G, eds. 1995; 569-83.1995-01-01T00:00:001995"Monitoring of Cardiovascular and Pulmonary Drugs"3294970Ludmer PL, McGowan NE, Antman EM, Friedman PLJournal of the American College of CardiologyEfficacy of propafenone in Wolff-Parkinson-White syndrome: electrophysiologic findings and long-term follow-up. J Am Coll Cardiol. 1987 Jun; 9(6):1357-63.J Am Coll Cardiol1987-06-01T00:00:001987Efficacy of propafenone in Wolff-Parkinson-White syndrome: electrophysiologic findings and long-term follow-up.Authorship 11134951030462220Steffel J, Ruff CT, Braunwald E, Hamershock RA, Murphy SA, Nieminen M, Lanz HJ, Mercuri MF, Peterson N, Antman EM, Giugliano RPEuropace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of CardiologyEdoxaban and implantable cardiac device interventions: insights from the ENGAGE AF-TIMI 48 trial. Europace. 2019 Feb 01; 21(2):306-312.Europace2019-02-01T00:00:002019Edoxaban and implantable cardiac device interventions: insights from the ENGAGE AF-TIMI 48 trial.Scheiman MM, Levine JH, Cannom DS, et al for the Intravenous Amiodarone Multicenter Investigators Group. Antman EM, Principal Investigator, Brigham and Women's HospitalCirculationDose-ranging study of intravenous amiodarone in patients with life-threatening ventricular tachyarrhythmias. Circulation. 1995; 92:3264-72.1995-01-01T00:00:001995Dose-ranging study of intravenous amiodarone in patients with life-threatening ventricular tachyarrhythmiasSpinler SA, Mahaffey KW, Gallup D, Levine GN, Ferguson JJ, Rao SV, Gallo R, Ducas J, Goodman SG, ANtman E, White HD, Biasucci L, Becker RC, Col JJ, Cohen M, Harrington RA, Califf RMInternational Journal of CardiologyRelationship between renal function and outcomes in high-risk patients with non-ST-segment elevation acute coronary syndromes: results from SYNERGY. International Journal of Cardiology. 2009.2009-01-01T00:00:002009Relationship between renal function and outcomes in high-risk patients with non-ST-segment elevation acute coronary syndromes: results from SYNERGYAntman EM, Murphy SA, Morrow DA, McCabe CH, Braunwald ECirculation Dynamic updating of TIMI risk score for STEMI: an ExTRACT-TIMI 25 analysis. Circulation. 2007; 116:II_675.2007-01-01T00:00:002007Dynamic updating of TIMI risk score for STEMI: an ExTRACT-TIMI 25 analysisSmith TW, Antman EM, Friedman PL, Blatt CM, Marsh JDPart II, Progr Cardiovasc Dis.Digitalis glycosides: mechanisms and manifestations of toxicity. Part II, Progr Cardiovasc Dis. 1984; 26:495-523.1984-01-01T00:00:001984Digitalis glycosides: mechanisms and manifestations of toxicityAntman EM, Yang P, Smetana RMagnesium -BulletinMagnesium in acute myocardial infarction: clinical benefits of intravenous magnesium therapy. Magnesium -Bulletin. 1996; 18(3):74-76.1996-01-01T00:00:001996Magnesium in acute myocardial infarction: clinical benefits of intravenous magnesium therapy14757697Sabatine MS, Morrow DA, Giugliano RP, Murphy SA, Demopoulos LA, DiBattiste PM, Weintraub WS, McCabe CH, Antman EM, Cannon CP, Braunwald ECirculationImplications of upstream glycoprotein IIb/IIIa inhibition and coronary artery stenting in the invasive management of unstable angina/non-ST-elevation myocardial infarction: a comparison of the Thrombolysis In Myocardial Infarction (TIMI) IIIB trial and the Treat angina with Aggrastat and determine Cost of Therapy with Invasive or Conservative Strategy (TACTICS)-TIMI 18 trial. Circulation. 2004 Feb 24; 109(7):874-80.Circulation2004-02-02T00:00:002004Implications of upstream glycoprotein IIb/IIIa inhibition and coronary artery stenting in the invasive management of unstable angina/non-ST-elevation myocardial infarction: a comparison of the Thrombolysis In Myocardial Infarction (TIMI) IIIB trial and the Treat angina with Aggrastat and determine Cost of Therapy with Invasive or Conservative Strategy (TACTICS)-TIMI 18 trial.15332148Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, Hochman JS, Krumholz HM, Kushner FG, Lamas GA, Mullany CJ, Ornato JP, Pearle DL, Sloan MA, Smith SCThe Canadian journal of cardiologyACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction). Can J Cardiol. 2004 Aug; 20(10):977-1025.Can J Cardiol2004-08-01T00:00:002004ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction).15353915Kirtane AJ, Bui A, Murphy SA, Karmpaliotis D, Kosmidou I, Boundy K, Rahman A, Pinto DS, Aroesty JM, Giugliano RP, Cannon CP, Antman EM, Gibson CMJournal of thrombosis and thrombolysisAssociation of epicardial and tissue-level reperfusion with left ventricular end-diastolic pressures in ST-elevation myocardial infarction. J Thromb Thrombolysis. 2004 Jun; 17(3):177-84.J Thromb Thrombolysis2004-06-01T00:00:002004Association of epicardial and tissue-level reperfusion with left ventricular end-diastolic pressures in ST-elevation myocardial infarction.15673542Ray KK, Morrow DA, Gibson CM, Murphy S, Antman EM, Braunwald EEuropean heart journalPredictors of the rise in vWF after ST elevation myocardial infarction: implications for treatment strategies and clinical outcome: An ENTIRE-TIMI 23 substudy. Eur Heart J. 2005 Mar; 26(5):440-6.Eur Heart J2005-01-26T00:00:002005Predictors of the rise in vWF after ST elevation myocardial infarction: implications for treatment strategies and clinical outcome: An ENTIRE-TIMI 23 substudy.16386696Smith SC, Feldman TE, Hirshfeld JW, Jacobs AK, Kern MJ, King SB, Morrison DA, O'neill WW, Schaff HV, Whitlow PL, Williams DO, Antman EM, Smith SC, Adams CD, Anderson JL, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Jacobs AK, Nishimura R, Ornato JP, Page RL, Riegel BJournal of the American College of CardiologyACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention-Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). J Am Coll Cardiol. 2006 Jan 03; 47(1):216-35.J Am Coll Cardiol2006-01-03T00:00:002006ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention-Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention).6255848Antman EM, Stone PH, Muller JE, Braunwald EAnnals of internal medicineCalcium channel blocking agents in the treatment of cardiovascular disorders. Part I: Basic and clinical electrophysiologic effects. Ann Intern Med. 1980 Dec; 93(6):875-85.Ann Intern Med1980-12-01T00:00:001980Calcium channel blocking agents in the treatment of cardiovascular disorders. Part I: Basic and clinical electrophysiologic effects.8252668Solomon SD, Ridker PM, Antman EMCirculationVentricular arrhythmias in trials of thrombolytic therapy for acute myocardial infarction. A meta-analysis. Circulation. 1993 Dec; 88(6):2575-81.Circulation1993-12-01T00:00:001993Ventricular arrhythmias in trials of thrombolytic therapy for acute myocardial infarction. A meta-analysis.6100818Mueller HS, Antman EM, Ferst JA, Muller JEPharmacotherapyNifedipine in the treatment of cardiovascular disease. Pharmacotherapy. 1981 Sep-Oct; 1(2):78-94.Pharmacotherapy1981-09-01T00:00:001981Nifedipine in the treatment of cardiovascular disease.6388300Lamas GA, Koller LR, Antman EM, Smith TWThe American journal of cardiologyElectrocardiogram by Einthoven 63 years earlier. Am J Cardiol. 1984 Nov 01; 54(8):1163-5.Am J Cardiol1984-11-01T00:00:001984Electrocardiogram by Einthoven 63 years earlier.6407436Stone PH, Antman EM, Muller JEArchives des maladies du coeur et des vaisseauxNifedipine therapy for coronary vasospasm. Arch Mal Coeur Vaiss. 1983 Feb; 76 Spec No:137-42.Arch Mal Coeur Vaiss1983-02-01T00:00:001983Nifedipine therapy for coronary vasospasm.6767986Antman E, Muller J, Goldberg S, MacAlpin R, Rubenfire M, Tabatznik B, Liang CS, Heupler F, Achuff S, Reichek N, Geltman E, Kerin NZ, Neff RK, Braunwald EThe New England journal of medicineNifedipine therapy for coronary-artery spasm. Experience in 127 patients. N Engl J Med. 1980 Jun 05; 302(23):1269-73.N Engl J Med1980-06-05T00:00:001980Nifedipine therapy for coronary-artery spasm. Experience in 127 patients.16935866Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, Gregoratos G, Klein G, Moss AJ, Myerburg RJ, Priori SG, Quinones MA, Roden DM, Silka MJ, Tracy C, Priori SG, Blanc JJ, Budaj A, Camm AJ, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL, Smith SC, Jacobs AK, Adams CD, Antman EM, Anderson JL, Hunt SA, Halperin JL, Nishimura R, Ornato JP, Page RL, Riegel BEuropace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of CardiologyACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace. 2006 Sep; 8(9):746-837.Europace2006-08-25T00:00:002006ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society.17139670Cantor WJ, Mahaffey KW, Huang Z, Das P, Gulba DC, Glezer S, Gallo R, Ducas J, Cohen M, Antman EM, Langer A, Kleiman NS, White HD, Chisholm RJ, Harrington RA, Ferguson JJ, Califf RM, Goodman SGCatheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & InterventionsBleeding complications in patients with acute coronary syndrome undergoing early invasive management can be reduced with radial access, smaller sheath sizes, and timely sheath removal. Catheter Cardiovasc Interv. 2007 Jan; 69(1):73-83.Catheter Cardiovasc Interv2007-01-01T00:00:002007Bleeding complications in patients with acute coronary syndrome undergoing early invasive management can be reduced with radial access, smaller sheath sizes, and timely sheath removal.17692738Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE, Chavey WE, Fesmire FM, Hochman JS, Levin TN, Lincoff AM, Peterson ED, Theroux P, Wenger NK, Wright RS, Smith SC, Jacobs AK, Adams CD, Anderson JL, Antman EM, Halperin JL, Hunt SA, Krumholz HM, Kushner FG, Lytle BW, Nishimura R, Ornato JP, Page RL, Riegel BJournal of the American College of CardiologyACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. J Am Coll Cardiol. 2007 Aug 14; 50(7):e1-e157.J Am Coll Cardiol2007-08-14T00:00:002007ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine.19249423Giraldez RR, Sabatine MS, Morrow DA, Mohanavelu S, McCabe CH, Antman EM, Braunwald EAmerican heart journalBaseline hemoglobin concentration and creatinine clearance composite laboratory index improves risk stratification in ST-elevation myocardial infarction. Am Heart J. 2009 Mar; 157(3):517-24.Am Heart J2009-03-01T00:00:002009Baseline hemoglobin concentration and creatinine clearance composite laboratory index improves risk stratification in ST-elevation myocardial infarction.19451347Morrow DA, Wiviott SD, White HD, Nicolau JC, Bramucci E, Murphy SA, Bonaca MP, Ruff CT, Scirica BM, McCabe CH, Antman EM, Braunwald ECirculationEffect of the novel thienopyridine prasugrel compared with clopidogrel on spontaneous and procedural myocardial infarction in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel-Thrombolysis in Myocardial Infarction 38: an application of the classification system from the universal definition of myocardial infarction. Circulation. 2009 Jun 02; 119(21):2758-64.Circulation2009-05-18T00:00:002009Effect of the novel thienopyridine prasugrel compared with clopidogrel on spontaneous and procedural myocardial infarction in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel-Thrombolysis in Myocardial Infarction 38: an application of the classification system from the universal definition of myocardial infarction.19546250Wrishko RE, Ernest CS, Small DS, Li YG, Weerakkody GJ, Riesmeyer JR, Macias WL, Rohatagi S, Salazar DE, Antman EM, Wiviott SD, Braunwald E, Ni LJournal of clinical pharmacologyPopulation pharmacokinetic analyses to evaluate the influence of intrinsic and extrinsic factors on exposure of prasugrel active metabolite in TRITON-TIMI 38. J Clin Pharmacol. 2009 Aug; 49(8):984-98.J Clin Pharmacol2009-06-22T00:00:002009Population pharmacokinetic analyses to evaluate the influence of intrinsic and extrinsic factors on exposure of prasugrel active metabolite in TRITON-TIMI 38.2648779Pohjola-Sintonen S, Muller JE, Stone PH, Willich SN, Antman EM, Davis VG, Parker CB, Braunwald EAmerican heart journalVentricular septal and free wall rupture complicating acute myocardial infarction: experience in the Multicenter Investigation of Limitation of Infarct Size. Am Heart J. 1989 Apr; 117(4):809-18.Am Heart J1989-04-01T00:00:001989Ventricular septal and free wall rupture complicating acute myocardial infarction: experience in the Multicenter Investigation of Limitation of Infarct Size.20400762Morrow DA, Antman EM, Fox KA, White HD, Giugliano R, Murphy SA, McCabe CH, Braunwald EEuropean heart journalOne-year outcomes after a strategy using enoxaparin vs. unfractionated heparin in patients undergoing fibrinolysis for ST-segment elevation myocardial infarction: 1-year results of the ExTRACT-TIMI 25 trial. Eur Heart J. 2010 Sep; 31(17):2097-102.Eur Heart J2010-04-17T00:00:002010One-year outcomes after a strategy using enoxaparin vs. unfractionated heparin in patients undergoing fibrinolysis for ST-segment elevation myocardial infarction: 1-year results of the ExTRACT-TIMI 25 trial.21444888Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE, Chavey WE, Fesmire FM, Hochman JS, Levin TN, Lincoff AM, Peterson ED, Theroux P, Wenger NK, Wright RS, Smith SCCirculation2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2011 May 10; 123(18):e426-579.Circulation2011-03-28T00:00:0020112011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.2859798White HD, Polak JF, Wynne J, Holman BL, Antman EM, Nesto RWThe American journal of cardiologyAddition of nifedipine to maximal nitrate and beta-adrenoreceptor blocker therapy in coronary artery disease. Am J Cardiol. 1985 May 01; 55(11):1303-7.Am J Cardiol1985-05-01T00:00:001985Addition of nifedipine to maximal nitrate and beta-adrenoreceptor blocker therapy in coronary artery disease.22998129Ito K, Shrank WH, Avorn J, Patrick AR, Brennan TA, Antman EM, Choudhry NKHealth services researchComparative cost-effectiveness of interventions to improve medication adherence after myocardial infarction. Health Serv Res. 2012 Dec; 47(6):2097-117.Health Serv Res2012-09-21T00:00:002012Comparative cost-effectiveness of interventions to improve medication adherence after myocardial infarction.23122801Leonardi S, Thomas L, Neely ML, Tricoci P, Lopes RD, White HD, Armstrong PW, Giugliano RP, Antman EM, Califf RM, Newby LK, Mahaffey KWJournal of the American College of CardiologyComparison of the prognosis of spontaneous and percutaneous coronary intervention-related myocardial infarction. J Am Coll Cardiol. 2012 Dec 04; 60(22):2296-304.J Am Coll Cardiol2012-11-01T00:00:002012Comparison of the prognosis of spontaneous and percutaneous coronary intervention-related myocardial infarction.Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikoff EL, Fleischmann KE, Freeman WK, Froehlich JB, Kasper EK, Kersten JR, Riegel B, Robb JF, Smith SC Jr., Jacobs AK, Adams CD, Anderson JL, Antman EM, Buller CE, Creager MA, Ettinger SM, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Lytle BW, Nishimura R, Ornato JP, Page RL, Riegel B, Tarkington LG, Yancy CWAnesth AnalgACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: executive summary. Anesth Analg. 2008; 106:685-712.2008-01-01T00:00:002008ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: executive summaryAntman EM, Corbalan R, Huber K, Jaffe ASEuropean Heart Journal SupplementsIssues in early risk stratification for UA/NSTEMI. European Heart Journal Supplements. 2001; 3 (Suppl J):J6-J14.2001-01-01T00:00:002001Issues in early risk stratification for UA/NSTEMIAcute Coronary Syndromes Monograph Series (EM Antman, ed.)"Unstable Angina/Non ST Elevation MI/ST Elevation MI". Acute Coronary Syndromes Monograph Series (EM Antman, ed.). 2002.2002-01-01T00:00:002002"Unstable Angina/Non ST Elevation MI/ST Elevation MI"Piana RN, Giugliano RP, Coulter S, de Lemos J, McCabe CH, Antman EM, Skene AM, Neuhaus K, Braunwald EJournal of the American College of CardiologyClinical outcome remains poor in diabetics with myocardial infarction despite early fibrinolytic therapy: findings from InTIME II. Journal of the American College of Cardiology. 2000; 35(Suppl. A):407A.2000-01-01T00:00:002000Clinical outcome remains poor in diabetics with myocardial infarction despite early fibrinolytic therapy: findings from InTIME IIAntman EMBraunwald's Heart Disease: A Textbook of Cardiovascular Medicine. Zipes DW, Libby P, Bonow RO, Braunwald E (eds.)"ST-Elevation Myocardial Infarction: Management". Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. Zipes DW, Libby P, Bonow RO, Braunwald E (eds.). 2005.2005-01-01T00:00:002005"ST-Elevation Myocardial Infarction: Management"Kirtane AJ, Murphy SA, Karha J, Wong GC, Giugliano RP, Antman EM, Gibson CMJACCA mathematical model of preventing plaque rupture with drug-eluting stents based upon distance from the ostium to the culprit lesion in ST elevation myocardial infarction. JACC. 2003; 41 (Suppl. A):20A.2003-01-01T00:00:002003A mathematical model of preventing plaque rupture with drug-eluting stents based upon distance from the ostium to the culprit lesion in ST elevation myocardial infarctionMorrow DA, Antman EMOptimal use of new cardiac makers in patients with chest pain syndromes: selecting the best tools for reaching an accurate diagnosis and determining the patient's prognosisOptimal use of new cardiac makers in patients with chest pain syndromes: selecting the best tools for reaching an accurate diagnosis and determining the patient's prognosis. 1999.1999-01-01T00:00:001999Optimal use of new cardiac makers in patients with chest pain syndromes: selecting the best tools for reaching an accurate diagnosis and determining the patient's prognosisAuthorship 11218126Authorship 1122219830586727Berg DD, Ruff CT, Jarolim P, Giugliano RP, Nordio F, Lanz HJ, Mercuri MF, Antman EM, Braunwald E, Morrow DACirculationPerformance of the ABC Scores for Assessing the Risk of Stroke or Systemic Embolism and Bleeding in Patients With Atrial Fibrillation in ENGAGE AF-TIMI 48. Circulation. 2019 02 05; 139(6):760-771.Circulation2019-02-05T00:00:002019Performance of the ABC Scores for Assessing the Risk of Stroke or Systemic Embolism and Bleeding in Patients With Atrial Fibrillation in ENGAGE AF-TIMI 48.30590425Chao TF, Chen SA, Ruff CT, Hamershock RA, Mercuri MF, Antman EM, Braunwald E, Giugliano RPEuropean heart journalClinical outcomes, edoxaban concentration, and anti-factor Xa activity of Asian patients with atrial fibrillation compared with non-Asians in the ENGAGE AF-TIMI 48 trial. Eur Heart J. 2019 05 14; 40(19):1518-1527.Eur Heart J2019-05-14T00:00:002019Clinical outcomes, edoxaban concentration, and anti-factor Xa activity of Asian patients with atrial fibrillation compared with non-Asians in the ENGAGE AF-TIMI 48 trial.Sabatine MS, Morrow DA, Heidbuchel H, de Lemos JA, Cooper HA, Schuhwerk KC, Murphy SA, McCabe CH, Giugliano RP, Antman EM, Gibson M, Braunwald E, Van de Werf FJournal of the American College of CardiologyCorrelation between ST resolution and angiographic findings in ST elevation myocardial infarction. Journal of the American College of Cardiology. 2002; 39(Suppl. A):301A.2002-01-01T00:00:002002Correlation between ST resolution and angiographic findings in ST elevation myocardial infarctionAnderson JL, Antman EM, Breall JA, Cannon CP, Gersh BJ, Grines CL, Hillis LD, Hochman HS, Solomon AJ, Weaver WD, Welsh JC"Acute Myocardial Infarction--The First 72 Hours" (Videocassette), teleconference"Acute Myocardial Infarction--The First 72 Hours" (Videocassette), teleconference. 1997.1997-03-01T00:00:001997"Acute Myocardial Infarction--The First 72 Hours" (Videocassette), teleconferenceThe Magnesium in Coronaries (MAGIC) Trial Investigators. E. Antman, Chair, Steering CommitteeLancetEarly administration of intravenous magnesium to high-risk patients with acute myocardial infarction in the Magnesium in Coronaries (MAGIC) Trial: a randomised controlled trial. Lancet. 2002; 360:1189-96.2002-01-01T00:00:002002Early administration of intravenous magnesium to high-risk patients with acute myocardial infarction in the Magnesium in Coronaries (MAGIC) Trial: a randomised controlled trial1388328Reimold SC, Chalmers TC, Berlin JA, Antman EMAmerican heart journalAssessment of the efficacy and safety of antiarrhythmic therapy for chronic atrial fibrillation: observations on the role of trial design and implications of drug-related mortality. Am Heart J. 1992 Oct; 124(4):924-32.Am Heart J1992-10-01T00:00:001992Assessment of the efficacy and safety of antiarrhythmic therapy for chronic atrial fibrillation: observations on the role of trial design and implications of drug-related mortality.Authorship 1123075430596310Granger CB, Bates ER, Jollis JG, Antman EM, Nichol G, O'Connor RE, Gregory T, Roettig ML, Peng SA, Ellrodt G, Henry TD, French WJ, Jacobs AKJournal of the American Heart AssociationImproving Care of STEMI in the United States 2008 to 2012. J Am Heart Assoc. 2019 01 08; 8(1):e008096.J Am Heart Assoc2019-01-08T00:00:002019Improving Care of STEMI in the United States 2008 to 2012.10520778Gibson CM, Ryan KA, Murphy SA, Mesley R, Marble SJ, Giugliano RP, Cannon CP, Antman EM, Braunwald EJournal of the American College of CardiologyImpaired coronary blood flow in nonculprit arteries in the setting of acute myocardial infarction. The TIMI Study Group. Thrombolysis in myocardial infarction. J Am Coll Cardiol. 1999 Oct; 34(4):974-82.J Am Coll Cardiol1999-10-01T00:00:001999Impaired coronary blood flow in nonculprit arteries in the setting of acute myocardial infarction. The TIMI Study Group. Thrombolysis in myocardial infarction.11792137Morrow DA, Antman EM, Snapinn SM, McCabe CH, Theroux P, Braunwald EEuropean heart journalAn integrated clinical approach to predicting the benefit of tirofiban in non-ST elevation acute coronary syndromes. Application of the TIMI Risk Score for UA/NSTEMI in PRISM-PLUS. Eur Heart J. 2002 Feb; 23(3):223-9.Eur Heart J2002-02-01T00:00:002002An integrated clinical approach to predicting the benefit of tirofiban in non-ST elevation acute coronary syndromes. Application of the TIMI Risk Score for UA/NSTEMI in PRISM-PLUS.12514662Bahit MC, Cannon CP, Antman EM, Murphy SA, Gibson CM, McCabe CH, Braunwald EAmerican heart journalDirect comparison of characteristics, treatment, and outcomes of patients enrolled versus patients not enrolled in a clinical trial at centers participating in the TIMI 9 Trial and TIMI 9 Registry. Am Heart J. 2003 Jan; 145(1):109-17.Am Heart J2003-01-01T00:00:002003Direct comparison of characteristics, treatment, and outcomes of patients enrolled versus patients not enrolled in a clinical trial at centers participating in the TIMI 9 Trial and TIMI 9 Registry.12644346Sabatine MS, Antman EMJournal of the American College of CardiologyThe thrombolysis in myocardial infarction risk score in unstable angina/non-ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2003 Feb 19; 41(4 Suppl S):89S-95S.J Am Coll Cardiol2003-02-19T00:00:002003The thrombolysis in myocardial infarction risk score in unstable angina/non-ST-segment elevation myocardial infarction.12849652Gibson CM, Karha J, Murphy SA, James D, Morrow DA, Cannon CP, Giugliano RP, Antman EM, Braunwald EJournal of the American College of CardiologyEarly and long-term clinical outcomes associated with reinfarction following fibrinolytic administration in the Thrombolysis in Myocardial Infarction trials. J Am Coll Cardiol. 2003 Jul 02; 42(1):7-16.J Am Coll Cardiol2003-07-02T00:00:002003Early and long-term clinical outcomes associated with reinfarction following fibrinolytic administration in the Thrombolysis in Myocardial Infarction trials.15289388Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, Hochman JS, Krumholz HM, Kushner FG, Lamas GA, Mullany CJ, Ornato JP, Pearle DL, Sloan MA, Smith SC, Alpert JS, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Gregoratos G, Halperin JL, Hiratzka LF, Hunt SA, Jacobs AKCirculationACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction). Circulation. 2004 Aug 03; 110(5):588-636.Circulation2004-08-03T00:00:002004ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction).15337207Gibson CM, Murphy SA, Kirtane AJ, Giugliano RP, Cannon CP, Antman EM, Braunwald EJournal of the American College of CardiologyAssociation of duration of symptoms at presentation with angiographic and clinical outcomes after fibrinolytic therapy in patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2004 Sep 01; 44(5):980-7.J Am Coll Cardiol2004-09-01T00:00:002004Association of duration of symptoms at presentation with angiographic and clinical outcomes after fibrinolytic therapy in patients with ST-segment elevation myocardial infarction.17405770Miller CD, Banerjee A, Mahaffey KW, Kontos MC, Fermann G, Pollack CV, Antman E, Aylward P, Goodman SG, Santos R, Ferguson JJ, Califf RM, Hoekstra JWEuropean heart journalTreatment and outcomes of patients with evolving myocardial infarction: experiences from the SYNERGY trial. Eur Heart J. 2007 May; 28(9):1079-84.Eur Heart J2007-04-03T00:00:002007Treatment and outcomes of patients with evolving myocardial infarction: experiences from the SYNERGY trial.17562672Giraldez RR, Nicolau JC, Corbalan R, Gurfinkel EP, Juarez U, Lopez-Sendon J, Parkhomenko A, Molhoek P, Mohanavelu S, Morrow DA, Antman EMEuropean heart journalEnoxaparin is superior to unfractionated heparin in patients with ST elevation myocardial infarction undergoing fibrinolysis regardless of the choice of lytic: an ExTRACT-TIMI 25 analysis. Eur Heart J. 2007 Jul; 28(13):1566-73.Eur Heart J2007-06-11T00:00:002007Enoxaparin is superior to unfractionated heparin in patients with ST elevation myocardial infarction undergoing fibrinolysis regardless of the choice of lytic: an ExTRACT-TIMI 25 analysis.Authorship 11247778Authorship 112488330615978Journal of the American College of CardiologyCorrection. J Am Coll Cardiol. 2019 Feb 12; 73(5):627.J Am Coll Cardiol2019-01-04T00:00:002019Correction.30624719Boriani G, Ruff CT, Kuder JF, Shi M, Lanz HJ, Rutman H, Mercuri MF, Antman EM, Braunwald E, Giugliano RPEuropean heart journalRelationship between body mass index and outcomes in patients with atrial fibrillation treated with edoxaban or warfarin in the ENGAGE AF-TIMI 48 trial. Eur Heart J. 2019 05 14; 40(19):1541-1550.Eur Heart J2019-05-14T00:00:002019Relationship between body mass index and outcomes in patients with atrial fibrillation treated with edoxaban or warfarin in the ENGAGE AF-TIMI 48 trial.18926324Antman EMJournal of the American College of CardiologyTime is muscle: translation into practice. J Am Coll Cardiol. 2008 Oct 07; 52(15):1216-21.J Am Coll Cardiol2008-10-07T00:00:002008Time is muscle: translation into practice.Authorship 1131253Mahaffey KW, Cohen M, Garg J, Traylor L, Chen M, Antman E, Kleiman NS, GOodman SG, Berdan LG, Reist C, Langer A, White HD, Aylward PE, Col JJ, Ferguson JJ, Califf RMAm J CardiolLong-term outcomes in high-risk acute coronary syndrome patients managed with an early invasive strategy: six-month SYNERGY results. Am J Cardiol. 2004; 94(Suppl 6A):85E.2004-01-01T00:00:002004Long-term outcomes in high-risk acute coronary syndrome patients managed with an early invasive strategy: six-month SYNERGY resultsAcute Coronary Syndromes Monograph Series (EM Antman, ed.)"Unstable Angina; Non-Q-wave Myocardial Infarction". Acute Coronary Syndromes Monograph Series (EM Antman, ed.). 1998.1998-01-01T00:00:001998"Unstable Angina; Non-Q-wave Myocardial Infarction"3197810Goldberger AL, Rigney DR, Mietus J, Antman EM, Greenwald SExperientiaNonlinear dynamics in sudden cardiac death syndrome: heartrate oscillations and bifurcations. Experientia. 1988 Dec 01; 44(11-12):983-7.Experientia1988-12-01T00:00:001988Nonlinear dynamics in sudden cardiac death syndrome: heartrate oscillations and bifurcations.Giraldez RR, Antman EM, Giugliano RPThrombosis ClinicThe challenge of treating ST-segment elevation myocardial infarction in the elderly. Thrombosis Clinic. 2007; 1:27-41.2007-01-01T00:00:002007The challenge of treating ST-segment elevation myocardial infarction in the elderlyThe NHLBI Working Group on Atrial Fibrillation. Antman EM, DiMarco J, Domanski MJ, Knatterud GL, Scheinman M, Singer D, Walso A, Wolf PA, Wyse DGJournal of the American College of Cardiology"Atrial Fibrillation: Current Understandings and Research Imperatives". Journal of the American College of Cardiology. 1993; 22:1830-34.1993-01-01T00:00:001993"Atrial Fibrillation: Current Understandings and Research Imperatives"Antman EM. EditorCD-ROM series on Acute Coronary SyndromesCD-ROM series on Acute Coronary Syndromes. 1999.1999-01-01T00:00:001999CD-ROM series on Acute Coronary SyndromesAuthorship 1145315Antman EMAmerican Journal of CardiologyMaintaining sinus rhythm by antifibrillatory drugs in atrial fibrillation. American Journal of Cardiology. 1996; 78 (suppl.4):67-72.1996-01-01T00:00:001996Maintaining sinus rhythm by antifibrillatory drugs in atrial fibrillationAuthorship 1125051Authorship 1131272Authorship 10932616Authorship 1283764D009203Disorders1626116680.217433Myocardial InfarctionD001281Disorders92650030.260528Atrial FibrillationAuthorship 1203858D017984Chemicals & Drugs1253770.804197EnoxaparinD000789Disorders1929260.691062Angina, UnstableD013844Chemicals & Drugs55214880.572763ThiazolesHarvard CatalystMemberMedicineCardiologyBrigham and Women's HospitalDLB20DeepakBhattDeepak L. Bhatt, M.D.42.33510370000000-71.1061649000000081016Bhatt, DeepakVisiting Professor of MedicineCTR2ChristianRuffChristian Thomas Ruff, M.D.42.33510370000000-71.1061649000000066787Ruff, ChristianAssociate Professor of MedicineJAL42JaneLeopoldJane Anne Leopold, M.D.42.33837200000000-71.1032690000000085108Leopold, JaneAssociate Professor of MedicineDAM6DavidMorrowDavid Andrew Morrow, M.D.42.33510370000000-71.106164900000008518Morrow, DavidProfessor of MedicineKAF9KathrynBrittonKathryn Britton, M.D.42.33510370000000-71.1061649000000042449Britton, KathrynInstructor in Medicine11875selected publications111groups7.814680.00133402938research areas14.41220.00457003135coauthor of893.30966.381660similar toTAG1ThomasGazianoThomas Andrew Gaziano, M.D.42.33510370000000-71.1061649000000046027Gaziano, ThomasAssociate Professor of MedicineMM311MelanieMaytinMelanie Maytin, M.D.42.33510370000000-71.106164900000005771Maytin, MelanieInstructor in MedicineCYH3CarolynHoCarolyn Yung Ho, M.D.42.33510370000000-71.1061649000000065728Ho, CarolynAssociate Professor of MedicineRG51RajatGuptaRajat Gupta, M.D.42.33510370000000-71.106164900000001782Gupta, RajatAssistant Professor of MedicineSZG1SamuelGoldhaberSamuel Zachary Goldhaber, M.D.42.33510370000000-71.106164900000004477Goldhaber, SamuelProfessor of MedicineRPG1RobertGiuglianoRobert Patrick Giugliano, M.D.42.33864350000000-71.1068662000000065551Giugliano, RobertProfessor of MedicineCPC1ChristopherCannonChristopher Paul Cannon, M.D.42.33510370000000-71.1061649000000077834Cannon, ChristopherProfessor of MedicineEB3EugeneBraunwaldEugene Braunwald, M.D.42.33864350000000-71.1068662000000062123Braunwald, EugeneHersey Distinguished Professor of the Theory and Practice of PhysicAuthorship 1244621Authorship 1169876231296289Qamar A, Antman EM, Ruff CT, Nordio F, Murphy SA, Grip LT, Greenberger NJ, Yin OQP, Choi Y, Lanz HJ, Mercuri MF, Braunwald E, Giugliano RPJournal of the American College of CardiologyEdoxaban Versus Warfarin in Patients With Atrial Fibrillation and History of Liver Disease. J Am Coll Cardiol. 2019 07 16; 74(2):179-189.J Am Coll Cardiol2019-07-16T00:00:002019Edoxaban Versus Warfarin in Patients With Atrial Fibrillation and History of Liver Disease.Authorship 1344572Authorship 1177477731352829Park S, Bergmark BA, Shi M, Lanz HJ, Chung N, Ruff CT, Antman EM, Braunwald E, Giugliano RPHypertension (Dallas, Tex. : 1979)Edoxaban Versus Warfarin Stratified by Average Blood Pressure in 19 679 Patients With Atrial Fibrillation and a History of Hypertension in the ENGAGE AF-TIMI 48 Trial. Hypertension. 2019 09; 74(3):597-605.Hypertension2019-07-29T00:00:002019Edoxaban Versus Warfarin Stratified by Average Blood Pressure in 19 679 Patients With Atrial Fibrillation and a History of Hypertension in the ENGAGE AF-TIMI 48 Trial.Authorship 1267151Authorship 1338141Authorship 139121Authorship 1191265931532795Kwong RY, Heydari B, Ge Y, Abdullah S, Fujikura K, Kaneko K, Harris WS, Jerosch-Herold M, Antman EM, Seidman JG, Pfeffer MAPloS oneGenetic profiling of fatty acid desaturase polymorphisms identifies patients who may benefit from high-dose omega-3 fatty acids in cardiac remodeling after acute myocardial infarction-Post-hoc analysis from the OMEGA-REMODEL randomized controlled trial. PLoS One. 2019; 14(9):e0222061.PLoS One2019-09-18T00:00:002019Genetic profiling of fatty acid desaturase polymorphisms identifies patients who may benefit from high-dose omega-3 fatty acids in cardiac remodeling after acute myocardial infarction-Post-hoc analysis from the OMEGA-REMODEL randomized controlled trial.Authorship 1480404Authorship 1538292Authorship 1541941Authorship 1197365531597460Bergmark BA, Kamphuisen PW, Wiviott SD, Ruff CT, Antman EM, Nordio F, Kuder JF, Mercuri MF, Lanz HJ, Braunwald E, Giugliano RPCirculationComparison of Events Across Bleeding Scales in the ENGAGE AF-TIMI 48 Trial. Circulation. 2019 11 26; 140(22):1792-1801.Circulation2019-10-10T00:00:002019Comparison of Events Across Bleeding Scales in the ENGAGE AF-TIMI 48 Trial.Authorship 1106843Authorship 1587611Authorship 1590523Authorship 1613677Authorship 120306812Authorship 1203109231699290Qamar A, Antman EM, Giugliano RPJournal of the American College of CardiologyReply: Anticoagulants in Atrial Fibrillation and Liver Disease. J Am Coll Cardiol. 2019 11 12; 74(19):2436-2437.J Am Coll Cardiol2019-11-12T00:00:002019Reply: Anticoagulants in Atrial Fibrillation and Liver Disease.31687762Nicolau AM, Corbalan R, Nicolau JC, Ruff CT, Zierhut W, Kerschnitzki M, Duris T, Juul-Möller S, Voitk J, Trevisan M, Nordio F, Antman EM, Giugliano RPEuropean heart journal. Cardiovascular pharmacotherapyEfficacy and safety of edoxaban compared with warfarin according to the burden of diseases in patients with atrial fibrillation: insights from the ENGAGE AF-TIMI 48 trial. Eur Heart J Cardiovasc Pharmacother. 2020 07 01; 6(3):167-175.Eur Heart J Cardiovasc Pharmacother2020-07-01T00:00:002020Efficacy and safety of edoxaban compared with warfarin according to the burden of diseases in patients with atrial fibrillation: insights from the ENGAGE AF-TIMI 48 trial.Authorship 1338091true1Assistant Professor of MedicineAssistant Professor of Medicinetrue1Instructor in MedicineInstructor in Medicinetrue1Instructor in MedicineInstructor in Medicinetrue1Professor of MedicineProfessor of Medicinetrue1Professor of MedicineProfessor of Medicinetrue1Associate Professor of MedicineAssociate Professor of Medicinetrue1Associate Professor of MedicineAssociate Professor of Medicinetrue1Professor of MedicineProfessor of Medicinetrue1Professor of MedicineProfessor of MedicineAuthorship 1449197Authorship 1377161Authorship 1265285Authorship 1269641Authorship 1206802731777160Inciardi RM, Giugliano RP, Claggett B, Gupta DK, Chandra A, Ruff CT, Antman EM, Mercuri MF, Grosso MA, Braunwald E, Solomon SDEuropean journal of heart failureLeft atrial structure and function and the risk of death or heart failure in atrial fibrillation. Eur J Heart Fail. 2019 12; 21(12):1571-1579.Eur J Heart Fail2019-11-27T00:00:002019Left atrial structure and function and the risk of death or heart failure in atrial fibrillation.Authorship 1480912Authorship 1482432Authorship 1213820631865968Sarma AA, Braunwald E, Cannon CP, Guo J, Im K, Antman EM, Gibson CM, Newby LK, Giugliano RP, Morrow DA, Wiviott SD, Sabatine MS, O'Donoghue MLJournal of the American College of CardiologyOutcomes of Women Compared With Men After Non-ST-Segment Elevation Acute Coronary Syndromes. J Am Coll Cardiol. 2019 12 17; 74(24):3013-3022.J Am Coll Cardiol2019-12-09T00:00:002019Outcomes of Women Compared With Men After Non-ST-Segment Elevation Acute Coronary Syndromes.Authorship 1443823Authorship 13346512Authorship 1223136932008850Plitt A, Ruff CT, Goudev A, Morais J, Ostojic MC, Grosso MA, Lanz HJ, Park JG, Antman EM, Braunwald E, Giugliano RPInternational journal of cardiologyEfficacy and safety of edoxaban in patients with diabetes mellitus in the ENGAGE AF-TIMI 48 trial. Int J Cardiol. 2020 04 01; 304:185-191.Int J Cardiol2020-01-31T00:00:002020Efficacy and safety of edoxaban in patients with diabetes mellitus in the ENGAGE AF-TIMI 48 trial.Authorship 1227304432081368Sun MT, Huang S, Wiviott SD, Antman EM, Roe MT, Ohman EM, Neely M, Wallentin L, Wong CXThe American journal of cardiologyMeta-Analysis of Intraocular Bleeding With Dual Antiplatelet Therapy Using P2Y12 Inhibitors Prasugrel or Ticagrelor. Am J Cardiol. 2020 04 15; 125(8):1280-1283.Am J Cardiol2020-01-29T00:00:002020Meta-Analysis of Intraocular Bleeding With Dual Antiplatelet Therapy Using P2Y12 Inhibitors Prasugrel or Ticagrelor.Authorship 160341Authorship 1310024Authorship 1233636432164882Scirica BM, Bergmark BA, Morrow DA, Antman EM, Bonaca MP, Murphy SA, Sabatine MS, Braunwald E, Wiviott SDJournal of the American College of CardiologyNonculprit Lesion Myocardial Infarction Following Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrome. J Am Coll Cardiol. 2020 03 17; 75(10):1095-1106.J Am Coll Cardiol2020-03-17T00:00:002020Nonculprit Lesion Myocardial Infarction Following Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrome.Authorship 1237277132227752Antman EM, Braunwald EThe New England journal of medicineManaging Stable Ischemic Heart Disease. N Engl J Med. 2020 04 09; 382(15):1468-1470.N Engl J Med2020-03-30T00:00:002020Managing Stable Ischemic Heart Disease.Authorship 1799924Authorship 1813586Authorship 1256447532505370Dietz N, Ruff C, Giugliano RP, Mercuri MF, Antman EMInternational journal of cardiologyPharmacogenetic-guided and clinical warfarin dosing algorithm assessments with bleeding outcomes risk-stratified by genetic and covariate subgroups. Int J Cardiol. 2020 Oct 15; 317:159-166.Int J Cardiol2020-03-21T00:00:002020Pharmacogenetic-guided and clinical warfarin dosing algorithm assessments with bleeding outcomes risk-stratified by genetic and covariate subgroups.Authorship 13332710Authorship 1544236Authorship 1565056Authorship 1271591232717043Petkova E, Antman EM, Troxel ABJAMAPooling Data From Individual Clinical Trials in the COVID-19 Era. JAMA. 2020 Aug 11; 324(6):543-545.JAMA2020-08-11T00:00:002020Pooling Data From Individual Clinical Trials in the COVID-19 Era.Authorship 1282446132877597Antman EM, Braunwald EThe New England journal of medicineInvasive or Conservative Strategy for Stable Coronary Disease. Reply. N Engl J Med. 2020 Sep 03; 383(10):e66.N Engl J Med2020-09-03T00:00:002020Invasive or Conservative Strategy for Stable Coronary Disease. Reply.Authorship 1320002Authorship 1410833Authorship 1283400632920808Boriani G, Ruff CT, Kuder JF, Shi M, Lanz HJ, Antman EM, Braunwald E, Giugliano RPThrombosis and haemostasisEdoxaban versus Warfarin in Patients with Atrial Fibrillation at the Extremes of Body Weight: An Analysis from the ENGAGE AF-TIMI 48 Trial. Thromb Haemost. 2021 Feb; 121(2):140-149.Thromb Haemost2020-09-13T00:00:002020Edoxaban versus Warfarin in Patients with Atrial Fibrillation at the Extremes of Body Weight: An Analysis from the ENGAGE AF-TIMI 48 Trial.Authorship 20344312Authorship 1297533633063112Plitt A, Zelniker TA, Park JG, McGuire DK, Ruff CT, Antman EM, Braunwald E, Giugliano RPEuropean heart journal. Cardiovascular pharmacotherapyPatients with diabetes mellitus and atrial fibrillation treated with non-vitamin K antagonist oral anticoagulants: meta-analysis of eight outcomes in 58 634 patients across four randomized controlled trials. Eur Heart J Cardiovasc Pharmacother. 2021 04 09; 7(FI1):f40-f49.Eur Heart J Cardiovasc Pharmacother2021-04-09T00:00:002021Patients with diabetes mellitus and atrial fibrillation treated with non-vitamin K antagonist oral anticoagulants: meta-analysis of eight outcomes in 58 634 patients across four randomized controlled trials.Authorship 1475952true1Associate Professor of MedicineAssociate Professor of MedicineAuthorship 1350171Authorship 1298738533115823Fader KA, Zhang J, Menetski JP, Thadhani RI, Antman EM, Friedman GS, Ramaiah SK, Vaidya VSThe Journal of pharmacology and experimental therapeuticsA Biomarker-Centric Approach to Drug Discovery and Development: Lessons Learned from the Coronavirus Disease 2019 Pandemic. J Pharmacol Exp Ther. 2021 01; 376(1):12-20.J Pharmacol Exp Ther2020-10-28T00:00:002020A Biomarker-Centric Approach to Drug Discovery and Development: Lessons Learned from the Coronavirus Disease 2019 Pandemic.33185476Marston NA, Patel PN, Kamanu FK, Nordio F, Melloni GM, Roselli C, Gurmu Y, Weng LC, Bonaca MP, Giugliano RP, Scirica BM, O'Donoghue ML, Cannon CP, Anderson CD, Bhatt DL, Gabriel Steg P, Cohen M, Storey RF, Sever P, Keech AC, Raz I, Mosenzon O, Antman EM, Braunwald E, Ellinor PT, Lubitz SA, Sabatine MS, Ruff CTCirculationClinical Application of a Novel Genetic Risk Score for Ischemic Stroke in Patients With Cardiometabolic Disease. Circulation. 2021 02 02; 143(5):470-478.Circulation2020-11-13T00:00:002020Clinical Application of a Novel Genetic Risk Score for Ischemic Stroke in Patients With Cardiometabolic Disease.Authorship 130547823Authorship 1304349433148013Vilain K, Li H, Kwong WJ, Antman EM, Ruff CT, Braunwald E, Cohen DJ, Giugliano RP, Magnuson EACirculation. Cardiovascular quality and outcomesCardiovascular- and Bleeding-Related Hospitalization Rates With Edoxaban Versus Warfarin in Patients With Atrial Fibrillation Based on Results of the ENGAGE AF-TIMI 48 Trial. Circ Cardiovasc Qual Outcomes. 2020 11; 13(11):e006511.Circ Cardiovasc Qual Outcomes2020-11-05T00:00:002020Cardiovascular- and Bleeding-Related Hospitalization Rates With Edoxaban Versus Warfarin in Patients With Atrial Fibrillation Based on Results of the ENGAGE AF-TIMI 48 Trial.Authorship 1319893333446422Nelson SE, Giugliano RP, Antman EM, Park JG, Norden AD, Rost NS, Silverman S, Singhal AB, Lanz HJ, Braunwald E, Ruff CTJournal of clinical neuroscience : official journal of the Neurosurgical Society of AustralasiaIntracranial hemorrhage in patients with atrial fibrillation receiving anticoagulation with warfarin or edoxaban: An in-depth analysis from the ENGAGE AF-TIMI 48 randomized trial. J Clin Neurosci. 2021 Apr; 86:294-300.J Clin Neurosci2021-01-12T00:00:002021Intracranial hemorrhage in patients with atrial fibrillation receiving anticoagulation with warfarin or edoxaban: An in-depth analysis from the ENGAGE AF-TIMI 48 randomized trial.Authorship 13238041033493453de Groot JR, Ruff CT, Murphy SA, Hamershock RA, Vehmeijer JT, Oude Ophuis AJM, Grip L, Lanz H, Mercuri MF, Antman EM, Giugliano RPAmerican heart journalEdoxaban versus warfarin in patients with atrial fibrillation in relation to the risk of stroke: A secondary analysis of the ENGAGE AF-TIMI 48 study. Am Heart J. 2021 05; 235:132-139.Am Heart J2021-01-22T00:00:002021Edoxaban versus warfarin in patients with atrial fibrillation in relation to the risk of stroke: A secondary analysis of the ENGAGE AF-TIMI 48 study.Authorship 13286451933558758Cheng F, Zhao J, Wang Y, Lu W, Liu Z, Zhou Y, Martin WR, Wang R, Huang J, Hao T, Yue H, Ma J, Hou Y, Castrillon JA, Fang J, Lathia JD, Keri RA, Lightstone FC, Antman EM, Rabadan R, Hill DE, Eng C, Vidal M, Loscalzo JNature geneticsComprehensive characterization of protein-protein interactions perturbed by disease mutations. Nat Genet. 2021 03; 53(3):342-353.Nat Genet2021-02-08T00:00:002021Comprehensive characterization of protein-protein interactions perturbed by disease mutations.Authorship 13318762Authorship 13316005Authorship 13318391033587659Zelniker TA, Ardissino M, Andreotti F, O'Donoghue ML, Yin O, Park JG, Murphy SA, Ruff CT, Lanz HJ, Antman EM, Braunwald E, Giugliano RP, Merlini PACirculationComparison of the Efficacy and Safety Outcomes of Edoxaban in 8040 Women Versus 13 065 Men With Atrial Fibrillation in the ENGAGE AF-TIMI 48 Trial. Circulation. 2021 02 16; 143(7):673-684.Circulation2021-02-15T00:00:002021Comparison of the Efficacy and Safety Outcomes of Edoxaban in 8040 Women Versus 13 065 Men With Atrial Fibrillation in the ENGAGE AF-TIMI 48 Trial.33587654Lau ES, Braunwald E, Morrow DA, Giugliano RP, Antman EM, Gibson CM, Scirica BM, Bohula EA, Wiviott SD, Bhatt DL, Bonaca MP, Cannon CP, Im K, Guo J, Sabatine MS, O'Donoghue MLCirculationSex, Permanent Drug Discontinuation, and Study Retention in Clinical Trials: Insights From the TIMI trials. Circulation. 2021 02 16; 143(7):685-695.Circulation2021-02-15T00:00:002021Sex, Permanent Drug Discontinuation, and Study Retention in Clinical Trials: Insights From the TIMI trials.33599361Braunwald E, Antman EMEuropean journal of heart failureThe path to universality. Eur J Heart Fail. 2021 03; 23(3):381-383.Eur J Heart Fail2021-03-11T00:00:002021The path to universality.Authorship 2178462Authorship 1962971Authorship 1335500833663737Steffel J, Ruff CT, Yin O, Braunwald E, Park JG, Murphy SA, Connolly S, Antman EM, Giugliano RPJournal of the American College of CardiologyRandomized, Double-Blind Comparison of Half-Dose Versus Full-Dose Edoxaban in 14,014 Patients With Atrial Fibrillation. J Am Coll Cardiol. 2021 03 09; 77(9):1197-1207.J Am Coll Cardiol2021-03-09T00:00:002021Randomized, Double-Blind Comparison of Half-Dose Versus Full-Dose Edoxaban in 14,014 Patients With Atrial Fibrillation.Authorship 1556616Authorship 13416741033760027Oyama K, Giugliano RP, Berg DD, Ruff CT, Jarolim P, Tang M, Murphy SA, Lanz HJ, Grosso MA, Antman EM, Braunwald E, Morrow DAEuropean heart journalSerial assessment of biomarkers and the risk of stroke or systemic embolism and bleeding in patients with atrial fibrillation in the ENGAGE AF-TIMI 48 trial. Eur Heart J. 2021 05 01; 42(17):1698-1706.Eur Heart J2021-05-01T00:00:002021Serial assessment of biomarkers and the risk of stroke or systemic embolism and bleeding in patients with atrial fibrillation in the ENGAGE AF-TIMI 48 trial.Authorship 1344833333801949Leopold JA, Davis RB, Antman EMJournal of personalized medicineData from Digital Health Devices Informs Ideal Cardiovascular Health. J Pers Med. 2021 Mar 10; 11(3).J Pers Med2021-03-10T00:00:002021Data from Digital Health Devices Informs Ideal Cardiovascular Health.Authorship 2021852Authorship 1346560233840208Churchwell K, Antman E, Birnbaum J, Desai NR, Harrington RA, Holubowich EJ, Ivy KN, Schoeberl M, Warner JJ, White CJ, Whitsel LP, Yancy CCirculationNonprofit Advocacy at the American Heart Association: Creating a Visionary Way Forward at Our 40th Anniversary: An American Heart Association Policy Statement. Circulation. 2021 05 11; 143(19):e947-e958.Circulation2021-04-12T00:00:002021Nonprofit Advocacy at the American Heart Association: Creating a Visionary Way Forward at Our 40th Anniversary: An American Heart Association Policy Statement.Authorship 13562995933999548Jones WS, Mulder H, Wruck LM, Pencina MJ, Kripalani S, Muñoz D, Crenshaw DL, Effron MB, Re RN, Gupta K, Anderson RD, Pepine CJ, Handberg EM, Manning BR, Jain SK, Girotra S, Riley D, DeWalt DA, Whittle J, Goldberg YH, Roger VL, Hess R, Benziger CP, Farrehi P, Zhou L, Ford DE, Haynes K, VanWormer JJ, Knowlton KU, Kraschnewski JL, Polonsky TS, Fintel DJ, Ahmad FS, McClay JC, Campbell JR, Bell DS, Fonarow GC, Bradley SM, Paranjape A, Roe MT, Robertson HR, Curtis LH, Sharlow AG, Berdan LG, Hammill BG, Harris DF, Qualls LG, Marquis-Gravel G, Modrow MF, Marcus GM, Carton TW, Nauman E, Waitman LR, Kho AN, Shenkman EA, McTigue KM, Kaushal R, Masoudi FA, Antman EM, Davidson DR, Edgley K, Merritt JG, Brown LS, Zemon DN, McCormick TE, Alikhaani JD, Gregoire KC, Rothman RL, Harrington RA, Hernandez AFThe New England journal of medicineComparative Effectiveness of Aspirin Dosing in Cardiovascular Disease. N Engl J Med. 2021 05 27; 384(21):1981-1990.N Engl J Med2021-05-15T00:00:002021Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease.Authorship 1535952Authorship 1765711Authorship 180572Authorship 182033Authorship 13703592Authorship 1373190334205862Leopold JA, Antman EMJournal of clinical medicineIdeal Cardiovascular Health in Former Smokers. J Clin Med. 2021 Jun 01; 10(11).J Clin Med2021-06-01T00:00:002021Ideal Cardiovascular Health in Former Smokers.34167651Steffel J, Ruff CT, Antman EM, Braunwald E, Giugliano RPJournal of the American College of CardiologyReply: Do We Need to Define Therapeutic Ranges for Edoxaban Plasma Concentration? J Am Coll Cardiol. 2021 06 29; 77(25):3232-3233.J Am Coll Cardiol2021-06-29T00:00:002021Reply: Do We Need to Define Therapeutic Ranges for Edoxaban Plasma Concentration?Authorship 1377366234290276Leopold JA, Antman EMScientific reportsA precision medicine approach to sex-based differences in ideal cardiovascular health. Sci Rep. 2021 07 21; 11(1):14848.Sci Rep2021-07-21T00:00:002021A precision medicine approach to sex-based differences in ideal cardiovascular health.Authorship 1382129834353540Berg DD, Giugliano RP, Ruff CT, Tang M, Im K, Jarolim P, Rutman H, Antman EM, Braunwald E, Morrow DAJournal of the American College of CardiologyA Targeted Proteomic Approach Identifies Novel Biomarkers of Arterial Thromboembolic Risk in ENGAGE AF-TIMI 48. J Am Coll Cardiol. 2021 08 10; 78(6):634-636.J Am Coll Cardiol2021-08-10T00:00:002021A Targeted Proteomic Approach Identifies Novel Biomarkers of Arterial Thromboembolic Risk in ENGAGE AF-TIMI 48.Authorship 1383822134367681Antman EM, Freeman MW, Golan DE, Kitterman R, McKenna E, Parrish J, Vaughan C, Watts L, Loscalzo JJournal of clinical and translational scienceAn overview of the process, progress, and outcomes of a National Center for Accelerated Innovation: The Boston Biomedical Innovation Center Experience. J Clin Transl Sci. 2021; 5(1):e137.J Clin Transl Sci2021-05-17T00:00:002021An overview of the process, progress, and outcomes of a National Center for Accelerated Innovation: The Boston Biomedical Innovation Center Experience.Authorship 1393755234532668Kuntz RE, Antman EM, Califf RM, Ingelfinger JR, Krumholz HM, Ommaya A, Peterson ED, Ross JS, Waldstreicher J, Wang SV, Zarin DA, Whicher DM, Siddiqi SM, Lopez MHNAM perspectivesIndividual Patient-Level Data Sharing for Continuous Learning: A Strategy for Trial Data Sharing. NAM Perspect. 2019; 2019.NAM Perspect2019-07-01T00:00:002019Individual Patient-Level Data Sharing for Continuous Learning: A Strategy for Trial Data Sharing.Authorship 1874587Authorship 1403360234649522Leopold JA, Antman EMBMC cardiovascular disordersDigital health device measured sleep duration and ideal cardiovascular health: an observational study. BMC Cardiovasc Disord. 2021 10 14; 21(1):497.BMC Cardiovasc Disord2021-10-14T00:00:002021Digital health device measured sleep duration and ideal cardiovascular health: an observational study.Authorship 1937601Authorship 2069292Authorship 2173752Authorship 1411289534810179Lauffenburger JC, Haff N, McDonnell ME, Solomon DH, Antman EM, Glynn RJ, Choudhry NKBMJ openExploring patient experiences coping with using multiple medications: a qualitative interview study. BMJ Open. 2021 11 22; 11(11):e046860.BMJ Open2021-11-22T00:00:002021Exploring patient experiences coping with using multiple medications: a qualitative interview study.Authorship 1450402Authorship 2288236Authorship 142268210Authorship 1423246234962979Bonaca MP, Antman EM, Cunningham JW, Wiviott SD, Murphy SA, Halperin JL, Weitz JI, Grosso MA, Lanz HJ, Braunwald E, Giugliano RP, Ruff CTEuropean heart journal. Cardiovascular pharmacotherapyIschaemic and bleeding risk in atrial fibrillation with and without peripheral artery disease and efficacy and safety of full- and half-dose edoxaban vs. warfarin: insights from ENGAGE AF-TIMI 48. Eur Heart J Cardiovasc Pharmacother. 2022 Sep 29; 8(7):695-706.Eur Heart J Cardiovasc Pharmacother2022-09-29T00:00:002022Ischaemic and bleeding risk in atrial fibrillation with and without peripheral artery disease and efficacy and safety of full- and half-dose edoxaban vs. warfarin: insights from ENGAGE AF-TIMI 48.34990581Gencer B, Eisen A, Berger D, Nordio F, Murphy SA, Grip LT, Chen C, Lanz H, Ruff CT, Antman EM, Braunwald E, Giugliano RPAmerican heart journalEdoxaban versus Warfarin in high-risk patients with atrial fibrillation: A comprehensive analysis of high-risk subgroups. Am Heart J. 2022 05; 247:24-32.Am Heart J2022-01-03T00:00:002022Edoxaban versus Warfarin in high-risk patients with atrial fibrillation: A comprehensive analysis of high-risk subgroups.Authorship 142816331Authorship 14278863635076698Park H, Tarpey T, Liu M, Goldfeld K, Wu Y, Wu D, Li Y, Zhang J, Ganguly D, Ray Y, Paul SR, Bhattacharya P, Belov A, Huang Y, Villa C, Forshee R, Verdun NC, Yoon HA, Agarwal A, Simonovich VA, Scibona P, Burgos Pratx L, Belloso W, Avendaño-Solá C, Bar KJ, Duarte RF, Hsue PY, Luetkemeyer AF, Meyfroidt G, Nicola AM, Mukherjee A, Ortigoza MB, Pirofski LA, Rijnders BJA, Troxel A, Antman EM, Petkova EJAMA network openDevelopment and Validation of a Treatment Benefit Index to Identify Hospitalized Patients With COVID-19 Who May Benefit From Convalescent Plasma. JAMA Netw Open. 2022 01 04; 5(1):e2147375.JAMA Netw Open2022-01-04T00:00:002022Development and Validation of a Treatment Benefit Index to Identify Hospitalized Patients With COVID-19 Who May Benefit From Convalescent Plasma.35076699Troxel AB, Petkova E, Goldfeld K, Liu M, Tarpey T, Wu Y, Wu D, Agarwal A, Avendaño-Solá C, Bainbridge E, Bar KJ, Devos T, Duarte RF, Gharbharan A, Hsue PY, Kumar G, Luetkemeyer AF, Meyfroidt G, Nicola AM, Mukherjee A, Ortigoza MB, Pirofski LA, Rijnders BJA, Rokx C, Sancho-Lopez A, Shaw P, Tebas P, Yoon HA, Grudzen C, Hochman J, Antman EMJAMA network openAssociation of Convalescent Plasma Treatment With Clinical Status in Patients Hospitalized With COVID-19: A Meta-analysis. JAMA Netw Open. 2022 01 04; 5(1):e2147331.JAMA Netw Open2022-01-04T00:00:002022Association of Convalescent Plasma Treatment With Clinical Status in Patients Hospitalized With COVID-19: A Meta-analysis.Authorship 2118821Authorship 2140931Authorship 2267599Authorship 1429788435106506Bazoukis G, Hall J, Loscalzo J, Antman EM, Fuster V, Armoundas AACell reports. MedicineThe inclusion of augmented intelligence in medicine: A framework for successful implementation. Cell Rep Med. 2022 01 18; 3(1):100485.Cell Rep Med2022-01-18T00:00:002022The inclusion of augmented intelligence in medicine: A framework for successful implementation.Authorship 242092Authorship 2634018Authorship 1436272235252395Leopold JA, Antman EMFrontiers in cardiovascular medicineIdeal Cardiovascular Health in Young Adults With Established Cardiovascular Diseases. Front Cardiovasc Med. 2022; 9:814610.Front Cardiovasc Med2022-02-17T00:00:002022Ideal Cardiovascular Health in Young Adults With Established Cardiovascular Diseases.Authorship 3307262Authorship 3510007Authorship 3519793Authorship 3528948Authorship 3627207Authorship 3707549Authorship 37992017Authorship 382514636017608Patel SM, Palazzolo MG, Murphy SA, Antman EM, Braunwald E, Lanz HJ, Lip GYH, Giugliano RP, Ruff CTEuropace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of CardiologyEvaluation of the atrial fibrillation better care pathway in the ENGAGE AF-TIMI 48 trial. Europace. 2022 Nov 22; 24(11):1730-1738.Europace2022-11-22T00:00:002022Evaluation of the atrial fibrillation better care pathway in the ENGAGE AF-TIMI 48 trial.Authorship 1648543Authorship 14907031Authorship 14844544Authorship 1488838136198177Antman EM, Leopold JA, Sauer WH, Zei PCThe New England journal of medicineAtrial Fibrillation and Catheter Ablation. N Engl J Med. 2022 10 06; 387(14):e31.N Engl J Med2022-10-06T00:00:002022Atrial Fibrillation and Catheter Ablation.36260791Antman EM, Leopold JA, Sauer WH, Zei PCThe New England journal of medicineAtrial Fibrillation - What Is It and How Is It Treated? N Engl J Med. 2022 10 20; 387(16):e38.N Engl J Med2022-10-20T00:00:002022Atrial Fibrillation - What Is It and How Is It Treated?Authorship 1527013736812603Späth J, Matschinske J, Kamanu FK, Murphy SA, Zolotareva O, Bakhtiari M, Antman EM, Loscalzo J, Brauneck A, Schmalhorst L, Buchholtz G, Baumbach JPLOS digital healthPrivacy-aware multi-institutional time-to-event studies. PLOS Digit Health. 2022 Sep; 1(9):e0000101.PLOS Digit Health2022-09-06T00:00:002022Privacy-aware multi-institutional time-to-event studies.Authorship 1757032Authorship 1820292Authorship 19450815Authorship 2178746Authorship 2591892Authorship 2659251Authorship 15531088Authorship 15586579Authorship 15539702Authorship 15588389Authorship 1570576837211048Fagundes A, Ruff CT, Morrow DA, Murphy SA, Palazzolo MG, Chen CZ, Jarolim P, Antman EM, Braunwald E, Giugliano RPInternational journal of cardiologyNeutrophil-lymphocyte ratio and clinical outcomes in 19,697 patients with atrial fibrillation: Analyses from ENGAGE AF- TIMI 48 trial. Int J Cardiol. 2023 09 01; 386:118-124.Int J Cardiol2023-05-19T00:00:002023Neutrophil-lymphocyte ratio and clinical outcomes in 19,697 patients with atrial fibrillation: Analyses from ENGAGE AF- TIMI 48 trial.37100536Inciardi RM, Giugliano RP, Park JG, Nordio F, Ruff CT, Chen C, Lanz HJ, Antman EM, Braunwald E, Solomon SDJACC. Clinical electrophysiologyRisks of Heart Failure, Stroke, and Bleeding in Atrial Fibrillation According to Heart Failure Phenotypes. JACC Clin Electrophysiol. 2023 04; 9(4):569-580.JACC Clin Electrophysiol2023-02-22T00:00:002023Risks of Heart Failure, Stroke, and Bleeding in Atrial Fibrillation According to Heart Failure Phenotypes.37019195Mills EW, Cassidy M, Sofer T, Tadros T, Zei P, Sauer W, Romero J, Martin D, Antman EM, Javaheri SAmerican heart journalEvaluation of obstructive sleep apnea among consecutive patients with all patterns of atrial fibrillation using WatchPAT home sleep testing. Am Heart J. 2023 07; 261:95-103.Am Heart J2023-04-03T00:00:002023Evaluation of obstructive sleep apnea among consecutive patients with all patterns of atrial fibrillation using WatchPAT home sleep testing.37127146Mills EW, Antman EM, Javaheri SHeart rhythmBreathless nights and heart flutters: Understanding the relationship between obstructive sleep apnea and atrial fibrillation. Heart Rhythm. 2023 09; 20(9):1267-1273.Heart Rhythm2023-04-29T00:00:002023Breathless nights and heart flutters: Understanding the relationship between obstructive sleep apnea and atrial fibrillation.36987929Oyama K, Giugliano RP, Ruff CT, Berg DD, Jarolim P, Tang M, Park JG, Lanz HJ, Antman EM, Braunwald E, Morrow DAEuropean journal of heart failureSerial assessment of biomarkers and heart failure outcomes in patients with atrial fibrillation. Eur J Heart Fail. 2023 06; 25(6):832-841.Eur J Heart Fail2023-04-18T00:00:002023Serial assessment of biomarkers and heart failure outcomes in patients with atrial fibrillation.Authorship 2095001Authorship 2949342Authorship 2215733Authorship 3408933Authorship 3798127Authorship 1538176Authorship 39006719true1Professor of MedicineProfessor of Medicinetrue1Hersey Distinguished Professor of the Theory and Practice of PhysicHersey Distinguished Professor of the Theory and Practice of Physictrue1Visiting Professor of MedicineVisiting Professor of MedicineAuthorship 4337578Authorship 438272237949625Lauffenburger JC, Tesfaye H, Solomon DH, Antman EM, Glynn RJ, Lee SB, Tong A, Choudhry NKBMJ openInvestigating the ability to adhere to cardiometabolic medications with different properties: a retrospective cohort study of >500 000 patients in the USA. BMJ Open. 2023 11 10; 13(11):e075840.BMJ Open2023-11-10T00:00:002023Investigating the ability to adhere to cardiometabolic medications with different properties: a retrospective cohort study of >500 000 patients in the USA.Authorship 1680902Authorship 1680971Authorship 1772602Authorship 4873693Authorship 16095324Authorship 514293238264923Patel SM, Braunwald E, Steffel J, Boriani G, Palazzolo MG, Antman EM, Bohula EA, Carnicelli AP, Connolly SJ, Eikelboom J, Gencer B, Granger CB, Morrow DA, Patel MR, Wallentin L, Ruff CT, Giugliano RPCirculationEfficacy and Safety of Non-Vitamin-K Antagonist Oral Anticoagulants Versus Warfarin Across the Spectrum of Body Mass Index and Body Weight: An Individual Patient Data Meta-Analysis of Four Randomized Clinical Trials of 58?464 Patients With Atrial Fibrillation. Circulation. 2024 Jan 24.Circulation2024-01-24T00:00:002024Efficacy and Safety of Non-Vitamin-K Antagonist Oral Anticoagulants Versus Warfarin Across the Spectrum of Body Mass Index and Body Weight: An Individual Patient Data Meta-Analysis of Four Randomized Clinical Trials of 58?464 Patients With Atrial Fibrillation.Authorship 16234016Authorship 5719075Authorship 586938Authorship 592402Authorship 16298531038416462Small AM, Melloni GEM, Kamanu FK, Bergmark BA, Bonaca MP, O'Donoghue ML, Giugliano RP, Scirica BM, Bhatt D, Antman EM, Raz I, Wiviott SD, Truong B, Wilson PWF, Cho K, O'Donnell CJ, Braunwald E, Lubitz SA, Ellinor P, Peloso GM, Ruff CT, Sabatine MS, Natarajan P, Marston NAJAMA cardiologyNovel Polygenic Risk Score and Established Clinical Risk Factors for Risk Estimation of Aortic Stenosis. JAMA Cardiol. 2024 Feb 28.JAMA Cardiol2024-02-28T00:00:002024Novel Polygenic Risk Score and Established Clinical Risk Factors for Risk Estimation of Aortic Stenosis.Authorship 52545815true1Associate Professor of MedicineAssociate Professor of MedicineAuthorship 5514328Authorship 580383Authorship 582168Authorship 593638Authorship 594410Authorship 596232Authorship 614378Authorship 618746Authorship 1630749Authorship 2344557Authorship 2348512Authorship 2364443Authorship 2546552Authorship 29814512Authorship 3095342Authorship 3406778Authorship 3445337Authorship 4866081Authorship 2586544Authorship 26890219Authorship 3168664Authorship 3302662Authorship 493598Authorship 597893Authorship 603637Authorship 610662Authorship 612546Authorship 6549531Authorship 663627323639841Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE, Chavey WE, Fesmire FM, Hochman JS, Levin TN, Lincoff AM, Peterson ED, Theroux P, Wenger NK, Wright RS, Jneid H, Ettinger SM, Ganiats TG, Philippides GJ, Jacobs AK, Halperin JL, Albert NM, Creager MA, DeMets D, Guyton RA, Kushner FG, Ohman EM, Stevenson W, Yancy CWJournal of the American College of Cardiology2012 ACCF/AHA focused update incorporated into the ACCF/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013 Jun 11; 61(23):e179-347.J Am Coll Cardiol2013-04-29T00:00:0020132012 ACCF/AHA focused update incorporated into the ACCF/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.23788526Antman EMCirculationBypassing the emergency department to improve the process of care for ST-elevation myocardial infarction: necessary but not sufficient. Circulation. 2013 Jul 23; 128(4):322-4.Circulation2013-06-20T00:00:002013Bypassing the emergency department to improve the process of care for ST-elevation myocardial infarction: necessary but not sufficient.Authorship 616539Authorship 616944Authorship 624781Authorship 90442Authorship 1771792Authorship 621755Authorship 627458Authorship 629203Authorship 2080922Authorship 764111Authorship 4976196Authorship 501649Authorship 5496266Authorship 1877297Authorship 1938391Authorship 2027932Authorship 5611364Authorship 5661242Authorship 580956Authorship 2419073Authorship 677423424030410Kulik A, Desai NR, Shrank WH, Antman EM, Glynn RJ, Levin R, Reisman L, Brennan T, Choudhry NKCirculationFull prescription coverage versus usual prescription coverage after coronary artery bypass graft surgery: analysis from the post-myocardial infarction free Rx event and economic evaluation (FREEE) randomized trial. Circulation. 2013 Sep 10; 128(11 Suppl 1):S219-25.Circulation2013-09-10T00:00:002013Full prescription coverage versus usual prescription coverage after coronary artery bypass graft surgery: analysis from the post-myocardial infarction free Rx event and economic evaluation (FREEE) randomized trial.Authorship 2620789Authorship 3456721Authorship 692644624064010Mogabgab O, Wiviott SD, Cannon CP, Sloan S, Sabatine MS, Antman EM, Braunwald E, Giugliano RPJournal of cardiovascular pharmacology and therapeuticsCircadian variation of stent thrombosis and the effect of more robust platelet inhibition: a post hoc analysis of the TRITON-TIMI 38 trial. J Cardiovasc Pharmacol Ther. 2013 Nov; 18(6):555-9.J Cardiovasc Pharmacol Ther2013-09-24T00:00:002013Circadian variation of stent thrombosis and the effect of more robust platelet inhibition: a post hoc analysis of the TRITON-TIMI 38 trial.Authorship 6944492124251359Giugliano RP, Ruff CT, Braunwald E, Murphy SA, Wiviott SD, Halperin JL, Waldo AL, Ezekowitz MD, Weitz JI, Špinar J, Ruzyllo W, Ruda M, Koretsune Y, Betcher J, Shi M, Grip LT, Patel SP, Patel I, Hanyok JJ, Mercuri M, Antman EMThe New England journal of medicineEdoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2013 Nov 28; 369(22):2093-104.N Engl J Med2013-11-19T00:00:002013Edoxaban versus warfarin in patients with atrial fibrillation.Authorship 22607010Authorship 3662915Authorship 25642417Authorship 2328603Authorship 606091Authorship 6984313Authorship 6987011024332142Choudhry NK, Glynn RJ, Avorn J, Lee JL, Brennan TA, Reisman L, Toscano M, Levin R, Matlin OS, Antman EM, Shrank WHAmerican heart journalUntangling the relationship between medication adherence and post-myocardial infarction outcomes: medication adherence and clinical outcomes. Am Heart J. 2014 Jan; 167(1):51-58.e5.Am Heart J2013-10-17T00:00:002013Untangling the relationship between medication adherence and post-myocardial infarction outcomes: medication adherence and clinical outcomes.24239201Ojeifo O, Wiviott SD, Antman EM, Murphy SA, Udell JA, Bates ER, Mega JL, Sabatine MS, O'Donoghue MLJACC. Cardiovascular interventionsConcomitant administration of clopidogrel with statins or calcium-channel blockers: insights from the TRITON-TIMI 38 (trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction 38). JACC Cardiovasc Interv. 2013 Dec; 6(12):1275-81.JACC Cardiovasc Interv2013-11-13T00:00:002013Concomitant administration of clopidogrel with statins or calcium-channel blockers: insights from the TRITON-TIMI 38 (trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction 38).Authorship 700123424052087Bohula May EA, Bonaca MP, Jarolim P, Antman EM, Braunwald E, Giugliano RP, Newby LK, Sabatine MS, Morrow DAClinical chemistryPrognostic performance of a high-sensitivity cardiac troponin I assay in patients with non-ST-elevation acute coronary syndrome. Clin Chem. 2014 Jan; 60(1):158-64.Clin Chem2013-09-19T00:00:002013Prognostic performance of a high-sensitivity cardiac troponin I assay in patients with non-ST-elevation acute coronary syndrome.Authorship 702067124401650Antman E, Arnett D, Jessup M, Sherwin CJournal of the American Heart AssociationThe 50th anniversary of the US surgeon general's report on tobacco: what we've accomplished and where we go from here. J Am Heart Assoc. 2014 Jan 08; 3(1):e000740.J Am Heart Assoc2014-01-08T00:00:002014The 50th anniversary of the US surgeon general's report on tobacco: what we've accomplished and where we go from here.Authorship 2346091Authorship 23949313Authorship 2684712Authorship 7046691Authorship 705060524458978Antman EBMJ (Clinical research ed.)Data sharing in research: benefits and risks for clinicians. BMJ. 2014 Jan 23; 348:g237.BMJ2014-01-23T00:00:002014Data sharing in research: benefits and risks for clinicians.24140678Kohli P, Udell JA, Murphy SA, Cannon CP, Antman EM, Braunwald E, Wiviott SDJournal of the American College of CardiologyDischarge aspirin dose and clinical outcomes in patients with acute coronary syndromes treated with prasugrel versus clopidogrel: an analysis from the TRITON-TIMI 38 study (trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction 38). J Am Coll Cardiol. 2014 Jan 28; 63(3):225-32.J Am Coll Cardiol2013-10-16T00:00:002013Discharge aspirin dose and clinical outcomes in patients with acute coronary syndromes treated with prasugrel versus clopidogrel: an analysis from the TRITON-TIMI 38 study (trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction 38).Authorship 2335683Authorship 23397818Authorship 3891118Authorship 2752131Authorship 615947Authorship 1760242Authorship 2688622Authorship 619130Authorship 625804Authorship 28408531Authorship 4273532Authorship 4605985Authorship 2849751Authorship 31255516Authorship 47650510Authorship 2072910Authorship 71116544Authorship 71863137Authorship 7200133Authorship 72323012Authorship 336944Authorship 717850122958960Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, Thygesen K, Alpert JS, White HD, Jaffe AS, Katus HA, Apple FS, Lindahl B, Morrow DA, Chaitman BR, Clemmensen PM, Johanson P, Hod H, Underwood R, Bax JJ, Bonow JJ, Pinto F, Gibbons RJ, Fox KA, Atar D, Newby LK, Galvani M, Hamm CW, Uretsky BF, Steg PG, Wijns W, Bassand JP, Menasche P, Ravkilde J, Ohman EM, Antman EM, Wallentin LC, Armstrong PW, Simoons ML, Januzzi JL, Nieminen MS, Gheorghiade M, Filippatos G, Luepker RV, Fortmann SP, Rosamond WD, Levy D, Wood D, Smith SC, Hu D, Lopez-Sendon JL, Robertson RM, Weaver D, Tendera M, Bove AA, Parkhomenko AN, Vasilieva EJ, Mendis S, Bax JJ, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Kirchhof P, Knuuti J, Kolh P, McDonagh T, Moulin C, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vahanian A, Windecker S, Morais J, Aguiar C, Almahmeed W, Arnar DO, Barili F, Bloch KD, Bolger AF, Botker HE, Bozkurt B, Bugiardini R, Cannon C, de Lemos J, Eberli FR, Escobar E, Hlatky M, James S, Kern KB, Moliterno DJ, Mueller C, Neskovic AN, Pieske BM, Schulman SP, Storey RF, Taubert KA, Vranckx P, Wagner DRJournal of the American College of CardiologyThird universal definition of myocardial infarction. J Am Coll Cardiol. 2012 Oct 16; 60(16):1581-98.J Am Coll Cardiol2012-09-05T00:00:002012Third universal definition of myocardial infarction.22922414Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, Thygesen K, Alpert JS, White HD, Jaffe AS, Katus HA, Apple FS, Lindahl B, Morrow DA, Chaitman BA, Clemmensen PM, Johanson P, Hod H, Underwood R, Bax JJ, Bonow RO, Pinto F, Gibbons RJ, Fox KA, Atar D, Newby LK, Galvani M, Hamm CW, Uretsky BF, Steg PG, Wijns W, Bassand JP, Menasché P, Ravkilde J, Ohman EM, Antman EM, Wallentin LC, Armstrong PW, Simoons ML, Januzzi JL, Nieminen MS, Gheorghiade M, Filippatos G, Luepker RV, Fortmann SP, Rosamond WD, Levy D, Wood D, Smith SC, Hu D, Lopez-Sendon JL, Robertson RM, Weaver D, Tendera M, Bove AA, Parkhomenko AN, Vasilieva EJ, Mendis SEuropean heart journalThird universal definition of myocardial infarction. Eur Heart J. 2012 Oct; 33(20):2551-67.Eur Heart J2012-08-24T00:00:002012Third universal definition of myocardial infarction.23630129Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE, Chavey WE, Fesmire FM, Hochman JS, Levin TN, Lincoff AM, Peterson ED, Theroux P, Wenger NK, Wright RS, Jneid H, Ettinger SM, Ganiats TG, Lincoff AM, Philippides GJ, Zidar JPCirculation2012 ACCF/AHA focused update incorporated into the ACCF/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013 Jun 11; 127(23):e663-828.Circulation2013-04-29T00:00:0020132012 ACCF/AHA focused update incorporated into the ACCF/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.24668097Antman EM, Jessup MJAMAClinical practice guidelines for chronic cardiovascular disorders: a roadmap for the future. JAMA. 2014 Mar 26; 311(12):1195-6.JAMA2014-03-26T00:00:002014Clinical practice guidelines for chronic cardiovascular disorders: a roadmap for the future.24315724Ruff CT, Giugliano RP, Braunwald E, Hoffman EB, Deenadayalu N, Ezekowitz MD, Camm AJ, Weitz JI, Lewis BS, Parkhomenko A, Yamashita T, Antman EMLancet (London, England)Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet. 2014 Mar 15; 383(9921):955-62.Lancet2013-12-04T00:00:002013Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials.Authorship 21403912Authorship 2333822Authorship 3282692Authorship 2477311Authorship 26089118Authorship 2820109Authorship 2122812Authorship 3446234Authorship 7301241024532082Bonaca MP, Murphy SA, Miller D, Herrman JP, Gottlieb S, Keltai M, Menozzi A, Nicolau JC, Widimsky P, Antman EM, Wiviott SDClinical cardiologyPatterns of long-term thienopyridine therapy and outcomes in patients with acute coronary syndrome treated with coronary stenting: Observations from the TIMI-38 Coronary Stent Registry. Clin Cardiol. 2014 May; 37(5):293-9.Clin Cardiol2014-02-14T00:00:002014Patterns of long-term thienopyridine therapy and outcomes in patients with acute coronary syndrome treated with coronary stenting: Observations from the TIMI-38 Coronary Stent Registry.Authorship 3594618Authorship 19412412Authorship 733655124837573Antman EMCirculation journal : official journal of the Japanese Circulation SocietyClinical research and the development of medical therapeutics. Circ J. 2014; 78(6):1267-71.Circ J2014-05-16T00:00:002014Clinical research and the development of medical therapeutics.Authorship 734981524302269Gupta DK, Shah AM, Giugliano RP, Ruff CT, Antman EM, Grip LT, Deenadayalu N, Hoffman E, Patel I, Shi M, Mercuri M, Mitrovic V, Braunwald E, Solomon SDEuropean heart journalLeft atrial structure and function in atrial fibrillation: ENGAGE AF-TIMI 48. Eur Heart J. 2014 Jun 07; 35(22):1457-65.Eur Heart J2013-12-02T00:00:002013Left atrial structure and function in atrial fibrillation: ENGAGE AF-TIMI 48.Authorship 2732572Authorship 7354491Authorship 735512324947719Udell JA, Braunwald E, Antman EM, Antman EM, Murphy SA, Montalescot G, Wiviott SDJACC. Cardiovascular interventionsPrasugrel versus clopidogrel in patients with ST-segment elevation myocardial infarction according to timing of percutaneous coronary intervention: a TRITON-TIMI 38 subgroup analysis (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel-Thrombolysis In Myocardial Infarction 38). JACC Cardiovasc Interv. 2014 Jun; 7(6):604-12.JACC Cardiovasc Interv2014-06-01T00:00:002014Prasugrel versus clopidogrel in patients with ST-segment elevation myocardial infarction according to timing of percutaneous coronary intervention: a TRITON-TIMI 38 subgroup analysis (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel-Thrombolysis In Myocardial Infarction 38).21147581Antman EMArchivos de cardiologia de MexicoBundle branch block in ST-elevation myocardial infarction: evidence for action. Arch Cardiol Mex. 2010 Jul-Sep; 80(3):159-62.Arch Cardiol Mex2010-07-01T00:00:002010Bundle branch block in ST-elevation myocardial infarction: evidence for action.Authorship 737605124799511Antman EM, Appel LJ, Balentine D, Johnson RK, Steffen LM, Miller EA, Pappas A, Stitzel KF, Vafiadis DK, Whitsel LCirculationStakeholder discussion to reduce population-wide sodium intake and decrease sodium in the food supply: a conference report from the American Heart Association Sodium Conference 2013 Planning Group. Circulation. 2014 Jun 24; 129(25):e660-79.Circulation2014-05-05T00:00:002014Stakeholder discussion to reduce population-wide sodium intake and decrease sodium in the food supply: a conference report from the American Heart Association Sodium Conference 2013 Planning Group.Authorship 2959122Authorship 3429202Authorship 3539652Authorship 741868424998809Ruff CT, Giugliano RP, Braunwald E, Antman EMLancet (London, England)New oral anticoagulants in patients with atrial fibrillation - Authors'reply. Lancet. 2014 Jul 05; 384(9937):25-6.Lancet2014-07-05T00:00:002014New oral anticoagulants in patients with atrial fibrillation - Authors'reply.Authorship 4182693Authorship 4335909Authorship 2740546Authorship 2948082Authorship 3126794Authorship 334023Authorship 4510019Authorship 74571812Authorship 7505472Authorship 7515341525092283Jessup M, Antman ECirculationReducing the risk of heart attack and stroke: the American Heart Association/American College of Cardiology prevention guidelines. Circulation. 2014 Aug 05; 130(6):e48-50.Circulation2014-08-05T00:00:002014Reducing the risk of heart attack and stroke: the American Heart Association/American College of Cardiology prevention guidelines.25104527Ruff CT, Giugliano RP, Braunwald E, Mercuri M, Curt V, Betcher J, Grip L, Cange AL, Crompton AE, Murphy SA, Deenadayalu N, Antman EMJournal of the American College of CardiologyTransition of patients from blinded study drug to open-label anticoagulation: the ENGAGE AF-TIMI 48 trial. J Am Coll Cardiol. 2014 Aug 12; 64(6):576-84.J Am Coll Cardiol2014-08-12T00:00:002014Transition of patients from blinded study drug to open-label anticoagulation: the ENGAGE AF-TIMI 48 trial.24947287Giugliano RP, Ruff CT, Rost NS, Silverman S, Wiviott SD, Lowe C, Deenadayalu N, Murphy SA, Grip LT, Betcher JM, Duggal A, Dave J, Shi M, Mercuri M, Antman EM, Braunwald EStrokeCerebrovascular events in 21 105 patients with atrial fibrillation randomized to edoxaban versus warfarin: Effective Anticoagulation with Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48. Stroke. 2014 Aug; 45(8):2372-8.Stroke2014-06-19T00:00:002014Cerebrovascular events in 21 105 patients with atrial fibrillation randomized to edoxaban versus warfarin: Effective Anticoagulation with Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48.Authorship 5115878Authorship 51680625Authorship 5571107Authorship 579952Authorship 580054Authorship 758190225086027Anderson JL, Antman EM, Harold JG, Jessup M, O'Gara PT, Pinto FJ, Vardas PE, Zamorano JLEuropean heart journalClinical Practice Guidelines on Perioperative Cardiovascular Evaluation: collaborative efforts among the American College of Cardiology, the American Heart Association, and the European Society of Cardiology. Eur Heart J. 2014 Sep 14; 35(35):2342-3.Eur Heart J2014-08-01T00:00:002014Clinical Practice Guidelines on Perioperative Cardiovascular Evaluation: collaborative efforts among the American College of Cardiology, the American Heart Association, and the European Society of Cardiology.Authorship 582428Authorship 591499Authorship 597003Authorship 601027Authorship 601294Authorship 605655Authorship 606020Authorship 608746Authorship 610576Authorship 611112Authorship 612935Authorship 36139117Authorship 7598543Authorship 760419325246447Zoghbi WA, Duncan T, Antman E, Barbosa M, Champagne B, Chen D, Gamra H, Harold JG, Josephson S, Komajda M, Logstrup S, Mayosi BM, Mwangi J, Ralston J, Sacco RL, Sim KH, Smith SC, Vardas PE, Wood DAJournal of the American Heart AssociationSustainable Development Goals and the future of cardiovascular health: a statement from the Global Cardiovascular Disease Taskforce. J Am Heart Assoc. 2014 Sep 22; 3(5):e000504.J Am Heart Assoc2014-09-22T00:00:002014Sustainable Development Goals and the future of cardiovascular health: a statement from the Global Cardiovascular Disease Taskforce.25257641Zoghbi WA, Duncan T, Antman E, Barbosa M, Champagne B, Chen D, Gamra H, Harold JG, Josephson S, Komajda M, Logstrup S, Mayosi BM, Mwangi J, Ralston J, Sacco RL, Sim KH, Smith SC, Vardas PE, Wood DAJournal of the American College of CardiologySustainable Development goals and the future of cardiovascular health: a statement from the Global Cardiovascular Disease Taskforce. J Am Coll Cardiol. 2014 Sep 30; 64(13):1385-7.J Am Coll Cardiol2014-09-30T00:00:002014Sustainable Development goals and the future of cardiovascular health: a statement from the Global Cardiovascular Disease Taskforce.Authorship 3994758Authorship 3995404Authorship 4315218Authorship 4475698Authorship 615292Authorship 622731Authorship 4738435Authorship 4249086Authorship 769774325399267Mega JL, Sabatine MS, Antman EMJAMAPopulation and personalized medicine in the modern era. JAMA. 2014 Nov 19; 312(19):1969-70.JAMA2014-11-19T00:00:002014Population and personalized medicine in the modern era.Authorship 3760431Authorship 47923310Authorship 43221412Authorship 43612113Authorship 43636218Authorship 4373622Authorship 774282225091542Anderson JL, Antman EM, Harold JG, Jessup M, O'Gara PT, Pinto FJ, Vardas PE, Zamorano JLJournal of the American College of CardiologyClinical practice guidelines on perioperative cardiovascular evaluation: collaborative efforts among the ACC, AHA, and ESC. J Am Coll Cardiol. 2014 Dec 09; 64(22):2371-2.J Am Coll Cardiol2014-08-01T00:00:002014Clinical practice guidelines on perioperative cardiovascular evaluation: collaborative efforts among the ACC, AHA, and ESC.Authorship 474662Authorship 4807635Authorship 49133612Authorship 50660616Authorship 5381112Authorship 4944264Authorship 7772321325403645Zahir H, Brown KS, Vandell AG, Desai M, Maa JF, Dishy V, Lomeli B, Feussner A, Feng W, He L, Grosso MA, Lanz HJ, Antman EMCirculationEdoxaban effects on bleeding following punch biopsy and reversal by a 4-factor prothrombin complex concentrate. Circulation. 2015 Jan 06; 131(1):82-90.Circulation2014-11-17T00:00:002014Edoxaban effects on bleeding following punch biopsy and reversal by a 4-factor prothrombin complex concentrate.Authorship 5055131Authorship 5072047Authorship 5756201Authorship 588725Authorship 5411984Authorship 579316Authorship 584062Authorship 589192Authorship 595039Authorship 598511Authorship 599949Authorship 601951Authorship 602529Authorship 605631Authorship 609849Authorship 612389Authorship 615325Authorship 618763Authorship 625029Authorship 765301Authorship 88814Authorship 961468Authorship 2559914Authorship 2606622Authorship 2802131Authorship 2822946Authorship 2859032Authorship 291943Authorship 591011Authorship 3211241Authorship 5196521Authorship 5199636Authorship 4104922Authorship 594099Authorship 596160Authorship 596771Authorship 55222611Authorship 55254516Authorship 581878Authorship 584094Authorship 600395Authorship 605963Authorship 628711Authorship 603814Authorship 604940Authorship 612404Authorship 613111Authorship 620643Authorship 625175Authorship 627571Authorship 709015Authorship 709348Authorship 720176Authorship 9156511Authorship 9586019Authorship 4098871Authorship 4024912Authorship 441093Authorship 4264056Authorship 4321431Authorship 2028475Authorship 3012552Authorship 5047351Authorship 4654471Authorship 471903Authorship 52257915Authorship 5091813Authorship 2215458Authorship 5170053Authorship 51881812Authorship 2250584Authorship 2704093Authorship 1658099Authorship 5278684Authorship 2240036Authorship 5302162Authorship 5305129Authorship 54597721Authorship 5770733Authorship 580994Authorship 596753Authorship 603065Authorship 607207Authorship 614360Authorship 616511Authorship 5632215Authorship 580476Authorship 583760Authorship 5085799Authorship 591703Authorship 593141Authorship 5114182Authorship 4091141Authorship 628104Authorship 629282Authorship 635812Authorship 4168114Authorship 4201828Authorship 603963Authorship 605049Authorship 611557Authorship 611877Authorship 23395918Authorship 3158946Authorship 5336282Authorship 618317Authorship 4348824Authorship 90184Authorship 4542229Authorship 489833Authorship 503375Authorship 5115126Authorship 5505272Authorship 5571672Authorship 5580382Authorship 5619682Authorship 580497Authorship 584379Authorship 55537910Authorship 594220Authorship 2411498Authorship 604496Authorship 2414636Authorship 605393Authorship 1981322Authorship 3275453Authorship 610354Authorship 621326Authorship 880481Authorship 606131Authorship 606411Authorship 607174Authorship 617278Authorship 618723Authorship 620734Authorship 622923Authorship 623250Authorship 722283Authorship 727651Authorship 995385Authorship 3387651Authorship 2725642Authorship 2738031Authorship 2457413Authorship 262091Authorship 26768615Authorship 28965215Authorship 3132861Authorship 34674311Authorship 2525841Authorship 4313892Authorship 27611611Authorship 28215312Authorship 2887104Authorship 2924312Authorship 33837933Authorship 3694114Authorship 42836821Authorship 485468Authorship 5027543Authorship 12969010Authorship 1313621Authorship 5174768Authorship 209112Authorship 2050807Authorship 2619523Authorship 5436252Authorship 5674121Authorship 5716579Authorship 5750514Authorship 581700Authorship 583184Authorship 585531Authorship 589174Authorship 610600Authorship 612996Authorship 621536Authorship 2433025Authorship 2503274Authorship 2547476Authorship 2690252Authorship 2803251Authorship 2856926Authorship 2928684Authorship 3017611Authorship 3097352Authorship 3242421Authorship 37472711Authorship 3769824Authorship 3976610Authorship 3992862Authorship 4108014Authorship 4131723Authorship 1446412Authorship 4535934Authorship 2706052Authorship 15080411Authorship 3359495Authorship 38810132Authorship 4143591Authorship 4353951Authorship 5274043Authorship 5575511Authorship 5693711Authorship 165151Authorship 57276612Authorship 5748862Authorship 2742652Authorship 2904191Authorship 3598712Authorship 579768Authorship 276305Authorship 583926Authorship 2395971Authorship 585284Authorship 3275692Authorship 3556822Authorship 3703157Authorship 3749061Authorship 3919271Authorship 464096Authorship 4747954Authorship 4935816Authorship 5249292Authorship 5367088Authorship 7932778Authorship 79574112Authorship 7983553Authorship 7962573Authorship 7926642Authorship 789415725667177Zoghbi WA, Duncan T, Antman E, Barbosa M, Champagne B, Chen D, Gamra H, Harold JG, Josephson S, Komajda M, Logstrup S, Mayosi BM, Mwangi J, Ralston J, Sacco RL, Sim KH, Smith SC, Vardas PE, Wood DAGlobal heartSustainable development goals and the future of cardiovascular health: a statement from the Global Cardiovascular Disease Taskforce. Glob Heart. 2014 Sep; 9(3):273-4.Glob Heart2014-09-22T00:00:002014Sustainable development goals and the future of cardiovascular health: a statement from the Global Cardiovascular Disease Taskforce.25085963Anderson JL, Antman EM, Harold JG, Jessup M, O'Gara PT, Pinto FJ, Vardas PE, Zamorano JLCirculationClinical practice guidelines on perioperative cardiovascular evaluation: collaborative efforts among the ACC, AHA, and ESC. Circulation. 2014 Dec 09; 130(24):2213-4.Circulation2014-08-01T00:00:002014Clinical practice guidelines on perioperative cardiovascular evaluation: collaborative efforts among the ACC, AHA, and ESC.25543971Ho CY, Lakdawala NK, Cirino AL, Lipshultz SE, Sparks E, Abbasi SA, Kwong RY, Antman EM, Semsarian C, González A, López B, Diez J, Orav EJ, Colan SD, Seidman CEJACC. Heart failureDiltiazem treatment for pre-clinical hypertrophic cardiomyopathy sarcomere mutation carriers: a pilot randomized trial to modify disease expression. JACC Heart Fail. 2015 Feb; 3(2):180-8.JACC Heart Fail2014-10-31T00:00:002014Diltiazem treatment for pre-clinical hypertrophic cardiomyopathy sarcomere mutation carriers: a pilot randomized trial to modify disease expression.25869199Fonarow GC, Calitz C, Arena R, Baase C, Isaac FW, Lloyd-Jones D, Peterson ED, Pronk N, Sanchez E, Terry PE, Volpp KG, Antman EMCirculationWorkplace wellness recognition for optimizing workplace health: a presidential advisory from the American Heart Association. Circulation. 2015 May 19; 131(20):e480-97.Circulation2015-04-13T00:00:002015Workplace wellness recognition for optimizing workplace health: a presidential advisory from the American Heart Association.25485876Vora AN, Holmes DN, Rokos I, Roe MT, Granger CB, French WJ, Antman E, Henry TD, Thomas L, Bates ER, Wang TYJAMA internal medicineFibrinolysis use among patients requiring interhospital transfer for ST-segment elevation myocardial infarction care: a report from the US National Cardiovascular Data Registry. JAMA Intern Med. 2015 Feb; 175(2):207-15.JAMA Intern Med2015-02-01T00:00:002015Fibrinolysis use among patients requiring interhospital transfer for ST-segment elevation myocardial infarction care: a report from the US National Cardiovascular Data Registry.25629099Zoghbi WA, Duncan T, Antman E, Barbosa M, Champagne B, Chen D, Gamra H, Harold JG, Josephson S, Komajda M, Logstrup S, Jur C, Mayosi BM, Mwangi J, Ralston J, Sacco RL, Sim KH, Smith SC, Vardas PE, Wood DAEuropean heart journalSustainable Development Goals and the future of cardiovascular health. A statement from the Global Cardiovascular Disease Taskforce. Eur Heart J. 2014 Dec 07; 35(46):3238-9.Eur Heart J2014-12-07T00:00:002014Sustainable Development Goals and the future of cardiovascular health. A statement from the Global Cardiovascular Disease Taskforce.Authorship 581996Authorship 584147Authorship 590548Authorship 591569Authorship 592458Authorship 599096Authorship 602725Authorship 603034Authorship 603785Authorship 611933Authorship 613808Authorship 619320Authorship 625139Authorship 629406Authorship 949852Authorship 2787991Authorship 3096548Authorship 2693173Authorship 2766101Authorship 30174918Authorship 31492416Authorship 3315363Authorship 333524Authorship 35932811Authorship 3815201Authorship 3850223Authorship 4491061Authorship 4604162Authorship 4792823Authorship 4832464Authorship 4832541Authorship 4912471Authorship 5055035Authorship 5306672Authorship 4624741Authorship 4818446Authorship 4925731Authorship 5546835Authorship 5598932Authorship 5766471Authorship 577677Authorship 585790Authorship 587076Authorship 589082Authorship 81105214Authorship 81324611Authorship 8086211Authorship 8130661225769357Mega JL, Walker JR, Ruff CT, Vandell AG, Nordio F, Deenadayalu N, Murphy SA, Lee J, Mercuri MF, Giugliano RP, Antman EM, Braunwald E, Sabatine MSLancet (London, England)Genetics and the clinical response to warfarin and edoxaban: findings from the randomised, double-blind ENGAGE AF-TIMI 48 trial. Lancet. 2015 Jun 06; 385(9984):2280-7.Lancet2015-03-11T00:00:002015Genetics and the clinical response to warfarin and edoxaban: findings from the randomised, double-blind ENGAGE AF-TIMI 48 trial.26099959Antman EMCirculationSaving and Improving Lives in the Information Age: Presidential Address at the American Heart Association 2014 Scientific Sessions. Circulation. 2015 Jun 23; 131(25):2238-42.Circulation2015-06-23T00:00:002015Saving and Improving Lives in the Information Age: Presidential Address at the American Heart Association 2014 Scientific Sessions.25769361Ruff CT, Giugliano RP, Braunwald E, Morrow DA, Murphy SA, Kuder JF, Deenadayalu N, Jarolim P, Betcher J, Shi M, Brown K, Patel I, Mercuri M, Antman EMLancet (London, England)Association between edoxaban dose, concentration, anti-Factor Xa activity, and outcomes: an analysis of data from the randomised, double-blind ENGAGE AF-TIMI 48 trial. Lancet. 2015 Jun 06; 385(9984):2288-95.Lancet2015-03-11T00:00:002015Association between edoxaban dose, concentration, anti-Factor Xa activity, and outcomes: an analysis of data from the randomised, double-blind ENGAGE AF-TIMI 48 trial.25687352O'Donoghue ML, Ruff CT, Giugliano RP, Murphy SA, Grip LT, Mercuri MF, Rutman H, Shi M, Kania G, Cermak O, Braunwald E, Antman EMEuropean heart journalEdoxaban vs. warfarin in vitamin K antagonist experienced and naive patients with atrial fibrillation†. Eur Heart J. 2015 Jun 14; 36(23):1470-7.Eur Heart J2015-02-16T00:00:002015Edoxaban vs. warfarin in vitamin K antagonist experienced and naive patients with atrial fibrillation†.Authorship 595635Authorship 598992Authorship 599161Authorship 599995Authorship 30376010Authorship 3297044Authorship 32998622Authorship 3605171Authorship 3735441Authorship 399322Authorship 4363224Authorship 43978523Authorship 828707825971288Steffel J, Giugliano RP, Braunwald E, Murphy SA, Atar D, Heidbuchel H, Camm AJ, Antman EM, Ruff CTEuropean heart journalEdoxaban vs. warfarin in patients with atrial fibrillation on amiodarone: a subgroup analysis of the ENGAGE AF-TIMI 48 trial. Eur Heart J. 2015 Sep 01; 36(33):2239-45.Eur Heart J2015-05-13T00:00:002015Edoxaban vs. warfarin in patients with atrial fibrillation on amiodarone: a subgroup analysis of the ENGAGE AF-TIMI 48 trial.Authorship 5653076Authorship 5701175Authorship 579767Authorship 585900Authorship 586426Authorship 589525Authorship 590852Authorship 591020Authorship 601372Authorship 602443Authorship 607695Authorship 608052Authorship 609382Authorship 609755Authorship 617116Authorship 618790Authorship 833915826386790Geller BJ, Giugliano RP, Braunwald E, Murphy SA, Hanyok JJ, Jin J, Mercuri M, Antman EM, Ruff CTAmerican heart journalSystemic, noncerebral, arterial embolism in 21,105 patients with atrial fibrillation randomized to edoxaban or warfarin: results from the Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction Study 48 trial. Am Heart J. 2015 Oct; 170(4):669-74.Am Heart J2015-07-02T00:00:002015Systemic, noncerebral, arterial embolism in 21,105 patients with atrial fibrillation randomized to edoxaban or warfarin: results from the Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction Study 48 trial.Authorship 628194Authorship 3676548Authorship 3807023Authorship 3833121Authorship 4300304Authorship 435313Authorship 4381815Authorship 44263312Authorship 843321126541391Antman EM, Benjamin EJ, Harrington RA, Houser SR, Peterson ED, Bauman MA, Brown N, Bufalino V, Califf RM, Creager MA, Daugherty A, Demets DL, Dennis BP, Ebadollahi S, Jessup M, Lauer MS, Lo B, MacRae CA, McConnell MV, McCray AT, Mello MM, Mueller E, Newburger JW, Okun S, Packer M, Philippakis A, Ping P, Prasoon P, Roger VL, Singer S, Temple R, Turner MB, Vigilante K, Warner J, Wayte PJournal of the American Heart AssociationAcquisition, Analysis, and Sharing of Data in 2015 and Beyond: A Survey of the Landscape: A Conference Report From the American Heart Association Data Summit 2015. J Am Heart Assoc. 2015 Nov 05; 4(11).J Am Heart Assoc2015-11-05T00:00:002015Acquisition, Analysis, and Sharing of Data in 2015 and Beyond: A Survey of the Landscape: A Conference Report From the American Heart Association Data Summit 2015.Authorship 4539821Authorship 5065562Authorship 848881826363722Smith SC, Fonarow GC, Piña IL, Suter R, Morgan L, Taubert K, Sanchez E, Antman ERevista espanola de cardiologia (English ed.)Improving Quality of Cardiac Care: A Global Mandate. Rev Esp Cardiol (Engl Ed). 2015 Nov; 68(11):924-7.Rev Esp Cardiol (Engl Ed)2015-09-10T00:00:002015Improving Quality of Cardiac Care: A Global Mandate.Authorship 527149Authorship 4281392Authorship 852240626678636Magnuson EA, Vilain K, Wang K, Li H, Kwong WJ, Antman EM, Ruff CT, Giugliano RP, Cohen DJAmerican heart journalCost-effectiveness of edoxaban vs warfarin in patients with atrial fibrillation based on results of the ENGAGE AF-TIMI 48 trial. Am Heart J. 2015 Dec; 170(6):1140-50.Am Heart J2015-09-25T00:00:002015Cost-effectiveness of edoxaban vs warfarin in patients with atrial fibrillation based on results of the ENGAGE AF-TIMI 48 trial.Authorship 5606603Authorship 57900826856226Eisen A, Giugliano RP, Ruff CT, Nordio F, Gogia HS, Awasty VR, Henderson DA, Mercuri MF, Rutman H, Antman EM, Braunwald EAmerican heart journalEdoxaban vs warfarin in patients with nonvalvular atrial fibrillation in the US Food and Drug Administration approval population: An analysis from the Effective Anticoagulation with Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48 (ENGAGE AF-TIMI 48) trial. Am Heart J. 2016 Feb; 172:144-51.Am Heart J2015-12-01T00:00:002015Edoxaban vs warfarin in patients with nonvalvular atrial fibrillation in the US Food and Drug Administration approval population: An analysis from the Effective Anticoagulation with Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48 (ENGAGE AF-TIMI 48) trial.Authorship 581799Authorship 595987Authorship 599303Authorship 601401Authorship 611658Authorship 617984Authorship 626463Authorship 859435Authorship 86547710Authorship 8701329Authorship 866642126908401Xu H, Ruff CT, Giugliano RP, Murphy SA, Nordio F, Patel I, Shi M, Mercuri M, Antman EM, Braunwald EJournal of the American Heart AssociationConcomitant Use of Single Antiplatelet Therapy With Edoxaban or Warfarin in Patients With Atrial Fibrillation: Analysis From the ENGAGE AF-TIMI48 Trial. J Am Heart Assoc. 2016 Feb 23; 5(2).J Am Heart Assoc2016-02-23T00:00:002016Concomitant Use of Single Antiplatelet Therapy With Edoxaban or Warfarin in Patients With Atrial Fibrillation: Analysis From the ENGAGE AF-TIMI48 Trial.26927004Antman EM, Bierer BECirculationStandards for Clinical Research: Keeping Pace With the Technology of the Future. Circulation. 2016 Mar 01; 133(9):823-5.Circulation2016-03-01T00:00:002016Standards for Clinical Research: Keeping Pace With the Technology of the Future.Authorship 605150Authorship 605622Authorship 609398Authorship 611134Authorship 613136Authorship 615553Authorship 616415Authorship 620460Authorship 622030Authorship 625182Authorship 627581Authorship 681411Authorship 3033001Authorship 3128062Authorship 3481083Authorship 8734931726573179Mega JL, Close SL, Wiviott SD, Man M, Duvvuru S, Walker JR, Sundseth SS, Collet JP, Delaney JT, Hulot JS, Murphy SA, Paré G, Price MJ, Sibbing D, Simon T, Trenk D, Antman EM, Sabatine MSJournal of thrombosis and thrombolysisPON1 Q192R genetic variant and response to clopidogrel and prasugrel: pharmacokinetics, pharmacodynamics, and a meta-analysis of clinical outcomes. J Thromb Thrombolysis. 2016 Apr; 41(3):374-83.J Thromb Thrombolysis2016-04-01T00:00:002016PON1 Q192R genetic variant and response to clopidogrel and prasugrel: pharmacokinetics, pharmacodynamics, and a meta-analysis of clinical outcomes.Authorship 3837695Authorship 40573625Authorship 880131327045139Labarthe DR, Goldstein LB, Antman EM, Arnett DK, Fonarow GC, Alberts MJ, Hayman LL, Khera A, Sallis JF, Daniels SR, Sacco RL, Li S, Ku L, Lantz PM, Robinson JG, Creager MA, Van Horn L, Kris-Etherton P, Bhatnagar A, Whitsel LPCirculationEvidence-Based Policy Making: Assessment of the American Heart Association's Strategic Policy Portfolio: A Policy Statement From the American Heart Association. Circulation. 2016 May 03; 133(18):e615-53.Circulation2016-04-04T00:00:002016Evidence-Based Policy Making: Assessment of the American Heart Association's Strategic Policy Portfolio: A Policy Statement From the American Heart Association.Authorship 4429251Authorship 4478987Authorship 5138424Authorship 52968916Authorship 8835701427207971Kato ET, Giugliano RP, Ruff CT, Koretsune Y, Yamashita T, Kiss RG, Nordio F, Murphy SA, Kimura T, Jin J, Lanz H, Mercuri M, Braunwald E, Antman EMJournal of the American Heart AssociationEfficacy and Safety of Edoxaban in Elderly Patients With Atrial Fibrillation in the ENGAGE AF-TIMI 48 Trial. J Am Heart Assoc. 2016 05 20; 5(5).J Am Heart Assoc2016-05-20T00:00:002016Efficacy and Safety of Edoxaban in Elderly Patients With Atrial Fibrillation in the ENGAGE AF-TIMI 48 Trial.Authorship 54443515Authorship 886363627106009Gupta DK, Giugliano RP, Ruff CT, Claggett B, Murphy S, Antman E, Mercuri MF, Braunwald E, Solomon SDJournal of the American Society of Echocardiography : official publication of the American Society of EchocardiographyThe Prognostic Significance of Cardiac Structure and Function in Atrial Fibrillation: The ENGAGE AF-TIMI 48 Echocardiographic Substudy. J Am Soc Echocardiogr. 2016 06; 29(6):537-44.J Am Soc Echocardiogr2016-04-20T00:00:002016The Prognostic Significance of Cardiac Structure and Function in Atrial Fibrillation: The ENGAGE AF-TIMI 48 Echocardiographic Substudy.Authorship 577344Authorship 579673Authorship 583771Authorship 585105Authorship 585175Authorship 587034Authorship 589282Authorship 589955Authorship 595477Authorship 595583Authorship 603227Authorship 608137Authorship 608872Authorship 618208Authorship 646706Authorship 7616234Authorship 764423Authorship 55010413Authorship 9087017Authorship 5573553Authorship 5634556Authorship 5702219Authorship 889801627358434Bohula EA, Giugliano RP, Ruff CT, Kuder JF, Murphy SA, Antman EM, Braunwald ECirculationImpact of Renal Function on Outcomes With Edoxaban in the ENGAGE AF-TIMI 48 Trial. Circulation. 2016 Jul 05; 134(1):24-36.Circulation2016-07-05T00:00:002016Impact of Renal Function on Outcomes With Edoxaban in the ENGAGE AF-TIMI 48 Trial.Authorship 584273Authorship 588040Authorship 5891112Assistant Professor1Associate Professor0Full Professor4InstructorAuthorship 603635Authorship 604130Authorship 610285Authorship 611916Authorship 613796Authorship 623005Authorship 625195Authorship 626049Authorship 68083227402235Eisen A, Ruff CT, Braunwald E, Nordio F, Corbalán R, Dalby A, Dorobantu M, Mercuri M, Lanz H, Rutman H, Wiviott SD, Antman EM, Giugliano RPJournal of the American Heart AssociationSudden Cardiac Death in Patients With Atrial Fibrillation: Insights From the ENGAGE AF-TIMI 48 Trial. J Am Heart Assoc. 2016 07 08; 5(7).J Am Heart Assoc2016-07-08T00:00:002016Sudden Cardiac Death in Patients With Atrial Fibrillation: Insights From the ENGAGE AF-TIMI 48 Trial.Authorship 961723Authorship 55316215Authorship 5624546Authorship 5643187Authorship 89206712Authorship 5687323Authorship 581431Authorship 582634Authorship 583808Authorship 584743Authorship 8930873Authorship 892887127206818Antman EM, Bax J, Chazal RA, Creager MA, Filippatos G, Halperin JL, Houser S, Lindenfeld J, Pinto FJ, Vardas P, Walsh MN, Williams KA, Zamorano JLEuropean heart journalUpdated Clinical Practice Guidelines on Heart Failure: An International Alignment. Eur Heart J. 2016 07 14; 37(27):2096.Eur Heart J2016-05-20T00:00:002016Updated Clinical Practice Guidelines on Heart Failure: An International Alignment.27436881Ruff CT, Giugliano RP, Antman EMCirculationManagement of Bleeding With Non-Vitamin K Antagonist Oral Anticoagulants in the Era of Specific Reversal Agents. Circulation. 2016 Jul 19; 134(3):248-61.Circulation2016-07-19T00:00:002016Management of Bleeding With Non-Vitamin K Antagonist Oral Anticoagulants in the Era of Specific Reversal Agents.Authorship 587200Authorship 588437Authorship 612638Authorship 620320Authorship 8938429Authorship 8945041227387994Rost NS, Giugliano RP, Ruff CT, Murphy SA, Crompton AE, Norden AD, Silverman S, Singhal AB, Nicolau JC, SomaRaju B, Mercuri MF, Antman EM, Braunwald EStrokeOutcomes With Edoxaban Versus Warfarin in Patients With Previous Cerebrovascular Events: Findings From ENGAGE AF-TIMI 48 (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48). Stroke. 2016 08; 47(8):2075-82.Stroke2016-07-07T00:00:002016Outcomes With Edoxaban Versus Warfarin in Patients With Previous Cerebrovascular Events: Findings From ENGAGE AF-TIMI 48 (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48).26994510Giugliano RP, Ruff CT, Wiviott SD, Nordio F, Murphy SA, Kappelhof JA, Shi M, Mercuri MF, Antman EM, Braunwald EThe American journal of medicineMortality in Patients with Atrial Fibrillation Randomized to Edoxaban or Warfarin: Insights from the ENGAGE AF-TIMI 48 Trial. Am J Med. 2016 Aug; 129(8):850-857.e2.Am J Med2016-03-17T00:00:002016Mortality in Patients with Atrial Fibrillation Randomized to Edoxaban or Warfarin: Insights from the ENGAGE AF-TIMI 48 Trial.Authorship 8958351Authorship 8955051727207021Antman EM, Bax J, Chazal RA, Creager MA, Filippatos G, Halperin JL, Houser S, Lindenfeld J, Pinto FJ, Vardas P, Walsh MN, Williams KA, Zamorano JLEuropean journal of heart failureUpdated Clinical Practice Guidelines on Heart Failure: An International Alignment. Eur J Heart Fail. 2016 08; 18(8):976.Eur J Heart Fail2016-05-20T00:00:002016Updated Clinical Practice Guidelines on Heart Failure: An International Alignment.27482002Heydari B, Abdullah S, Pottala JV, Shah R, Abbasi S, Mandry D, Francis SA, Lumish H, Ghoshhajra BB, Hoffmann U, Appelbaum E, Feng JH, Blankstein R, Steigner M, McConnell JP, Harris W, Antman EM, Jerosch-Herold M, Kwong RYCirculationEffect of Omega-3 Acid Ethyl Esters on Left Ventricular Remodeling After Acute Myocardial Infarction: The OMEGA-REMODEL Randomized Clinical Trial. Circulation. 2016 Aug 02; 134(5):378-91.Circulation2016-08-02T00:00:002016Effect of Omega-3 Acid Ethyl Esters on Left Ventricular Remodeling After Acute Myocardial Infarction: The OMEGA-REMODEL Randomized Clinical Trial.Authorship 4955651Authorship 5073744Authorship 567547Authorship 57398911Authorship 579404Authorship 580776Authorship 587102Authorship 587253Authorship 588320Authorship 588338Authorship 589741Authorship 592056Authorship 599693Authorship 611404Authorship 615431Authorship 616164Authorship 718172Authorship 800546Authorship 5275584Authorship 910336127394188Antman EM, Bax J, Chazal RA, Creager MA, Filippatos G, Halperin JL, Houser S, Lindenfeld J, Pinto FJ, Vardas P, Walsh MN, Williams KA, Zamorano JLJournal of cardiac failureUpdated Clinical Practice Guidelines on Heart Failure: An International Alignment. J Card Fail. 2016 09; 22(9):670-1.J Card Fail2016-07-06T00:00:002016Updated Clinical Practice Guidelines on Heart Failure: An International Alignment.Authorship 5383818Authorship 55514413Authorship 55662028Authorship 5741258Authorship 5759364Authorship 578658Authorship 580514Authorship 588787Authorship 589509Authorship 591467Authorship 609028Authorship 614376Authorship 615769Authorship 617850Authorship 622990Authorship 624565Authorship 628822Authorship 91199910Authorship 9135931127349698Magnani G, Giugliano RP, Ruff CT, Murphy SA, Nordio F, Metra M, Moccetti T, Mitrovic V, Shi M, Mercuri M, Antman EM, Braunwald EEuropean journal of heart failureEfficacy and safety of edoxaban compared with warfarin in patients with atrial fibrillation and heart failure: insights from ENGAGE AF-TIMI 48. Eur J Heart Fail. 2016 09; 18(9):1153-61.Eur J Heart Fail2016-06-28T00:00:002016Efficacy and safety of edoxaban compared with warfarin in patients with atrial fibrillation and heart failure: insights from ENGAGE AF-TIMI 48.27609678Steffel J, Giugliano RP, Braunwald E, Murphy SA, Mercuri M, Choi Y, Aylward P, White H, Zamorano JL, Antman EM, Ruff CTJournal of the American College of CardiologyEdoxaban Versus Warfarin in Atrial Fibrillation Patients at Risk of Falling: ENGAGE AF-TIMI 48 Analysis. J Am Coll Cardiol. 2016 09 13; 68(11):1169-1178.J Am Coll Cardiol2016-09-13T00:00:002016Edoxaban Versus Warfarin in Atrial Fibrillation Patients at Risk of Falling: ENGAGE AF-TIMI 48 Analysis.Authorship 9153361Authorship 914965227356875Antman EM, Loscalzo JNature reviews. CardiologyPrecision medicine in cardiology. Nat Rev Cardiol. 2016 10; 13(10):591-602.Nat Rev Cardiol2016-06-30T00:00:002016Precision medicine in cardiology.27574716Bohula EA, Antman EMJAMAManagement of Non-ST-Elevation Myocardial Infarction: The Bright Gleam of Progress, but Much Work Remains. JAMA. 2016 Sep 13; 316(10):1045-7.JAMA2016-09-13T00:00:002016Management of Non-ST-Elevation Myocardial Infarction: The Bright Gleam of Progress, but Much Work Remains.Authorship 908082Authorship 593594Authorship 595805Authorship 916648127216110Antman EM, Bax J, Chazal RA, Creager MA, Filippatos G, Halperin JL, Houser S, Lindenfeld J, Pinto FJ, Vardas P, Walsh MN, Williams KA, Zamorano JLJournal of the American College of CardiologyUpdated Clinical Practice Guidelines on Heart Failure: An International Alignment. J Am Coll Cardiol. 2016 09 27; 68(13):1474-1475.J Am Coll Cardiol2016-05-20T00:00:002016Updated Clinical Practice Guidelines on Heart Failure: An International Alignment.Authorship 602324Authorship 611791Authorship 614330Authorship 614877Authorship 620731Authorship 622719Authorship 624423Authorship 626664Authorship 629422Authorship 918319127208049Antman EM, Bax J, Chazal RA, Creager MA, Filippatos G, Halperin JL, Houser S, Lindenfeld J, Pinto FJ, Vardas P, Walsh MN, Williams KA, Zamorano JLCirculationUpdated Clinical Practice Guidelines on Heart Failure: An International Alignment. Circulation. 2016 09 27; 134(13):e280-1.Circulation2016-05-20T00:00:002016Updated Clinical Practice Guidelines on Heart Failure: An International Alignment.Authorship 773835Authorship 319991Authorship 3380291Authorship 3396591Authorship 9193298Authorship 924454327706467Ruff CT, Giugliano RP, Braunwald E, Murphy SA, Brown K, Jarolim P, Mercuri M, Antman EM, Morrow DAJAMA cardiologyCardiovascular Biomarker Score and Clinical Outcomes in Patients With Atrial Fibrillation: A Subanalysis of the ENGAGE AF-TIMI 48 Randomized Clinical Trial. JAMA Cardiol. 2016 Dec 01; 1(9):999-1006.JAMA Cardiol2016-12-01T00:00:002016Cardiovascular Biomarker Score and Clinical Outcomes in Patients With Atrial Fibrillation: A Subanalysis of the ENGAGE AF-TIMI 48 Randomized Clinical Trial.27765193Jones WS, Roe MT, Antman EM, Pletcher MJ, Harrington RA, Rothman RL, Oetgen WJ, Rao SV, Krucoff MW, Curtis LH, Hernandez AF, Masoudi FAJournal of the American College of CardiologyThe Changing Landscape of Randomized Clinical Trials in Cardiovascular Disease. J Am Coll Cardiol. 2016 10 25; 68(17):1898-1907.J Am Coll Cardiol2016-10-25T00:00:002016The Changing Landscape of Randomized Clinical Trials in Cardiovascular Disease.Authorship 499933Authorship 5479456Authorship 5480443Authorship 55176918Authorship 5658551Authorship 5767616Authorship 579520Authorship 583675Authorship 583757Authorship 609192Authorship 623706Authorship 625564Authorship 626348Authorship 1960571Authorship 2746213Authorship 28112413Authorship 3262101Authorship 34019618Authorship 3418311Authorship 348163Authorship 3632662Authorship 39058313Authorship 3988053Authorship 4062204Authorship 4680471Authorship 4686939Authorship 4811088Authorship 94945811Authorship 949086728064150Fanola CL, Giugliano RP, Ruff CT, Trevisan M, Nordio F, Mercuri MF, Antman EM, Braunwald EEuropean heart journalA novel risk prediction score in atrial fibrillation for a net clinical outcome from the ENGAGE AF-TIMI 48 randomized clinical trial. Eur Heart J. 2017 Mar 21; 38(12):888-896.Eur Heart J2017-03-21T00:00:002017A novel risk prediction score in atrial fibrillation for a net clinical outcome from the ENGAGE AF-TIMI 48 randomized clinical trial.28077507Link MS, Giugliano RP, Ruff CT, Scirica BM, Huikuri H, Oto A, Crompton AE, Murphy SA, Lanz H, Mercuri MF, Antman EM, Braunwald ECirculation. Arrhythmia and electrophysiologyStroke and Mortality Risk in Patients With Various Patterns of Atrial Fibrillation: Results From the ENGAGE AF-TIMI 48 Trial (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48). Circ Arrhythm Electrophysiol. 2017 01; 10(1).Circ Arrhythm Electrophysiol2017-01-01T00:00:002017Stroke and Mortality Risk in Patients With Various Patterns of Atrial Fibrillation: Results From the ENGAGE AF-TIMI 48 Trial (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48).Authorship 54188311Authorship 5423528Authorship 5465743Authorship 5619671Authorship 5657111Authorship 587151Authorship 593304Authorship 600425Authorship 604164Authorship 605288Authorship 618227Authorship 628808Authorship 638412Authorship 9356228857017Antman EM, Tanasijevic MJ, Thompson B, Schactman M, McCabe CH, Cannon CP, Fischer GA, Fung AY, Thompson C, Wybenga D, Braunwald EThe New England journal of medicineCardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med. 1996 Oct 31; 335(18):1342-9.N Engl J Med1996-10-31T00:00:001996Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes.8809506Antman EM, Braunwald EEuropean heart journalTrials and tribulations of thrombin inhibition. Eur Heart J. 1996 Jul; 17(7):971-3.Eur Heart J1996-07-01T00:00:001996Trials and tribulations of thrombin inhibition.8780331Antman EMThe American journal of cardiologyMaintaining sinus rhythm with antifibrillatory drugs in atrial fibrillation. Am J Cardiol. 1996 Aug 29; 78(4A):67-72.Am J Cardiol1996-08-29T00:00:001996Maintaining sinus rhythm with antifibrillatory drugs in atrial fibrillation.8800027Greaves SC, Rutherford JD, Aranki SF, Cohn LH, Couper GS, Adams DH, Rizzo RJ, Collins JJ, Antman EMAmerican heart journalCurrent incidence and determinants of perioperative myocardial infarction in coronary artery surgery. Am Heart J. 1996 Sep; 132(3):572-8.Am Heart J1996-09-01T00:00:001996Current incidence and determinants of perioperative myocardial infarction in coronary artery surgery.8901709Ryan TJ, Anderson JL, Antman EM, Braniff BA, Brooks NH, Califf RM, Hillis LD, Hiratzka LF, Rapaport E, Riegel BJ, Russell RO, Smith EE, Weaver WDCirculationACC/AHA guidelines for the management of patients with acute myocardial infarction: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). Circulation. 1996 Nov 01; 94(9):2341-50.Circulation1996-11-01T00:00:001996ACC/AHA guidelines for the management of patients with acute myocardial infarction: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction).8877070Antman EM, Seelig MS, Fleischmann K, Lau J, Kuntz K, Berkey CS, McIntosh MWCardiovascular drugs and therapyMagnesium in acute myocardial infarction: scientific, statistical, and economic rationale for its use. Cardiovasc Drugs Ther. 1996 Jul; 10(3):297-301.Cardiovasc Drugs Ther1996-07-01T00:00:001996Magnesium in acute myocardial infarction: scientific, statistical, and economic rationale for its use.8914777Rabbani LE, Antman EMClinical cardiologyThe role of magnesium therapy in acute myocardial infarction. Clin Cardiol. 1996 Nov; 19(11):841-4.Clin Cardiol1996-11-01T00:00:001996The role of magnesium therapy in acute myocardial infarction.8932970Berkey CS, Mosteller F, Lau J, Antman EMControlled clinical trialsUncertainty of the time of first significance in random effects cumulative meta-analysis. Control Clin Trials. 1996 Oct; 17(5):357-71.Control Clin Trials1996-10-01T00:00:001996Uncertainty of the time of first significance in random effects cumulative meta-analysis.11009278Cohen M, Antman EM, Gurfinkel E, Turpie AG, Furst J, Bigonzi F, Radley DThe American journal of cardiologyImpact of enoxaparin low molecular weight heparin in patients with Q-wave myocardial infarction. Am J Cardiol. 2000 Sep 01; 86(5):553-6, A9.Am J Cardiol2000-09-01T00:00:002000Impact of enoxaparin low molecular weight heparin in patients with Q-wave myocardial infarction.11113418Gibson CM, Anshelevich M, Murphy S, Luu L, Hynes C, Kliris J, Kermgard S, Otten MH, Antman EM, Cannon CP, Braunwald EThe American journal of cardiologyImpact of injections during diagnostic coronary arteriography on coronary patency in the setting of acute myocardial infarction from the TIMI trials. Thrombolysis In Myocardial Infarction. Am J Cardiol. 2000 Dec 15; 86(12):1378-9, A5.Am J Cardiol2000-12-15T00:00:002000Impact of injections during diagnostic coronary arteriography on coronary patency in the setting of acute myocardial infarction from the TIMI trials. Thrombolysis In Myocardial Infarction.11275925de Lemos JA, Gibson CM, Antman EM, Murphy SA, Morrow DA, Schuhwerk KC, Schweiger M, Coussement P, Van de Werf F, Braunwald EAmerican heart journalAbciximab and early adjunctive percutaneous coronary intervention are associated with improved ST-segment resolution after thrombolysis: Observations from the TIMI 14 Trial. Am Heart J. 2001 Apr; 141(4):592-8.Am Heart J2001-04-01T00:00:002001Abciximab and early adjunctive percutaneous coronary intervention are associated with improved ST-segment resolution after thrombolysis: Observations from the TIMI 14 Trial.11560541Morrow DA, Antman EM, Parsons L, de Lemos JA, Cannon CP, Giugliano RP, McCabe CH, Barron HV, Braunwald EJAMAApplication of the TIMI risk score for ST-elevation MI in the National Registry of Myocardial Infarction 3. JAMA. 2001 Sep 19; 286(11):1356-9.JAMA2001-09-19T00:00:002001Application of the TIMI risk score for ST-elevation MI in the National Registry of Myocardial Infarction 3.11673357Fuster V, Rydén LE, Asinger RW, Cannom DS, Crijns HJ, Frye RL, Halperin JL, Kay GN, Klein WW, Lévy S, McNamara RL, Prystowsky EN, Wann LS, Wyse DG, Gibbons RJ, Antman EM, Alpert JS, Faxon DP, Fuster V, Gregoratos G, Hiratzka LF, Jacobs AK, Russell RO, Smith SC, Klein WW, Alonso-Garcia A, Blomström-Lundqvist C, de Backer G, Flather M, Hradec J, Oto A, Parkhomenko A, Silber S, Torbicki ACirculationACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and Electrophysiology. Circulation. 2001 Oct 23; 104(17):2118-50.Circulation2001-10-23T00:00:002001ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and Electrophysiology.11889023Eagle KA, Berger PB, Calkins H, Chaitman BR, Ewy GA, Fleischmann KE, Fleisher LA, Froehlich JB, Gusberg RJ, Leppo JA, Ryan T, Schlant RC, Winters WL, Gibbons RJ, Antman EM, Alpert JS, Faxon DP, Fuster V, Gregoratos G, Jacobs AK, Hiratzka LF, Russell RO, Smith SCCirculationACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery---executive summary a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Circulation. 2002 Mar 12; 105(10):1257-67.Circulation2002-03-12T00:00:002002ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery---executive summary a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery).12525234Wong GC, Giugliano RP, Antman EMJAMAUse of low-molecular-weight heparins in the management of acute coronary artery syndromes and percutaneous coronary intervention. JAMA. 2003 Jan 15; 289(3):331-42.JAMA2003-01-15T00:00:002003Use of low-molecular-weight heparins in the management of acute coronary artery syndromes and percutaneous coronary intervention.14563598Blomström-Lundqvist C, Scheinman MM, Aliot EM, Alpert JS, Calkins H, Camm AJ, Campbell WB, Haines DE, Kuck KH, Lerman BB, Miller DD, Shaeffer CW, Stevenson WG, Tomaselli GF, Antman EM, Smith SC, Alpert JS, Faxon DP, Fuster V, Gibbons RJ, Gregoratos G, Hiratzka LF, Hunt SA, Jacobs AK, Russell RO, Priori SG, Blanc JJ, Budaj A, Burgos EF, Cowie M, Deckers JW, Garcia MA, Klein WW, Lekakis J, Lindahl B, Mazzotta G, Morais JC, Oto A, Smiseth O, Trappe HJJournal of the American College of CardiologyACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias--executive summary. a report of the American college of cardiology/American heart association task force on practice guidelines and the European society of cardiology committee for practice guidelines (writing committee to develop guidelines for the management of patients with supraventricular arrhythmias) developed in collaboration with NASPE-Heart Rhythm Society. J Am Coll Cardiol. 2003 Oct 15; 42(8):1493-531.J Am Coll Cardiol2003-10-15T00:00:002003ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias--executive summary. a report of the American college of cardiology/American heart association task force on practice guidelines and the European society of cardiology committee for practice guidelines (writing committee to develop guidelines for the management of patients with supraventricular arrhythmias) developed in collaboration with NASPE-Heart Rhythm Society.15165915Giugliano RP, Sabatine MS, Gibson CM, Roe MT, Harrington RA, Murphy SA, Morrow DA, Antman EM, Braunwald EThe American journal of cardiologyCombined assessment of thrombolysis in myocardial infarction flow grade, myocardial perfusion grade, and ST-segment resolution to evaluate epicardial and myocardial reperfusion. Am J Cardiol. 2004 Jun 01; 93(11):1362-7, A5-6.Am J Cardiol2004-06-01T00:00:002004Combined assessment of thrombolysis in myocardial infarction flow grade, myocardial perfusion grade, and ST-segment resolution to evaluate epicardial and myocardial reperfusion.15541835Gibson CM, Dumaine RL, Gelfand EV, Murphy SA, Morrow DA, Wiviott SD, Giugliano RP, Cannon CP, Antman EM, Braunwald EEuropean heart journalAssociation of glomerular filtration rate on presentation with subsequent mortality in non-ST-segment elevation acute coronary syndrome; observations in 13,307 patients in five TIMI trials. Eur Heart J. 2004 Nov; 25(22):1998-2005.Eur Heart J2004-11-01T00:00:002004Association of glomerular filtration rate on presentation with subsequent mortality in non-ST-segment elevation acute coronary syndrome; observations in 13,307 patients in five TIMI trials.15684280Morrow DA, Murphy SA, McCabe CH, Mackman N, Wong HC, Antman EMEuropean heart journalPotent inhibition of thrombin with a monoclonal antibody against tissue factor (Sunol-cH36): results of the PROXIMATE-TIMI 27 trial. Eur Heart J. 2005 Apr; 26(7):682-8.Eur Heart J2005-01-31T00:00:002005Potent inhibition of thrombin with a monoclonal antibody against tissue factor (Sunol-cH36): results of the PROXIMATE-TIMI 27 trial.15894966Mega JL, Morrow DA, Sabatine MS, Zhao XQ, Snapinn SM, DiBattiste PM, Gibson CM, Antman EM, Braunwald E, Théroux PAmerican heart journalCorrelation between the TIMI risk score and high-risk angiographic findings in non-ST-elevation acute coronary syndromes: observations from the Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) trial. Am Heart J. 2005 May; 149(5):846-50.Am Heart J2005-05-01T00:00:002005Correlation between the TIMI risk score and high-risk angiographic findings in non-ST-elevation acute coronary syndromes: observations from the Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) trial.9462575Antman EM, Sacks DB, Rifai N, McCabe CH, Cannon CP, Braunwald EJournal of the American College of CardiologyTime to positivity of a rapid bedside assay for cardiac-specific troponin T predicts prognosis in acute coronary syndromes: a Thrombolysis in Myocardial Infarction (TIMI) 11A substudy. J Am Coll Cardiol. 1998 Feb; 31(2):326-30.J Am Coll Cardiol1998-02-01T00:00:001998Time to positivity of a rapid bedside assay for cardiac-specific troponin T predicts prognosis in acute coronary syndromes: a Thrombolysis in Myocardial Infarction (TIMI) 11A substudy.16880336Bonow RO, Carabello BA, Kanu C, de Leon AC, Faxon DP, Freed MD, Gaasch WH, Lytle BW, Nishimura RA, O'Gara PT, O'Rourke RA, Otto CM, Shah PM, Shanewise JS, Smith SC, Jacobs AK, Adams CD, Anderson JL, Antman EM, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Lytle BW, Nishimura R, Page RL, Riegel BCirculationACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation. 2006 Aug 01; 114(5):e84-231.Circulation2006-08-01T00:00:002006ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons.16949478Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, Gregoratos G, Klein G, Moss AJ, Myerburg RJ, Priori SG, Quinones MA, Roden DM, Silka MJ, Tracy C, Smith SC, Jacobs AK, Adams CD, Antman EM, Anderson JL, Hunt SA, Halperin JL, Nishimura R, Ornato JP, Page RL, Riegel B, Priori SG, Blanc JJ, Budaj A, Camm AJ, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JLJournal of the American College of CardiologyACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). J Am Coll Cardiol. 2006 Sep 05; 48(5):e247-346.J Am Coll Cardiol2006-09-05T00:00:002006ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death).16996826Wiviott SD, Antman EM, Gibson CM, Montalescot G, Riesmeyer J, Weerakkody G, Winters KJ, Warmke JW, McCabe CH, Braunwald EAmerican heart journalEvaluation of prasugrel compared with clopidogrel in patients with acute coronary syndromes: design and rationale for the TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet InhibitioN with prasugrel Thrombolysis In Myocardial Infarction 38 (TRITON-TIMI 38). Am Heart J. 2006 Oct; 152(4):627-35.Am Heart J2006-10-01T00:00:002006Evaluation of prasugrel compared with clopidogrel in patients with acute coronary syndromes: design and rationale for the TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet InhibitioN with prasugrel Thrombolysis In Myocardial Infarction 38 (TRITON-TIMI 38).9626820Morrow DA, Rifai N, Antman EM, Weiner DL, McCabe CH, Cannon CP, Braunwald EJournal of the American College of CardiologyC-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. Thrombolysis in Myocardial Infarction. J Am Coll Cardiol. 1998 Jun; 31(7):1460-5.J Am Coll Cardiol1998-06-01T00:00:001998C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. Thrombolysis in Myocardial Infarction.9973029Becker RC, Hochman JS, Cannon CP, Spencer FA, Ball SP, Rizzo MJ, Antman EMJournal of the American College of CardiologyFatal cardiac rupture among patients treated with thrombolytic agents and adjunctive thrombin antagonists: observations from the Thrombolysis and Thrombin Inhibition in Myocardial Infarction 9 Study. J Am Coll Cardiol. 1999 Feb; 33(2):479-87.J Am Coll Cardiol1999-02-01T00:00:001999Fatal cardiac rupture among patients treated with thrombolytic agents and adjunctive thrombin antagonists: observations from the Thrombolysis and Thrombin Inhibition in Myocardial Infarction 9 Study.10639292Morrow DA, Antman EMEuropean heart journalCardiac marker elevation after cardioversion: sorting out chicken and egg. Eur Heart J. 2000 Feb; 21(3):171-3.Eur Heart J2000-02-01T00:00:002000Cardiac marker elevation after cardioversion: sorting out chicken and egg.156094Antman EM, Green LH, Grossman WCirculationPhysiologic determinants of the electrocardiographic diagnosis of left ventricular hypertrophy. Circulation. 1979 Aug; 60(2):386-96.Circulation1979-08-01T00:00:001979Physiologic determinants of the electrocardiographic diagnosis of left ventricular hypertrophy.11431653Srinivas VS, Cannon CP, Gibson CM, Antman EM, Greenberg MA, Tanasijevic MJ, Murphy S, de Lemos JA, Sokol S, Braunwald E, Mueller HSAmerican heart journalMyoglobin levels at 12 hours identify patients at low risk for 30-day mortality after thrombolysis in acute myocardial infarction: a Thrombolysis in Myocardial Infarction 10B substudy. Am Heart J. 2001 Jul; 142(1):29-36.Am Heart J2001-07-01T00:00:002001Myoglobin levels at 12 hours identify patients at low risk for 30-day mortality after thrombolysis in acute myocardial infarction: a Thrombolysis in Myocardial Infarction 10B substudy.12422146Cooper HA, de Lemos JA, Morrow DA, Sabatine MS, Murphy SA, McCabe CH, Gibson CM, Antman EM, Braunwald EAmerican heart journalMinimal ST-segment deviation: a simple, noninvasive method for identifying patients with a patent infarction-related artery after fibrinolytic administration. Am Heart J. 2002 Nov; 144(5):790-5.Am Heart J2002-11-01T00:00:002002Minimal ST-segment deviation: a simple, noninvasive method for identifying patients with a patent infarction-related artery after fibrinolytic administration.12891179Antman EMAmerican heart journalLow molecular weight heparins for acute coronary syndrome: tackling the issues head-on. Am Heart J. 2003 Aug; 146(2):191-3.Am Heart J2003-08-01T00:00:002003Low molecular weight heparins for acute coronary syndrome: tackling the issues head-on.12913404Gibson CM, de Lemos JA, Murphy SA, Marble SJ, Dauterman KW, Michaels A, Barron HV, Antman EMJournal of thrombosis and thrombolysisMethodologic and clinical validation of the TIMI myocardial perfusion grade in acute myocardial infarction. J Thromb Thrombolysis. 2002 Dec; 14(3):233-7.J Thromb Thrombolysis2002-12-01T00:00:002002Methodologic and clinical validation of the TIMI myocardial perfusion grade in acute myocardial infarction.14564302Antman EMAmerican heart journalGlycoprotein IIb/IIIa inhibitors in patients with unstable angina/non-ST-segment elevation myocardial infarction: appropriate interpretation of the guidelines. Am Heart J. 2003 Oct; 146(4 Suppl):S18-22.Am Heart J2003-10-01T00:00:002003Glycoprotein IIb/IIIa inhibitors in patients with unstable angina/non-ST-segment elevation myocardial infarction: appropriate interpretation of the guidelines.15215808Wylie JV, Murphy SA, Morrow DA, de Lemos JA, Antman EM, Cannon CPAmerican heart journalValidated risk score predicts the development of congestive heart failure after presentation with unstable angina or non-ST-elevation myocardial infarction: results from OPUS-TIMI 16 and TACTICS-TIMI 18. Am Heart J. 2004 Jul; 148(1):173-80.Am Heart J2004-07-01T00:00:002004Validated risk score predicts the development of congestive heart failure after presentation with unstable angina or non-ST-elevation myocardial infarction: results from OPUS-TIMI 16 and TACTICS-TIMI 18.15374786Morrow DA, Sabatine MS, Antman EM, Cannon CP, Braunwald E, Theroux PThe American journal of cardiologyUsefulness of tirofiban among patients treated without percutaneous coronary intervention (TIMI high risk patients in PRISM-PLUS). Am J Cardiol. 2004 Sep 15; 94(6):774-6.Am J Cardiol2004-09-15T00:00:002004Usefulness of tirofiban among patients treated without percutaneous coronary intervention (TIMI high risk patients in PRISM-PLUS).15451148Kashani A, Giugliano RP, Antman EM, Morrow DA, Gibson CM, Murphy SA, Braunwald EEuropean heart journalSeverity of heart failure, treatments, and outcomes after fibrinolysis in patients with ST-elevation myocardial infarction. Eur Heart J. 2004 Oct; 25(19):1702-10.Eur Heart J2004-10-01T00:00:002004Severity of heart failure, treatments, and outcomes after fibrinolysis in patients with ST-elevation myocardial infarction.15670541Kirtane AJ, Kosmidou I, Karmpaliotis D, Murphy SA, Giugliano RP, Cannon CP, Antman EM, Braunwald E, Gibson CMThe American journal of cardiologyAssociation of culprit lesion calcium with angiographic and clinical outcomes in patients with ST-elevation myocardial infarction treated with fibrinolytic therapy. Am J Cardiol. 2005 Feb 01; 95(3):337-42.Am J Cardiol2005-02-01T00:00:002005Association of culprit lesion calcium with angiographic and clinical outcomes in patients with ST-elevation myocardial infarction treated with fibrinolytic therapy.8890834Ryan TJ, Anderson JL, Antman EM, Braniff BA, Brooks NH, Califf RM, Hillis LD, Hiratzka LF, Rapaport E, Riegel BJ, Russell RO, Smith EE, Weaver WDJournal of the American College of CardiologyACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol. 1996 Nov 01; 28(5):1328-428.J Am Coll Cardiol1996-11-01T00:00:001996ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction).9628449Antman EMAmerican heart journalTIMI 11B. Enoxaparin versus unfractionated heparin for unstable angina or non-Q-wave myocardial infarction: a double-blind, placebo-controlled, parallel-group, multicenter trial. Rationale, study design, and methods. Thrombolysis in Myocardial Infarction (TIMI) 11B Trial Investigators. Am Heart J. 1998 Jun; 135(6 Pt 3 Su):S353-60.Am Heart J1998-06-01T00:00:001998TIMI 11B. Enoxaparin versus unfractionated heparin for unstable angina or non-Q-wave myocardial infarction: a double-blind, placebo-controlled, parallel-group, multicenter trial. Rationale, study design, and methods. Thrombolysis in Myocardial Infarction (TIMI) 11B Trial Investigators.Authorship 961973115358047Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, Hochman JS, Krumholz HM, Kushner FG, Lamas GA, Mullany CJ, Ornato JP, Pearle DL, Sloan MA, Smith SC, Alpert JS, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Gregoratos G, Halperin JL, Hiratzka LF, Hunt SA, Jacobs AK, Ornato JPJournal of the American College of CardiologyACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction; A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of patients with acute myocardial infarction). J Am Coll Cardiol. 2004 Aug 04; 44(3):E1-E211.J Am Coll Cardiol2004-08-04T00:00:002004ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction; A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of patients with acute myocardial infarction).9141383Antman EM, Grudzien C, Mitchell RN, Sacks DBAmerican heart journalDetection of unsuspected myocardial necrosis by rapid bedside assay for cardiac troponin T. Am Heart J. 1997 May; 133(5):596-8.Am Heart J1997-05-01T00:00:001997Detection of unsuspected myocardial necrosis by rapid bedside assay for cardiac troponin T.Authorship 967346928209729Carnicelli AP, De Caterina R, Halperin JL, Renda G, Ruff CT, Trevisan M, Nordio F, Mercuri MF, Antman E, Giugliano RPCirculationEdoxaban for the Prevention of Thromboembolism in Patients With Atrial Fibrillation and Bioprosthetic Valves. Circulation. 2017 03 28; 135(13):1273-1275.Circulation2017-02-16T00:00:002017Edoxaban for the Prevention of Thromboembolism in Patients With Atrial Fibrillation and Bioprosthetic Valves.10689261Antman EM, Fox KMAmerican heart journalGuidelines for the diagnosis and management of unstable angina and non-Q-wave myocardial infarction: proposed revisions. International Cardiology Forum. Am Heart J. 2000 Mar; 139(3):461-75.Am Heart J2000-03-01T00:00:002000Guidelines for the diagnosis and management of unstable angina and non-Q-wave myocardial infarction: proposed revisions. International Cardiology Forum.16391169Smith SC, Feldman TE, Hirshfeld JW, Jacobs AK, Kern MJ, King SB, Morrison DA, O'Neill WW, Schaff HV, Whitlow PL, Williams DO, Antman EM, Adams CD, Anderson JL, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Nishimura R, Ornato JP, Page RL, Riegel BCirculationACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). Circulation. 2006 Jan 03; 113(1):156-75.Circulation2006-01-03T00:00:002006ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention).16687939Dumaine R, Gibson CM, Murphy SA, Southard M, Ly HQ, McCabe CH, Giugliano RP, Cannon CP, Antman EM, Braunwald EJournal of clinical hypertension (Greenwich, Conn.)Association of a history of systemic hypertension with mortality, thrombotic, and bleeding complications following non-ST-segment elevation acute coronary syndrome. J Clin Hypertens (Greenwich). 2006 May; 8(5):315-22.J Clin Hypertens (Greenwich)2006-05-01T00:00:002006Association of a history of systemic hypertension with mortality, thrombotic, and bleeding complications following non-ST-segment elevation acute coronary syndrome.16754815Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikof E, Fleischmann KE, Freeman WK, Froehlich JB, Kasper EK, Kersten JR, Riegel B, Robb JF, Smith SC, Jacobs AK, Adams CD, Anderson JL, Antman EM, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Lytle BW, Nishimura R, Page RL, Riegel BCirculationACC/AHA 2006 guideline update on perioperative cardiovascular evaluation for noncardiac surgery: focused update on perioperative beta-blocker therapy: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery): developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society for Vascular Medicine and Biology. Circulation. 2006 Jun 06; 113(22):2662-74.Circulation2006-06-06T00:00:002006ACC/AHA 2006 guideline update on perioperative cardiovascular evaluation for noncardiac surgery: focused update on perioperative beta-blocker therapy: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery): developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society for Vascular Medicine and Biology.16978994Kereiakes DJ, Antman EMJournal of the American College of CardiologyClinical guidelines and practice: in search of the truth. J Am Coll Cardiol. 2006 Sep 19; 48(6):1129-35; discussion 1136-8.J Am Coll Cardiol2006-08-28T00:00:002006Clinical guidelines and practice: in search of the truth.9458438Antman EMEuropean heart journalAnother chapter of the antithrombin story has been written... Eur Heart J. 1997 Sep; 18(9):1365-7.Eur Heart J1997-09-01T00:00:001997Another chapter of the antithrombin story has been written...10351964Antman EM, Giugliano RP, Gibson CM, McCabe CH, Coussement P, Kleiman NS, Vahanian A, Adgey AA, Menown I, Rupprecht HJ, Van der Wieken R, Ducas J, Scherer J, Anderson K, Van de Werf F, Braunwald ECirculationAbciximab facilitates the rate and extent of thrombolysis: results of the thrombolysis in myocardial infarction (TIMI) 14 trial. The TIMI 14 Investigators. Circulation. 1999 Jun 01; 99(21):2720-32.Circulation1999-06-01T00:00:001999Abciximab facilitates the rate and extent of thrombolysis: results of the thrombolysis in myocardial infarction (TIMI) 14 trial. The TIMI 14 Investigators.10676681Morrow DA, Rifai N, Antman EM, Weiner DL, McCabe CH, Cannon CP, Braunwald EJournal of the American College of CardiologySerum amyloid A predicts early mortality in acute coronary syndromes: A TIMI 11A substudy. J Am Coll Cardiol. 2000 Feb; 35(2):358-62.J Am Coll Cardiol2000-02-01T00:00:002000Serum amyloid A predicts early mortality in acute coronary syndromes: A TIMI 11A substudy.Authorship 971341828302288De Caterina R, Renda G, Carnicelli AP, Nordio F, Trevisan M, Mercuri MF, Ruff CT, Antman EM, Braunwald E, Giugliano RPJournal of the American College of CardiologyValvular Heart Disease Patients on Edoxaban or Warfarin in the ENGAGE AF-TIMI 48 Trial. J Am Coll Cardiol. 2017 Mar 21; 69(11):1372-1382.J Am Coll Cardiol2017-03-21T00:00:002017Valvular Heart Disease Patients on Edoxaban or Warfarin in the ENGAGE AF-TIMI 48 Trial.11101192Marsh JD, Antman EMCardiovascular drugs and therapyT-type calcium channel blockade in the management of chronic ischemic heart disease. Cardiovasc Drugs Ther. 2000 Oct; 14(5):459-61.Cardiovasc Drugs Ther2000-10-01T00:00:002000T-type calcium channel blockade in the management of chronic ischemic heart disease.2193495Tofler GH, Stone PH, Maclure M, Edelman E, Davis VG, Robertson T, Antman EM, Muller JEThe American journal of cardiologyAnalysis of possible triggers of acute myocardial infarction (the MILIS study). Am J Cardiol. 1990 Jul 01; 66(1):22-7.Am J Cardiol1990-07-01T00:00:001990Analysis of possible triggers of acute myocardial infarction (the MILIS study).18519158Pollack CV, Antman EM, Hollander JEAnnals of emergency medicine2007 focused update to the ACC/AHA guidelines for the management of patients with ST-segment elevation myocardial infarction: implications for emergency department practice. Ann Emerg Med. 2008 Oct; 52(4):344-355.e1.Ann Emerg Med2008-06-02T00:00:0020082007 focused update to the ACC/AHA guidelines for the management of patients with ST-segment elevation myocardial infarction: implications for emergency department practice.2457890Lamas GA, Dawley D, Splaine K, Folland ED, Friedman PL, Antman EMPacing and clinical electrophysiology : PACEDocumented symptomatic bradycardia and symptom relief in patients receiving permanent pacemakers: an evaluation of the joint ACC/AHA pacing guidelines. Pacing Clin Electrophysiol. 1988 Jul; 11(7):1098-104.Pacing Clin Electrophysiol1988-07-01T00:00:001988Documented symptomatic bradycardia and symptom relief in patients receiving permanent pacemakers: an evaluation of the joint ACC/AHA pacing guidelines.20102867Harkness JR, Sabatine MS, Braunwald E, Morrow DA, Sloan S, Wiviott SD, Giugliano RP, Antman EM, Cannon CP, Scirica BMAmerican heart journalExtent of ST-segment resolution after fibrinolysis adds improved risk stratification to clinical risk score for ST-segment elevation myocardial infarction. Am Heart J. 2010 Jan; 159(1):55-62.Am Heart J2010-01-01T00:00:002010Extent of ST-segment resolution after fibrinolysis adds improved risk stratification to clinical risk score for ST-segment elevation myocardial infarction.11329210Gibson CM, Kirtane AJ, Murphy SA, Marble SJ, de Lemos JA, Antman EM, Braunwald ECatheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & InterventionsImpact of contrast agent type (ionic versus nonionic) used for coronary angiography on angiographic, electrocardiographic, and clinical outcomes following thrombolytic administration in acute myocardial infarction. Catheter Cardiovasc Interv. 2001 May; 53(1):6-11.Catheter Cardiovasc Interv2001-05-01T00:00:002001Impact of contrast agent type (ionic versus nonionic) used for coronary angiography on angiographic, electrocardiographic, and clinical outcomes following thrombolytic administration in acute myocardial infarction.11835024Antman EM, McCabe CH, Braunwald EAmerican heart journalBivalirudin as a replacement for unfractionated heparin in unstable angina/non-ST-elevation myocardial infarction: observations from the TIMI 8 trial. The Thrombolysis in Myocardial Infarction. Am Heart J. 2002 Feb; 143(2):229-34.Am Heart J2002-02-01T00:00:002002Bivalirudin as a replacement for unfractionated heparin in unstable angina/non-ST-elevation myocardial infarction: observations from the TIMI 8 trial. The Thrombolysis in Myocardial Infarction.12355029Angeja BG, Kermgard S, Chen MS, McKay M, Murphy SA, Antman EM, Cannon CP, Braunwald E, Gibson CMJournal of thrombosis and thrombolysisThe smoker's paradox: insights from the angiographic substudies of the TIMI trials. J Thromb Thrombolysis. 2002 Jun; 13(3):133-9.J Thromb Thrombolysis2002-06-01T00:00:002002The smoker's paradox: insights from the angiographic substudies of the TIMI trials.12392846Gibbons RJ, Balady GJ, Bricker JT, Chaitman BR, Fletcher GF, Froelicher VF, Mark DB, McCallister BD, Mooss AN, O'Reilly MG, Winters WL, Gibbons RJ, Antman EM, Alpert JS, Faxon DP, Fuster V, Gregoratos G, Hiratzka LF, Jacobs AK, Russell RO, Smith SCJournal of the American College of CardiologyACC/AHA 2002 guideline update for exercise testing: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). J Am Coll Cardiol. 2002 Oct 16; 40(8):1531-40.J Am Coll Cardiol2002-10-16T00:00:002002ACC/AHA 2002 guideline update for exercise testing: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines).12814985Gibbons RJ, Smith S, Antman ECirculationAmerican College of Cardiology/American Heart Association clinical practice guidelines: Part I: where do they come from? Circulation. 2003 Jun 17; 107(23):2979-86.Circulation2003-06-17T00:00:002003American College of Cardiology/American Heart Association clinical practice guidelines: Part I: where do they come from?15309006Gibson CM, Murphy SA, Morrow DA, Aroesty JM, Gibbons RJ, Gourlay SG, Barron HV, Giugliano RP, Antman EM, Braunwald EAmerican heart journalAngiographic perfusion score: an angiographic variable that integrates both epicardial and tissue level perfusion before and after facilitated percutaneous coronary intervention in acute myocardial infarction. Am Heart J. 2004 Aug; 148(2):336-40.Am Heart J2004-08-01T00:00:002004Angiographic perfusion score: an angiographic variable that integrates both epicardial and tissue level perfusion before and after facilitated percutaneous coronary intervention in acute myocardial infarction.15518603Karmpaliotis D, Turakhia MP, Kirtane AJ, Murphy SA, Kosmidou I, Morrow DA, Giugliano RP, Cannon CP, Antman EM, Braunwald E, Gibson CMThe American journal of cardiologySequential risk stratification using TIMI risk score and TIMI flow grade among patients treated with fibrinolytic therapy for ST-segment elevation acute myocardial infarction. Am J Cardiol. 2004 Nov 01; 94(9):1113-7.Am J Cardiol2004-11-01T00:00:002004Sequential risk stratification using TIMI risk score and TIMI flow grade among patients treated with fibrinolytic therapy for ST-segment elevation acute myocardial infarction.15670549Ly HQ, Kirtane AJ, Buros J, Giugliano RP, Popma JJ, Antman EM, Harrington RA, Ohman EM, Gibson CMThe American journal of cardiologyAngiographic and clinical outcomes associated with direct versus conventional stenting among patients treated with fibrinolytic therapy for ST-elevation acute myocardial infarction. Am J Cardiol. 2005 Feb 01; 95(3):383-6.Am J Cardiol2005-02-01T00:00:002005Angiographic and clinical outcomes associated with direct versus conventional stenting among patients treated with fibrinolytic therapy for ST-elevation acute myocardial infarction.15846258Antman EM, Morrow DA, McCabe CH, Jiang F, White HD, Fox KA, Sharma D, Chew P, Braunwald EAmerican heart journalEnoxaparin versus unfractionated heparin as antithrombin therapy in patients receiving fibrinolysis for ST-elevation myocardial infarction. Design and rationale for the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25). Am Heart J. 2005 Feb; 149(2):217-26.Am Heart J2005-02-01T00:00:002005Enoxaparin versus unfractionated heparin as antithrombin therapy in patients receiving fibrinolysis for ST-elevation myocardial infarction. Design and rationale for the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25).8998085Selker HP, Zalenski RJ, Antman EM, Aufderheide TP, Bernard SA, Bonow RO, Gibler WB, Hagen MD, Johnson P, Lau J, McNutt RA, Ornato J, Schwartz JS, Scott JD, Tunick PA, Weaver WDAnnals of emergency medicineAn evaluation of technologies for identifying acute cardiac ischemia in the emergency department: executive summary of a National Heart Attack Alert Program Working Group Report. Ann Emerg Med. 1997 Jan; 29(1):1-12.Ann Emerg Med1997-01-01T00:00:001997An evaluation of technologies for identifying acute cardiac ischemia in the emergency department: executive summary of a National Heart Attack Alert Program Working Group Report.9351728Tanasijevic MJ, Cannon CP, Wybenga DR, Fischer GA, Grudzien C, Gibson CM, Winkelman JW, Antman EM, Braunwald EAmerican heart journalMyoglobin, creatine kinase MB, and cardiac troponin-I to assess reperfusion after thrombolysis for acute myocardial infarction: results from TIMI 10A. Am Heart J. 1997 Oct; 134(4):622-30.Am Heart J1997-10-01T00:00:001997Myoglobin, creatine kinase MB, and cardiac troponin-I to assess reperfusion after thrombolysis for acute myocardial infarction: results from TIMI 10A.1614465Lau J, Antman EM, Jimenez-Silva J, Kupelnick B, Mosteller F, Chalmers TCThe New England journal of medicineCumulative meta-analysis of therapeutic trials for myocardial infarction. N Engl J Med. 1992 Jul 23; 327(4):248-54.N Engl J Med1992-07-23T00:00:001992Cumulative meta-analysis of therapeutic trials for myocardial infarction.11806038Juárez U, Antman EMArchivos de cardiologia de Mexico[Magnesium in the treatment of acute myocardial infarction. Review and controversies]. Arch Cardiol Mex. 2001 Oct-Dec; 71(4):335-44.Arch Cardiol Mex2001-10-01T00:00:002001[Magnesium in the treatment of acute myocardial infarction. Review and controversies].12208217Antman EMEuropean heart journal'I can see clearly now': a new view on the use of IV GP IIb/IIIa inhibitors in acute coronary syndromes. Eur Heart J. 2002 Sep; 23(18):1408-11.Eur Heart J2002-09-01T00:00:002002'I can see clearly now': a new view on the use of IV GP IIb/IIIa inhibitors in acute coronary syndromes.16386656Smith SC, Feldman TE, Hirshfeld JW, Jacobs AK, Kern MJ, King SB, Morrison DA, O'Neill WW, Schaff HV, Whitlow PL, Williams DO, Antman EM, Smith SC, Adams CD, Anderson JL, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Jacobs AK, Nishimura R, Ornato JP, Page RL, Riegel BJournal of the American College of CardiologyACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). J Am Coll Cardiol. 2006 Jan 03; 47(1):e1-121.J Am Coll Cardiol2006-01-03T00:00:002006ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention).16935995Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, Gregoratos G, Klein G, Moss AJ, Myerburg RJ, Priori SG, Quinones MA, Roden DM, Silka MJ, Tracy C, Smith SC, Jacobs AK, Adams CD, Antman EM, Anderson JL, Hunt SA, Halperin JL, Nishimura R, Ornato JP, Page RL, Riegel B, Blanc JJ, Budaj A, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JLCirculationACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation. 2006 Sep 05; 114(10):e385-484.Circulation2006-08-25T00:00:002006ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society.2180591Cole PL, Beamer AD, McGowan N, Cantillon CO, Benfell K, Kelly RA, Hartley LH, Smith TW, Antman EMCirculationEfficacy and safety of perhexiline maleate in refractory angina. A double-blind placebo-controlled clinical trial of a novel antianginal agent. Circulation. 1990 Apr; 81(4):1260-70.Circulation1990-04-01T00:00:001990Efficacy and safety of perhexiline maleate in refractory angina. A double-blind placebo-controlled clinical trial of a novel antianginal agent.17584551Steinberg BA, Moghbeli N, Buros J, Ruda M, Parkhomenko A, Raju BS, García-Castillo A, Janion M, Nicolau JC, Fox KA, Morrow DA, Gibson CM, Antman EMAmerican heart journalGlobal outcomes of ST-elevation myocardial infarction: comparisons of the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25) registry and trial. Am Heart J. 2007 Jul; 154(1):54-61.Am Heart J2007-07-01T00:00:002007Global outcomes of ST-elevation myocardial infarction: comparisons of the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25) registry and trial.8790025Antman EMCirculationHirudin in acute myocardial infarction. Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9B trial. Circulation. 1996 Sep 01; 94(5):911-21.Circulation1996-09-01T00:00:001996Hirudin in acute myocardial infarction. Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9B trial.8998086Selker HP, Zalenski RJ, Antman EM, Aufderheide TP, Bernard SA, Bonow RO, Gibler WB, Hagen MD, Johnson P, Lau J, McNutt RA, Ornato J, Schwartz JS, Scott JD, Tunick PA, Weaver WDAnnals of emergency medicineAn evaluation of technologies for identifying acute cardiac ischemia in the emergency department: a report from a National Heart Attack Alert Program Working Group. Ann Emerg Med. 1997 Jan; 29(1):13-87.Ann Emerg Med1997-01-01T00:00:001997An evaluation of technologies for identifying acute cardiac ischemia in the emergency department: a report from a National Heart Attack Alert Program Working Group.12360156Kereiakes DJ, Montalescot G, Antman EM, Cohen M, Darius H, Ferguson JJ, Grines C, Karsch KR, Kleiman NS, Moliterno DJ, Steg PG, Teirstein P, Van de Werf F, Wallentin LAmerican heart journalLow-molecular-weight heparin therapy for non-ST-elevation acute coronary syndromes and during percutaneous coronary intervention: an expert consensus. Am Heart J. 2002 Oct; 144(4):615-24.Am Heart J2002-10-01T00:00:002002Low-molecular-weight heparin therapy for non-ST-elevation acute coronary syndromes and during percutaneous coronary intervention: an expert consensus.12515758Gibbons RJ, Abrams J, Chatterjee K, Daley J, Deedwania PC, Douglas JS, Ferguson TB, Fihn SD, Fraker TD, Gardin JM, O'Rourke RA, Pasternak RC, Williams SV, Gibbons RJ, Alpert JS, Antman EM, Hiratzka LF, Fuster V, Faxon DP, Gregoratos G, Jacobs AK, Smith SCCirculationACC/AHA 2002 guideline update for the management of patients with chronic stable angina--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina). Circulation. 2003 Jan 07; 107(1):149-58.Circulation2003-01-07T00:00:002003ACC/AHA 2002 guideline update for the management of patients with chronic stable angina--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina).12605754Antman EMRevista espanola de cardiologia[Present and future of antithrombotic therapy in acute coronary syndromes]. Rev Esp Cardiol. 2003 Feb; 56(2):115-20.Rev Esp Cardiol2003-02-01T00:00:002003[Present and future of antithrombotic therapy in acute coronary syndromes].10551685Gibson CM, Murphy S, Menown IB, Sequeira RF, Greene R, Van de Werf F, Schweiger MJ, Ghali M, Frey MJ, Ryan KA, Marble SJ, Giugliano RP, Antman EM, Cannon CP, Braunwald EJournal of the American College of CardiologyDeterminants of coronary blood flow after thrombolytic administration. TIMI Study Group. Thrombolysis in Myocardial Infarction. J Am Coll Cardiol. 1999 Nov 01; 34(5):1403-12.J Am Coll Cardiol1999-11-01T00:00:001999Determinants of coronary blood flow after thrombolytic administration. TIMI Study Group. Thrombolysis in Myocardial Infarction.11579347Henry TD, Satran D, Knox LL, Iacarella CL, Laxson DD, Antman EMAmerican heart journalAre activated clotting times helpful in the management of anticoagulation with subcutaneous low-molecular-weight heparin? Am Heart J. 2001 Oct; 142(4):590-3.Am Heart J2001-10-01T00:00:002001Are activated clotting times helpful in the management of anticoagulation with subcutaneous low-molecular-weight heparin?11686667Llevadot J, Giugliano RP, Antman EM, Wilcox RG, Gurfinkel EP, Henry T, McCabe CH, Charlesworth A, Thompson S, Nicolau JC, Tebbe U, Sadowski Z, Braunwald EEuropean heart journalAvailability of on-site catheterization and clinical outcomes in patients receiving fibrinolysis for ST-elevation myocardial infarction. Eur Heart J. 2001 Nov; 22(22):2104-15.Eur Heart J2001-11-01T00:00:002001Availability of on-site catheterization and clinical outcomes in patients receiving fibrinolysis for ST-elevation myocardial infarction.12127617Scirica BM, Cannon CP, Antman EM, Murphy SA, Morrow DA, Sabatine MS, McCabe CH, Gibson CM, Braunwald EThe American journal of cardiologyValidation of the thrombolysis in myocardial infarction (TIMI) risk score for unstable angina pectoris and non-ST-elevation myocardial infarction in the TIMI III registry. Am J Cardiol. 2002 Aug 01; 90(3):303-5.Am J Cardiol2002-08-01T00:00:002002Validation of the thrombolysis in myocardial infarction (TIMI) risk score for unstable angina pectoris and non-ST-elevation myocardial infarction in the TIMI III registry.15632887Cooper HA, Domanski MJ, Rosenberg Y, Norman J, Scott JH, Assmann SF, McKinlay SM, Hochman JS, Antman EMAmerican heart journalAcute ST-segment elevation myocardial infarction and prior stroke: an analysis from the Magnesium in Coronaries (MAGIC) trial. Am Heart J. 2004 Dec; 148(6):1012-9.Am Heart J2004-12-01T00:00:002004Acute ST-segment elevation myocardial infarction and prior stroke: an analysis from the Magnesium in Coronaries (MAGIC) trial.11382373Menon V, Berkowitz SD, Antman EM, Fuchs RM, Hochman JSThe American journal of medicineNew heparin dosing recommendations for patients with acute coronary syndromes. Am J Med. 2001 Jun 01; 110(8):641-50.Am J Med2001-06-01T00:00:002001New heparin dosing recommendations for patients with acute coronary syndromes.11427095Turpie AG, Antman EMArchives of internal medicineLow-molecular-weight heparins in the treatment of acute coronary syndromes. Arch Intern Med. 2001 Jun 25; 161(12):1484-90.Arch Intern Med2001-06-25T00:00:002001Low-molecular-weight heparins in the treatment of acute coronary syndromes.11981102Cohen M, Antman EM, Gurfinkel EP, Radley DJournal of thrombosis and thrombolysisEnoxaparin in unstable angina/non-ST-segment elevation myocardial infarction: treatment benefits in prespecified subgroups. J Thromb Thrombolysis. 2001 Dec; 12(3):199-206.J Thromb Thrombolysis2001-12-01T00:00:002001Enoxaparin in unstable angina/non-ST-segment elevation myocardial infarction: treatment benefits in prespecified subgroups.9737475Gurfinkel E, Fareed J, Antman E, Cohen M, Mautner BThe American journal of cardiologyRationale for the management of coronary syndromes with low-molecular-weight heparins. Am J Cardiol. 1998 Sep 10; 82(5B):15L-18L.Am J Cardiol1998-09-10T00:00:001998Rationale for the management of coronary syndromes with low-molecular-weight heparins.10645918de Lemos JA, Antman EM, Gibson CM, McCabe CH, Giugliano RP, Murphy SA, Coulter SA, Anderson K, Scherer J, Frey MJ, Van Der Wieken R, Van De Werf F, Braunwald ECirculationAbciximab improves both epicardial flow and myocardial reperfusion in ST-elevation myocardial infarction. Observations from the TIMI 14 trial. Circulation. 2000 Jan 25; 101(3):239-43.Circulation2000-01-25T00:00:002000Abciximab improves both epicardial flow and myocardial reperfusion in ST-elevation myocardial infarction. Observations from the TIMI 14 trial.10851205Coulter SA, Cannon CP, Ault KA, Antman EM, Van de Werf F, Adgey AA, Gibson CM, Giugliano RP, Mascelli MA, Scherer J, Barnathan ES, Braunwald E, Kleiman NSCirculationHigh levels of platelet inhibition with abciximab despite heightened platelet activation and aggregation during thrombolysis for acute myocardial infarction: results from TIMI (thrombolysis in myocardial infarction) 14. Circulation. 2000 Jun 13; 101(23):2690-5.Circulation2000-06-13T00:00:002000High levels of platelet inhibition with abciximab despite heightened platelet activation and aggregation during thrombolysis for acute myocardial infarction: results from TIMI (thrombolysis in myocardial infarction) 14.11156721Antman EM, Kereiakes DJThe Journal of invasive cardiologyAntithrombotic therapy in unstable angina/non-ST elevation myocardial infarction: the evolving role of low-molecular-weight heparin. J Invasive Cardiol. 2000 Dec; 12 Suppl E:E1-4;discussion E25-8.J Invasive Cardiol2000-12-01T00:00:002000Antithrombotic therapy in unstable angina/non-ST elevation myocardial infarction: the evolving role of low-molecular-weight heparin.11676942Schweiger MJ, Cannon CP, Murphy SA, Gibson CM, Cook JR, Giugliano RP, Changezi HU, Antman EM, Braunwald EThe American journal of cardiologyEarly coronary intervention following pharmacologic therapy for acute myocardial infarction (the combined TIMI 10B-TIMI 14 experience). Am J Cardiol. 2001 Oct 15; 88(8):831-6.Am J Cardiol2001-10-15T00:00:002001Early coronary intervention following pharmacologic therapy for acute myocardial infarction (the combined TIMI 10B-TIMI 14 experience).11728139Giugliano RP, Antman EMEuropean heart journalCaeteris paribus - all things being equal. Eur Heart J. 2001 Dec; 22(24):2221-3.Eur Heart J2001-12-01T00:00:002001Caeteris paribus - all things being equal.22817110Kuriachan V, Tedrow U, Antman E, Epstein LMPacing and clinical electrophysiology : PACEAcute hyperkalemia detected by alert from implantable cardioverter-defibrillator. Pacing Clin Electrophysiol. 2012 Sep; 35(9):e276-9.Pacing Clin Electrophysiol2012-07-21T00:00:002012Acute hyperkalemia detected by alert from implantable cardioverter-defibrillator.Antman EM, Seelig MS, Fleischmann K, Lau J, Kuntz K, Berkey C, McIntosh MCardiovascular Drugs and TherapyMagnesium in acute myocardial infarction: scientific, statistical and economic rationale for its use. (Editorial). Cardiovascular Drugs and Therapy. 1996; 10:297-301.1996-01-01T00:00:001996Magnesium in acute myocardial infarction: scientific, statistical and economic rationale for its use. (Editorial)Antman EMJournal of Thrombosis and ThrombolysisThe thrombin hypothesis: dead or alive?. Journal of Thrombosis and Thrombolysis. 1998; 5:S131-S135.1998-01-01T00:00:001998The thrombin hypothesis: dead or alive?Antman EMHeart Disease: A Textbook of Cardiovascular Medicine. Braunwald E, ed."Medical management of the patient undergoing cardiac surgery". Heart Disease: A Textbook of Cardiovascular Medicine. Braunwald E, ed. 1991; 1670-93.1991-01-01T00:00:001991"Medical management of the patient undergoing cardiac surgery"Ndumele CE, Friedberg M, Antman EM, Strichartz GR, Lilly LSPathophysiology of Heart Disease: A Collaborative Project of Medical Students and Faculty. Lilly LS, ed.Cardiovascular drugs. Pathophysiology of Heart Disease: A Collaborative Project of Medical Students and Faculty. Lilly LS, ed. 2003; 371-421.2003-01-01T00:00:002003Cardiovascular drugsAntman EM, Smith TWOxford Textbook of Critical Care. Webb AR, Shapiro MJ, singer M, Suter PM, eds."Digitalis Toxicity". Oxford Textbook of Critical Care. Webb AR, Shapiro MJ, singer M, Suter PM, eds. 1999; 64-42.1999-01-01T00:00:001999"Digitalis Toxicity"12106926de Lemos JA, Morrow DA, Gibson CM, Murphy SA, Sabatine MS, Rifai N, McCabe CH, Antman EM, Cannon CP, Braunwald EJournal of the American College of CardiologyThe prognostic value of serum myoglobin in patients with non-ST-segment elevation acute coronary syndromes. Results from the TIMI 11B and TACTICS-TIMI 18 studies. J Am Coll Cardiol. 2002 Jul 17; 40(2):238-44.J Am Coll Cardiol2002-07-17T00:00:002002The prognostic value of serum myoglobin in patients with non-ST-segment elevation acute coronary syndromes. Results from the TIMI 11B and TACTICS-TIMI 18 studies.12777317Armstrong PW, Collen D, Antman ECirculationFibrinolysis for acute myocardial infarction: the future is here and now. Circulation. 2003 May 27; 107(20):2533-7.Circulation2003-05-27T00:00:002003Fibrinolysis for acute myocardial infarction: the future is here and now.17456482White HD, Braunwald E, Murphy SA, Jacob AJ, Gotcheva N, Polonetsky L, Antman EMEuropean heart journalEnoxaparin vs. unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction in elderly and younger patients: results from ExTRACT-TIMI 25. Eur Heart J. 2007 May; 28(9):1066-71.Eur Heart J2007-04-24T00:00:002007Enoxaparin vs. unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction in elderly and younger patients: results from ExTRACT-TIMI 25.17901357Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikof E, Fleischmann KE, Freeman WK, Froehlich JB, Kasper EK, Kersten JR, Riegel B, Robb JF, Smith SC, Jacobs AK, Adams CD, Anderson JL, Antman EM, Buller CE, Creager MA, Ettinger SM, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Lytle BW, Nishimura R, Ornato JP, Page RL, Tarkington LG, Yancy CWCirculationACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery): developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. Circulation. 2007 Oct 23; 116(17):e418-99.Circulation2007-09-27T00:00:002007ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery): developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery.10577463Antman EM, Cohen MAmerican heart journalNewer antithrombin agents in acute coronary syndromes. Am Heart J. 1999 Dec; 138(6 Pt 2):S563-9.Am Heart J1999-12-01T00:00:001999Newer antithrombin agents in acute coronary syndromes.10876006de Lemos JA, Antman EM, Morrow DA, Llevadot J, Giugliano RP, Coulter SA, Schuhwerk KC, Arslanian S, McCabe CH, Gibson CM, Rifai NClinica chimica acta; international journal of clinical chemistryHeart-type fatty acid binding protein as a marker of reperfusion after thrombolytic therapy. Clin Chim Acta. 2000 Aug; 298(1-2):85-97.Clin Chim Acta2000-08-01T00:00:002000Heart-type fatty acid binding protein as a marker of reperfusion after thrombolytic therapy.11078296de Lemos JA, Antman EM, Giugliano RP, McCabe CH, Murphy SA, Van de Werf F, Gibson CM, Braunwald EThe American journal of cardiologyST-segment resolution and infarct-related artery patency and flow after thrombolytic therapy. Thrombolysis in Myocardial Infarction (TIMI) 14 investigators. Am J Cardiol. 2000 Feb 01; 85(3):299-304.Am J Cardiol2000-02-01T00:00:002000ST-segment resolution and infarct-related artery patency and flow after thrombolytic therapy. Thrombolysis in Myocardial Infarction (TIMI) 14 investigators.11773913Cohen M, Antman EM, Murphy SA, Radley DAmerican heart journalMode and timing of treatment failure (recurrent ischemic events) after hospital admission for non-ST segment elevation acute coronary syndromes. Am Heart J. 2002 Jan; 143(1):63-9.Am Heart J2002-01-01T00:00:002002Mode and timing of treatment failure (recurrent ischemic events) after hospital admission for non-ST segment elevation acute coronary syndromes.14638523Antman EM, Ferguson JJCirculationShould evidence-based proof of efficacy as defined for a specific therapeutic agent be extrapolated to encompass a therapeutic class of agents? Circulation. 2003 Nov 25; 108(21):2604-7.Circulation2003-11-25T00:00:002003Should evidence-based proof of efficacy as defined for a specific therapeutic agent be extrapolated to encompass a therapeutic class of agents?15063425Gibson CM, Karha J, Murphy SA, de Lemos JA, Morrow DA, Giugliano RP, Roe MT, Harrington RA, Cannon CP, Antman EM, Califf RM, Braunwald EJournal of the American College of CardiologyAssociation of a pulsatile blood flow pattern on coronary arteriography and short-term clinical outcomes in acute myocardial infarction. J Am Coll Cardiol. 2004 Apr 07; 43(7):1170-6.J Am Coll Cardiol2004-04-07T00:00:002004Association of a pulsatile blood flow pattern on coronary arteriography and short-term clinical outcomes in acute myocardial infarction.16160202Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, Jessup M, Konstam MA, Mancini DM, Michl K, Oates JA, Rahko PS, Silver MA, Stevenson LW, Yancy CW, Antman EM, Smith SC, Adams CD, Anderson JL, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Jacobs AK, Nishimura R, Ornato JP, Page RL, Riegel BCirculationACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation. 2005 Sep 20; 112(12):e154-235.Circulation2005-09-13T00:00:002005ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society.16622607Ahmed S, Antman EM, Murphy SA, Giugliano RP, Cannon CP, White H, Morrow DA, Braunwald EJournal of thrombosis and thrombolysisPoor outcomes after fibrinolytic therapy for ST-segment elevation myocardial infarction: impact of age (a meta-analysis of a decade of trials). J Thromb Thrombolysis. 2006 Apr; 21(2):119-29.J Thromb Thrombolysis2006-04-01T00:00:002006Poor outcomes after fibrinolytic therapy for ST-segment elevation myocardial infarction: impact of age (a meta-analysis of a decade of trials).10483955Tanasijevic MJ, Cannon CP, Antman EM, Wybenga DR, Fischer GA, Grudzien C, Gibson CM, Winkelman JW, Braunwald EJournal of the American College of CardiologyMyoglobin, creatine-kinase-MB and cardiac troponin-I 60-minute ratios predict infarct-related artery patency after thrombolysis for acute myocardial infarction: results from the Thrombolysis in Myocardial Infarction study (TIMI) 10B. J Am Coll Cardiol. 1999 Sep; 34(3):739-47.J Am Coll Cardiol1999-09-01T00:00:001999Myoglobin, creatine-kinase-MB and cardiac troponin-I 60-minute ratios predict infarct-related artery patency after thrombolysis for acute myocardial infarction: results from the Thrombolysis in Myocardial Infarction study (TIMI) 10B.11071800Antman EM, Gibson CM, de Lemos JA, Giugliano RP, McCabe CH, Coussement P, Menown I, Nienaber CA, Rehders TC, Frey MJ, Van der Wieken R, Andresen D, Scherer J, Anderson K, Van de Werf F, Braunwald EEuropean heart journalCombination reperfusion therapy with abciximab and reduced dose reteplase: results from TIMI 14. The Thrombolysis in Myocardial Infarction (TIMI) 14 Investigators. Eur Heart J. 2000 Dec; 21(23):1944-53.Eur Heart J2000-12-01T00:00:002000Combination reperfusion therapy with abciximab and reduced dose reteplase: results from TIMI 14. The Thrombolysis in Myocardial Infarction (TIMI) 14 Investigators.11092649Morrow DA, Antman EM, Tanasijevic M, Rifai N, de Lemos JA, McCabe CH, Cannon CP, Braunwald EJournal of the American College of CardiologyCardiac troponin I for stratification of early outcomes and the efficacy of enoxaparin in unstable angina: a TIMI-11B substudy. J Am Coll Cardiol. 2000 Nov 15; 36(6):1812-7.J Am Coll Cardiol2000-11-15T00:00:002000Cardiac troponin I for stratification of early outcomes and the efficacy of enoxaparin in unstable angina: a TIMI-11B substudy.11305685Lev D, Watemberg N, Aviram A, Fishoff J, Antman E, Lerman-Sagie TJournal of child neurologyFebrile convulsions, ataxia, developmental delay, and obesity: a new syndrome? J Child Neurol. 2001 Mar; 16(3):174-6.J Child Neurol2001-03-01T00:00:002001Febrile convulsions, ataxia, developmental delay, and obesity: a new syndrome?11382738Antman EMCirculationClinical trials in cardiovascular medicine. Circulation. 2001 May 29; 103(21):E101-4.Circulation2001-05-29T00:00:002001Clinical trials in cardiovascular medicine.12578870de Lemos JA, Morrow DA, Sabatine MS, Murphy SA, Gibson CM, Antman EM, McCabe CH, Cannon CP, Braunwald ECirculationAssociation between plasma levels of monocyte chemoattractant protein-1 and long-term clinical outcomes in patients with acute coronary syndromes. Circulation. 2003 Feb 11; 107(5):690-5.Circulation2003-02-11T00:00:002003Association between plasma levels of monocyte chemoattractant protein-1 and long-term clinical outcomes in patients with acute coronary syndromes.18025532Tricoci P, Lokhnygina Y, Berdan LG, Steinhubl SR, Gulba DC, White HD, Kleiman NS, Aylward PE, Langer A, Califf RM, Ferguson JJ, Antman EM, Newby LK, Harrington RA, Goodman SG, Mahaffey KWCirculationTime to coronary angiography and outcomes among patients with high-risk non ST-segment elevation acute coronary syndromes: results from the SYNERGY trial. Circulation. 2007 Dec 04; 116(23):2669-77.Circulation2007-11-19T00:00:002007Time to coronary angiography and outcomes among patients with high-risk non ST-segment elevation acute coronary syndromes: results from the SYNERGY trial.9363822Ganz LI, Antman EMJournal of cardiovascular electrophysiologyAntiarrhythmic drug therapy in the management of atrial fibrillation. J Cardiovasc Electrophysiol. 1997 Oct; 8(10):1175-89.J Cardiovasc Electrophysiol1997-10-01T00:00:001997Antiarrhythmic drug therapy in the management of atrial fibrillation.9416931Gibson CM, Dodge JT, Goel M, Al-Mousa EN, Rizzo M, McLean C, Ryan K, Sparano A, Marble SJ, Daley WL, Cannon CP, Antman EMThe American journal of cardiologyAngioplasty guidewire velocity: a new simple method to calculate absolute coronary blood velocity and flow. Am J Cardiol. 1997 Dec 15; 80(12):1536-9.Am J Cardiol1997-12-15T00:00:001997Angioplasty guidewire velocity: a new simple method to calculate absolute coronary blood velocity and flow.9809903Reimold SC, Maisel WH, Antman EMThe American journal of cardiologyPropafenone for the treatment of supraventricular tachycardia and atrial fibrillation: a meta-analysis. Am J Cardiol. 1998 Oct 16; 82(8A):66N-71N.Am J Cardiol1998-10-16T00:00:001998Propafenone for the treatment of supraventricular tachycardia and atrial fibrillation: a meta-analysis.10856384Llevadot J, Giugliano RP, McCabe CH, Cannon CP, Antman EM, Murphy S, Gibson CMThe American journal of cardiologyDegree of residual stenosis in the culprit coronary artery after thrombolytic administration (Thrombolysis In Myocardial Infarction [TIMI] trials). Am J Cardiol. 2000 Jun 15; 85(12):1409-13.Am J Cardiol2000-06-15T00:00:002000Degree of residual stenosis in the culprit coronary artery after thrombolytic administration (Thrombolysis In Myocardial Infarction [TIMI] trials).10973852Braunwald E, Antman EM, Beasley JW, Califf RM, Cheitlin MD, Hochman JS, Jones RH, Kereiakes D, Kupersmith J, Levin TN, Pepine CJ, Schaeffer JW, Smith EE, Steward DE, Theroux P, Gibbons RJ, Alpert JS, Eagle KA, Faxon DP, Fuster V, Gardner TJ, Gregoratos G, Russell RO, Smith SCCirculationACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: executive summary and recommendations. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee on the management of patients with unstable angina). Circulation. 2000 Sep 05; 102(10):1193-209.Circulation2000-09-05T00:00:002000ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: executive summary and recommendations. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee on the management of patients with unstable angina).17179035Dzau VJ, Antman EM, Black HR, Hayes DL, Manson JE, Plutzky J, Popma JJ, Stevenson WCirculationThe cardiovascular disease continuum validated: clinical evidence of improved patient outcomes: part II: Clinical trial evidence (acute coronary syndromes through renal disease) and future directions. Circulation. 2006 Dec 19; 114(25):2871-91.Circulation2006-12-19T00:00:002006The cardiovascular disease continuum validated: clinical evidence of improved patient outcomes: part II: Clinical trial evidence (acute coronary syndromes through renal disease) and future directions.11179533Gibson CM, Murphy SA, Marble SJ, McCabe CH, Antman EM, Cannon CP, Braunwald EThe American journal of cardiologyCan we replace the 90-minute thrombolysis in myocardial infarction (TIMI) flow grades with those at 60 minutes as a primary end point in thrombolytic trials? TIMI Study Group. Am J Cardiol. 2001 Feb 15; 87(4):450-3, A6.Am J Cardiol2001-02-15T00:00:002001Can we replace the 90-minute thrombolysis in myocardial infarction (TIMI) flow grades with those at 60 minutes as a primary end point in thrombolytic trials? TIMI Study Group.2582394Lamas GA, Antman EMPacing and clinical electrophysiology : PACEPacemaker-mediated tachycardia initiated by coincident P-wave undersensing and ventricular blanking period. Pacing Clin Electrophysiol. 1985 May; 8(3 Pt 1):436-9.Pacing Clin Electrophysiol1985-05-01T00:00:001985Pacemaker-mediated tachycardia initiated by coincident P-wave undersensing and ventricular blanking period.16549646Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, Hiratzka LF, Murphy WR, Olin JW, Puschett JB, Rosenfield KA, Sacks D, Stanley JC, Taylor LM, White CJ, White J, White RA, Antman EM, Smith SC, Adams CD, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Hunt SA, Jacobs AK, Nishimura R, Ornato JP, Page RL, Riegel BCirculationACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation. 2006 Mar 21; 113(11):e463-654.Circulation2006-03-21T00:00:002006ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation.Authorship 984353128533319Antman EMCirculationEvaluating the Cardiovascular Safety of Nonsteroidal Anti-Inflammatory Drugs. Circulation. 2017 May 23; 135(21):2062-2072.Circulation2017-05-23T00:00:002017Evaluating the Cardiovascular Safety of Nonsteroidal Anti-Inflammatory Drugs.11834347Hunt SA, Baker DW, Chin MH, Cinquegrani MP, Feldman AM, Francis GS, Ganiats TG, Goldstein S, Gregoratos G, Jessup ML, Noble RJ, Packer M, Silver MA, Stevenson LW, Gibbons RJ, Antman EM, Alpert JS, Faxon DP, Fuster V, Gregoratos G, Jacobs AK, Hiratzka LF, Russell RO, Smith SCThe Journal of heart and lung transplantation : the official publication of the International Society for Heart TransplantationACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. J Heart Lung Transplant. 2002 Feb; 21(2):189-203.J Heart Lung Transplant2002-02-01T00:00:002002ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary.11939692Cohen M, Antman EMPharmacotherapySuperiority of enoxaparin over unfractionated heparin for the treatment of acute coronary syndromes. Pharmacotherapy. 2002 Apr; 22(4):542-6; author reply 546-50.Pharmacotherapy2002-04-01T00:00:002002Superiority of enoxaparin over unfractionated heparin for the treatment of acute coronary syndromes.11940541Antman EM, Louwerenburg HW, Baars HF, Wesdorp JC, Hamer B, Bassand JP, Bigonzi F, Pisapia G, Gibson CM, Heidbuchel H, Braunwald E, Van de Werf FCirculationEnoxaparin as adjunctive antithrombin therapy for ST-elevation myocardial infarction: results of the ENTIRE-Thrombolysis in Myocardial Infarction (TIMI) 23 Trial. Circulation. 2002 Apr 09; 105(14):1642-9.Circulation2002-04-09T00:00:002002Enoxaparin as adjunctive antithrombin therapy for ST-elevation myocardial infarction: results of the ENTIRE-Thrombolysis in Myocardial Infarction (TIMI) 23 Trial.14522503Klocke FJ, Baird MG, Lorell BH, Bateman TM, Messer JV, Berman DS, O'Gara PT, Carabello BA, Russell RO, Cerqueira MD, St John Sutton MG, DeMaria AN, Udelson JE, Kennedy JW, Verani MS, Williams KA, Antman EM, Smith SC, Alpert JS, Gregoratos G, Anderson JL, Hiratzka LF, Faxon DP, Hunt SA, Fuster V, Jacobs AK, Gibbons RJ, Russell ROJournal of the American College of CardiologyACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging). J Am Coll Cardiol. 2003 Oct 01; 42(7):1318-33.J Am Coll Cardiol2003-10-01T00:00:002003ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging).Antman EM, Califf RM, Kupersmith JCardiovascular Therapeutics: A Companion to Braunwald's Heart Disease"Tools for Assesment for Cardiovascular Tests and Therapies". Cardiovascular Therapeutics: A Companion to Braunwald's Heart Disease. 2002; 1-33.2002-01-01T00:00:002002"Tools for Assesment for Cardiovascular Tests and Therapies"14744964Kessler KM, Gibbons RJ, Smith SC, Antman ECirculationAll opinions are not equal. Circulation. 2004 Jan 27; 109(3):E21.Circulation2004-01-27T00:00:002004All opinions are not equal.Calcium Channel Blocking Agents in the Treatment of Cardiovascular Disorders (P Stone, EM Antman, eds.)Calcium Channel Blocking Agents in the Treatment of Cardiovascular Disorders (P Stone, EM Antman, eds.). 1983.1983-01-01T00:00:001983Calcium Channel Blocking Agents in the Treatment of Cardiovascular Disorders (P Stone, EM Antman, eds.)Abben RP, Antman EMCardiovascular MedicineManaging tachyarrhythmias. Cardiovascular Medicine. 1985; 10:52-8.1985-01-01T00:00:001985Managing tachyarrhythmias15680712Gibson CM, Kirtane AJ, Boundy K, Ly H, Karmpaliotis D, Murphy SA, Giugliano RP, Cannon CP, Antman EM, Braunwald EJournal of the American College of CardiologyAssociation of a negative residual stenosis following rescue/adjunctive percutaneous coronary intervention with impaired myocardial perfusion and adverse outcomes among ST-segment elevation myocardial infarction patients. J Am Coll Cardiol. 2005 Feb 01; 45(3):357-62.J Am Coll Cardiol2005-02-01T00:00:002005Association of a negative residual stenosis following rescue/adjunctive percutaneous coronary intervention with impaired myocardial perfusion and adverse outcomes among ST-segment elevation myocardial infarction patients.Antman EMCybersessions (Conceptis): ENTIRE-TIMI 23Cybersessions (Conceptis): ENTIRE-TIMI 23. 2001.2001-01-01T00:00:002001Cybersessions (Conceptis): ENTIRE-TIMI 2315339866Eagle KA, Guyton RA, Davidoff R, Edwards FH, Ewy GA, Gardner TJ, Hart JC, Herrmann HC, Hillis LD, Hutter AM, Lytle BW, Marlow RA, Nugent WC, Orszulak TA, Antman EM, Smith SC, Alpert JS, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Gregoratos G, Halperin JL, Hiratzka LF, Hunt SA, Jacobs AK, Ornato JPCirculationACC/AHA 2004 guideline update for coronary artery bypass graft surgery: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). Circulation. 2004 Aug 31; 110(9):1168-76.Circulation2004-08-31T00:00:002004ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery).16987906Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Le Heuzey JY, Kay GN, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann S, Smith SC, Jacobs AK, Adams CD, Anderson JL, Antman EM, Halperin JL, Hunt SA, Nishimura R, Ornato JP, Page RL, Riegel B, Priori SG, Blanc JJ, Budaj A, Camm AJ, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JLEuropace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of CardiologyACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 guidelines for the management of patients with atrial fibrillation) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace. 2006 Sep; 8(9):651-745.Europace2006-09-01T00:00:002006ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 guidelines for the management of patients with atrial fibrillation) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society.16990459Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, Hiratzka LF, Murphy WR, Olin JW, Puschett JB, Rosenfield KA, Sacks D, Stanley JC, Taylor LM, White CJ, White J, White RA, Antman EM, Smith SC, Adams CD, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Hunt SA, Jacobs AK, Nishimura R, Ornato JP, Page RL, Riegel BJournal of vascular and interventional radiology : JVIRACC/AHA Guidelines for the Management of Patients with Peripheral Arterial Disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Associations for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (writing committee to develop guidelines for the management of patients with peripheral arterial disease)--summary of recommendations. J Vasc Interv Radiol. 2006 Sep; 17(9):1383-97; quiz 1398.J Vasc Interv Radiol2006-09-01T00:00:002006ACC/AHA Guidelines for the Management of Patients with Peripheral Arterial Disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Associations for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (writing committee to develop guidelines for the management of patients with peripheral arterial disease)--summary of recommendations.17600038Murphy SA, Gibson CM, Morrow DA, Van de Werf F, Menown IB, Goodman SG, Mahaffey KW, Cohen M, McCabe CH, Antman EM, Braunwald EEuropean heart journalEfficacy and safety of the low-molecular weight heparin enoxaparin compared with unfractionated heparin across the acute coronary syndrome spectrum: a meta-analysis. Eur Heart J. 2007 Sep; 28(17):2077-86.Eur Heart J2007-06-28T00:00:002007Efficacy and safety of the low-molecular weight heparin enoxaparin compared with unfractionated heparin across the acute coronary syndrome spectrum: a meta-analysis.12943884Gibson CM, Gibson WJ, Murphy SA, Marble SJ, McCabe CH, Turakhia MP, Kirtane AJ, Karha J, Aroesty JM, Giugliano RP, Antman EMThe American journal of cardiologyAssociation of the Fibonacci Cascade with the distribution of coronary artery lesions responsible for ST-segment elevation myocardial infarction. Am J Cardiol. 2003 Sep 01; 92(5):595-7.Am J Cardiol2003-09-01T00:00:002003Association of the Fibonacci Cascade with the distribution of coronary artery lesions responsible for ST-segment elevation myocardial infarction.16750714Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikof E, Fleischmann KE, Freeman WK, Froehlich JB, Kasper EK, Kersten JR, Riegel B, Robb JF, Smith SC, Jacobs AK, Adams CD, Anderson JL, Antman EM, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Lytle BW, Nishimura R, Page RL, Riegel BJournal of the American College of CardiologyACC/AHA 2006 guideline update on perioperative cardiovascular evaluation for noncardiac surgery: focused update on perioperative beta-blocker therapy: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery) developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society for Vascular Medicine and Biology. J Am Coll Cardiol. 2006 Jun 06; 47(11):2343-55.J Am Coll Cardiol2006-06-06T00:00:002006ACC/AHA 2006 guideline update on perioperative cardiovascular evaluation for noncardiac surgery: focused update on perioperative beta-blocker therapy: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery) developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society for Vascular Medicine and Biology.16875962Bonow RO, Carabello BA, Chatterjee K, de Leon AC, Faxon DP, Freed MD, Gaasch WH, Lytle BW, Nishimura RA, O'Gara PT, O'Rourke RA, Otto CM, Shah PM, Shanewise JS, Smith SC, Jacobs AK, Adams CD, Anderson JL, Antman EM, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Lytle BW, Nishimura R, Page RL, Riegel BJournal of the American College of CardiologyACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing Committee to Revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. J Am Coll Cardiol. 2006 Aug 01; 48(3):e1-148.J Am Coll Cardiol2006-08-01T00:00:002006ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing Committee to Revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons.15173037Antman EM, Van de Werf FCirculationPharmacoinvasive therapy: the future of treatment for ST-elevation myocardial infarction. Circulation. 2004 Jun 01; 109(21):2480-6.Circulation2004-06-01T00:00:002004Pharmacoinvasive therapy: the future of treatment for ST-elevation myocardial infarction.15261928Mega JL, Morrow DA, De Lemos JA, Sabatine MS, Murphy SA, Rifai N, Gibson CM, Antman EM, Braunwald EJournal of the American College of CardiologyB-type natriuretic peptide at presentation and prognosis in patients with ST-segment elevation myocardial infarction: an ENTIRE-TIMI-23 substudy. J Am Coll Cardiol. 2004 Jul 21; 44(2):335-9.J Am Coll Cardiol2004-07-21T00:00:002004B-type natriuretic peptide at presentation and prognosis in patients with ST-segment elevation myocardial infarction: an ENTIRE-TIMI-23 substudy.15642555Kashani A, Gibson CM, Murphy SA, Sabatine MS, Morrow DA, Antman EM, Giugliano RPThe American journal of cardiologyAngiography and revascularization in patients with heart failure following fibrinolytic therapy for ST-elevation acute myocardial infarction. Am J Cardiol. 2005 Jan 15; 95(2):228-33.Am J Cardiol2005-01-15T00:00:002005Angiography and revascularization in patients with heart failure following fibrinolytic therapy for ST-elevation acute myocardial infarction.17901356Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikof E, Fleischmann KE, Freeman WK, Froehlich JB, Kasper EK, Kersten JR, Riegel B, Robb JF, Smith SC, Jacobs AK, Adams CD, Anderson JL, Antman EM, Buller CE, Creager MA, Ettinger SM, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Lytle BW, Nishimura R, Ornato JP, Page RL, Riegel B, Tarkington LG, Yancy CWCirculationACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery): Developed in Collaboration With the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. Circulation. 2007 Oct 23; 116(17):1971-96.Circulation2007-09-27T00:00:002007ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery): Developed in Collaboration With the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery.18035078Morrow DA, Antman EM, Murphy SA, Qin J, Ruda M, Guneri S, Jacob AJ, Budaj A, Braunwald EAmerican heart journalEffect of enoxaparin versus unfractionated heparin in diabetic patients with ST-elevation myocardial infarction in the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25) trial. Am Heart J. 2007 Dec; 154(6):1078-84, 1084.e1.Am Heart J2007-12-01T00:00:002007Effect of enoxaparin versus unfractionated heparin in diabetic patients with ST-elevation myocardial infarction in the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25) trial.18196350Mahaffey KW, Yang Q, Pieper KS, Antman EM, White HD, Goodman SG, Cohen M, Kleiman NS, Langer A, Aylward PE, Col JJ, Reist C, Ferguson JJ, Califf RMJournal of general internal medicinePrediction of one-year survival in high-risk patients with acute coronary syndromes: results from the SYNERGY trial. J Gen Intern Med. 2008 Mar; 23(3):310-6.J Gen Intern Med2008-01-15T00:00:002008Prediction of one-year survival in high-risk patients with acute coronary syndromes: results from the SYNERGY trial.18283303Antman EMNature clinical practice. Cardiovascular medicineIs fondaparinux safer than enoxaparin for patients undergoing percutaneous coronary intervention? Nat Clin Pract Cardiovasc Med. 2008 Apr; 5(4):184-5.Nat Clin Pract Cardiovasc Med2008-02-19T00:00:002008Is fondaparinux safer than enoxaparin for patients undergoing percutaneous coronary intervention?17600039Scirica BM, Morrow DA, Sadowski Z, Ruda M, Nicolau JC, Giugliano RP, Wiviott SD, Sabatine MS, Shui A, Antman EM, Braunwald EEuropean heart journalA strategy of using enoxaparin as adjunctive antithrombin therapy reduces death and recurrent myocardial infarction in patients who achieve early ST-segment resolution after fibrinolytic therapy: the ExTRACT-TIMI 25 ECG study. Eur Heart J. 2007 Sep; 28(17):2070-6.Eur Heart J2007-06-28T00:00:002007A strategy of using enoxaparin as adjunctive antithrombin therapy reduces death and recurrent myocardial infarction in patients who achieve early ST-segment resolution after fibrinolytic therapy: the ExTRACT-TIMI 25 ECG study.18435974Wiviott SD, Braunwald E, Murphy SA, Antman EMThe American journal of cardiologyA perspective on the efficacy and safety of intensive antiplatelet therapy in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction 38. Am J Cardiol. 2008 May 01; 101(9):1367-70.Am J Cardiol2008-04-01T00:00:002008A perspective on the efficacy and safety of intensive antiplatelet therapy in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction 38.15238590Ferguson JJ, Califf RM, Antman EM, Cohen M, Grines CL, Goodman S, Kereiakes DJ, Langer A, Mahaffey KW, Nessel CC, Armstrong PW, Avezum A, Aylward P, Becker RC, Biasucci L, Borzak S, Col J, Frey MJ, Fry E, Gulba DC, Guneri S, Gurfinkel E, Harrington R, Hochman JS, Kleiman NS, Leon MB, Lopez-Sendon JL, Pepine CJ, Ruzyllo W, Steinhubl SR, Teirstein PS, Toro-Figueroa L, White HJAMAEnoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial. JAMA. 2004 Jul 07; 292(1):45-54.JAMA2004-07-07T00:00:002004Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial.9265427Maisel WH, Kuntz KM, Reimold SC, Lee TH, Antman EM, Friedman PL, Stevenson WGAnnals of internal medicineRisk of initiating antiarrhythmic drug therapy for atrial fibrillation in patients admitted to a university hospital. Ann Intern Med. 1997 Aug 15; 127(4):281-4.Ann Intern Med1997-08-15T00:00:001997Risk of initiating antiarrhythmic drug therapy for atrial fibrillation in patients admitted to a university hospital.2303641Antman EM, Beamer AD, Cantillon C, McGowan N, Friedman PLJournal of the American College of CardiologyTherapy of refractory symptomatic atrial fibrillation and atrial flutter: a staged care approach with new antiarrhythmic drugs. J Am Coll Cardiol. 1990 Mar 01; 15(3):698-707.J Am Coll Cardiol1990-03-01T00:00:001990Therapy of refractory symptomatic atrial fibrillation and atrial flutter: a staged care approach with new antiarrhythmic drugs.10517729Antman EM, McCabe CH, Gurfinkel EP, Turpie AG, Bernink PJ, Salein D, Bayes De Luna A, Fox K, Lablanche JM, Radley D, Premmereur J, Braunwald ECirculationEnoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trial. Circulation. 1999 Oct 12; 100(15):1593-601.Circulation1999-10-12T00:00:001999Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trial.10599535Holper EM, Giugliano RP, Antman EMCoronary artery diseaseGlycoprotein IIb/IIIa inhibitors in acute ST segment elevation myocardial infarction. Coron Artery Dis. 1999 Dec; 10(8):567-73.Coron Artery Dis1999-12-01T00:00:001999Glycoprotein IIb/IIIa inhibitors in acute ST segment elevation myocardial infarction.Authorship 991954928625512Steffel J, Ruff CT, Hamershock RA, Murphy SA, Senior R, Roy D, Lanz HJ, Mercuri MF, Antman EM, Giugliano RPInternational journal of cardiologyFirst experience with edoxaban and atrial fibrillation ablation - Insights from the ENGAGE AF-TIMI 48 trial. Int J Cardiol. 2017 Oct 01; 244:192-195.Int J Cardiol2017-06-02T00:00:002017First experience with edoxaban and atrial fibrillation ablation - Insights from the ENGAGE AF-TIMI 48 trial.11835931Omland T, de Lemos JA, Morrow DA, Antman EM, Cannon CP, Hall C, Braunwald EThe American journal of cardiologyPrognostic value of N-terminal pro-atrial and pro-brain natriuretic peptide in patients with acute coronary syndromes. Am J Cardiol. 2002 Feb 15; 89(4):463-5.Am J Cardiol2002-02-15T00:00:002002Prognostic value of N-terminal pro-atrial and pro-brain natriuretic peptide in patients with acute coronary syndromes.11956114Sabatine MS, Morrow DA, de Lemos JA, Gibson CM, Murphy SA, Rifai N, McCabe C, Antman EM, Cannon CP, Braunwald ECirculationMultimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide. Circulation. 2002 Apr 16; 105(15):1760-3.Circulation2002-04-16T00:00:002002Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide.12103258Morrow DA, Antman EM, Sayah A, Schuhwerk KC, Giugliano RP, deLemos JA, Waller M, Cohen SA, Rosenberg DG, Cutler SS, McCabe CH, Walls RM, Braunwald EJournal of the American College of CardiologyEvaluation of the time saved by prehospital initiation of reteplase for ST-elevation myocardial infarction: results of The Early Retavase-Thrombolysis in Myocardial Infarction (ER-TIMI) 19 trial. J Am Coll Cardiol. 2002 Jul 03; 40(1):71-7.J Am Coll Cardiol2002-07-03T00:00:002002Evaluation of the time saved by prehospital initiation of reteplase for ST-elevation myocardial infarction: results of The Early Retavase-Thrombolysis in Myocardial Infarction (ER-TIMI) 19 trial.12651803Morrow DA, de Lemos JA, Sabatine MS, Antman EMClinical chemistryThe search for a biomarker of cardiac ischemia. Clin Chem. 2003 Apr; 49(4):537-9.Clin Chem2003-04-01T00:00:002003The search for a biomarker of cardiac ischemia.Authorship 9927411128666993Eisen A, Ruff CT, Braunwald E, Hamershock RA, Lewis BS, Hassager C, Chao TF, Le Heuzey JY, Mercuri M, Rutman H, Antman EM, Giugliano RPJournal of the American Heart AssociationDigoxin Use and Subsequent Clinical Outcomes in Patients With Atrial Fibrillation With or Without Heart Failure in the ENGAGE AF-TIMI 48 Trial. J Am Heart Assoc. 2017 Jun 30; 6(7).J Am Heart Assoc2017-06-30T00:00:002017Digoxin Use and Subsequent Clinical Outcomes in Patients With Atrial Fibrillation With or Without Heart Failure in the ENGAGE AF-TIMI 48 Trial.19249633Montalescot G, Wiviott SD, Braunwald E, Murphy SA, Gibson CM, McCabe CH, Antman EMLancet (London, England)Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial. Lancet. 2009 Feb 28; 373(9665):723-31.Lancet2009-02-28T00:00:002009Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial.19414633Mega JL, Close SL, Wiviott SD, Shen L, Hockett RD, Brandt JT, Walker JR, Antman EM, Macias WL, Braunwald E, Sabatine MSCirculationCytochrome P450 genetic polymorphisms and the response to prasugrel: relationship to pharmacokinetic, pharmacodynamic, and clinical outcomes. Circulation. 2009 May 19; 119(19):2553-60.Circulation2009-05-04T00:00:002009Cytochrome P450 genetic polymorphisms and the response to prasugrel: relationship to pharmacokinetic, pharmacodynamic, and clinical outcomes.20432399Cohen M, Levine GN, Pieper KS, Lan L, Antman EM, Aylward PE, White HD, Kleiman NS, Califf RM, Mahaffey KWCatheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & InterventionsEnoxaparin 0.3 mg/kg IV supplement for patients transitioning to PCI after subcutaneous enoxaparin therapy for NSTE ACS: a subgroup analysis from the SYNERGY trial. Catheter Cardiovasc Interv. 2010 May 01; 75(6):928-35.Catheter Cardiovasc Interv2010-05-01T00:00:002010Enoxaparin 0.3 mg/kg IV supplement for patients transitioning to PCI after subcutaneous enoxaparin therapy for NSTE ACS: a subgroup analysis from the SYNERGY trial.Giugliano RP, Antman EM, Thompson SL, McCabe CH, Braunwald EJournal of the American College of CardiologyLipid lowering drug therapy initiated during hospitalization for acute MI is associated with lower postdischarge 1-year mortality. Journal of the American College of Cardiology. 2001; 37(Suppl. A):316A.2001-01-01T00:00:002001Lipid lowering drug therapy initiated during hospitalization for acute MI is associated with lower postdischarge 1-year mortalityAntman EMCurrent Therapy. Rakel RE, ed."Acute Myocardial Infarction". Current Therapy. Rakel RE, ed. 1984; 190-212.1984-01-01T00:00:001984"Acute Myocardial Infarction"Marsh JD, Antman EMCardiovascular Drugs and TherapyT-type calcium channel blockade in the management of chronic ischemic heart disease. (Editorial). Cardiovascular Drugs and Therapy. 2000; 14:459-61.2000-01-01T00:00:002000T-type calcium channel blockade in the management of chronic ischemic heart disease. (Editorial)Leopold JA, Antman EMCirculationDual antiplatelet therapy for coronary stenting. Circulation. 2005; 111:1097-1099.2005-01-01T00:00:002005Dual antiplatelet therapy for coronary stentingSabatine MS, Morrow DA, Giugliano RP, Murphy SA, McCabe CH, Gibson CM, Cannon CP, Antman EM, Braunwald EJournal of the American College of CardiologyLow hemoglobin predicts worse clinical outcomes in acute coronary syndromes. Journal of the American College of Cardiology. 2004; 43(Suppl. A):278A.2004-01-01T00:00:002004Low hemoglobin predicts worse clinical outcomes in acute coronary syndromesWiviott SD, Antman EMFreedman JE, Loscalzo (eds.) New Therapeutic Agents in Thrombosis and ThrombolysisThree generations of thienopyrdines: ticlopidine, clopidogrel, and prasugrel. Freedman JE, Loscalzo (eds.) New Therapeutic Agents in Thrombosis and Thrombolysis. 2009.2009-01-01T00:00:002009Three generations of thienopyrdines: ticlopidine, clopidogrel, and prasugrelWiviott SD, Morrow DA, Sabatine M, Murphy SA, Winters JK, Antman EM, Braunwald ECirculationPrasugrel suppresses the early rise of sCD40 ligand levels following PCI compared to clopidogrel: a JUMBO-TIMI 26 substudy. Circulation. 2005; 112:II-432.2005-01-01T00:00:002005Prasugrel suppresses the early rise of sCD40 ligand levels following PCI compared to clopidogrel: a JUMBO-TIMI 26 substudyKarmpaliotis D, Turakhia MP, Kirtane AJ, Murphy SA, Kosmidou I, Morrow DA, Giugliano RP, Cannon CP, Antman EM, Braunwald E, Gibson CMAmerican Journal of CardiologySequential risk stratification using the TIMI risk score and TIMI flow grade among patients treated with fibrinolytic therapy for acute ST- segment elevation acute myocardial infarction. American Journal of Cardiology. 2004; 94:1113-1117.2004-01-01T00:00:002004Sequential risk stratification using the TIMI risk score and TIMI flow grade among patients treated with fibrinolytic therapy for acute ST- segment elevation acute myocardial infarctionAntman EMLibby P, Bonow RO, Mann DL, Zipes DP (eds.). Braunwald's Heart Disease: A Textbook of Cardiovascular MedicineST-Elevation Myocardial Infarction: Management. Libby P, Bonow RO, Mann DL, Zipes DP (eds.). Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. 2008; 1233-1299.2008-01-01T00:00:002008ST-Elevation Myocardial Infarction: ManagementSabatine M, Morrow DA, Antman EMAcute Coronary Syndromes: A Companion to Braunwald's Heart Disease. Theroux P, ed."Risk Stratification in Non-ST-Segment Elevation Acute Coronary Syndromes". Acute Coronary Syndromes: A Companion to Braunwald's Heart Disease. Theroux P, ed. 2003; 308-321.2003-01-01T00:00:002003"Risk Stratification in Non-ST-Segment Elevation Acute Coronary Syndromes"Antman EMEuropean Heart Journal SupplementsEnoxaparin: a new standard of care. European Heart Journal Supplements. 2000; 2 (Suppl F):F7-F11.2000-01-01T00:00:002000Enoxaparin: a new standard of care14564315Ferguson JJ, Antman EM, Bates ER, Cohen M, Every NR, Harrington RA, Pepine CJ, Theroux PAmerican heart journalCombining enoxaparin and glycoprotein IIb/IIIa antagonists for the treatment of acute coronary syndromes: final results of the National Investigators Collaborating on Enoxaparin-3 (NICE-3) study. Am Heart J. 2003 Oct; 146(4):628-34.Am Heart J2003-10-01T00:00:002003Combining enoxaparin and glycoprotein IIb/IIIa antagonists for the treatment of acute coronary syndromes: final results of the National Investigators Collaborating on Enoxaparin-3 (NICE-3) study.15050484Bavry AA, Kumbhani DJ, Quiroz R, Ramchandani SR, Kenchaiah S, Antman EMThe American journal of cardiologyInvasive therapy along with glycoprotein IIb/IIIa inhibitors and intracoronary stents improves survival in non-ST-segment elevation acute coronary syndromes: a meta-analysis and review of the literature. Am J Cardiol. 2004 Apr 01; 93(7):830-5.Am J Cardiol2004-04-01T00:00:002004Invasive therapy along with glycoprotein IIb/IIIa inhibitors and intracoronary stents improves survival in non-ST-segment elevation acute coronary syndromes: a meta-analysis and review of the literature.15226220Wiviott SD, Antman EMCirculationClopidogrel resistance: a new chapter in a fast-moving story. Circulation. 2004 Jun 29; 109(25):3064-7.Circulation2004-06-29T00:00:002004Clopidogrel resistance: a new chapter in a fast-moving story.15489115Alpert JS, Shine KI, Adams RJ, Antman EM, Kavey RE, Friedman L, Frye RL, Harrington RA, Korn D, Merz JF, Ofili EJournal of the American College of CardiologyTask force 1: The ACCF and AHA codes of conduct in human subjects research. J Am Coll Cardiol. 2004 Oct 19; 44(8):1724-8.J Am Coll Cardiol2004-10-19T00:00:002004Task force 1: The ACCF and AHA codes of conduct in human subjects research.15967851Wiviott SD, Antman EM, Winters KJ, Weerakkody G, Murphy SA, Behounek BD, Carney RJ, Lazzam C, McKay RG, McCabe CH, Braunwald ECirculationRandomized comparison of prasugrel (CS-747, LY640315), a novel thienopyridine P2Y12 antagonist, with clopidogrel in percutaneous coronary intervention: results of the Joint Utilization of Medications to Block Platelets Optimally (JUMBO)-TIMI 26 trial. Circulation. 2005 Jun 28; 111(25):3366-73.Circulation2005-06-20T00:00:002005Randomized comparison of prasugrel (CS-747, LY640315), a novel thienopyridine P2Y12 antagonist, with clopidogrel in percutaneous coronary intervention: results of the Joint Utilization of Medications to Block Platelets Optimally (JUMBO)-TIMI 26 trial.6766728Antman E, Gunther S, Barry WBritish heart journalBeneficial effects of intravenous glyceryl trinitrate in a case of Prinzmetal angina. Br Heart J. 1980 Jan; 43(1):88-91.Br Heart J1980-01-01T00:00:001980Beneficial effects of intravenous glyceryl trinitrate in a case of Prinzmetal angina.7405839Antman EM, Marsh JD, Green LH, Grossman WThe American journal of cardiologyBlood oxygen measurements in the assessment of intracardiac left to right shunts: a critical appraisal of methodology. Am J Cardiol. 1980 Aug; 46(2):265-71.Am J Cardiol1980-08-01T00:00:001980Blood oxygen measurements in the assessment of intracardiac left to right shunts: a critical appraisal of methodology.7987530Cubanski D, Cyganski D, Antman EM, Feldman CLJournal of cardiovascular electrophysiologyA neural network system for detection of atrial fibrillation in ambulatory electrocardiograms. J Cardiovasc Electrophysiol. 1994 Jul; 5(7):602-8.J Cardiovasc Electrophysiol1994-07-01T00:00:001994A neural network system for detection of atrial fibrillation in ambulatory electrocardiograms.8420236Strickberger SA, Fish RD, Lamas GA, Cantillon C, Bhatia S, McGowan N, Antman EM, Friedman PLThe American journal of cardiologyComparison of effects of propranolol versus pindolol on sinus rate and pacing frequency in sick sinus syndrome. Am J Cardiol. 1993 Jan 01; 71(1):53-6.Am J Cardiol1993-01-01T00:00:001993Comparison of effects of propranolol versus pindolol on sinus rate and pacing frequency in sick sinus syndrome.16545667Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, Hiratzka LF, Murphy WR, Olin JW, Puschett JB, Rosenfield KA, Sacks D, Stanley JC, Taylor LM, White CJ, White J, White RA, Antman EM, Smith SC, Adams CD, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Halperin JL, Hiratzka LF, Hunt SA, Jacobs AK, Nishimura R, Ornato JP, Page RL, Riegel BJournal of the American College of CardiologyACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease) endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. J Am Coll Cardiol. 2006 Mar 21; 47(6):1239-312.J Am Coll Cardiol2006-03-21T00:00:002006ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease) endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation.16569790Jacobs AK, Antman EM, Ellrodt G, Faxon DP, Gregory T, Mensah GA, Moyer P, Ornato J, Peterson ED, Sadwin L, Smith SCCirculationRecommendation to develop strategies to increase the number of ST-segment-elevation myocardial infarction patients with timely access to primary percutaneous coronary intervention. Circulation. 2006 May 02; 113(17):2152-63.Circulation2006-03-28T00:00:002006Recommendation to develop strategies to increase the number of ST-segment-elevation myocardial infarction patients with timely access to primary percutaneous coronary intervention.17560289Fox KA, Antman EM, Montalescot G, Agewall S, SomaRaju B, Verheugt FW, Lopez-Sendon J, Hod H, Murphy SA, Braunwald EJournal of the American College of CardiologyThe impact of renal dysfunction on outcomes in the ExTRACT-TIMI 25 trial. J Am Coll Cardiol. 2007 Jun 12; 49(23):2249-55.J Am Coll Cardiol2007-05-25T00:00:002007The impact of renal dysfunction on outcomes in the ExTRACT-TIMI 25 trial.17976428Ruff CT, Wiviott SD, Morrow DA, Mohanavelu S, Murphy SA, Antman EM, Braunwald EThe American journal of medicineTIMI risk index and the benefit of enoxaparin in patients with ST-elevation myocardial infarction. Am J Med. 2007 Nov; 120(11):993-8.Am J Med2007-11-01T00:00:002007TIMI risk index and the benefit of enoxaparin in patients with ST-elevation myocardial infarction.18292406Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikof E, Fleischmann KE, Freeman WK, Froehlich JB, Kasper EK, Kersten JR, Riegel B, Robb JF, Smith SC, Jacobs AK, Adams CD, Anderson JL, Antman EM, Buller CE, Creager MA, Ettinger SM, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Lytle BW, Nishimura R, Ornato JP, Page RL, Riegel B, Tarkington LG, Yancy CWAnesthesia and analgesiaACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Anesth Analg. 2008 Mar; 106(3):685-712.Anesth Analg2008-03-01T00:00:002008ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery).19273729Antman EM, Peterson EDCirculationTools for guiding clinical practice from the american heart association and the american college of cardiology: what are they and how should clinicians use them? Circulation. 2009 Mar 10; 119(9):1180-5.Circulation2009-03-10T00:00:002009Tools for guiding clinical practice from the american heart association and the american college of cardiology: what are they and how should clinicians use them?19406493Spinler SA, Mahaffey KW, Gallup D, Levine GN, Ferguson JJ, Rao SV, Gallo R, Ducas J, Goodman SG, Antman E, White HD, Biasucci L, Becker RC, Col JJ, Cohen M, Harrington RA, Califf RMInternational journal of cardiologyRelationship between renal function and outcomes in high-risk patients with non-ST-segment elevation acute coronary syndromes: results from SYNERGY. Int J Cardiol. 2010 Sep 24; 144(1):36-41.Int J Cardiol2009-05-05T00:00:002009Relationship between renal function and outcomes in high-risk patients with non-ST-segment elevation acute coronary syndromes: results from SYNERGY.20660815Wiviott SD, Antman EM, Braunwald ECirculationPrasugrel. Circulation. 2010 Jul 27; 122(4):394-403.Circulation2010-07-27T00:00:002010Prasugrel.7754943Reimold SC, Lamas GA, Cantillon CO, Antman EMAmerican heart journalRisk factors for the development of recurrent atrial fibrillation: role of pacing and clinical variables. Am Heart J. 1995 Jun; 129(6):1127-32.Am Heart J1995-06-01T00:00:001995Risk factors for the development of recurrent atrial fibrillation: role of pacing and clinical variables.22619274Jollis JG, Granger CB, Henry TD, Antman EM, Berger PB, Moyer PH, Pratt FD, Rokos IC, Acuña AR, Roettig ML, Jacobs AKCirculation. Cardiovascular quality and outcomesSystems of care for ST-segment-elevation myocardial infarction: a report From the American Heart Association's Mission: Lifeline. Circ Cardiovasc Qual Outcomes. 2012 Jul 01; 5(4):423-8.Circ Cardiovasc Qual Outcomes2012-05-22T00:00:002012Systems of care for ST-segment-elevation myocardial infarction: a report From the American Heart Association's Mission: Lifeline.22760283Antman EM, Harrington R, Tomaselli GJAMAUsefulness of medical conferences. JAMA. 2012 Jul 04; 308(1):31-2; author reply 32-3.JAMA2012-07-04T00:00:002012Usefulness of medical conferences.9790283Fox KA, Antman EMEuropean heart journalTreatment options in unstable angina: a clinical update. Eur Heart J. 1998 Sep; 19 Suppl K:K8-10.Eur Heart J1998-09-01T00:00:001998Treatment options in unstable angina: a clinical update.10155224Cannon CP, Braunwald E, McCabe CH, Antman EMJournal of interventional cardiologyThe Thrombolysis in Myocardial Infarction (TIMI) trials: the first decade. J Interv Cardiol. 1995 Apr; 8(2):117-35.J Interv Cardiol1995-04-01T00:00:001995The Thrombolysis in Myocardial Infarction (TIMI) trials: the first decade.10987628Alpert JS, Thygesen K, Antman E, Bassand JPJournal of the American College of CardiologyMyocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol. 2000 Sep; 36(3):959-69.J Am Coll Cardiol2000-09-01T00:00:002000Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction.11011339Bozovich GE, Gurfinkel EP, Antman EM, McCabe CH, Mautner BAmerican heart journalSuperiority of enoxaparin versus unfractionated heparin for unstable angina/non-Q-wave myocardial infarction regardless of activated partial thromboplastin time. Am Heart J. 2000 Oct; 140(4):637-42.Am Heart J2000-10-01T00:00:002000Superiority of enoxaparin versus unfractionated heparin for unstable angina/non-Q-wave myocardial infarction regardless of activated partial thromboplastin time.75 Francis StBrigham and Women's HospitalCardiovascular75 Francis StBoston02115MA18836135Bhatt DL, Scheiman J, Abraham NS, Antman EM, Chan FK, Furberg CD, Johnson DA, Mahaffey KW, Quigley EMCirculationACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. Circulation. 2008 Oct 28; 118(18):1894-909.Circulation2008-10-03T00:00:002008ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents.19892046Linefsky JP, Lin M, Pieper KS, Reist CJ, Berdan LG, Antman EM, Goodman SG, French JK, Guneri S, Roe MT, Newby LK, Harrington RA, Ferguson JJ, Califf RM, Mahaffey KWThe American journal of cardiologyComparison of site-reported and core laboratory-reported creatine kinase-MB values in non-ST-segment elevation acute coronary syndrome (from the international trial SYNERGY). Am J Cardiol. 2009 Nov 15; 104(10):1330-5.Am J Cardiol2009-09-25T00:00:002009Comparison of site-reported and core laboratory-reported creatine kinase-MB values in non-ST-segment elevation acute coronary syndrome (from the international trial SYNERGY).2900259Kirshenbaum JM, Kloner RF, McGowan N, Antman EMJournal of the American College of CardiologyUse of an ultrashort-acting beta-receptor blocker (esmolol) in patients with acute myocardial ischemia and relative contraindications to beta-blockade therapy. J Am Coll Cardiol. 1988 Sep; 12(3):773-80.J Am Coll Cardiol1988-09-01T00:00:001988Use of an ultrashort-acting beta-receptor blocker (esmolol) in patients with acute myocardial ischemia and relative contraindications to beta-blockade therapy.21060077Abraham NS, Hlatky MA, Antman EM, Bhatt DL, Bjorkman DJ, Clark CB, Furberg CD, Johnson DA, Kahi CJ, Laine L, Mahaffey KW, Quigley EM, Scheiman J, Sperling LS, Tomaselli GFCirculationACCF/ACG/AHA 2010 Expert Consensus Document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. Circulation. 2010 Dec 14; 122(24):2619-33.Circulation2010-11-08T00:00:002010ACCF/ACG/AHA 2010 Expert Consensus Document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents.23256168Guyatt G, Akl EA, Oxman A, Wilson K, Puhan MA, Wilt T, Gutterman D, Woodhead M, Antman EM, Schünemann HJProceedings of the American Thoracic SocietySynthesis, grading, and presentation of evidence in guidelines: article 7 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report. Proc Am Thorac Soc. 2012 Dec; 9(5):256-61.Proc Am Thorac Soc2012-12-01T00:00:002012Synthesis, grading, and presentation of evidence in guidelines: article 7 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report.Wiviott SD, Antman EMAngiolillo DJ, Kastrati A, Simon DI (eds). Clinical Guide to the Use of Antithrombotic Drugs in Coronary Artery DiseasePrasugrel--a third-generation thienopyridine. Angiolillo DJ, Kastrati A, Simon DI (eds). Clinical Guide to the Use of Antithrombotic Drugs in Coronary Artery Disease. 2008; 79-84.2008-01-01T00:00:002008Prasugrel--a third-generation thienopyridineBittl JA, White HD, Antman EMManson, JE, Burling JE, Ridker PM, Gaziano JM (eds.) Clinical Trials in Cardiovascular Disease: A Companion to Braunwald's Heart Disease"Direct Thrombin Inhibitors". Manson, JE, Burling JE, Ridker PM, Gaziano JM (eds.) Clinical Trials in Cardiovascular Disease: A Companion to Braunwald's Heart Disease. 2004; 83-06.2004-01-01T00:00:002004"Direct Thrombin Inhibitors"Giri S, Gibson M, Eisenhauer AC, Kuntz RE, Rogers C, Murphy S, Michel J, Antman EM, Simon DIJournal of the American College of CardiologyAging of intracoronary thrombus due to delayed time-to-perfusion increases ischemic and angiographic complications in acute myocardial infarction. Journal of the American College of Cardiology. 2002; 39(Suppl. A):281A.2002-01-01T00:00:002002Aging of intracoronary thrombus due to delayed time-to-perfusion increases ischemic and angiographic complications in acute myocardial infarctionAdams D, Filsoufi F, Antman EMBraunwald's Heart Disease: A Textbook of Cardiovascular Medicine. Zipes DW, Libby P, Bonow RO, Braunwald E (eds.)"Medical Management of the Patient Undergoing Cardiac Surgery". Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. Zipes DW, Libby P, Bonow RO, Braunwald E (eds.). 2005.2005-01-01T00:00:002005"Medical Management of the Patient Undergoing Cardiac Surgery"3127076Horowitz JD, Henry CA, Syrjanen ML, Louis WJ, Fish RD, Smith TW, Antman EMCirculationCombined use of nitroglycerin and N-acetylcysteine in the management of unstable angina pectoris. Circulation. 1988 Apr; 77(4):787-94.Circulation1988-04-01T00:00:001988Combined use of nitroglycerin and N-acetylcysteine in the management of unstable angina pectoris.3154322Antman EM, Arnold JM, Friedman PL, Smith TWCardiovascular drugs and therapyPharmacokinetic drug interactions between digoxin and antiarrhythmic agents and calcium channel blocking agents: an appraisal of study methodology. Cardiovasc Drugs Ther. 1987 Aug; 1(2):183-9.Cardiovasc Drugs Ther1987-08-01T00:00:001987Pharmacokinetic drug interactions between digoxin and antiarrhythmic agents and calcium channel blocking agents: an appraisal of study methodology.Cannon CP, McCabe CH, Borzak S, Henry TK, Tischler MD, Mueller HS, Feldman R, Palmeri ST, Ault K, Hamilton SA, Rothman JM, Novotny WF, Braunwald E, for the TIMI 12 Investigators. Antman EM, CoinvestigatorCirculationRandomized trial of an oral platelet glycoprotein IIb/IIIa antagonist, sibrafiban, in patients after an acute coronary syndrome: results of the TIMI 12 trial. Circulation. 1998; 97:340-9.1998-01-01T00:00:001998Randomized trial of an oral platelet glycoprotein IIb/IIIa antagonist, sibrafiban, in patients after an acute coronary syndrome: results of the TIMI 12 trialLoscalzo J, Antman EMJournal of Critical Care"Artificial Cardiac Pacemakers: Current Concepts". Journal of Critical Care. 1986; 3.1986-01-01T00:00:001986"Artificial Cardiac Pacemakers: Current Concepts"Antman EMContemporary Management of Acute Myocardial Infarction. Julian D & Braunwald E, eds."The General Hospital Management of Acute Myocardial Infarction". Contemporary Management of Acute Myocardial Infarction. Julian D & Braunwald E, eds. 1994; 29-70.1994-01-01T00:00:001994"The General Hospital Management of Acute Myocardial Infarction"Bonaca MP, Wiviott SD, Sabatine M, Buros J, Murphy SA, Scirica BM, Rifai N, Antman EM, Morrow DAAmerican Journal of CardiologyHemodynamic significance of peri-procedural myocardial injury assessed with N-terminal pro-B-type natriuretic peptide after percutaneous coronary intervention in patients with stable and unstable coronary artery disease (from the JUMBO-TIMI 26 trial). American Journal of Cardiology. 2007; 99:344-348.2007-01-01T00:00:002007Hemodynamic significance of peri-procedural myocardial injury assessed with N-terminal pro-B-type natriuretic peptide after percutaneous coronary intervention in patients with stable and unstable coronary artery disease (from the JUMBO-TIMI 26 trial)Authorship 10013111Smith TW, Antman EW, Friedman PL, Blatt CM, Marsh JDPart III, Progr Cardiovasc Dis.Digitalis glycosides: mechanisms and manifestations of toxicity. Part III, Progr Cardiovasc Dis. 1984; 27(1):21-56.1984-01-01T00:00:001984Digitalis glycosides: mechanisms and manifestations of toxicityAuthorship 1004351128755397Antman EMClinical pharmacology and therapeuticsThe Introduction and Clinical Use of Cardiac-Specific Troponin Assays. Clin Pharmacol Ther. 2018 Jan; 103(1):31-33.Clin Pharmacol Ther2017-07-29T00:00:002017The Introduction and Clinical Use of Cardiac-Specific Troponin Assays.28775338Antman EM, Di Corleto PE, Freeman MW, Ganz T, Golan DE, Kitterman R, Loscalzo J, Low M, McKenna E, O'Connor AC, Palazzolo M, Parrish J, Reizes O, Ross RS, Vaughan C, Vince DG, Watts LNature reviews. Drug discoveryNIH Centers for Accelerated Innovations Program: principles, practices, successes and challenges. Nat Rev Drug Discov. 2017 10; 16(10):663-664.Nat Rev Drug Discov2017-08-04T00:00:002017NIH Centers for Accelerated Innovations Program: principles, practices, successes and challenges.Wijns W, Antman EMPrior SG, Zipes DP (eds). Sudden Cardiac Death: A Handbook for Clinical PracticeIschemic Heart Disease. Prior SG, Zipes DP (eds). Sudden Cardiac Death: A Handbook for Clinical Practice. 2006; 91-108.2006-01-01T00:00:002006Ischemic Heart DiseaseAntman EMCurrent Therapy. Cohn HF, ed."Acute Myocardial Infarction". Current Therapy. Cohn HF, ed. 1983; 205-27.1983-01-01T00:00:001983"Acute Myocardial Infarction"Ryan TG, Antman EM, Brooks NH, Califf RM, Hillis LD, Hiratzka LF, Rapoport E, Riegel B, Russell RO, Smith EE III, Weaver WDACC/AHA guidelines for the management of patients with acute myocardial infarctionACC/AHA guidelines for the management of patients with acute myocardial infarction. 1999.1999-01-01T00:00:001999ACC/AHA guidelines for the management of patients with acute myocardial infarctionGibson M, Murphy SA, James D, Wong G, Cannon CP, Giugliano RP, Antman EM, Braunwald EJournal of the American College of CardiologyIs recurrent myocardial infarction following thrombolytic administration associated with long-term mortality?. Journal of the American College of Cardiology. 2002; 39 (Suppl. A):280A.2002-01-01T00:00:002002Is recurrent myocardial infarction following thrombolytic administration associated with long-term mortality?20801494Mega JL, Close SL, Wiviott SD, Shen L, Walker JR, Simon T, Antman EM, Braunwald E, Sabatine MSLancet (London, England)Genetic variants in ABCB1 and CYP2C19 and cardiovascular outcomes after treatment with clopidogrel and prasugrel in the TRITON-TIMI 38 trial: a pharmacogenetic analysis. Lancet. 2010 Oct 16; 376(9749):1312-9.Lancet2010-10-16T00:00:002010Genetic variants in ABCB1 and CYP2C19 and cardiovascular outcomes after treatment with clopidogrel and prasugrel in the TRITON-TIMI 38 trial: a pharmacogenetic analysis.20978260Mega JL, Simon T, Collet JP, Anderson JL, Antman EM, Bliden K, Cannon CP, Danchin N, Giusti B, Gurbel P, Horne BD, Hulot JS, Kastrati A, Montalescot G, Neumann FJ, Shen L, Sibbing D, Steg PG, Trenk D, Wiviott SD, Sabatine MSJAMAReduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis. JAMA. 2010 Oct 27; 304(16):1821-30.JAMA2010-10-27T00:00:002010Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis.Antman EMHeart Disease: A Textbook of Cardiovascular Medicine. Braunwald E, ed."Acute Myocardial Infarction". Heart Disease: A Textbook of Cardiovascular Medicine. Braunwald E, ed. 1996; 1184-1288.1996-01-01T00:00:001996"Acute Myocardial Infarction"3776841Antman EM, Ludmer PL, McGowan N, Bosak M, Friedman PLThe American journal of cardiologyTranstelephonic electrocardiographic transmission for management of cardiac arrhythmias. Am J Cardiol. 1986 Nov 01; 58(10):1021-4.Am J Cardiol1986-11-01T00:00:001986Transtelephonic electrocardiographic transmission for management of cardiac arrhythmias.3780766Campbell S, Holman BL, Kirshenbaum JM, Antman EM, Lister-James J, Davison A, Kozlowski J, English RJ, Jones AGEuropean journal of nuclear medicineThe scintigraphic evaluation of myocardial infarction and regional ventricular performance using technetium-99m hexakis (t-butylisonitrile) technetium (I) (TBI): a new myocardial imaging agent. Eur J Nucl Med. 1986; 12(5-6):219-25.Eur J Nucl Med1986-01-01T00:00:001986The scintigraphic evaluation of myocardial infarction and regional ventricular performance using technetium-99m hexakis (t-butylisonitrile) technetium (I) (TBI): a new myocardial imaging agent.3886190Zoll PM, Zoll RH, Falk RH, Clinton JE, Eitel DR, Antman EMCirculationExternal noninvasive temporary cardiac pacing: clinical trials. Circulation. 1985 May; 71(5):937-44.Circulation1985-05-01T00:00:001985External noninvasive temporary cardiac pacing: clinical trials.Authorship 1008802428862934Wang K, Li H, Kwong WJ, Antman EM, Ruff CT, Giugliano RP, Cohen DJ, Magnuson EAJournal of the American Heart AssociationImpact of Spontaneous Extracranial Bleeding Events on Health State Utility in Patients with Atrial Fibrillation: Results from the ENGAGE AF-TIMI 48 Trial. J Am Heart Assoc. 2017 Aug 11; 6(8).J Am Heart Assoc2017-08-11T00:00:002017Impact of Spontaneous Extracranial Bleeding Events on Health State Utility in Patients with Atrial Fibrillation: Results from the ENGAGE AF-TIMI 48 Trial.16084152Ohman EM, Van de Werf F, Antman EM, Califf RM, de Lemos JA, Gibson CM, Oliverio RL, Harrelson L, McCabe C, DiBattiste P, Braunwald EAmerican heart journalTenecteplase and tirofiban in ST-segment elevation acute myocardial infarction: results of a randomized trial. Am Heart J. 2005 Jul; 150(1):79-88.Am Heart J2005-07-01T00:00:002005Tenecteplase and tirofiban in ST-segment elevation acute myocardial infarction: results of a randomized trial.6969163Muller Je, Antman E, Green LH, Koster JKClinical cardiologySalvage of acutely ischemic myocardium by emergency coronary artery bypass grafting. Clin Cardiol. 1980 Aug; 3(4):276-80.Clin Cardiol1980-08-01T00:00:001980Salvage of acutely ischemic myocardium by emergency coronary artery bypass grafting.16513664Gersh BJ, Antman EMEuropean heart journalSelection of the optimal reperfusion strategy for STEMI: does time matter? Eur Heart J. 2006 Apr; 27(7):761-3.Eur Heart J2006-03-02T00:00:002006Selection of the optimal reperfusion strategy for STEMI: does time matter?7856535Antman EMThe American journal of cardiologyRandomized trials of magnesium in acute myocardial infarction: big numbers do not tell the whole story. Am J Cardiol. 1995 Feb 15; 75(5):391-3.Am J Cardiol1995-02-15T00:00:001995Randomized trials of magnesium in acute myocardial infarction: big numbers do not tell the whole story.8694009Antman EMAmerican heart journalMagnesium in acute myocardial infarction: overview of available evidence. Am Heart J. 1996 Aug; 132(2 Pt 2 Su):487-95; discussion 496-502.Am Heart J1996-08-01T00:00:001996Magnesium in acute myocardial infarction: overview of available evidence.9878939Kizer JR, Cannon CP, McCabe CH, Mueller HS, Schweiger MJ, Davis VG, Perritt R, Antman EMAmerican heart journalTrends in the use of pharmacotherapies for acute myocardial infarction among physicians who design and/or implement randomized trials versus physicians in routine clinical practice: the MILIS-TIMI experience. Multicenter Investigation on Limitation of Infarct Size. Thrombolysis in Myocardial Infarction. Am Heart J. 1999 Jan; 137(1):79-92.Am Heart J1999-01-01T00:00:001999Trends in the use of pharmacotherapies for acute myocardial infarction among physicians who design and/or implement randomized trials versus physicians in routine clinical practice: the MILIS-TIMI experience. Multicenter Investigation on Limitation of Infarct Size. Thrombolysis in Myocardial Infarction.10468535Ryan TJ, Antman EM, Brooks NH, Califf RM, Hillis LD, Hiratzka LF, Rapaport E, Riegel B, Russell RO, Smith EE, Weaver WD, Gibbons RJ, Alpert JS, Eagle KA, Gardner TJ, Garson A, Gregoratos G, Smith SCCirculation1999 update: ACC/AHA Guidelines for the Management of Patients With Acute Myocardial Infarction: Executive Summary and Recommendations: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). Circulation. 1999 Aug 31; 100(9):1016-30.Circulation1999-08-31T00:00:0019991999 update: ACC/AHA Guidelines for the Management of Patients With Acute Myocardial Infarction: Executive Summary and Recommendations: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction).10759468Morrow DA, Rifai N, Tanasijevic MJ, Wybenga DR, de Lemos JA, Antman EMClinical chemistryClinical efficacy of three assays for cardiac troponin I for risk stratification in acute coronary syndromes: a Thrombolysis In Myocardial Infarction (TIMI) 11B Substudy. Clin Chem. 2000 Apr; 46(4):453-60.Clin Chem2000-04-01T00:00:002000Clinical efficacy of three assays for cardiac troponin I for risk stratification in acute coronary syndromes: a Thrombolysis In Myocardial Infarction (TIMI) 11B Substudy.10938172Antman EM, Cohen M, Bernink PJ, McCabe CH, Horacek T, Papuchis G, Mautner B, Corbalan R, Radley D, Braunwald EJAMAThe TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making. JAMA. 2000 Aug 16; 284(7):835-42.JAMA2000-08-16T00:00:002000The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making.11044416Morrow DA, Antman EM, Charlesworth A, Cairns R, Murphy SA, de Lemos JA, Giugliano RP, McCabe CH, Braunwald ECirculationTIMI risk score for ST-elevation myocardial infarction: A convenient, bedside, clinical score for risk assessment at presentation: An intravenous nPA for treatment of infarcting myocardium early II trial substudy. Circulation. 2000 Oct 24; 102(17):2031-7.Circulation2000-10-24T00:00:002000TIMI risk score for ST-elevation myocardial infarction: A convenient, bedside, clinical score for risk assessment at presentation: An intravenous nPA for treatment of infarcting myocardium early II trial substudy.11275921Santopinto J, Gurfinkel EP, Torres V, Marcos E, Bozovich GE, Mautner B, McCabe CH, Antman EMAmerican heart journalPrior aspirin users with acute non-ST-elevation coronary syndromes are at increased risk of cardiac events and benefit from enoxaparin. Am Heart J. 2001 Apr; 141(4):566-72.Am Heart J2001-04-01T00:00:002001Prior aspirin users with acute non-ST-elevation coronary syndromes are at increased risk of cardiac events and benefit from enoxaparin.15374785Nallamothu BK, Antman EM, Bates ERThe American journal of cardiologyPrimary percutaneous coronary intervention versus fibrinolytic therapy in acute myocardial infarction: does the choice of fibrinolytic agent impact on the importance of time-to-treatment? Am J Cardiol. 2004 Sep 15; 94(6):772-4.Am J Cardiol2004-09-15T00:00:002004Primary percutaneous coronary intervention versus fibrinolytic therapy in acute myocardial infarction: does the choice of fibrinolytic agent impact on the importance of time-to-treatment?16490830Smith SC, Feldman TE, Hirshfeld JW, Jacobs AK, Kern MJ, King SB, Morrison DA, O'Neil WW, Schaff HV, Whitlow PL, Williams DO, Antman EM, Adams CD, Anderson JL, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Nishimura R, Ornato JP, Page RL, Riegel BCirculationACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update 2001 Guidelines for Percutaneous Coronary Intervention). Circulation. 2006 Feb 21; 113(7):e166-286.Circulation2006-02-21T00:00:002006ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update 2001 Guidelines for Percutaneous Coronary Intervention).17699010Donahoe SM, Stewart GC, McCabe CH, Mohanavelu S, Murphy SA, Cannon CP, Antman EMJAMADiabetes and mortality following acute coronary syndromes. JAMA. 2007 Aug 15; 298(7):765-75.JAMA2007-08-15T00:00:002007Diabetes and mortality following acute coronary syndromes.19923169Kushner FG, Hand M, Smith SC, King SB, Anderson JL, Antman EM, Bailey SR, Bates ER, Blankenship JC, Casey DE, Green LA, Hochman JS, Jacobs AK, Krumholz HM, Morrison DA, Ornato JP, Pearle DL, Peterson ED, Sloan MA, Whitlow PL, Williams DOCirculation2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (updating the 2005 Guideline and 2007 Focused Update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2009 Dec 01; 120(22):2271-306.Circulation2009-11-18T00:00:0020092009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (updating the 2005 Guideline and 2007 Focused Update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.19942100Kushner FG, Hand M, Smith SC, King SB, Anderson JL, Antman EM, Bailey SR, Bates ER, Blankenship JC, Casey DE, Green LA, Hochman JS, Jacobs AK, Krumholz HM, Morrison DA, Ornato JP, Pearle DL, Peterson ED, Sloan MA, Whitlow PL, Williams DOJournal of the American College of Cardiology2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update) a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2009 Dec 01; 54(23):2205-41.J Am Coll Cardiol2009-12-01T00:00:0020092009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update) a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.22923432Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, Katus HA, Lindahl B, Morrow DA, Clemmensen PM, Johanson P, Hod H, Underwood R, Bax JJ, Bonow RO, Pinto F, Gibbons RJ, Fox KA, Atar D, Newby LK, Galvani M, Hamm CW, Uretsky BF, Steg PG, Wijns W, Bassand JP, Menasché P, Ravkilde J, Ohman EM, Antman EM, Wallentin LC, Armstrong PW, Simoons ML, Januzzi JL, Nieminen MS, Gheorghiade M, Filippatos G, Luepker RV, Fortmann SP, Rosamond WD, Levy D, Wood D, Smith SC, Hu D, Lopez-Sendon JL, Robertson RM, Weaver D, Tendera M, Bove AA, Parkhomenko AN, Vasilieva EJ, Mendis SCirculationThird universal definition of myocardial infarction. Circulation. 2012 Oct 16; 126(16):2020-35.Circulation2012-08-24T00:00:002012Third universal definition of myocardial infarction.James D, Murphy SA, Wong GC, Morrow DA, Antman EM, McCabe CH, Marble SJ, Markovic R, Gibson CMCirculationIncreased AHA lesion complexity following thrombolytic administration is associated with mortality in ST elevation myocardial infarction. Circulation. 2002; 106 (Suppl. II):II-660.2002-01-01T00:00:002002Increased AHA lesion complexity following thrombolytic administration is associated with mortality in ST elevation myocardial infarctionShemin RJ, Tam S, Hein R, Hill S, Sun SC, Laurence R, Cohn LH, Antman EMCirculationEsmolol, a new intravenous titratable B-blocker to control experimental acute aortic dissection in hypertensive greyhounds. Circulation. 1987; 76:IV-22.1987-01-01T00:00:001987Esmolol, a new intravenous titratable B-blocker to control experimental acute aortic dissection in hypertensive greyhoundsThe Joint European Society of Cardiology/American College of Cardiology Committee. Antman EM: Member of Consensus Panel [ACC Representative] and Member of Writing CommitteeEuropean Heart JournalMyocardial infarction redefined--a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. European Heart Journal. 2000; 21:1502-13.2000-01-01T00:00:002000Myocardial infarction redefined--a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial InfarctionGiugliano R, Antman EMEuropean Heart JournalCaeteris paribus--all things being equal. (Editorial). European Heart Journal. 2001; 22 (doi: 10.1053/euhj.2001.268:2221-23.2001-01-01T00:00:002001Caeteris paribus--all things being equal. (Editorial)The Thrombolysis in Myocardial Infarction (TIMI) 11A Investigators. Antman EM, Principal InvestigatorJournal of the American College of CardiologyDose-ranging trial of enoxaparin for unstable angina: Results of TIMI 11A. Journal of the American College of Cardiology. 1997; 29:1474-82.1997-01-01T00:00:001997Dose-ranging trial of enoxaparin for unstable angina: Results of TIMI 11AKirtane AJ, Karmpaliotis D, Weisbrod A, Bui A, Murphy SA, Budiu D, Kosmidou I, Aroesty JM, Giugliano RP, Cannon CP, Antman EM, Braunwald E, Gibson CMJournal of the American College of CardiologyAngiographically apparent thrombus after fibrinolytic administration is associated with impaired epicardial flow and myocardial perfusion in ST elevation myocardial infarction patients with open arteries. Journal of the American College of Cardiology. 2004; 43(Suppl. A):262A.2004-01-01T00:00:002004Angiographically apparent thrombus after fibrinolytic administration is associated with impaired epicardial flow and myocardial perfusion in ST elevation myocardial infarction patients with open arteriesFerguson JJ, Mahaffey KW, Huang Y, Armstrong P, Levine G, Kleiman NS, Goodman SG, Cohen M, Antman E, Califf RMJournal of the American College of CardiologyEnoxaparin versus unfractionated heparin: consequences of treatment duration on efficacy and safety in SYNERGY. Journal of the American College of Cardiology. 2005; 45(Suppl1):247A.2005-01-01T00:00:002005Enoxaparin versus unfractionated heparin: consequences of treatment duration on efficacy and safety in SYNERGYMega JL, Shen L, Wiviott SD, Walker JR, Hockett RD, Brandt JT, Moser BA, Macias W, Antman EM, Close SL, Sabatine MSCirculationCytochrome P450 genetic variants predict cardiovascular outcomes following treatment with clopidogrel but not with prasugrel. Circulation. 2008; 118(Suppl2):S325.2008-01-01T00:00:002008Cytochrome P450 genetic variants predict cardiovascular outcomes following treatment with clopidogrel but not with prasugrelMahaffey KW, Levine G, Gallo R, Ducas J, Goodman SG, Lokhnygina Y, Traylor L, Antman E, White HD, Becker RC, Col JJ, Cohen M, Harrington RA, Fergusion JJ, Califf RMJournal of the American College of CardiologyRelationships between renal function, age, and obesity and outcomes in high-risk patients with acute coronary syndromes: results from SYNERGY. Journal of the American College of Cardiology. 2005; 45(Suppl1):214A.2005-01-01T00:00:002005Relationships between renal function, age, and obesity and outcomes in high-risk patients with acute coronary syndromes: results from SYNERGYRabbani LE, Antman EMThe Guide to Cardiology, Kloner RA, ed."Exercise Testing and Ambulatory Electrocardiographic Monitoring". The Guide to Cardiology, Kloner RA, ed. 1990; 55-72.1990-01-01T00:00:001990"Exercise Testing and Ambulatory Electrocardiographic Monitoring"6550460Rossi LP, Antman EMThe American journal of nursingCalcium channel blockers. New treatment for cardiovascular disease. Am J Nurs. 1983 Mar; 83(3):382-7.Am J Nurs1983-03-01T00:00:001983Calcium channel blockers. New treatment for cardiovascular disease.8615714McLaughlin TJ, Soumerai SB, Willison DJ, Gurwitz JH, Borbas C, Guadagnoli E, McLaughlin B, Morris N, Cheng SC, Hauptman PJ, Antman E, Casey L, Asinger R, Gobel FArchives of internal medicineAdherence to national guidelines for drug treatment of suspected acute myocardial infarction: evidence for undertreatment in women and the elderly. Arch Intern Med. 1996 Apr 08; 156(7):799-805.Arch Intern Med1996-04-08T00:00:001996Adherence to national guidelines for drug treatment of suspected acute myocardial infarction: evidence for undertreatment in women and the elderly.10347349Gibson CM, Ryan KA, Kelley M, Rizzo MJ, Mesley R, Murphy S, Swanson J, Marble SJ, Dodge JT, Giugliano RP, Cannon CP, Antman EMAmerican heart journalMethodologic drift in the assessment of TIMI grade 3 flow and its implications with respect to the reporting of angiographic trial results. The TIMI Study Group. Am Heart J. 1999 Jun; 137(6):1179-84.Am Heart J1999-06-01T00:00:001999Methodologic drift in the assessment of TIMI grade 3 flow and its implications with respect to the reporting of angiographic trial results. The TIMI Study Group.10483976Ryan TJ, Antman EM, Brooks NH, Califf RM, Hillis LD, Hiratzka LF, Rapaport E, Riegel B, Russell RO, Smith EE, Weaver WD, Gibbons RJ, Alpert JS, Eagle KA, Gardner TJ, Garson A, Gregoratos G, Ryan TJ, Smith SCJournal of the American College of Cardiology1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol. 1999 Sep; 34(3):890-911.J Am Coll Cardiol1999-09-01T00:00:0019991999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction).Friedman PL, Antman EM, Smith TWDigitalis Glycosides. Smith TW, ed. "Clinical Management of Digitalis Toxicity". Digitalis Glycosides. Smith TW, ed. 1986; 295-310.1986-01-01T00:00:001986"Clinical Management of Digitalis Toxicity"11090796de Lemos JA, Antman EM, Giugliano RP, Morrow DA, McCabe CH, Cutler SS, Charlesworth A, Schröder R, Braunwald EThe American journal of cardiologyComparison of a 60- versus 90-minute determination of ST-segment resolution after thrombolytic therapy for acute myocardial infarction. In TIME-II Investigators. Intravenous nPA for Treatment of Infarcting Myocardium Early-II. Am J Cardiol. 2000 Dec 01; 86(11):1235-7, A5.Am J Cardiol2000-12-01T00:00:002000Comparison of a 60- versus 90-minute determination of ST-segment resolution after thrombolytic therapy for acute myocardial infarction. In TIME-II Investigators. Intravenous nPA for Treatment of Infarcting Myocardium Early-II.Morrow DA, Antman EMHarrison's Advances in Cardiology. Braunwald E, ed.Low-molecular-weight heparin in non-ST elevation acute coronary syndromes. Harrison's Advances in Cardiology. Braunwald E, ed. 2003; 155-67.2003-01-01T00:00:002003Low-molecular-weight heparin in non-ST elevation acute coronary syndromes12588276Antman EMJAMAShould bivalirudin replace heparin during percutaneous coronary interventions? JAMA. 2003 Feb 19; 289(7):903-5.JAMA2003-02-19T00:00:002003Should bivalirudin replace heparin during percutaneous coronary interventions?14556865Karha J, Murphy SA, Kirtane AJ, de Lemos JA, Aroesty JM, Cannon CP, Antman EM, Braunwald E, Gibson CMThe American journal of cardiologyEvaluation of the association of proximal coronary culprit artery lesion location with clinical outcomes in acute myocardial infarction. Am J Cardiol. 2003 Oct 15; 92(8):913-8.Am J Cardiol2003-10-15T00:00:002003Evaluation of the association of proximal coronary culprit artery lesion location with clinical outcomes in acute myocardial infarction.15312859Wiviott SD, Morrow DA, Frederick PD, Giugliano RP, Gibson CM, McCabe CH, Cannon CP, Antman EM, Braunwald EJournal of the American College of CardiologyPerformance of the thrombolysis in myocardial infarction risk index in the National Registry of Myocardial Infarction-3 and -4: a simple index that predicts mortality in ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2004 Aug 18; 44(4):783-9.J Am Coll Cardiol2004-08-18T00:00:002004Performance of the thrombolysis in myocardial infarction risk index in the National Registry of Myocardial Infarction-3 and -4: a simple index that predicts mortality in ST-segment elevation myocardial infarction.1973691Antman EM, Braunwald EHospital practice (Office ed.)Acute MI management in the 1990s. Hosp Pract (Off Ed). 1990 Jul 15; 25(7):65-75, 79-82.Hosp Pract (Off Ed)1990-07-15T00:00:001990Acute MI management in the 1990s.16904574Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Le Heuzey JY, Kay GN, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann S, Smith SC, Jacobs AK, Adams CD, Anderson JL, Antman EM, Hunt SA, Nishimura R, Ornato JP, Page RL, Riegel B, Priori SG, Blanc JJ, Budaj A, Camm AJ, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Zamorano JLJournal of the American College of CardiologyACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation). J Am Coll Cardiol. 2006 Aug 15; 48(4):854-906.J Am Coll Cardiol2006-08-15T00:00:002006ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation).16923744Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, Gregoratos G, Klein G, Moss AJ, Myerburg RJ, Priori SG, Quinones MA, Roden DM, Silka MJ, Tracy C, Blanc JJ, Budaj A, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL, Smith SC, Jacobs AK, Adams CD, Antman EM, Anderson JL, Hunt SA, Halperin JL, Nishimura R, Ornato JP, Page RL, Riegel BEuropean heart journalACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death--executive summary: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Eur Heart J. 2006 Sep; 27(17):2099-140.Eur Heart J2006-09-01T00:00:002006ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death--executive summary: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society.17560287Gibson CM, Murphy SA, Montalescot G, Morrow DA, Ardissino D, Cohen M, Gulba DC, Kracoff OH, Lewis BS, Roguin N, Antman EM, Braunwald EJournal of the American College of CardiologyPercutaneous coronary intervention in patients receiving enoxaparin or unfractionated heparin after fibrinolytic therapy for ST-segment elevation myocardial infarction in the ExTRACT-TIMI 25 trial. J Am Coll Cardiol. 2007 Jun 12; 49(23):2238-46.J Am Coll Cardiol2007-05-25T00:00:002007Percutaneous coronary intervention in patients receiving enoxaparin or unfractionated heparin after fibrinolytic therapy for ST-segment elevation myocardial infarction in the ExTRACT-TIMI 25 trial.274623Antman E, Jacob G, Volpe B, Finkel S, Savona MNew York state journal of medicineCamphor overdosage. Therapeutic considerations. N Y State J Med. 1978 May; 78(6):896-7.N Y State J Med1978-05-01T00:00:001978Camphor overdosage. Therapeutic considerations.11583869Antman EMJournal of the American College of CardiologyTroponin measurements in ischemic heart disease: more than just a black and white picture. J Am Coll Cardiol. 2001 Oct; 38(4):987-90.J Am Coll Cardiol2001-10-01T00:00:002001Troponin measurements in ischemic heart disease: more than just a black and white picture.12360161Angeja BG, de Lemos J, Murphy SA, Marble SJ, Antman EM, Cannon CP, Braunwald E, Gibson CMAmerican heart journalImpact of diabetes mellitus on epicardial and microvascular flow after fibrinolytic therapy. Am Heart J. 2002 Oct; 144(4):649-56.Am Heart J2002-10-01T00:00:002002Impact of diabetes mellitus on epicardial and microvascular flow after fibrinolytic therapy.12428118Cohen M, Antman EMThrombosis and haemostasisEnoxaparin and unfractionated heparin in acute coronary syndromes without ST-segment elevation. Thromb Haemost. 2002 Nov; 88(5):884-6; 886-7.Thromb Haemost2002-11-01T00:00:002002Enoxaparin and unfractionated heparin in acute coronary syndromes without ST-segment elevation.12821590Gibbons RJ, Smith SC, Antman ECirculationAmerican College of Cardiology/American Heart Association clinical practice guidelines: Part II: evolutionary changes in a continuous quality improvement project. Circulation. 2003 Jun 24; 107(24):3101-7.Circulation2003-06-24T00:00:002003American College of Cardiology/American Heart Association clinical practice guidelines: Part II: evolutionary changes in a continuous quality improvement project.2144796Coplen SE, Antman EM, Berlin JA, Hewitt P, Chalmers TCCirculationEfficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials. Circulation. 1990 Oct; 82(4):1106-16.Circulation1990-10-01T00:00:001990Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials.17060962Antman EMTransactions of the American Clinical and Climatological AssociationCoronary care medicine: it's not your father's CCU anymore. Trans Am Clin Climatol Assoc. 2004; 115:123-34; discussion 134-5.Trans Am Clin Climatol Assoc2004-01-01T00:00:002004Coronary care medicine: it's not your father's CCU anymore.17261395Bonaca MP, Wiviott SD, Sabatine MS, Buros J, Murphy SA, Scirica BM, Rifai N, Antman EM, Morrow DAThe American journal of cardiologyHemodynamic significance of periprocedural myocardial injury assessed with N-terminal pro-B-type natriuretic peptide after percutaneous coronary intervention in patients with stable and unstable coronary artery disease (from the JUMBO-TIMI 26 trial). Am J Cardiol. 2007 Feb 01; 99(3):344-8.Am J Cardiol2006-11-30T00:00:002006Hemodynamic significance of periprocedural myocardial injury assessed with N-terminal pro-B-type natriuretic peptide after percutaneous coronary intervention in patients with stable and unstable coronary artery disease (from the JUMBO-TIMI 26 trial).18071078Antman EM, Hand M, Armstrong PW, Bates ER, Green LA, Halasyamani LK, Hochman JS, Krumholz HM, Lamas GA, Mullany CJ, Pearle DL, Sloan MA, Smith SC, Anbe DT, Kushner FG, Ornato JP, Jacobs AK, Adams CD, Anderson JL, Buller CE, Creager MA, Ettinger SM, Halperin JL, Hunt SA, Lytle BW, Nishimura R, Page RL, Riegel B, Tarkington LG, Yancy CWCirculation2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in collaboration With the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 Writing Group to Review New Evidence and Update the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction, Writing on Behalf of the 2004 Writing Committee. Circulation. 2008 Jan 15; 117(2):296-329.Circulation2007-12-10T00:00:0020072007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in collaboration With the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 Writing Group to Review New Evidence and Update the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction, Writing on Behalf of the 2004 Writing Committee.19028812Morrow DA, Antman EMClinical chemistryEvaluation of high-sensitivity assays for cardiac troponin. Clin Chem. 2009 Jan; 55(1):5-8.Clin Chem2008-11-21T00:00:002008Evaluation of high-sensitivity assays for cardiac troponin.21606391Hochholzer W, Wiviott SD, Antman EM, Contant CF, Guo J, Giugliano RP, Dalby AJ, Montalescot G, Braunwald ECirculationPredictors of bleeding and time dependence of association of bleeding with mortality: insights from the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel--Thrombolysis in Myocardial Infarction 38 (TRITON-TIMI 38). Circulation. 2011 Jun 14; 123(23):2681-9.Circulation2011-05-23T00:00:002011Predictors of bleeding and time dependence of association of bleeding with mortality: insights from the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel--Thrombolysis in Myocardial Infarction 38 (TRITON-TIMI 38).21690494Mathews R, Peterson ED, Li S, Roe MT, Glickman SW, Wiviott SD, Saucedo JF, Antman EM, Jacobs AK, Wang TYCirculationUse of emergency medical service transport among patients with ST-segment-elevation myocardial infarction: findings from the National Cardiovascular Data Registry Acute Coronary Treatment Intervention Outcomes Network Registry-Get With The Guidelines. Circulation. 2011 Jul 12; 124(2):154-63.Circulation2011-06-20T00:00:002011Use of emergency medical service transport among patients with ST-segment-elevation myocardial infarction: findings from the National Cardiovascular Data Registry Acute Coronary Treatment Intervention Outcomes Network Registry-Get With The Guidelines.22916357Antman EMCirculationImplications of contemporary clinical trials series: the Placement of Aortic Transcatheter Valve trial (PARTNER). Circulation. 2012 Jun 26; 125(25):3054.Circulation2012-06-26T00:00:002012Implications of contemporary clinical trials series: the Placement of Aortic Transcatheter Valve trial (PARTNER).23124030Whelton PK, Appel LJ, Sacco RL, Anderson CA, Antman EM, Campbell N, Dunbar SB, Frohlich ED, Hall JE, Jessup M, Labarthe DR, MacGregor GA, Sacks FM, Stamler J, Vafiadis DK, Van Horn LVCirculationSodium, blood pressure, and cardiovascular disease: further evidence supporting the American Heart Association sodium reduction recommendations. Circulation. 2012 Dec 11; 126(24):2880-9.Circulation2012-11-02T00:00:002012Sodium, blood pressure, and cardiovascular disease: further evidence supporting the American Heart Association sodium reduction recommendations.23230312Jacobs AK, Kushner FG, Ettinger SM, Guyton RA, Anderson JL, Ohman EM, Albert NM, Antman EM, Arnett DK, Bertolet M, Bhatt DL, Brindis RG, Creager MA, DeMets DL, Dickersin K, Fonarow GC, Gibbons RJ, Halperin JL, Hochman JS, Koster MA, Normand SL, Ortiz E, Peterson ED, Roach WH, Sacco RL, Smith SC, Stevenson WG, Tomaselli GF, Yancy CW, Zoghbi WACirculationACCF/AHA clinical practice guideline methodology summit report: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013 Jan 15; 127(2):268-310.Circulation2012-12-10T00:00:002012ACCF/AHA clinical practice guideline methodology summit report: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.Landzberg MJ, Antman EMUnstable Angina. Rutherford JD, ed.Nitrates, beta adrenoceptor blockers, and calcium antagonists". Unstable Angina. Rutherford JD, ed. 1991; 159-190.1991-01-01T00:00:001991Nitrates, beta adrenoceptor blockers, and calcium antagonists"Wilcox R, Charlesworth A, Antman E, Braunwald E, Neuhaus KJournal of the American College of CardiologyPrior MI or angina and the risk from acute myocardial infarction: observations from InTIME II. Journal of the American College of Cardiology. 2000; 35(Suppl. A):390A.2000-01-01T00:00:002000Prior MI or angina and the risk from acute myocardial infarction: observations from InTIME IILee VL, for the TIMI 6 Investigators. Antman EM, Senior Investigator, TIMI Study Chairman's OfficeAmerican Journal of CardiologyInitial experience with hirudin and streptokinase in acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 6 trial. American Journal of Cardiology. 1995; 75:7-13.1995-01-01T00:00:001995Initial experience with hirudin and streptokinase in acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 6 trialCannon CP, Antman EMCardiology Clinics: Annual Drug Therapy. Crawford MH, ed.Heparin and low-molecular-weight heparin in acute coronary syndromes and angioplasty. Cardiology Clinics: Annual Drug Therapy. Crawford MH, ed. 1997; 1(1):105-119.1997-01-01T00:00:001997Heparin and low-molecular-weight heparin in acute coronary syndromes and angioplastyDirect Thrombin Inhibitor Trialists' Collaborative Group. Direct Thrombin Inhibitor Trialist: TIMI 9A and 9B: Elliott M. Antman, M.D.American Heart JournalDirect thrombin inhibitors in acute coronary syndromes and during percutaneous coronary intervention: design of a meta-analysis based on individual patient data. American Heart Journal. 2001; 141:E2.2001-01-01T00:00:002001Direct thrombin inhibitors in acute coronary syndromes and during percutaneous coronary intervention: design of a meta-analysis based on individual patient dataGanz LI, Antman EMCardiac Electrophysiology ReviewLong-term pharmacologic management of atrial fibrillation for control of rate and rhythm. Cardiac Electrophysiology Review. 1997; 1:40-43.1997-01-01T00:00:001997Long-term pharmacologic management of atrial fibrillation for control of rate and rhythmFuchs J, Cannon CP, and the TIMI 7 investigators. Antman, EM, Co-Investigator, TIMI Study Chairman's Office; Principal Investigator, Brigham and Women's HospitalCirculationHirulog in the treatment of unstable angina: Results of the Thrombin inhibition in Myocardial Ischemia (TIMI 7) trial. Circulation. 1995; 92:727-33.1995-01-01T00:00:001995Hirulog in the treatment of unstable angina: Results of the Thrombin inhibition in Myocardial Ischemia (TIMI 7) trialPaul S, McCabe CH, Antman EMCirculationRisk stratification for acute myocardial infarction in the emergency department: results of TIMI 9B. Circulation. 1997; 96:I-182.1997-01-01T00:00:001997Risk stratification for acute myocardial infarction in the emergency department: results of TIMI 9BTurakhia M, Murphy SA, Pinto T, Antman EM, Giugliano RP, Cannon CP, Braunwald E, Gibson CMAmerican Journal of CardiologyAssociation of higher platelet count with residual thrombus in the myocardial infarct-related coronary artery among patients treated with fibrinolytic therapy for ST-segment elevation acute myocardial infarction. American Journal of Cardiology. 2004; 94:1406-1410.2004-01-01T00:00:002004Association of higher platelet count with residual thrombus in the myocardial infarct-related coronary artery among patients treated with fibrinolytic therapy for ST-segment elevation acute myocardial infarctionVekshtein, VI, Yeung AC, Vita JA, Fish D, Antman EM, Selwyn AP, Ganz PJournal of the American College of CardiologyN-acetylcysteine potentiates coronary artery dilation by nitroglycerin. Journal of the American College of Cardiology. 1990; 15:159A.1990-01-01T00:00:001990N-acetylcysteine potentiates coronary artery dilation by nitroglycerinSalazar DE, Ernest CS, Wrishko RE, Weerakkody GJ, Small DS, Li YG, Rhohatagi S, Dornseif BE, Ni L, Antman EM, Wiviott SD, Macias WL, Reismeyer JSCirculationRelationship between exposure to the prasugrel active metabolite with TIMI major/minor bleeding in TRITON-TIMI 38. Circulation. 2008; 118(Suppl2):S815.2008-01-01T00:00:002008Relationship between exposure to the prasugrel active metabolite with TIMI major/minor bleeding in TRITON-TIMI 38Ware JH, Antman EMNew England Journal of MedicineEquivalence trials. (Editorial). New England Journal of Medicine. 1997; 337:1159-61.1997-01-01T00:00:001997Equivalence trials. (Editorial)3417972Antman EM, Beamer AD, Cantillon C, McGowan N, Goldman L, Friedman PLJournal of the American College of CardiologyLong-term oral propafenone therapy for suppression of refractory symptomatic atrial fibrillation and atrial flutter. J Am Coll Cardiol. 1988 Oct; 12(4):1005-11.J Am Coll Cardiol1988-10-01T00:00:001988Long-term oral propafenone therapy for suppression of refractory symptomatic atrial fibrillation and atrial flutter.14607434Gibson CM, Pinto DS, Murphy SA, Morrow DA, Hobbach HP, Wiviott SD, Giugliano RP, Cannon CP, Antman EM, Braunwald EJournal of the American College of CardiologyAssociation of creatinine and creatinine clearance on presentation in acute myocardial infarction with subsequent mortality. J Am Coll Cardiol. 2003 Nov 05; 42(9):1535-43.J Am Coll Cardiol2003-11-05T00:00:002003Association of creatinine and creatinine clearance on presentation in acute myocardial infarction with subsequent mortality.9092321Braunwald E, Antman EMAnnals of internal medicineEvidence-based coronary care. Ann Intern Med. 1997 Apr 01; 126(7):551-3.Ann Intern Med1997-04-01T00:00:001997Evidence-based coronary care.14769678Wiviott SD, Cannon CP, Morrow DA, Murphy SA, Gibson CM, McCabe CH, Sabatine MS, Rifai N, Giugliano RP, DiBattiste PM, Demopoulos LA, Antman EM, Braunwald ECirculationDifferential expression of cardiac biomarkers by gender in patients with unstable angina/non-ST-elevation myocardial infarction: a TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy-Thrombolysis In Myocardial Infarction 18) substudy. Circulation. 2004 Feb 10; 109(5):580-6.Circulation2004-02-10T00:00:002004Differential expression of cardiac biomarkers by gender in patients with unstable angina/non-ST-elevation myocardial infarction: a TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy-Thrombolysis In Myocardial Infarction 18) substudy.15191768Gibson CM, de Lemos JA, Antman EMEuropean heart journalTime is muscle in primary PCI: the strength of the evidence grows. Eur Heart J. 2004 Jun; 25(12):1001-2.Eur Heart J2004-06-01T00:00:002004Time is muscle in primary PCI: the strength of the evidence grows.15339869Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, Hochman JS, Krumholz HM, Kushner FG, Lamas GA, Mullany CJ, Ornato JP, Pearle DL, Sloan MA, Smith SC, Alpert JS, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Gregoratos G, Halperin JL, Hiratzka LF, Hunt SA, Jacobs AKCirculationACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). Circulation. 2004 Aug 31; 110(9):e82-292.Circulation2004-08-31T00:00:002004ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction).Authorship 1025790129122813Antman EM, Creager MA, Houser SR, Warner JJ, Konig MCirculationAmerican Heart Association Principles on the Accessibility and Affordability of Drugs and Biologics: A Presidential Advisory From the American Heart Association. Circulation. 2017 Dec 12; 136(24):e441-e447.Circulation2017-11-09T00:00:002017American Heart Association Principles on the Accessibility and Affordability of Drugs and Biologics: A Presidential Advisory From the American Heart Association.10517730Antman EM, Cohen M, Radley D, McCabe C, Rush J, Premmereur J, Braunwald ECirculationAssessment of the treatment effect of enoxaparin for unstable angina/non-Q-wave myocardial infarction. TIMI 11B-ESSENCE meta-analysis. Circulation. 1999 Oct 12; 100(15):1602-8.Circulation1999-10-12T00:00:001999Assessment of the treatment effect of enoxaparin for unstable angina/non-Q-wave myocardial infarction. TIMI 11B-ESSENCE meta-analysis.10717017Antman EM, Kuntz KMThe New England journal of medicineThe length of the hospital stay after myocardial infarction. N Engl J Med. 2000 Mar 16; 342(11):808-10.N Engl J Med2000-03-16T00:00:002000The length of the hospital stay after myocardial infarction.17679616Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE, Chavey WE, Fesmire FM, Hochman JS, Levin TN, Lincoff AM, Peterson ED, Theroux P, Wenger NK, Wright RS, Smith SC, Jacobs AK, Halperin JL, Hunt SA, Krumholz HM, Kushner FG, Lytle BW, Nishimura R, Ornato JP, Page RL, Riegel BCirculationACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction): developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. Circulation. 2007 Aug 14; 116(7):e148-304.Circulation2007-08-06T00:00:002007ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction): developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine.11305997Holper EM, Antman EM, McCabe CH, Premmereur J, Gurfinkel E, Bernink PJ, Turpie AG, Bayes de Luna A, Lablanche JM, Fox KM, Salein D, Radley DR, Braunwald EThe American journal of cardiologyA simple, readily available method for risk stratification of patients with unstable angina and non-ST elevation myocardial infarction. Am J Cardiol. 2001 Apr 15; 87(8):1008-10; A5.Am J Cardiol2001-04-15T00:00:002001A simple, readily available method for risk stratification of patients with unstable angina and non-ST elevation myocardial infarction.11320361Giugliano RP, McCabe CH, Antman EM, Cannon CP, Van de Werf F, Wilcox RG, Braunwald EAmerican heart journalLower-dose heparin with fibrinolysis is associated with lower rates of intracranial hemorrhage. Am Heart J. 2001 May; 141(5):742-50.Am Heart J2001-05-01T00:00:002001Lower-dose heparin with fibrinolysis is associated with lower rates of intracranial hemorrhage.11342482Antman EMCirculationThe search for replacements for unfractionated heparin. Circulation. 2001 May 08; 103(18):2310-4.Circulation2001-05-08T00:00:002001The search for replacements for unfractionated heparin.18340288Cannon CP, Bahit MC, Haugland JM, Henry TD, Schweiger MJ, McKendall GR, Shah PK, Murphy S, Gibson CM, McCabe CH, Antman EM, Braunwald ECritical pathways in cardiologyUnderutilization of evidence-based medications in acute ST elevation myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 9 Registry. Crit Pathw Cardiol. 2002 Mar; 1(1):44-52.Crit Pathw Cardiol2002-03-01T00:00:002002Underutilization of evidence-based medications in acute ST elevation myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 9 Registry.18377975Wiviott SD, Braunwald E, McCabe CH, Horvath I, Keltai M, Herrman JP, Van de Werf F, Downey WE, Scirica BM, Murphy SA, Antman EMLancet (London, England)Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trial. Lancet. 2008 Apr 19; 371(9621):1353-63.Lancet2008-04-02T00:00:002008Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trial.3618486Nesto RW, White HD, Wynne J, Holman BL, Antman EMThe American journal of cardiologyComparison of nifedipine and isosorbide dinitrate when added to maximal propranolol therapy in stable angina pectoris. Am J Cardiol. 1987 Aug 01; 60(4):256-61.Am J Cardiol1987-08-01T00:00:001987Comparison of nifedipine and isosorbide dinitrate when added to maximal propranolol therapy in stable angina pectoris.3923813Nesto RW, White HD, Ganz P, Koslowski J, Wynne J, Holman BL, Antman EThe American journal of cardiologyAddition of nifedipine to maximal beta-blocker-nitrate therapy: effects on exercise capacity and global left ventricular performance at rest and during exercise. Am J Cardiol. 1985 May 17; 55(12):3E-8E.Am J Cardiol1985-05-17T00:00:001985Addition of nifedipine to maximal beta-blocker-nitrate therapy: effects on exercise capacity and global left ventricular performance at rest and during exercise.6146162Smith TW, Antman EM, Friedman PL, Blatt CM, Marsh JDProgress in cardiovascular diseasesDigitalis glycosides: mechanisms and manifestations of toxicity. Part III. Prog Cardiovasc Dis. 1984 Jul-Aug; 27(1):21-56.Prog Cardiovasc Dis1984-07-01T00:00:001984Digitalis glycosides: mechanisms and manifestations of toxicity. Part III.6192159Lewis BH, Antman EM, Graboys TBJournal of the American College of CardiologyDetailed analysis of 24 hour ambulatory electrocardiographic recordings during ventricular fibrillation or torsade de pointes. J Am Coll Cardiol. 1983 Sep; 2(3):426-36.J Am Coll Cardiol1983-09-01T00:00:001983Detailed analysis of 24 hour ambulatory electrocardiographic recordings during ventricular fibrillation or torsade de pointes.727131Antman EM, Angoff GH, Sloss LJThe American journal of cardiologyDemonstration of the mechanism by which mitral regurgitation mimics aortic stenosis. Am J Cardiol. 1978 Dec; 42(6):1044-8.Am J Cardiol1978-12-01T00:00:001978Demonstration of the mechanism by which mitral regurgitation mimics aortic stenosis.12356395Murphy SA, Chen C, Cannon CP, Antman EM, Gibson CMThe American journal of cardiologyImpact of gender on angiographic and clinical outcomes after fibrinolytic therapy in acute myocardial infarction. Am J Cardiol. 2002 Oct 01; 90(7):766-70.Am J Cardiol2002-10-01T00:00:002002Impact of gender on angiographic and clinical outcomes after fibrinolytic therapy in acute myocardial infarction.12475117Gregoratos G, Abrams J, Epstein AE, Freedman RA, Hayes DL, Hlatky MA, Kerber RE, Naccarelli GV, Schoenfeld MH, Silka MJ, Winters SL, Gibbons RI, Antman EM, Alpert JS, Hiratzka LF, Faxon DP, Jacobs AK, Fuster V, Smith SCJournal of cardiovascular electrophysiologyACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). J Cardiovasc Electrophysiol. 2002 Nov; 13(11):1183-99.J Cardiovasc Electrophysiol2002-11-01T00:00:002002ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines).15219518Gibson CM, Bigelow B, James D, Tepper MR, Murphy SA, Kirtane AJ, Giugliano RP, Cannon CP, Antman EMThe American journal of cardiologyAssociation of lesion complexity following fibrinolytic administration with mortality in ST-elevation myocardial infarction. Am J Cardiol. 2004 Jul 01; 94(1):108-11.Am J Cardiol2004-07-01T00:00:002004Association of lesion complexity following fibrinolytic administration with mortality in ST-elevation myocardial infarction.15358045Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, Hochman JS, Krumholz HM, Kushner FG, Lamas GA, Mullany CJ, Ornato JP, Pearle DL, Sloan MA, Smith SCJournal of the American College of CardiologyACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction). J Am Coll Cardiol. 2004 Aug 04; 44(3):671-719.J Am Coll Cardiol2004-08-04T00:00:002004ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction).20530021Antman E, Pfeffer M, Stevenson W, Loscalzo JCirculationNew section in Circulation: implications of contemporary clinical trials. Circulation. 2010 Jun 08; 121(22):2446.Circulation2010-06-08T00:00:002010New section in Circulation: implications of contemporary clinical trials.2711997Vita JA, Friedman PL, Cantillon C, Antman EMThe American journal of cardiologyEfficacy of intravenous propafenone for the acute management of atrial fibrillation. Am J Cardiol. 1989 May 15; 63(17):1275-8.Am J Cardiol1989-05-15T00:00:001989Efficacy of intravenous propafenone for the acute management of atrial fibrillation.21321184Antman EMCirculationEvidence and education. Circulation. 2011 Feb 15; 123(6):681-5.Circulation2011-02-15T00:00:002011Evidence and education.15642554Kirtane AJ, Weisbord A, Karmpaliotis D, Murphy SA, Giugliano RP, Cannon CP, Antman EM, Ohman EM, Roe MT, Braunwald E, Gibson CMThe American journal of cardiologyRelation of impaired Thrombolysis In Myocardial Infarction myocardial perfusion grades to residual thrombus following the restoration of epicardial patency in ST-elevation myocardial infarction. Am J Cardiol. 2005 Jan 15; 95(2):224-7.Am J Cardiol2005-01-15T00:00:002005Relation of impaired Thrombolysis In Myocardial Infarction myocardial perfusion grades to residual thrombus following the restoration of epicardial patency in ST-elevation myocardial infarction.1116233Kupersmith J, Antman EM, Hoffman BFCirculation researchIn vivo electrophysiological effects of lidocaine in canine acute myocardial infarction. Circ Res. 1975 Jan; 36(1):84-91.Circ Res1975-01-01T00:00:001975In vivo electrophysiological effects of lidocaine in canine acute myocardial infarction.16291601Sabatine MS, Morrow DA, Montalescot G, Dellborg M, Leiva-Pons JL, Keltai M, Murphy SA, McCabe CH, Gibson CM, Cannon CP, Antman EM, Braunwald ECirculationAngiographic and clinical outcomes in patients receiving low-molecular-weight heparin versus unfractionated heparin in ST-elevation myocardial infarction treated with fibrinolytics in the CLARITY-TIMI 28 Trial. Circulation. 2005 Dec 20; 112(25):3846-54.Circulation2005-11-15T00:00:002005Angiographic and clinical outcomes in patients receiving low-molecular-weight heparin versus unfractionated heparin in ST-elevation myocardial infarction treated with fibrinolytics in the CLARITY-TIMI 28 Trial.16304073Mahaffey KW, Cohen M, Garg J, Antman E, Kleiman NS, Goodman SG, Berdan LG, Reist CJ, Langer A, White HD, Aylward PE, Col JJ, Ferguson JJ, Califf RMJAMAHigh-risk patients with acute coronary syndromes treated with low-molecular-weight or unfractionated heparin: outcomes at 6 months and 1 year in the SYNERGY trial. JAMA. 2005 Nov 23; 294(20):2594-600.JAMA2005-11-23T00:00:002005High-risk patients with acute coronary syndromes treated with low-molecular-weight or unfractionated heparin: outcomes at 6 months and 1 year in the SYNERGY trial.16630990Wiviott SD, Morrow DA, Frederick PD, Antman EM, Braunwald EJournal of the American College of CardiologyApplication of the Thrombolysis in Myocardial Infarction risk index in non-ST-segment elevation myocardial infarction: evaluation of patients in the National Registry of Myocardial Infarction. J Am Coll Cardiol. 2006 Apr 18; 47(8):1553-8.J Am Coll Cardiol2006-03-29T00:00:002006Application of the Thrombolysis in Myocardial Infarction risk index in non-ST-segment elevation myocardial infarction: evaluation of patients in the National Registry of Myocardial Infarction.17211028Choudhry NK, Avorn J, Antman EM, Schneeweiss S, Shrank WHHealth affairs (Project Hope)Should patients receive secondary prevention medications for free after a myocardial infarction? An economic analysis. Health Aff (Millwood). 2007 Jan-Feb; 26(1):186-94.Health Aff (Millwood)2007-01-01T00:00:002007Should patients receive secondary prevention medications for free after a myocardial infarction? An economic analysis.18853965Bhatt DL, Scheiman J, Abraham NS, Antman EM, Chan FK, Furberg CD, Johnson DA, Mahaffey KW, Quigley EM, Harrington RA, Bates ER, Bridges CR, Eisenberg MJ, Ferrari VA, Hlatky MA, Kaul S, Lindner JR, Moliterno DJ, Mukherjee D, Schofield RS, Rosenson RS, Stein JH, Weitz HH, Wesley DJThe American journal of gastroenterologyACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use. Am J Gastroenterol. 2008 Nov; 103(11):2890-907.Am J Gastroenterol2008-10-03T00:00:002008ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use.Cannon CP, Rizzo MJ, Antman EM, McCabe CH, Gibson CM, Braunwald EJournal of the American College of CardiologyValidation of a multivariate model for risk stratification in acute ST elevation myocardial infarction: results from TIMI 9B. Journal of the American College of Cardiology. 1999; 33(suppl.A):396A.1999-01-01T00:00:001999Validation of a multivariate model for risk stratification in acute ST elevation myocardial infarction: results from TIMI 9BReiffel JA, Antman EM, Casella AJ, Drusin RJournal of ElectrocardiographySimultaneous intermittent intra-atrial and intraventricular conduction delay. Journal of Electrocardiography. 1977; 10:59-62.1977-01-01T00:00:001977Simultaneous intermittent intra-atrial and intraventricular conduction delayStone PH, Antman EMCalcium Channel Blocking Agents in the Treatment of Cardiovascular Disorders. Stone PH, Antman EM, eds."Use of Calcium Channel Blocking Agents in Unstable Angina Pectoris and Acute Myocardial Infarction". Calcium Channel Blocking Agents in the Treatment of Cardiovascular Disorders. Stone PH, Antman EM, eds. 1983; 321-46.1983-01-01T00:00:001983"Use of Calcium Channel Blocking Agents in Unstable Angina Pectoris and Acute Myocardial Infarction"Cardiovascular Therapeutics: A Companion to Braunwald's Heart Disease (EM Antman, Editor-in-Chief)Cardiovascular Therapeutics: A Companion to Braunwald's Heart Disease (EM Antman, Editor-in-Chief). 2002.2002-01-01T00:00:002002Cardiovascular Therapeutics: A Companion to Braunwald's Heart Disease (EM Antman, Editor-in-Chief)Antman EM, Braunwald EHeart Disease: A Textbook of Cardiovascular Medicine. Braunwald E, Zipes DW, Libby P, eds."Acute Myocardial Infarction". Heart Disease: A Textbook of Cardiovascular Medicine. Braunwald E, Zipes DW, Libby P, eds. 2001; 1114-1219.2001-01-01T00:00:002001"Acute Myocardial Infarction"Gibson CM, Pride YB, Mohanavelu S, Wiviott SD, Antman EM, Braunwald ECirculationAngiographic and clinical outcomes among patients with acute coronary syndrome presenting with isolated anterior ST-segment depressions. Circulation. 2008; 118(Suppl2):S654.2008-01-01T00:00:002008Angiographic and clinical outcomes among patients with acute coronary syndrome presenting with isolated anterior ST-segment depressions7923644Antman EMCirculationHirudin in acute myocardial infarction. Safety report from the Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9A Trial. Circulation. 1994 Oct; 90(4):1624-30.Circulation1994-10-01T00:00:001994Hirudin in acute myocardial infarction. Safety report from the Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9A Trial.8548117Antman EMJournal of cardiovascular electrophysiologyAtrial fibrillation and flutter: maintaining stability of sinus rhythm versus ventricular rate control. J Cardiovasc Electrophysiol. 1995 Oct; 6(10 Pt 2):962-71.J Cardiovasc Electrophysiol1995-10-01T00:00:001995Atrial fibrillation and flutter: maintaining stability of sinus rhythm versus ventricular rate control.23131034Mogabgab O, Giugliano RP, Sabatine MS, Cannon CP, Mohanavelu S, Wiviott SD, Antman EM, Braunwald EChronobiology internationalCircadian variation in patient characteristics and outcomes in ST-segment elevation myocardial infarction. Chronobiol Int. 2012 Dec; 29(10):1390-6.Chronobiol Int2012-11-06T00:00:002012Circadian variation in patient characteristics and outcomes in ST-segment elevation myocardial infarction.The MAGIC Steering Committee. Antman EM; Chair, Steering CommitteeAmerican Heart JournalRationale and design of the Magnesium in Coronaries (MAGIC) study: A clinical trial to reevaluate the efficacy of early administration of magnesium in acute myocardial infarction. American Heart Journal. 2000; 139:10-14.2000-01-01T00:00:002000Rationale and design of the Magnesium in Coronaries (MAGIC) study: A clinical trial to reevaluate the efficacy of early administration of magnesium in acute myocardial infarctionAntman EMU.S. Government Printing OfficeNew cardiovascular agents. Testimony at Hearing before the Subcommitee on Natural Resources, Agriculture Research and Environment and the Committee on Investigations and Oversight of the Committee on Science and Technology, U.S. House of Representatives. Ninety-Seventh Congress, 1st Sessions. U.S. Government Printing Office. 1982; 145:108-67.1982-01-01T00:00:001982New cardiovascular agents. Testimony at Hearing before the Subcommitee on Natural Resources, Agriculture Research and Environment and the Committee on Investigations and Oversight of the Committee on Science and Technology, U.S. House of Representatives. Ninety-Seventh Congress, 1st SessionsAntman EM, Smith TWCurrent Therapy in Adult Medicine. Kassirer JP, Greene HL, eds.Digitalis Toxicity. Current Therapy in Adult Medicine. Kassirer JP, Greene HL, eds. 1997; 414-18.1997-01-01T00:00:001997Digitalis Toxicity3137075Horowitz JD, Henry CA, Syrjanen ML, Louis WJ, Fish RD, Antman EM, Smith TWEuropean heart journalNitroglycerine/N-acetylcysteine in the management of unstable angina pectoris. Eur Heart J. 1988 Jan; 9 Suppl A:95-100.Eur Heart J1988-01-01T00:00:001988Nitroglycerine/N-acetylcysteine in the management of unstable angina pectoris.Antman EM, Cohn PFHosp. MedCoronary artery disease - clinical and angiographic correlations. Hosp. Med. 1979; 15:8-22.1979-01-01T00:00:001979Coronary artery disease - clinical and angiographic correlationsGibson CM, Murphy SA, James D, Marble SJ, Wong GC, Kalapanda R, Kraimer N, Antman EMCirculationFacilitated angioplasty is associated with an improvement in the number of frames required for dye to fill the myocardium (TIMI Myocardial Frame Count) in ST segment elevation myocardial infarction (STEMI). Circulation. 2002; 106 (Suppl. II):II-598.2002-01-01T00:00:002002Facilitated angioplasty is associated with an improvement in the number of frames required for dye to fill the myocardium (TIMI Myocardial Frame Count) in ST segment elevation myocardial infarction (STEMI)2188752Antman EM, Wenger TL, Butler VP, Haber E, Smith TWCirculationTreatment of 150 cases of life-threatening digitalis intoxication with digoxin-specific Fab antibody fragments. Final report of a multicenter study. Circulation. 1990 Jun; 81(6):1744-52.Circulation1990-06-01T00:00:001990Treatment of 150 cases of life-threatening digitalis intoxication with digoxin-specific Fab antibody fragments. Final report of a multicenter study.17950140Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikof EL, Chaikof E, Fleischmann KE, Freeman WK, Froehlich JB, Kasper EK, Kersten JR, Riegel B, Robb JF, Smith SC, Jacobs AK, Adams CD, Anderson JL, Antman EM, Buller CE, Creager MA, Ettinger SM, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Lytle BW, Nishimura R, Ornato JP, Page RL, Riegel B, Tarkington LG, Yancy CWJournal of the American College of CardiologyACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery) developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. J Am Coll Cardiol. 2007 Oct 23; 50(17):e159-241.J Am Coll Cardiol2007-10-23T00:00:002007ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery) developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery.2439845Antman EM, Arnold M, Friedman PL, White H, Bosak M, Smith TWJournal of cardiovascular pharmacologyDrug interactions with cardiac glycosides: evaluation of a possible digoxin-ethmozine pharmacokinetic interaction. J Cardiovasc Pharmacol. 1987 May; 9(5):622-7.J Cardiovasc Pharmacol1987-05-01T00:00:001987Drug interactions with cardiac glycosides: evaluation of a possible digoxin-ethmozine pharmacokinetic interaction.21304094Mahaffey KW, Pieper KS, Lokhnygina Y, Califf RM, Antman EM, Kleiman NS, Goodman SG, White HD, Rao SV, Hochman JS, Cohen M, Col JJ, Roe MT, Ferguson JJCirculation. Cardiovascular quality and outcomesThe impact of postrandomization crossover of therapy in acute coronary syndromes care. Circ Cardiovasc Qual Outcomes. 2011 Mar; 4(2):211-9.Circ Cardiovasc Qual Outcomes2011-02-08T00:00:002011The impact of postrandomization crossover of therapy in acute coronary syndromes care.22080794Choudhry NK, Avorn J, Glynn RJ, Antman EM, Schneeweiss S, Toscano M, Reisman L, Fernandes J, Spettell C, Lee JL, Levin R, Brennan T, Shrank WHThe New England journal of medicineFull coverage for preventive medications after myocardial infarction. N Engl J Med. 2011 Dec 01; 365(22):2088-97.N Engl J Med2011-11-14T00:00:002011Full coverage for preventive medications after myocardial infarction.18498956Antman EM, Wiviott SD, Murphy SA, Voitk J, Hasin Y, Widimsky P, Chandna H, Macias W, McCabe CH, Braunwald EJournal of the American College of CardiologyEarly and late benefits of prasugrel in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a TRITON-TIMI 38 (TRial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet InhibitioN with Prasugrel-Thrombolysis In Myocardial Infarction) analysis. J Am Coll Cardiol. 2008 May 27; 51(21):2028-33.J Am Coll Cardiol2008-05-27T00:00:002008Early and late benefits of prasugrel in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a TRITON-TIMI 38 (TRial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet InhibitioN with Prasugrel-Thrombolysis In Myocardial Infarction) analysis.18682445Murphy SA, Antman EM, Wiviott SD, Weerakkody G, Morocutti G, Huber K, Lopez-Sendon J, McCabe CH, Braunwald EEuropean heart journalReduction in recurrent cardiovascular events with prasugrel compared with clopidogrel in patients with acute coronary syndromes from the TRITON-TIMI 38 trial. Eur Heart J. 2008 Oct; 29(20):2473-9.Eur Heart J2008-08-05T00:00:002008Reduction in recurrent cardiovascular events with prasugrel compared with clopidogrel in patients with acute coronary syndromes from the TRITON-TIMI 38 trial.18809101Antman EMAnnals of emergency medicineThe specialty of emergency medicine: needed now more than ever before. Ann Emerg Med. 2008 Oct; 52(4):317-9.Ann Emerg Med2008-10-01T00:00:002008The specialty of emergency medicine: needed now more than ever before.Syllabus material on meta-analysisSyllabus material on meta-analysis. 2000.2000-01-01T00:00:002000Syllabus material on meta-analysisAntman EM, Smith TWDigitalis Glycosides. Smith TW, ed"Bioavailability of Digitalis Glycosides". Digitalis Glycosides. Smith TW, ed. 1986; 61-4.1986-01-01T00:00:001986"Bioavailability of Digitalis Glycosides"Antman EM, Braunwald EHarrison's Principles of Internal Medicine. Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DO, Jameson JL (eds.)"ST Segment Elevation Myocardial Infarction". Harrison's Principles of Internal Medicine. Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DO, Jameson JL (eds.). 2005; 1448-1459.2005-01-01T00:00:002005"ST Segment Elevation Myocardial Infarction"The InTIME-II Investigators. Antman EM, Operations and Writing CommitteesEuropean Heart JournalIntravenous NPA for the Treatment of Infarcting Myocardial Early: InTIME-II, a double blind comparison of single bolus lanoteplase vs. accelerated alteplase for the treatment of patients with acute myocardial infarction. European Heart Journal. 2000; 21:2005-13.2000-01-01T00:00:002000Intravenous NPA for the Treatment of Infarcting Myocardial Early: InTIME-II, a double blind comparison of single bolus lanoteplase vs. accelerated alteplase for the treatment of patients with acute myocardial infarctionSloan MA, Giugliano RP, Thompson, SL, Antman EM, McCabe CH, Braunwald EJournal of the American College of CardiologyPrediction of intracranical hemorrhage in the InTIME-II trial. Journal of the American College of Cardiology. 2001; 37(Suppl. A):372A.2001-01-01T00:00:002001Prediction of intracranical hemorrhage in the InTIME-II trialComprehensive Syllabus Material on Cardiovascular Pharmacology: General Principles, Antiarrhythmic Drugs, Anti-ischemic drugsComprehensive Syllabus Material on Cardiovascular Pharmacology: General Principles, Antiarrhythmic Drugs, Anti-ischemic drugs. 1981.1981-01-01T00:00:001981Comprehensive Syllabus Material on Cardiovascular Pharmacology: General Principles, Antiarrhythmic Drugs, Anti-ischemic drugsCannon CP, McCabe CH, Gibson CM, Ghali M, Sequeira RF, McKendall GR, Breed J, Modi NB, Fox NL, Tracy R, Love TW, Braunwald E, and the TIMI 10A Investigators. Antman EM, Co-InvestigatorTNK-tissue plasminogen activator in acute myocardial infarction: Results of the Thrombolysis in Myocardial Infarction (TIMI) 10A dose-ranging trial. 1997; 95:351-56.1997-01-01T00:00:001997TNK-tissue plasminogen activator in acute myocardial infarction: Results of the Thrombolysis in Myocardial Infarction (TIMI) 10A dose-ranging trialSinnaeve PR, Antman EM, Ross AM, Hasselblad V, Van de Werf FJ, Granger CBJACCEnoxaparin is superior to unfractionated heparin after fibrinolysis in acute myocardial infarction: meta-analysis of ASSENT-3, HART-II, and ENTIRE-TIMI-23 trials. JACC. 2003; 41(Suppl. A):334A.2003-01-01T00:00:002003Enoxaparin is superior to unfractionated heparin after fibrinolysis in acute myocardial infarction: meta-analysis of ASSENT-3, HART-II, and ENTIRE-TIMI-23 trials3966317Lee TH, Friedman PL, Goldman L, Stone PH, Antman EMAmerican heart journalSinus arrest and hypotension with combined amiodarone-diltiazem therapy. Am Heart J. 1985 Jan; 109(1):163-4.Am Heart J1985-01-01T00:00:001985Sinus arrest and hypotension with combined amiodarone-diltiazem therapy.6139183Horowitz JD, Antman EM, Lorell BH, Barry WH, Smith TWCirculationPotentiation of the cardiovascular effects of nitroglycerin by N-acetylcysteine. Circulation. 1983 Dec; 68(6):1247-53.Circulation1983-12-01T00:00:001983Potentiation of the cardiovascular effects of nitroglycerin by N-acetylcysteine.6371896Smith TW, Antman EM, Friedman PL, Blatt CM, Marsh JDProgress in cardiovascular diseasesDigitalis glycosides: mechanisms and manifestations of toxicity. Part I. Prog Cardiovasc Dis. 1984 Mar-Apr; 26(5):413-58.Prog Cardiovasc Dis1984-03-01T00:00:001984Digitalis glycosides: mechanisms and manifestations of toxicity. Part I.7715040Antman EM, Grudzien C, Sacks DBJAMAEvaluation of a rapid bedside assay for detection of serum cardiac troponin T. JAMA. 1995 Apr 26; 273(16):1279-82.JAMA1995-04-26T00:00:001995Evaluation of a rapid bedside assay for detection of serum cardiac troponin T.8272099Solomon SD, Antman EThe New England journal of medicinePrehospital thrombolytic therapy for myocardial infarction. N Engl J Med. 1994 Jan 27; 330(4):291.N Engl J Med1994-01-27T00:00:001994Prehospital thrombolytic therapy for myocardial infarction.19435740Michelson AD, Frelinger AL, Braunwald E, Downey WE, Angiolillo DJ, Xenopoulos NP, Jakubowski JA, Li Y, Murphy SA, Qin J, McCabe CH, Antman EM, Wiviott SDEuropean heart journalPharmacodynamic assessment of platelet inhibition by prasugrel vs. clopidogrel in the TRITON-TIMI 38 trial. Eur Heart J. 2009 Jul; 30(14):1753-63.Eur Heart J2009-05-12T00:00:002009Pharmacodynamic assessment of platelet inhibition by prasugrel vs. clopidogrel in the TRITON-TIMI 38 trial.19717184Sabatine MS, Antman EM, Widimsky P, Ebrahim IO, Kiss RG, Saaiman A, Polasek R, Contant CF, McCabe CH, Braunwald ELancet (London, England)Otamixaban for the treatment of patients with non-ST-elevation acute coronary syndromes (SEPIA-ACS1 TIMI 42): a randomised, double-blind, active-controlled, phase 2 trial. Lancet. 2009 Sep 05; 374(9692):787-95.Lancet2009-08-28T00:00:002009Otamixaban for the treatment of patients with non-ST-elevation acute coronary syndromes (SEPIA-ACS1 TIMI 42): a randomised, double-blind, active-controlled, phase 2 trial.2644767Antman EM, Smith TWAdvances in internal medicineCurrent concepts in the use of digitalis. Adv Intern Med. 1989; 34:425-54.Adv Intern Med1989-01-01T00:00:001989Current concepts in the use of digitalis.21816379Wiviott SD, Desai N, Murphy SA, Musumeci G, Ragosta M, Antman EM, Braunwald EThe American journal of cardiologyEfficacy and safety of intensive antiplatelet therapy with prasugrel from TRITON-TIMI 38 in a core clinical cohort defined by worldwide regulatory agencies. Am J Cardiol. 2011 Oct 01; 108(7):905-11.Am J Cardiol2011-08-02T00:00:002011Efficacy and safety of intensive antiplatelet therapy with prasugrel from TRITON-TIMI 38 in a core clinical cohort defined by worldwide regulatory agencies.23520015Mogabgab O, Wiviott SD, Antman EM, Foody JM, Wang TY, Sabatine MS, Cannon CP, Li S, Giugliano RPClinical cardiologyRelation between time of symptom onset of ST-segment elevation myocardial infarction and patient baseline characteristics: from the National Cardiovascular Data Registry. Clin Cardiol. 2013 Apr; 36(4):222-7.Clin Cardiol2013-03-20T00:00:002013Relation between time of symptom onset of ST-segment elevation myocardial infarction and patient baseline characteristics: from the National Cardiovascular Data Registry.Antman EMACCEL (ACC audio journal). Interviews at AHA, ACC, ESC annual meetings on clinical trial reports (TIMI 9, TIMI 11B, TIMI 14, TIMI 23, MAGIC), cardiac troponins, initial evaluation and management of patients with UA/NSTEMI/STEMIACCEL (ACC audio journal). Interviews at AHA, ACC, ESC annual meetings on clinical trial reports (TIMI 9, TIMI 11B, TIMI 14, TIMI 23, MAGIC), cardiac troponins, initial evaluation and management of patients with UA/NSTEMI/STEMI. 1998.1998-01-01T00:00:001998ACCEL (ACC audio journal). Interviews at AHA, ACC, ESC annual meetings on clinical trial reports (TIMI 9, TIMI 11B, TIMI 14, TIMI 23, MAGIC), cardiac troponins, initial evaluation and management of patients with UA/NSTEMI/STEMIAntman EMCybersessions: Incorporating the TIMI Risk Score into ACS Critical Pathways. www.TIMI.tvCybersessions: Incorporating the TIMI Risk Score into ACS Critical Pathways. www.TIMI.tv. 2001.2001-01-01T00:00:002001Cybersessions: Incorporating the TIMI Risk Score into ACS Critical Pathways. www.TIMI.tvAntman EMHeart Disease: A Textbook of Cardiovascular Medicine. Braunwald E, ed."Medical Management of the Patient Undergoing Cardiac Surgery". Heart Disease: A Textbook of Cardiovascular Medicine. Braunwald E, ed. 1996; 1715-40.1996-01-01T00:00:001996"Medical Management of the Patient Undergoing Cardiac Surgery"Giugliano RP, Antman EM, Braunwald EJournal of Thrombosis and ThrombolysisReexamination of the thrombin hypothesis: what we have learned from TIMI 9B and GUSTO IIb. (Editorial). Journal of Thrombosis and Thrombolysis. 1997; 4:321-23.1997-01-01T00:00:001997Reexamination of the thrombin hypothesis: what we have learned from TIMI 9B and GUSTO IIb. (Editorial)Cannon CP, McCabe CH, Antman EM, Bentley J, Rifai N, Braunwald EJournal of the American College of CardiologyAre there high-risk patients who are troponin negative? Further risk stratification with the TIMI risk score in patients with acute coronary syndromes: results from OPUS-TIMI 16. Journal of the American College of Cardiology. 2001; 37(Suppl. A):326A.2001-01-01T00:00:002001Are there high-risk patients who are troponin negative? Further risk stratification with the TIMI risk score in patients with acute coronary syndromes: results from OPUS-TIMI 16Giugliano RP, Antman EM, McCabe CH, Menown I, Kleiman NS, Ghali M, Coussement P, Braunwald EJournal of the American College of CardiologyFactors associated with major hemorrhage during reperfusion therapy in acute myocardial infarction: a TIMI 14 substudy. Journal of the American College of Cardiology. 1999; 33(suppl.A):398A.1999-01-01T00:00:001999Factors associated with major hemorrhage during reperfusion therapy in acute myocardial infarction: a TIMI 14 substudyForman DE, Giugliano RP, Cannon CP, Morrow DA, Qin J, Antman EM, Braunwald ECirculationA simple TIMI discharge risk score post ACS predicts CV mortality at 2 years. Circulation. 2008; 218(Suppl2):S1060.2008-01-01T00:00:002008A simple TIMI discharge risk score post ACS predicts CV mortality at 2 yearsLamas G, Dawley D, Splaine K, Freedman P, Folland E, Antman EMPACEDoes documenting a symptomatic bradycardia increase the likelihood of symptom relief in patients receiving permanent pacemakers?. PACE. 1986; 9:280.1986-01-01T00:00:001986Does documenting a symptomatic bradycardia increase the likelihood of symptom relief in patients receiving permanent pacemakers?Sabatine MS, Antman EM, Ganz LI, Strichartz GR, Lilly LSPathophysiology of Heart Disease: a Collaborative Project of Medical Students and Faculty. Lilly LS, ed.Mechanisms of cardiac arrhythmias. Pathophysiology of Heart Disease: a Collaborative Project of Medical Students and Faculty. Lilly LS, ed. 1997; 233-48.1997-01-01T00:00:001997Mechanisms of cardiac arrhythmias17538045Jacobs AK, Antman EM, Faxon DP, Gregory T, Solis PCirculationDevelopment of systems of care for ST-elevation myocardial infarction patients: executive summary. Circulation. 2007 Jul 10; 116(2):217-30.Circulation2007-05-30T00:00:002007Development of systems of care for ST-elevation myocardial infarction patients: executive summary.17560290Sabatine MS, Morrow DA, Dalby A, Pfisterer M, Duris T, Lopez-Sendon J, Murphy SA, Gao R, Antman EM, Braunwald EJournal of the American College of CardiologyEfficacy and safety of enoxaparin versus unfractionated heparin in patients with ST-segment elevation myocardial infarction also treated with clopidogrel. J Am Coll Cardiol. 2007 Jun 12; 49(23):2256-63.J Am Coll Cardiol2007-05-25T00:00:002007Efficacy and safety of enoxaparin versus unfractionated heparin in patients with ST-segment elevation myocardial infarction also treated with clopidogrel.18585494Choudhry NK, Brennan T, Toscano M, Spettell C, Glynn RJ, Rubino M, Schneeweiss S, Brookhart AM, Fernandes J, Mathew S, Christiansen B, Antman EM, Avorn J, Shrank WHAmerican heart journalRationale and design of the Post-MI FREEE trial: a randomized evaluation of first-dollar drug coverage for post-myocardial infarction secondary preventive therapies. Am Heart J. 2008 Jul; 156(1):31-6.Am Heart J2008-06-06T00:00:002008Rationale and design of the Post-MI FREEE trial: a randomized evaluation of first-dollar drug coverage for post-myocardial infarction secondary preventive therapies.18757948Wiviott SD, Braunwald E, Angiolillo DJ, Meisel S, Dalby AJ, Verheugt FW, Goodman SG, Corbalan R, Purdy DA, Murphy SA, McCabe CH, Antman EMCirculationGreater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-Thrombolysis in Myocardial Infarction 38. Circulation. 2008 Oct 14; 118(16):1626-36.Circulation2008-08-31T00:00:002008Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-Thrombolysis in Myocardial Infarction 38.Antman EM, Smith TWCurrent Therapy in Cardiovascular Disease. Hurst JW, ed."Digitalis Toxicity". Current Therapy in Cardiovascular Disease. Hurst JW, ed. 1994; 89-93.1994-01-01T00:00:001994"Digitalis Toxicity"Smith TW, Antman EM, Friedman PL, Blatt CM, Marsh JDPart I, Progr Cardiovasc Dis.Digitalis glycosides: mechanisms and manifestations of toxicity. Part I, Progr Cardiovasc Dis. 1984; 26:413-41.1984-01-01T00:00:001984Digitalis glycosides: mechanisms and manifestations of toxicity4072936Lamas GA, Rebecca GS, Braunwald NS, Antman EMThe American journal of cardiologyPacemaker malfunction after nitrous oxide anesthesia. Am J Cardiol. 1985 Dec 01; 56(15):995.Am J Cardiol1985-12-01T00:00:001985Pacemaker malfunction after nitrous oxide anesthesia.20413397Giugliano RP, Giraldez RR, Morrow DA, Antman EM, Gibson CM, Mohanavelu S, Murphy SA, McCabe CH, Braunwald EEuropean heart journalRelations between bleeding and outcomes in patients with ST-elevation myocardial infarction in the ExTRACT-TIMI 25 trial. Eur Heart J. 2010 Sep; 31(17):2103-10.Eur Heart J2010-04-22T00:00:002010Relations between bleeding and outcomes in patients with ST-elevation myocardial infarction in the ExTRACT-TIMI 25 trial.21450428Wright RS, Anderson JL, Adams CD, Bridges CR, Casey DE, Ettinger SM, Fesmire FM, Ganiats TG, Jneid H, Lincoff AM, Peterson ED, Philippides GJ, Theroux P, Wenger NK, Zidar JP, Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE, Chavey WE, Fesmire FM, Hochman JS, Levin TN, Lincoff AM, Peterson ED, Theroux P, Wenger NK, Wright RSJournal of the American College of Cardiology2011 ACCF/AHA focused update of the Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction (updating the 2007 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in collaboration with the American College of Emergency Physicians, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2011 May 10; 57(19):1920-59.J Am Coll Cardiol2011-03-28T00:00:0020112011 ACCF/AHA focused update of the Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction (updating the 2007 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in collaboration with the American College of Emergency Physicians, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.3055910Held AC, Cole PL, Lipton B, Gore JM, Antman EM, Hockman JS, Corrao J, Goldberg RJ, Alpert JSAmerican heart journalRupture of the interventricular septum complicating acute myocardial infarction: a multicenter analysis of clinical findings and outcome. Am Heart J. 1988 Nov; 116(5 Pt 1):1330-6.Am Heart J1988-11-01T00:00:001988Rupture of the interventricular septum complicating acute myocardial infarction: a multicenter analysis of clinical findings and outcome.Lamas GA, Antman EM, Gold J, Braunwald N, Collins, JJAnnals of Thoracic SurgeryPacemaker back-up mode reversion and injury during cardiac surgery. Annals of Thoracic Surgery. 1986; 41:155-57.1986-01-01T00:00:001986Pacemaker back-up mode reversion and injury during cardiac surgery1535110Antman EM, Lau J, Kupelnick B, Mosteller F, Chalmers TCJAMAA comparison of results of meta-analyses of randomized control trials and recommendations of clinical experts. Treatments for myocardial infarction. JAMA. 1992 Jul 08; 268(2):240-8.JAMA1992-07-08T00:00:001992A comparison of results of meta-analyses of randomized control trials and recommendations of clinical experts. Treatments for myocardial infarction.11382722Gibson CM, de Lemos JA, Murphy SA, Marble SJ, McCabe CH, Cannon CP, Antman EM, Braunwald ECirculationCombination therapy with abciximab reduces angiographically evident thrombus in acute myocardial infarction: a TIMI 14 substudy. Circulation. 2001 May 29; 103(21):2550-4.Circulation2001-05-29T00:00:002001Combination therapy with abciximab reduces angiographically evident thrombus in acute myocardial infarction: a TIMI 14 substudy.12379588Gregoratos G, Abrams J, Epstein AE, Freedman RA, Hayes DL, Hlatky MA, Kerber RE, Naccarelli GV, Schoenfeld MH, Silka MJ, Winters SL, Gibbons RJ, Antman EM, Alpert JS, Gregoratos G, Hiratzka LF, Faxon DP, Jacobs AK, Fuster V, Smith SCCirculationACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). Circulation. 2002 Oct 15; 106(16):2145-61.Circulation2002-10-15T00:00:002002ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines).12952829Cheitlin MD, Armstrong WF, Aurigemma GP, Beller GA, Bierman FZ, Davis JL, Douglas PS, Faxon DP, Gillam LD, Kimball TR, Kussmaul WG, Pearlman AS, Philbrick JT, Rakowski H, Thys DM, Antman EM, Smith SC, Alpert JS, Gregoratos G, Anderson JL, Hiratzka LF, Hunt SA, Fuster V, Jacobs AK, Gibbons RJ, Russell ROCirculationACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography). Circulation. 2003 Sep 02; 108(9):1146-62.Circulation2003-09-02T00:00:002003ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography).14658129Armstrong PW, Antman EMThe New England journal of medicineCoronary angioplasty versus fibrinolytic therapy in acute myocardial infarction. N Engl J Med. 2003 Nov 27; 349(22):2167-9; author reply 2167-9.N Engl J Med2003-11-27T00:00:002003Coronary angioplasty versus fibrinolytic therapy in acute myocardial infarction.15117853Shimpo M, Morrow DA, Weinberg EO, Sabatine MS, Murphy SA, Antman EM, Lee RTCirculationSerum levels of the interleukin-1 receptor family member ST2 predict mortality and clinical outcome in acute myocardial infarction. Circulation. 2004 May 11; 109(18):2186-90.Circulation2004-04-26T00:00:002004Serum levels of the interleukin-1 receptor family member ST2 predict mortality and clinical outcome in acute myocardial infarction.15246895Gardner GS, Frisch DR, Murphy SA, Kirtane AJ, Giugliano RP, Antman EM, Braunwald E, Gibson CMThe American journal of cardiologyEffect of rescue or adjunctive percutaneous coronary intervention of the culprit artery after fibrinolytic administration on epicardial flow in nonculprit arteries. Am J Cardiol. 2004 Jul 15; 94(2):178-81.Am J Cardiol2004-07-15T00:00:002004Effect of rescue or adjunctive percutaneous coronary intervention of the culprit artery after fibrinolytic administration on epicardial flow in nonculprit arteries.9412306Nichol G, Walls R, Goldman L, Pearson S, Hartley LH, Antman E, Stockman M, Teich JM, Cannon CP, Johnson PA, Kuntz KM, Lee THAnnals of internal medicineA critical pathway for management of patients with acute chest pain who are at low risk for myocardial ischemia: recommendations and potential impact. Ann Intern Med. 1997 Dec 01; 127(11):996-1005.Ann Intern Med1997-12-01T00:00:001997A critical pathway for management of patients with acute chest pain who are at low risk for myocardial ischemia: recommendations and potential impact.Antman EM, Braunwald EHarrison's Principles of Internal Medicine. Fauci AS, Braunwald E, Isselbacher KJ, Wilson JD, Martin JB, Kasper DL, Hauser SL, Longo DO, eds."Acute Myocardial Infarction". Harrison's Principles of Internal Medicine. Fauci AS, Braunwald E, Isselbacher KJ, Wilson JD, Martin JB, Kasper DL, Hauser SL, Longo DO, eds. 2001; 1386-1399.2001-01-01T00:00:002001"Acute Myocardial Infarction"Antman EMJournal of Intensive Care MedicineTachyarrhythmia Management. Journal of Intensive Care Medicine. 1987; 2:61-3.1987-01-01T00:00:001987Tachyarrhythmia ManagementPaul SD, Antman EM, McCabe CH, Braunwald ECirculationInsights from TIMI 9B on sex differences in prognosis after acute myocardial infarction: development and validation of a clinical index to predict outcome. Circulation. 1997; 96:I-259.1997-01-01T00:00:001997Insights from TIMI 9B on sex differences in prognosis after acute myocardial infarction: development and validation of a clinical index to predict outcome15827315De Luca G, Suryapranata H, Stone GW, Antoniucci D, Tcheng JE, Neumann FJ, Van de Werf F, Antman EM, Topol EJJAMAAbciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized trials. JAMA. 2005 Apr 13; 293(14):1759-65.JAMA2005-04-13T00:00:002005Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized trials.Authorship 100344616301351Kushner FG, Antman EMCirculationOral anticoagulation for atrial fibrillation after ST-elevation myocardial infarction: new evidence to guide clinical practice. Circulation. 2005 Nov 22; 112(21):3212-4.Circulation2005-11-22T00:00:002005Oral anticoagulation for atrial fibrillation after ST-elevation myocardial infarction: new evidence to guide clinical practice.23117771Antman EM, Harrington RAJAMATransforming clinical trials in cardiovascular disease: mission critical for health and economic well-being. JAMA. 2012 Nov 07; 308(17):1743-4.JAMA2012-11-07T00:00:002012Transforming clinical trials in cardiovascular disease: mission critical for health and economic well-being.Friedman PL, Antman EMHospital FormularyPropafenone: A new class IC antiarrhythmic drug for the management of ventricular arrhythmias. Hospital Formulary. 1988; 23:531-42.1988-01-01T00:00:001988Propafenone: A new class IC antiarrhythmic drug for the management of ventricular arrhythmiasThe Atrial Fibrillation Follow-up of Investigation of Rhythm Management (AFFIRM) Investigators. E. Antman, member of Steering CommitteeN Engl J MedA comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med. 2002; 347:1825-33.2002-01-01T00:00:002002A comparison of rate control and rhythm control in patients with atrial fibrillationFleisher LA, Beckman JA, Brown KA, Calkins H, Chaikoff EL, Fleischmann KE, Freeman WK, Froehlich JB, Kasper EK, Kersten JR, Riegel B, Robb JF, Smith SC Jr., Jacobs AK, Adams CD, Anderson JL, Antman EM, Buller CE, Creager MA, Ettinger SM, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Lytle BW, Nishimura R, Ornato JP, Page RL, Riegel B, Tarkington LG, Yancy CWJournal of the American College of CardiologyACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: executive summary. Journal of the American College of Cardiology. 2007; 50:1707-1732.2007-01-01T00:00:002007ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: executive summaryde Lemos JA, Antman EM, Giugliano RP, Coulter SA, McCabe CH, Lambrew C, Ghali M, Gibson MCirculationNon-culprit blood flow is an independent correlate of ECG injury patterns after thrombolytic therapy: a TIMI 14 substudy. Circulation. 1998; 98:I-826.1998-01-01T00:00:001998Non-culprit blood flow is an independent correlate of ECG injury patterns after thrombolytic therapy: a TIMI 14 substudyDalby AJ, Wiviott SD, Murphy SA, Dawood SY, Antman EMCirculationThe influence of the arterial access site and its management of bleeding events in acute coronary syndromes in TRITON-TIMI 38. Circulation. 2008; 118(Suppl2):S638.2008-01-01T00:00:002008The influence of the arterial access site and its management of bleeding events in acute coronary syndromes in TRITON-TIMI 38Antman EM, Califf RMCardiovascular Therapeutics. Smith TW, ed."Clinical Trials and Meta-analysis". Cardiovascular Therapeutics. Smith TW, ed. 1996; 678-95.1996-01-01T00:00:001996"Clinical Trials and Meta-analysis"Friedman PL, Antman EM, Berkovits BJournal of the American College of CardiologyPrevention of accessory pathway mediated tachycardia with a new antitachycardia pacemaker. Journal of the American College of Cardiology. 1986; 7:183A.1986-01-01T00:00:001986Prevention of accessory pathway mediated tachycardia with a new antitachycardia pacemakerNallamothu BK, Antman EM, Bates ERAmerican Journal of CardiologyPercutaneous coronary intervention versus fibrinolytic therapy in acute myocardial infarction: does the choice of fibrinolytic agent impact on the importance of time-to-treatment?. American Journal of Cardiology. 2004; 94:772-774.2004-01-01T00:00:002004Percutaneous coronary intervention versus fibrinolytic therapy in acute myocardial infarction: does the choice of fibrinolytic agent impact on the importance of time-to-treatment?Mega JL, Wiviott SD, Mohanavelu S, Nicolau JC, McCabe CH, Antman EM, Braunwald ECirculationCardiovascular outcomes of woman and men with acute coronary syndromes and angiographically confirmed epicardial coronary artery disease in TRITON-TIMI 38. Circulation. 2008; 118(Suppl2):S967.2008-01-01T00:00:002008Cardiovascular outcomes of woman and men with acute coronary syndromes and angiographically confirmed epicardial coronary artery disease in TRITON-TIMI 38Authorship 1017739531250Kloner RA, Shook T, Antman EM, Cannon CP, Przyklenk K, Yoo K, McCabe CH, Braunwald ECirculationProspective temporal analysis of the onset of preinfarction angina versus outcome: an ancillary study in TIMI-9B. Circulation. 1998 Mar 24; 97(11):1042-5.Circulation1998-03-24T00:00:001998Prospective temporal analysis of the onset of preinfarction angina versus outcome: an ancillary study in TIMI-9B.9627532Seelig MS, Elin RJ, Antman EMThe Canadian journal of cardiologyMagnesium in acute myocardial infarction: still an open question. Can J Cardiol. 1998 May; 14(5):745-9.Can J Cardiol1998-05-01T00:00:001998Magnesium in acute myocardial infarction: still an open question.Antman EM, Muller J, Goldberg S, et alNew England Journal of MedicineNifedipine therapy for coronary spasm: experience in 127 patients. New England Journal of Medicine. 1980; 302:1269-1273.1980-01-01T00:00:001980Nifedipine therapy for coronary spasm: experience in 127 patientsAntman EMJ Behav TherFlooding in vivo for a case of vermiphobia. J Behav Ther. 1973; 4:275-78.1973-01-01T00:00:001973Flooding in vivo for a case of vermiphobiaAntman EM, Friedman PLRecent Advances in Cardiology. Rowlands DJ, ed."Digitalis Toxicity: Mechanisms, Manifestations, and Management". Recent Advances in Cardiology. Rowlands DJ, ed. 1987; 117-45.1987-01-01T00:00:001987"Digitalis Toxicity: Mechanisms, Manifestations, and Management"Antman EM, Loscalzo JIn: Fauci AS, Kasper DL, Longo DL, Braunwald E, Hauser SL, Jameson JL, Loscalzo J (eds). Harrison's Principles of Internal MedicineIschemic Heart Disease. In: Fauci AS, Kasper DL, Longo DL, Braunwald E, Hauser SL, Jameson JL, Loscalzo J (eds). Harrison's Principles of Internal Medicine. 2008; 1514-1527.2008-01-01T00:00:002008Ischemic Heart DiseaseFrelinger AL, Michelson AD, Braunwald E, Trenk D, Neumann FJ, Miller DL, Jakubowski JA, Cairns R, Murphy SA, McCabe CH, Antman EM, Wiviott SDCirculationComparison of the effects of prasugrel and high dose clopidogrel on in vivo and in vitro platelet activation: results from PRINCIPLE-TIMI 44. Circulation. 2008; 118(Suppl2):S814.2008-01-01T00:00:002008Comparison of the effects of prasugrel and high dose clopidogrel on in vivo and in vitro platelet activation: results from PRINCIPLE-TIMI 446378423White HD, Antman EM, Glynn MA, Collins JJ, Cohn LH, Shemin RJ, Friedman PLCirculationEfficacy and safety of timolol for prevention of supraventricular tachyarrhythmias after coronary artery bypass surgery. Circulation. 1984 Sep; 70(3):479-84.Circulation1984-09-01T00:00:001984Efficacy and safety of timolol for prevention of supraventricular tachyarrhythmias after coronary artery bypass surgery.1516188Antman EM, Berlin JACirculationDeclining incidence of ventricular fibrillation in myocardial infarction. Implications for the prophylactic use of lidocaine. Circulation. 1992 Sep; 86(3):764-73.Circulation1992-09-01T00:00:001992Declining incidence of ventricular fibrillation in myocardial infarction. Implications for the prophylactic use of lidocaine.11545753de Lemos JA, Morrow DA, Gibson CM, Murphy SA, Rifai N, Tanasijevic M, Giugliano RP, Schuhwerk KC, McCabe CH, Cannon CP, Antman EM, Braunwald EThe American journal of cardiologyEarly noninvasive detection of failed epicardial reperfusion after fibrinolytic therapy. Am J Cardiol. 2001 Aug 15; 88(4):353-8.Am J Cardiol2001-08-15T00:00:002001Early noninvasive detection of failed epicardial reperfusion after fibrinolytic therapy.11583910Fuster V, Rydén LE, Asinger RW, Cannom DS, Crijns HJ, Frye RL, Halperin JL, Kay GN, Klein WW, Lévy S, McNamara RL, Prystowsky EN, Wann LS, Wyse DG, Gibbons RJ, Antman EM, Alpert JS, Faxon DP, Fuster V, Gregoratos G, Hiratzka LF, Jacobs AK, Russell RO, Smith SC, Klein WW, Alonso-Garcia A, Blomström-Lundqvist C, De Backer G, Flather M, Hradec J, Oto A, Parkhomenko A, Silber S, Torbicki AJournal of the American College of CardiologyACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary. A Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation): developed in Collaboration With the North American Society of Pacing and Electrophysiology. J Am Coll Cardiol. 2001 Oct; 38(4):1231-66.J Am Coll Cardiol2001-10-01T00:00:002001ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary. A Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation): developed in Collaboration With the North American Society of Pacing and Electrophysiology.11739319Hunt SA, Baker DW, Chin MH, Cinquegrani MP, Feldman AM, Francis GS, Ganiats TG, Goldstein S, Gregoratos G, Jessup ML, Noble RJ, Packer M, Silver MA, Stevenson LW, Gibbons RJ, Antman EM, Alpert JS, Faxon DP, Fuster V, Gregoratos G, Jacobs AK, Hiratzka LF, Russell RO, Smith SCCirculationACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure): Developed in Collaboration With the International Society for Heart and Lung Transplantation; Endorsed by the Heart Failure Society of America. Circulation. 2001 Dec 11; 104(24):2996-3007.Circulation2001-12-11T00:00:002001ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure): Developed in Collaboration With the International Society for Heart and Lung Transplantation; Endorsed by the Heart Failure Society of America.11812067Antman EM, Cohen M, McCabe C, Goodman SG, Murphy SA, Braunwald EEuropean heart journalEnoxaparin is superior to unfractionated heparin for preventing clinical events at 1-year follow-up of TIMI 11B and ESSENCE. Eur Heart J. 2002 Feb; 23(4):308-14.Eur Heart J2002-02-01T00:00:002002Enoxaparin is superior to unfractionated heparin for preventing clinical events at 1-year follow-up of TIMI 11B and ESSENCE.12040334Becker RC, Spencer FA, Gibson M, Rush JE, Sanderink G, Murphy SA, Ball SP, Antman EMAmerican heart journalInfluence of patient characteristics and renal function on factor Xa inhibition pharmacokinetics and pharmacodynamics after enoxaparin administration in non-ST-segment elevation acute coronary syndromes. Am Heart J. 2002 May; 143(5):753-9.Am Heart J2002-05-01T00:00:002002Influence of patient characteristics and renal function on factor Xa inhibition pharmacokinetics and pharmacodynamics after enoxaparin administration in non-ST-segment elevation acute coronary syndromes.12075250Sabatine MS, McCabe CH, Morrow DA, Giugliano RP, de Lemos JA, Cohen M, Antman EM, Braunwald EAmerican heart journalIdentification of patients at high risk for death and cardiac ischemic events after hospital discharge. Am Heart J. 2002 Jun; 143(6):966-70.Am Heart J2002-06-01T00:00:002002Identification of patients at high risk for death and cardiac ischemic events after hospital discharge.12356646Gibbons RJ, Balady GJ, Bricker JT, Chaitman BR, Fletcher GF, Froelicher VF, Mark DB, McCallister BD, Mooss AN, O'Reilly MG, Winters WL, Gibbons RJ, Antman EM, Alpert JS, Faxon DP, Fuster V, Gregoratos G, Hiratzka LF, Jacobs AK, Russell RO, Smith SCCirculationACC/AHA 2002 guideline update for exercise testing: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). Circulation. 2002 Oct 01; 106(14):1883-92.Circulation2002-10-01T00:00:002002ACC/AHA 2002 guideline update for exercise testing: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines).12356647Braunwald E, Antman EM, Beasley JW, Califf RM, Cheitlin MD, Hochman JS, Jones RH, Kereiakes D, Kupersmith J, Levin TN, Pepine CJ, Schaeffer JW, Smith EE, Steward DE, Theroux P, Gibbons RJ, Alpert JS, Faxon DP, Fuster V, Gregoratos G, Hiratzka LF, Jacobs AK, Smith SCCirculationACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--2002: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). Circulation. 2002 Oct 01; 106(14):1893-900.Circulation2002-10-01T00:00:002002ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--2002: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina).12851606Murphy SA, Dauterman K, de Lemos JA, Kermgard S, Antman EM, Braunwald E, Gibson CMAmerican heart journalAngiographic and clinical characteristics associated with the development of Q-wave and non-Q-wave myocardial infarction in the thrombolysis in myocardial infarction (TIMI) 14 trial. Am Heart J. 2003 Jul; 146(1):42-7.Am Heart J2003-07-01T00:00:002003Angiographic and clinical characteristics associated with the development of Q-wave and non-Q-wave myocardial infarction in the thrombolysis in myocardial infarction (TIMI) 14 trial.14566308Cheitlin MD, Armstrong WF, Aurigemma GP, Beller GA, Bierman FZ, Davis JL, Douglas PS, Faxon DP, Gillam LD, Kimball TR, Kussmaul WG, Pearlman AS, Philbrick JT, Rakowski H, Thys DM, Antman EM, Smith SC, Alpert JS, Gregoratos G, Anderson JL, Hiratzka LF, Faxon DP, Hunt SA, Fuster V, Jacobs AK, Gibbons RJ, Russell ROJournal of the American Society of Echocardiography : official publication of the American Society of EchocardiographyACC/AHA/ASE 2003 Guideline Update for the Clinical Application of Echocardiography: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography). J Am Soc Echocardiogr. 2003 Oct; 16(10):1091-110.J Am Soc Echocardiogr2003-10-01T00:00:002003ACC/AHA/ASE 2003 Guideline Update for the Clinical Application of Echocardiography: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography).Cantor WJ, Goodman SG, Huang Z, Mahaffey KW, Das P, Gulba DC, Glezer S, Gallo R, Ducas J, Cohen M, Antman EM, Langer A, Kleiman NS, White HD, Chisholm RJ, Harrington RA, Ferguson JJ, Califf RMIn preparationBleeding complications in patients with acute coronary syndrome undergoing early invasive management may be reduced with radial access, smaller sheath sizes and timely sheath removal. In preparation. 2005.2005-01-01T00:00:002005Bleeding complications in patients with acute coronary syndrome undergoing early invasive management may be reduced with radial access, smaller sheath sizes and timely sheath removalLinefsky JP, Mahaffey KW, Pieper KS, Lin A, Reist CJ, Antman E, Goodman SG, French JK, Roe MT, Harrington RA, Ferguson, III, JJ, CaliffCirculationDifferences between site-reported and core laboratory creatinine kinase-MB values in an international clinical trial: results from the SYNERGY trial. Circulation. 2006; 114:II_417.2006-01-01T00:00:002006Differences between site-reported and core laboratory creatinine kinase-MB values in an international clinical trial: results from the SYNERGY trialAntman EMSupraventricular ArrhythmiasSupraventricular Arrhythmias. 1981.1981-01-01T00:00:001981Supraventricular ArrhythmiasAntman EM, Young EPrac CardiolInterpretation of P wave abnormalities on the electrocardiograph. Prac Cardiol. 1978; 4:104-16.1978-01-01T00:00:001978Interpretation of P wave abnormalities on the electrocardiographAntman EMAmerican Heart JournalMagnesium in acute myocardial infarction: Overview of available evidence. (5th European Magnesium Congress, Vienna, 1995). American Heart Journal. 1996; 132:487-95.1996-01-01T00:00:001996Magnesium in acute myocardial infarction: Overview of available evidence. (5th European Magnesium Congress, Vienna, 1995)Antman EM, Rutherford JDAcute Coronary Care in the Thrombolytic Era. Califf RM, Wagner G, Mark D, eds."The role of early beta blockade in the thrombolytic era". Acute Coronary Care in the Thrombolytic Era. Califf RM, Wagner G, Mark D, eds. 1988; 239-59.1988-01-01T00:00:001988"The role of early beta blockade in the thrombolytic era"Kelly RA, Antman EMJournal of Thrombosis and ThrombolysisPharmacological therapy of cardiac arrhythmias. Journal of Thrombosis and Thrombolysis. 1998; 6:211-38.1998-01-01T00:00:001998Pharmacological therapy of cardiac arrhythmias7402225Porterfield JG, Antman EM, Lown BThe New England journal of medicineRespiratory difficulty after use of disopyramide. N Engl J Med. 1980 Sep 04; 303(10):584.N Engl J Med1980-09-04T00:00:001980Respiratory difficulty after use of disopyramide.9329939Ware JH, Antman EMThe New England journal of medicineEquivalence trials. N Engl J Med. 1997 Oct 16; 337(16):1159-61.N Engl J Med1997-10-16T00:00:001997Equivalence trials.